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Abstract 
Shigellajlexneri strains are most frequentl y linked with endemic outbreaks ofshigellosis 
(bacillary dysentery). S.jlexneri invades the colonic and recta l epithelium of humans and 
non-human primates and causes severe ti ssue damage whi ch mani fests in a spectrum of 
clinical symptoms ranging from watery diarrhoea to severe dysentery. The overall aim of this 
study is to furth er our understanding of S.jlexneri pathogenesis by characteriz ing novel 
virulence facto rs and to characteri ze a new animal model of shigellosis. 
The first aim of this study is to further our understanding of the complex S. jlexneri infection 
process by characterizing the contribution of L-asparaginase (AnsB) and y-
glutamyltranspeptidase (GGT), to bacterial pathogenesis. These proteins are of particular 
interest as they are characterized virulence factors in a number of other enteropathogenic 
bacterial species including f-!elicobacter pylori and Escherichia coli. Both AnsB and GGT of 
S. jlexneri are immunogenic and have not been previously characterized for S. jlexneri. Using 
a reverse genetic approach we show that both AnsB and Ggt are required for bacterial 
adherence to host epithelial ce lls. In vivo studi es in both the Caenorhabditis elegans and the 
murine pulmonary model of shigellosis revealed that these genes contribute to S. jlexneri 
virulence. Differential in-gel e lectrophoresis showed that ansB and ggt mutations exert 
ple iotropi c effects on the express ion of a number of S. jlexneri genes, including prominent 
bacterial outer membrane proteins, OmpA and YaeT. T his is the first report in S. jlexneri 
where the functions of AnsB and GGT have been found to extend beyond their canonical 
metaboli c roles. The requirement of AnsB and GGT for the virulence of S. jlexneri makes 
these genes attractive candidates for des igning new therapeutic measures and preventive 
approaches to curb the spread of shigellosis. 
iii 
The second aim of this study is to identify bacteriophage genes that contribute to the 
virulence of S. jlexneri. S. flexneri strains are susceptible to infection by several temperate 
lambdoid bacteriophages. To date in S. jlexneri, the 0 -antigen modifying genes - the 
glucosyltransferase (gtr) cluster is the only set of bacteriophage genes that have been linked 
to bacterial pathogenesis. Studies in both Gram-positive and Gram-negative pathogens have 
identified bacteriophage genes that play a role in di ffere nt stages of bacterial pathogenes is; 
these findings warrant the need to study S. flexneri phages further. In this study the S. .flexneri 
phage Sfll was isolated from a highl y prevalent S.jlexneri serotype 2a strain and completely 
sequenced to identify novel bacteriophage-encoded genes. The complete Sfll genome 
sequences were analysed and compared to publi shed bacteriophage genomes. Although 
sequence analysis of the Sfll genome found similariti es w ith S. jlexneri bacteriophages, S fl, 
SfIY and SfV, the host ranges of all four phages were found to differ significantly. Homology 
searches of the predicted open reading frames of Sfll usi ng BlastX searches, identified, 4 1 
had assigned function s and 17 as hypothetical prote ins. Further studie£ designed to 
investigate the funct ions of these hypothetical proteins wi ll broaden our understanding of the 
molecular biology of S. jlexneri phages and potent ia ll y shed light on why S. jlexneri serotype 
2a strains are highly prevalent. 
While bacteriophage Sfll was being sequenced, uncharacteri zed genes in the sequenced S. 
jlexneri serotype-converting phage, SfV were studied to identify potential phage-encoded 
genes that play a ro le in the virulence of S.jlexneri. Reverse transcription PCR was used to 
determine the express ion of 15 uncharacterized, bacteriophage-encoded genes in an SN 
lysogenic strain grown at 37°C (S. jlexneri virulence genes are expressed at thi s temperature) . 
Us ing this approach, 12 uncharacterized, SN-encoded genes were identified as expressed in 
lysogenic strain , making them potential virulence facto rs. A mutant lysogenic stra in lacking 5 
iv 
of these expressed phage genes, or/28-32, was generated and the effect of this mutation on 
the virulence of the host strain was assessed. In vitro and in vivo virulence studies indicate 
that gc;nes within the SN or/28-32 five-gene cassette play a role in the virulence of the host 
strain. This is the first reported study to identify bacteriophage-encoded genes outside of the 
0-antigen modifying cluster that may enhance the virulence of S. jlexneri strains. 
The third aim of this study is to characterize C.elegans as a new small animal model of 
shigellosis. S.flexneri strictly infects human and non-human primate hosts consequently there 
is no simple intestinal animal model available. The lack of a relevant animal model of 
shigellosis has been one of the major impairments to vaccine development. In recent years 
the use of C. elegans as an animal model for several microbial diseases has been gaining 
momentum as these nematodes are extremely convenient animal models, as they are self-
fertilizing hermaphrodites with a rapid generation time. Here we have shown that virulent 
strains of Sflexneri are ingested by the nematode C.elegans and that S.flexneri cells invade 
the nematode intestinal cells. In order to further characterize S. flexneri infection in C. 
elegans we used 2-dimensional gel electrophoresis to compare the proteomes of nematodes 
infected with S.jlexneri and avirulent E.coli strains and successfully identified several 
differential expressed nematode proteins in response to S. flexneri infection. To further our 
understanding of the interactions between S.flexneri and C.elegans we used transmission 
electron microscopy (TEM) and proved for the first time that S. flexneri cells invade 
nematode intestinal cells. These findings are extremely significant as they provide further 
evidence supporting the use of C. elegans as a viable model to study shigellosis. 
V 
Publications 
D.T.George, Stephenson D., Tran E, Marona R. and N.K. Verma. 2013. 'Complete Genome 
Sequence of Sfll, a Serotype-Converting Bacteriophage of the Highly Prevalent Shigella 
jlexneri Serotype 2a'. GenomeA, September/October 2013 ;1 :doi: 1 O. l 128/gcnomcA.00626-
13. 
Publications under review 
D.T.George, Mathesius U., Behm C.A. and N.K. Verma, 2013 ' The periplasmic enzyme, 
AnsB, of Shigellaflexneri modulates bacterial adherence to host epithelial cells by regulating 
the expression of outer membrane protein A ', Submitted to PlosOne. 
D.T.George, Behm C.A, Hall D.A. , Mathesius U., Rug M. , Nguyen K.C.Q. and N.K. 
Verma, 2013 , 'Shigellaflexneri infection in Caenorhabditis elegans : Cytopathological 
Examination and Identification of Host Responses ' Submitted to PlosOne. 
Publication in preparation 
D.T.George, Mathesius U. , Behm C.A. and N.K. Venna, 2014 'Shigellaflexneri y-
glutamyltranspeptidase (GGT) activity required for bacterial virulence ', To be submitted to 
FEMS, Pathogen and Disease. 
vi 
2-DE 
aa 
AECOM 
AGM 
Amp 
AnsB 
ANOVA 
ANU 
bp 
BHK 
BRF 
BSA 
CAM 
CASS 
CDD 
CDS 
CFU 
Abbreviations 
2-dimensional gel electrophoresis 
amino acid 
Albert Einstein College of Medicine 
Advanced Microscopy Group 
ampicillin 
L-asparaginase 
Analysis Of Variance 
Australian National University 
base pairs 
Baby Hamster Kidney 
Biomolecular Resource Facility 
Bovine Serum Albumin 
Centre for Advanced Microscopy 
The CRISPR/Cas system 
conserved domain 
coding sequences 
Colony Forming Units 
vii 
CGC Caenorhabditis Genetics Center 
CIAP Calf-Intestinal Alkaline Phosphatase 
Cm chloramphenicol 
CMI cell mediated immunity 
CRISPR Clustered Regularly lnterspaced Short Palindromic Repeats 
CRP cyclic AMP receptor protein 
Ctx cholera toxin 
Dam DNA adenine methyltransferase 
DIGE Differential In-Gel electrophoresis 
DNA deoxyribonucleic acid 
DMF Dimethyl formamide 
EOP Efficiency of plaguing 
EAEC Enteroaggregative Escherichia coli 
ECVAM European Centre for the Validation of Alternative Methods 
EIEC Enteroinvasive Escherichia coli 
EPEC Enteropathogenic Escherichia coli 
ETEC Enterotoxigenic Escherichia coli 
FAE follicle-associated epithelium 
FCS Foetal calf serum 
viii 
GDAR Glutamate-Dependent Acid Resistance 
GGT gamma-glutamyltranspeptidase 
gtr glucosyltransferase 
HRP Horse radish peroxidase 
HSY Herpes simplex virus 
IEF Isoelectric focusing 
IFN interferon 
IL interleukin 
int integrase 
lpa invasion protein antigens 
IPTG iso-propyl-~-DD-thiogalactopyranoside 
IS insertion element 
Kb kilo base 
kDa kilodalton 
LB Luria-Bertani medium 
LC-MS Liquid chromatography-mass spectrometry 
LEE locus of enterocyte effacement 
LPS lipopolysaccharide 
M molar 
ix 
M cell microfold cell 
MAPK mitogen activated protein kinases 
MCS multiple cloning site 
MEM minimal essential medium 
mM millimolar 
MM minimal essential salts media 
Mwt Moleculat weight 
MYD88 myeloid differentiation primary-response protein 88 
NGM nematode growth medium 
NK natural killer 
oac 0-acteyltrensferase 
OD optical density 
OMV Outer Membrane Vesicle 
orf open reading frame 
nt nucleotide 
NLRs nod-like receptors 
NRT no reverse transcriptase 
NTC no template control 
PAGE polyacrylamide gel electrophoresis 
X 
PAI 
PAMPs 
PBS 
PCR 
PDK-1 
PEG 
PFU 
PMK-1 
PMN 
PRRs 
PVDF 
qRT-PCR 
RBS 
RdRP 
REML 
RFX 
RISC 
RNA 
ROS 
pathogenicity island 
pathogen-associated molecular patterns 
phosphate buffered saline 
polymerase chain reaction 
phosphoinositide-dependent kinase l 
polyethylene glycol 
plaque forming units 
p38 MAPK family member 1 
polymorphonuclear cell 
pathogen recognition receptors 
polyvinylidene fluoride 
quantitative real time reverse transcriptase polymerase chain reaction 
ribosome binding site 
RNA-dependent RNA polymerase 
restricted maximum likelihood 
regulatory factor X 
RNA-induced silencing complex 
ribonucleic acid 
reactive oxygen species 
xi 
RT-PCR reverse transcriptase polymerase chain reaction 
Rpm revolutions per minute 
SEK-1 SAPK/ERK kinase 1 
SDS sodium dodecyl sulphate 
SGK-1 semm/glucocorticoid-regulated kinase I 
T3SS type three secretion system 
TBE Tris-Borate-EDTA buffer 
TCA trichloroacetic acid 
TCP toxin-coregulated pilus 
TDso the time taken to kill 50% of the initial population 
TE Tris-EDT A buffer 
TLRs toll-like receptors 
UPRm' mitochondria-specific unfolded protein response 
U.V. Ultraviolet 
V volts 
WHO World Health Organization 
WRAIR Walter Reed Army Institute of Research 
X-Gal 5-bromo-4-chloro-3-indolyl-~-D-galactopyranoside 
xis excisionase 
xii 
Table of Contents 
Declaration ....... . 
Acknowledgements ... • ..................... . .. .. ... .... 11 
Abstract. ......... . . .. ... ............ . . . . ........ . . . .......... 111 
Publications ....... .. . ...... .. . ... .. . .. . ...... . .. . .. .. .. .... ..... . .... .. .. ..... ... ........ .... . ... ........ v1 
Abbreviations .. .Vil 
Chapter 1: Introduction ................................... .. .. .. ..................................... 1 
1.1 Shigellosis ................................................... ...... . .... . ........... .. ............ 2 
1.2 Epidemiology of Shigellajlexneri .......... ...... . ... . .. . . . ... .. ... . ... . .. ... . .. . .... . ... .... 2 
1.3 Pathogenesis of Shigellajlexneri .......... . ....... ..... ... . ...... . .. ... . .. .. ....... ... . ...... 3 
1.3.l Crossing the epithelial barrier..... .. ...... . .. .. .. .... .. ... . ...... .... .. ......... 5 
1.3.2 Macrophage apoptosis ...................................... . . . ..... . 
l.3.3 Bacterial adherence and invasion of epithelia l cells ......... ........ .... .... .... 6 
1.4 Host immune responses to S.jlexneri ...... . . . .. ............. ... .......... . ........... ....... 8 
1.4.1 lnnate immune response ............. .......... .... .................................. 8 
1.4.2 Humoral immune response ............. . . ... . ... .. .. . . . ..... , .... ...... .. .. . . ...... ... I 0 
1.4.3 Cellular immune response ..... . .............. .... . ...... .. .... . . .. ...... . ............. 11 
1.5 Virulence genes of S.jlexneri ..... .. .............. ..... ....... ... .. ......... .. ................. 12 
1.6 Shigella vaccine development. ............................... ........ ..... .. .................... 13 
1.7 
1.6.1 Serotype-specific Shigella vaccine candidates .... ... . . ..... . .... . . . .. . . . . ..... ... 16 
l.6 .2 Conserved antigen vaccines .. . 
Bacteriophages ... ..................... .. . 
1.7.1 
1.7 .2 
1.7.3 
Temperate phages ........ ....... .... . 
Lambdoid phages ................... . 
Bacteriophages and bacterial pathogenesis. 
. .... ... 16 
. ......... 18 
.. ...................... 19 
.. . ... ... .. .. . . .. .. .. . ........ . .. ...... 2 1 
. ................... 21 
1.7.4 Bacteriophage-encoded virulence factors in prominent enteric pathogens .. . 22 
1.7.4. 1 Vibrio cholerae .... ............................. .... .......... .. .. ........... 22 
1.7.4.2 Pathogenic E.coli ...... .......... .. .. 
1.7.4.3 Salmonella spp . ..... . 
24 
. .. 25 
xiii 
J .7.4 .4 Shigella spp ........... · ....... .. .. .. .. ............ ..... .. ....... ............ 26 
1.8 In vitro and in vivo models of shigellosis .. .. 26 
l.9 Caenorhabditis elegans as an in vivo model to study host-pathogen interactions ..... 27 
1.9.1 C. elegans anatomy and lifecycle . ...... . . . .... .. .. ... . ...... . .. .. ........ .... . ...... 29 
l.9.2 The C. elegans intestine ................ ....... . . ......... .. . . .. . ...... .... .. . ...... 31 
l.9 .3 Immune responses in C. elegans.... .. ............................... . ........ 33 
1.9.3 .1 The intestinal epithelial layer and pathogen resistance .................. 33 
l.9.3 .2 Innate immunity in C. elegans is TLR-independent. .................... 34 
l.9.3.3 The p38 mitogen-activated protein kinase pathway (MAPK) . .. . ... .. .. 35 
l. 9.3.4 The insulin signaling pathway ............................................. 35 
1.9.4 Us ing RNA in terference to study the function of C. elegans genes ............ 38 
1.9.4.1 The mechanism of RN Ai in C. elegans ........... .. . .. . .. . . . ......... ..... 38 
l.9.5 Caenorhabditis elegans as an in vivo model for shi gellosis .............. . ...... 40 
I.IO Objectives of thesis ............ .. .. .... ...... .... .. ........... .. ........ .. .. .................. .4 1 
Chapter 2: Materials and methods ....... . ..................................................... . .. .43 
2.1 Bacterial cu lture condi tions and media . ............ . .. ....... .. . . . ... .......... .. ........ .44 
2.2 Bacterial strains and plasmid vectors ........ .. . ... ... .. .. ..... . . .. .. .. .. . .... ....... . ..... .44 
2.3 DNA methods ............ .............. .............................. .. . .... .. . . . . ........... .49 
2.3.1 Iso lation of plasmid DNA by Alkaline lys is .. ........................ . .......... 49 
2.3.2 Isolation of plasmid DNA using the Axygen mini prep Spin kjt.... ...50 
2.3.3 Determination of DNA concentration ........................ ... . . . ........ ....... 50 
2.3.4 DNA separation and purificat ion by electrophoresis .. .. . . ... . . . . . .... .. .. .. .... 51 
2.3.4. 1 Agarose gel electrophoresis ................... .... . ........................ 5 1 
2.3.4.2 DNA purification form agarose gels ....... . . .. ...... . ...... ... ..... 51 
2.3.5 Seq uencing and polymerase chain reaction (PCR) .............. .. . .. .. .. .. ...... 51 
2.3.5.1 Primer design .................................. . .. . .. . ... . . .... .. . ........... .. 5 1 
2.3.5.2 Sequencing reaction and purification .... .. .... 57 
2.3.5.3 Sequence analysis ....... ... . . . ....... .... . . . . .... ......... .. 57 
xiv 
2.4 
2.3.6 PCR ampl ification of genes ........ ......... ... . . . ........... . . ..... 58 
2.3.6.1 Colony PCR ............................. . 
Cloning techniques and DNA manipulations . . . 
.58 
..59 
2.4.1 Restriction enzyme digestion ................ . .. . .. ... . .. .... .......... ..... ... . .. . .. 59 
2.4.2 Dephosphorylation of DNA 5'-termini ..... .. . . ..... . .. . . . . . .... .. ................. 59 
2.4.3 Ligation reactions ..... .. ........... ... ... .... ...... .. . .. ...... .. ..... .. . . .. .......... 60 
2.4.4 Transformation of DNA into competent ce lls ....... . ........... ... ........ ...... 60 
2.4.4.1 Preparation of electrocompetent ce lls .... . .. .. ... . ... ...... ... .. .. . . ..... 60 
2.4.4.2 Determining the efficiency of competent cells ................... .. .. .. 61 
2.4.4.3 Transformation of DNA into electrocompetent cells ................... 61 
2.5 Screening techniques for cloned plasmids and gene disruption mutant strains ........ 62 
2.5. l Antibiotic selection ....... . . ... . . . ..... . . . . . ... ... ... . .. . . .... ... .. .. ... .. ... ... ....... 62 
2.5.2 Blue-white screening ............... . .... . ....... 62 
2.6 PCR Lambda red recombinase gene disruption in S. jlexneri strains ........... ..... .. 63 
2.6.1 Generat ing knockout templates carrying antibiotic cassettes flanked 
by regions of homology to target genes of interest. .. . ............... . . . .. .. 63 
2.6.2 PCR transformation into red-recombinase induced strains ........ .. .... .. ..... 64 
2.7 Characterization of gene disruption mutants ....... . .. . .. . . .. .. .. .. . . . . .. . ... . .. . . ........ 67 
2.7.1 Growth curves ............................ . .... 67 
2.7.2 Measurement ofasparaginase and glutaminase activity ........... . ... . . . ........ 67 
2.8 RNA methods ................................... . . ..................... .... .................... 68 
2.8.l Isolat ion of total bacterial RNA ..... ....... ............... .. . . .. . . .... . .......... 68 
2.8.2 Reverse transcription polymerase chain reaction .................... . .. .. ...... 69 
2.8.3 Quantitative real time reverse transcriptase PCR (qRT-PCR) .. .............. 69 
2.9 Protein methods ........................................ . .. .............. .................. . 70 
2.9.1 l-D SOS-PAGE and western blotting ............... . .. . ... ...... . ....... . . ..... 70 
2.9 .1.1 Preparation of whole cell lysates .. ......... . . . . ............ .. ... . .. ..... 70 
2.9.1.2 Isolation of secretory proteins....... . ............... . 
2.9.1.3 ID SOS- PAGE gel preparation and electrophoresis .. . 
70 
.7 1 
xv 
2.9. 1.4 Coomass ie staining of SDS-PAGE gels ..... . ............. . .. . .... ... .. 7 1 
2.9.1.5 Western blotting .......... . . . . ... . .. . 73 
2.9 .2 Differenti al in gel electrophoresis (DIGE) and liquid chromatography 
mass spectrometry 
(LCMS) ........................ .. .. .. ... .. ............. . . .. . ..... ........... .. .. . ......... . .. ........... 73 
2.9.2.l 
2.9.2.2 
2.9 .2.3 
2.9 .2.4 
Iso lation of total bacterial protein for different ial in gel electrophoresis .. 73 
2-D electrophoresis . ... . . . .. .. . ..... .. . .. . . ... ........... .. ... . . ...... .... .. . ...... 75 
Ge l imaging and image analysis .... . .. . .. .. ........ .. ...... ..... ... . .. .. .. .. . . . . 75 
ln gel trypsin digestion of protein spots and LC-MS .. . ... . .. . 76 
2.10 Cell culture . ... ... .. .. .. ... . ....... . .. . . .... . .... 77 
2.1 0.1 Subculturing cells ........... . . ... . ... . . .. .. .. . . . . .. .. .. . .. .... .... .... 77 
2.10.2 Counting cells with a haemocytometer ................................. . ........ 78 
2.10.3 Preparing bacterial inoculums for in vitro cell cu lture assays .... . . ......... 78 
2.10.4 Preparing BHK monolayers for in vitro cell culture assays . ..... ...... . ..... 79 
2.10.5 Invas ion Assay ........... . ........... ... ...... . . .............. . . ............ . . ...... 79 
2.10.6 Bacterial adherence assay .. . . ....... .. . .. ... . ... . .. ........... . .. 8 1 
2.10.7 Covers lip adherence assay ......... .. . .. . ....... . .... ..... .. .... . . . . . .. . . . .. .. . ... 8 1 
2.11 Mouse studi es .. . .. . . . ..... 81 
2.11. l in vivo studies : mouse pulmonary model. .............. . . .......... 82 
2.11.2 Monitoring infec ted mice .... . ..... ... . .. . .. .. ... .... .. .... . . .. ... ............... 82 
2.12 Bacteriophage techniques ... . ....... . ..... ..... . ...... . .. .. . .... .. . . . . . ... . .... ... ... ..... 83 
2.12 . l Propagation of bacteriophage ...... . . .... . .... .. . ...... . .... . .. . ... .. ... . . . . . ..... 83 
2.12 .2 T itration of phage .. ...... ......................... ... ............. .. .. .. .. ....... . 84 
2.12.3 Purification of bacteriophage . .. . ... ... .. . 
2.12.4 Isolation of bacteriophage DNA ......... . 
. .. 84 
. .... 85 
2.12.5 Determining bacteriophage host range . .... . ...... . .. . .... . ... .. . . . . ... . ... . ..... 86 
2.13 C. elegans techniques ........ .. ... . .......... . . . .. . ..... . .. .. . . . .. .. ...... ... . ....... 86 
2.13. l C. elegans strains and growth conditions .. .. . . .. . . . . .. . . . . . . .. . .. . .. . . . . . . . . . . 86 
2. 13.2 E. coli strains ......... ... ......... . . . ..... .... 87 
2. 13.3 Obtaining a synchronized population of young adult Nematodes . .. . ... . ... . 87 
xvi 
2. 13.4 Liquid killing assays .................. . 
2.13.5 C.elegans bacterial accumulation assays .. . 
............. 87 
.. .. 88 
2.13.6 Isolation ofTotal Nematode RNA .. .. .... .... .. ........ ... ........ .. .. .. ......... 89 
2.13.7 qRT-PCR of nematode mRNA .................. .... .. .... .. ........ .. .... .. ..... 90 
2.13. 7.1 Primer design for qRT-PCR ... . .... . .......... .. ... .. .. ... . . . . . . . ....... 90 
2.13.8 Isolation of Total Nematode Protein .... ... 90 
2.13.9 RN Ai Experiments ... ..... .. . ... . .... . .... ..... .... . . . ...... .. . .. .. . .. . . ........ 91 
2.13.9. l RN Ai constructs ........ .. .... .. .. .91 
2.13.9.2 Feeding protocol for RNA interference (RN Ai) in C.elegans ..... . 92 
2.13. LO Microscopy of C. elegans ............. ............ ................................ 94 
2.13.10.1 Fluorescence microscopy ............. .. ....... .... .. .. ... .... .... ...... 94 
2.13.10.2 Electron Microscopy .............. . ............ . .......... .. ............ 94 
2.14 Statistical ana lysis ...... .... ......... .... ........ .. ... . . . . .... .. .......... .. .............. 95 
Chapter 3: Characterizing the role of L-asparaginase (AnsB) and y-
glutamyltranspeptidase (GGT) in the virulence of Shigella flexneri.. .. ................... . 97 
3. 1 
3.2 
Introduction .. 
Results .. .. 
.. .... ............ 98 
. .............. 100 
3.2.1 lnsertional inactivation of ansB and ggt in the wi ld type S. jlexneri serotype 3b ... LOO 
3 .2.2 Assessing the expression and secretion of !pa proteins ........................ . . .. ...... I 02 
3 .2.3 Physiological characterization of ansB and ggt mutations in S. flexneri ...... ........ l 04 
3.2.3 .1 Confirming the expression ofansB and ggt in SFLl520 grown in vitro ...... l 04 
3.2 .3.2 Measuring the effects of ansB and ggt mutations 
on cellul ar asparaginase and glutam inase activities ....... 
3.2.3.3 Effects of ansB and ggt mutations on bacterial growth .. 
3.2.4 Virulence studies ...................... .. ..... ...... .. 
3.2.4.1 in vitro Virulence Assays ..... . 
104 
106 
. .. 109 
109 
3.2.4.1. 1 Bacterial adherence assays .. 
3.2.4. 1.2 Coverslip adherence assays 
3.2.4.2 in vivo Virulence Assays ... 
.. .... .. .. ............... 109 
.................. .. .. ... ...... .. l 09 
.. ...... .. . .. . .. . .... .. .... .. .. ... .. 111 
xvii 
3.2.4.2. l C. elegans bacterial accumu lation assays ...... .. .. . .......... ..... . . ... 11 I 
3.2 .4.2.2 C.elegans liquid killing assay ...... . .......... .. ... .............. . ..... 113 
3.2.4.2 .3 Murine pulmonary model of shigellosis .. .... .. ........ .. ... .. . .. ..... 113 
3.2.5 Identification of changes in the S. /lexneri proteome caused by 
ansB and ggt mutations ............................ . ........ . . ...... 116 
3.2.5.1 qRT-PCR to confirm DIGE analysis .... . . ....... 121 
3.2.5.2 Western blots to compare YaeT expression in 
wild type and 1'1ggt cell. ........ .. . ...... 123 
3.2 .5.3 Overexpression of OmpA in SFL1520 and increased 
expression ofYaeT in the 1'1ggt strain . ..... ....................... ... .. .. .. .... ....... 125 
3.2.5.3.1 in vitro adherence assays of SFL2443 and SFL2444 .. .... . 127 
3.2.5.3.2 in vivo C.elegans bacterial accumulation assays of 
SFL2443 and SFL2444 ... . ........................... .. ... . . ... .. . ........ 127 
3.2 .5.3 .3 Morphology of 1'1ansB and 1'1ggt cells ........ .. . . . . . . . . . . . .... 130 
3.3 Di scussion .. .................... 132 
3.3.1 AnsB and GGT aid S.jlexneri adherence to host cells, 
in an lpaB-independent manner. .. . ... . .. ... . . . .. . . ... .. . .... .. . .. .. ..... . . .. . . 132 
3.3.2 AnsB and S. jlexneri adherence .... ........... . .. .. . .. . . . . .. . . . ......... 133 
3.3.2. 1 Metabolic activity of AnsB and bacterial viru lence ....... .. . .......... 133 
3.3.2.2 Up-regulation of OmpA in ansB mutants, 
and defective adherence .............. . . . .. ... . . . ... .... . . . ..... . .. . .. ............... .. 134 
3.3.3 GGT and S.jlexneri adherence ..................... ... . ........... . .. . . . .......... 136 
3.3.3.1 Metabolic activity of GGT and bacterial viru lence ......... .... ....... 136 
3.3.3.2 Differential expression ofYaeT (BamA) in ggt mutants 
and defecti ve adherence ...... . . . ..... .. . .. ...... . .. .. ... ...... .. .... . ... ... .... .. .. 137 
3.4 Conclusion ..... ...... .. . ..... . . .... ............. . . .. .. ... ........ . .. .... .. .. . . . ...... . .. ....... 138 
Chapter 4: Determining the complete genome sequence of S. jlexneri bacteriophage, 
Sill and the identification and characterization of potential bacteriophage, SIV-encoded 
virulence factors ........... ... . ...... ........ ....... ............. ... .. .. ............... .. .. .. .......... 140 
xviii 
4.1 
4.2 
Introduction .. . .. 
Resu lts .. ............ ......... ... ... .. . .... .. .. .. .. . .... . ... . 
4.2.1 Complete Genome Sequence of Sfll: a Serotype Converting 
. ... 141 
. ... 144 
bacteriophage of the highly prevalent, Shigellajlexneri serotype 2a . .. .. . . . ... .. . ... 144 
4.2.1.1 Sequencing bacteriophage Sfll ... . .. .. .... ........ . . .. . ... ... .... . . . . .. .. 144 
4.2.1.2 Overview of the Sfll genome .. .. . ... . ....... . .. ............ .... . .. .. .. ... 144 
4.2 .1 .3 Alignments of bacteriophage Sfll with lambdoid phage genomes .. . 146 
4.2. 1.4 Al ignments of the coding regions of bacteriophage Sfll 
and Sflexneri phages Sfl, SflV and SN .................. .. ..................... 153 
4.2.1.5 Comparing the host ranges of S jlexneri phages, Sfll and SN ...... 153 
4.2 .2 Identification and characterization of potential bacteriophage 
SN-encoded viru lence factors .................................................... .......... 156 
4.2.2 .1 Lysogenization of wild type S jlexneri serotype Y by bacteriophage 
Stv, increases bacterial virulence .. . ...... . ................................ . ..... 158 
4.2.2 .1.1 SN genes enhance the adherence and invasion of 
S jlexneri serotype Y in vitro ................ . .. . .. -· .. .. . . . . . 158 
4.2.2. l.2 SN genes increase the accumu lat ion of Sjlexneri 
serotype Yin the C elegans intestinal lumina .... ... . .......... .... .... 15 8 
4.2.2 . 1.3 SN genes increase S. jlexneri serotype Y-medi ated 
kil lingofC elegans .. .. ... ...... .. .... . .... ................ . ........ ... ... 16 1 
4.2.2.2 ldentification of potential Stv genes that contribute to 
the virulence of its host.. .. ..... . ... ..... . . ...... .. . . . . . ...... 161 
4.2.2.3 Disruption of the SN orj28-32 gene cluster in SFLl 87 1 . .. .. ....... 165 
4.2.2.4 Knocking out or/28-32 increases the adherence of 
SFL 187 l in vitro but decreases invas ion .......... . ............... ... . .. .. . ... .. 167 
4.2 .2.5 The expression of genes within the SN oif28-32 gene cluster is 
required for accumulation of SFLJ 87 1 in C elegans . . . . . . . . . . . . .. . . . . . 169 
4.2.2.6 The expression of genes within the SN or/28-32 gene cluster is not 
required for ki lling of C elegans .. 17 1 
xix 
4.3 Discussion .................... ...... ................. . . ... .. .. ..... . . . . . . ... . .. . .. . . ..... . . .... 171 
4.3.1 Complete Genome Sequence of Sfll . . .. . .. ... . .. .......... .. ........... . ... .. .. .. 171 
4.3.1.1 DNA packaging....... . . . . . . .. . . .. . . . ........... .. ................ 173 
4.3.1.2 Structural proteins .. . ............ . ............ . ...... . .. .. . ................ 174 
4.3.1.3 0-antigen modification .................. . . .. . . . ... . . . . . . . . . . . . ........... 176 
4.3.1.4 Early Regulatory elements in Sfll ... . . .. . ..... . .. . .. . ...... .. .. .. ....... l 76 
4.3 .1.5 DNA Replication ...... ..... . ...... .......... ......................... . . . . .. 177 
4.3. 1.6 Late Regulatory elements in Sfll .. .. . ... ................. . .. ....... ...... 178 
4.3.1.7 Genes unique to Sfll .............................................. ... .... 178 
4.3.2 Characterizing cryptic Stv genes and the identification of nove l 
SN-encoded viru lence factors ...................... . ...................... .. ......... 179 
4.3 .2. I Lysogenization of wild type S. jlexneri serotype Y by 
Stv, increases the virulence of the host strain ........................ . .......... 179 
4.3.2.2 Uncharacterized SfV genes expressed in the Stv lysogen ........... 180 
4.3 .2.3 Construction of orf28-32 knockout mutant, SFL2500 ..... . . .. ...... 183 
4 .3.2.4 Predicted role of SfV Orfs28-32 in bacterial hosts . . ......... .. . ..... 183 
4.3.2.4. l orf28 encodes a putative DNA-binding protein that could 
negatively regulate host gene expression . .. . ....................... . ....... 184 
4.3.2.4.2 orj29 encodes a hypothetical protein that may be involved in 
RN Ai -based immunity ............ ...... ..... . .. .... . ..... ................... 185 
4.3 .2 .4.3 or/30 encodes a putative phosphodiesterase that may regulate 
host viru lence by modulating oxidative stress responses .................... 187 
4.3.2.4.4 01j]1 and orf32 encode hypothetical protein with unknown 
functio ns ............. .. . . ..... . . . . ...... .. . . . . . . . . ... . . . ....... .. . . ...... ... . . ... 188 
4.4 Conclusion .... .. ..... . .. . .. . . .. .... . . .... .. ........... .... 188 
Chapter 5: Characterizing a new animal model for shigellosis- C. elegans ........ ....... 190 
5.1 Introduction ................. . . ....... .... . .. ........ .. ... . .. .... . .... .. . . . . . ... . ..... . . .. .... 191 
5.2 Results .. 
. ...... .. . .. .. .. .... . . ... .. . . .. . .. . . . . .. .... . l93 
xx 
5.2. l Wild type S. jlexneri serotype 3b kills C. elegans and killing requires the 
expression of bacterial virulence plasm id-encoded genes .......... .. ...... 193 
5.2.2 Wi ld type S.flexneri accumulate in the nematode intestinal lumen .......... 195 
5.2.3 lntraluminal S. flexneri cells produce outer membrane vesi cles (OMVs) and 
invade the C.elegans intest inal epitheli al cells ........ .. . .. . . ........... .... 197 
5.2.4 Other phenotypes observed in the cytopathological examination of in fected 
nematodes using transmission electron microscopy (TEM) .......... .... 199 
5.2.4. 1 Worms infected with wi ld type S. jlexneri for 24 hours display 
symptoms of fluid imbalance in the in testinal epithelial ce lls ..... .. ... . 199 
5.2 .4.2 infected worms retain embryos and show accumulation of 
cytoplasmic yolk granules......... .. ... . ...................... ... ... 204 
5.2.5 Identification of nematode responses to S.jlexneri infection using two-
dimensional differential in-gel electrophores is ........... . ................ . .. ... 207 
5.2.5. 1 Confirming the results of DlGE analys is using quantitative real -
time reverse transcription PCR (qRT-PCR) ............ .. . ...... 210 
5.2.5.2 RNAi-mediated knockdown of aco-1 , cct-2, .daf-19 
and hsp-60 ..... .............................. . ... .... ...... . ... . ..... . 212 
5.2 .5 .3 Effect of silencing S. jlexneri-induced host response genes on 
nematode survival. ...................... .......... .. ... ..... .. . . . ... .. 212 
5.2.5.4 Effect of silencing S.jlexneri-induced host response genes on 
bacterial accumulation ....................... .. .. ...... . .... .... .. .. . 2 14 
5.2 .6 Nematode proteins predicted to be induced by S.jlexneri infect ion using DIGE 
and low stringency MASCOT search parameters.. ..... . ........ . .. .. 2 16 
5.2.6. 1 Detennining the change in expression of HSP-6, a nematode protein 
predicted to be up-regul ated in response to S. jlexneri infect ion , using 
low stringency MASCOT search parameters ...... . .. .. .. . .. . . . . .. .. ... 221 
5.3 Discussion . .. ................................... .... ......................................... 223 
5.3.1 Virulent S. jlexneri cells ingested by C. elegans evade pharyngeal grinding, 
accumulate in the nematode intestinal lumen and invade the intestinal cells ......... 224 
xxi 
5.3.2 S.jlexneri infection potentiall y causes osmotic imbalance in nematode 
intestinal ce ll s .... 
5.3 .3 S. jlexneri in fec tion in C. elegans causes embryo retention and/or 
. ..... 227 
defective egg laying....................... . . . ........... .. ... ... . ... ... . . . .. . . . . ... . .. . .. 228 
5.3.4 Limitations ofTEM analysis .. . ...... .. ................. .... . . . .. ... ...... 229 
5.3.5 F irst study to scan the proteome of S. jlexneri infec ted worms . ................. 229 
5.3.6 S. jlexneri disrupts iron homeostasis in the nematode intestinal cells by altering 
AC0-1 levels, potentially inducing a hypoxic response resulting in death . . ....... .. . 230 
5.3.7 Innate immune responses triggered by CCT-2 and OAF- I 9 .. .. .. .. . ............ 23 1 
5.3.8 Up-regulation of HSP-60 and HSP-6 in response to S.Jlexneri infection, 
indicates the activat ion of the mitochondrial unfo lded protein stress response ...... 233 
5.4 Conclusion .. .. ... . .. . . . . ... .. .. . . .. .. . . . .. . ... .. . . ...... ... ...... . ...... . .. . .. . ... . ... . . . .. .. ... 234 
Chapter 6: General discussion ................... .................... .............................. 235 
6.1 AnsB and GGT novel Shigella virulence factors ........ . .. ...... . .. .. . .... .. .. .. .. .. . .. ..... 237 
6. 1.1 AnsB up-regulates OmpA expression ........ . . .. 237 
6. 1.2 GGT modul ates extracellular glutathione levels and therefore maintains the redox 
potential of the extracellular and periplasmic compartments ... .. ... ... ......... ....... ... ... .... .... ... 240 
6.1.3 Future work ................ . . . . . ...................... . . . ..... . . . .. . .. . . .. .. .......... . . . . .... . 244 
6.2 Bacteriophage-encoded genes in host pathogenes is .. .... .... . .. ....... ... ... . .. .. .. ......... 246 
6.2 .1 Future work . ... . .................. .. . . . .............. . .......... . ... ...... ........... 248 
6.3 C. elegans as a model for shigellosis .... ........ . . ..... 249 
6.3.1 Nematodes ingest S. jlexneri and bacteri al cells invade the intestinal 
epithelial ce ll s ............. . .. .. ... .............. ...... . ....... . ... .. .. ................ .. .. 250 
6.3 .2 S.Jlexneri virulence factors required for infection of mammalian tissue are 
also required for virulence in C. elegans . .. ..... ... .. .. ................ .... .. .. . ...... 250 
6.3.3 S. jlexneri infection induces the MAPK signaling pathway in 
mammalian cells and C.elegans ...... ........................... ...... ..... .. ....... ... . 251 
6.3.4 S.jlexneri causes mitochondrial dysfunction in humans and nematodes, 
xxii 
which leads to necrotic cell death ................. . ........................ .. ... . ..... .. .. 252 
6.3.5 S.flexneri infection triggers an inflammatory response in humans and 
nematodes that causes tissue damage and osmotic imbalance .. . ... . ........ . . . . .. ... 252 
6.3.6 Future work ............................. . .. ..................... .... ....... .... . . . ..... 253 
Appendix A Buffers, solutions and media ....... .. . ..... .......... .. . .... ............. . . . .. . .. . . . 257 
References ........ . . . .. .. . ... . . ... . . . ... . . .. .. .. .. .. . . .. ....... . .. .. . . .. . . . . .. . .. . . . . . . . . .... 265 
xxiii 
Chapter 1 
Introduction 
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Chapter 1: Introduction 
1.1 Shigellosis 
Shigellosis, also known as bacillary dysentery, is a food-borne illness caused by the enteric 
bacterium Shigella . Shigel/a cells invade the colonic and rectal epithelium ofhwnans and 
non-human primates and cause severe tissue damage which manifests in a spectrum of 
clinical symptoms ranging from watery diarrhoea to severe dysentery; characterized by fever, 
abdominal cramping and bloody, mucoid stool [ 1]. Shigella species are commonly found in 
water contaminated with human faeces and are transmitted via the faecal-oral route. 
1.2 Epidemiology of Shigellajlexneri 
Shigella species belonging to the family Enterobacteriaceae, are Gram negative, non-spore 
forming, facultative anaerobes that are believed to have evolved from multiple Escherichia 
coli strains [2]. The genus is subdivided into four recognized species: S.jlexneri, S. 
dysenteriae, S. boydii, and S. sonnei [3] . Each species is further divided into serotypes based 
on differences in the structural and functional properties of their 0-antigen, a component of 
the bacterial lipopolysaccharide (LPS) [4] . 
The 0-antigen backbone of all serotypes except serotype 6, is composed of repeating units of 
the rhamnose-rhamnose-rhamnose-N-acetylglucosamine tetrasaccharide. S. jlexneri cells with 
this basic 0-antigen structure are recognized as serotype Y. Differences between the 
serotypes are conferred by the addition of bacteriophage-encoded glucosyl and/or 0-acetyl 
groups to different sugars within the basic tetrasaccharide repeat unit [5] . More recently, 
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phosphorylated variants of the 0-antigens of serotypes 4a, X and Y called 4av, Xv and Yv 
have been reported [6, 7]. These variants carry a phosphoethanolamine (PEtN) group on 
rharnnose II or III [6, 7). There are currently l 9 recognized serotypes of S. jlexneri (Figure 
I.I) [7-14) . Sero-diversity has been one oftbe leading impediments to Shigella vaccine 
development as each serotype elicits a specific immune response. 
The World Health Organization (WHO) estimated that 165 million people are infected with 
Shigella annually, with over I million deaths per annum [15]. Shigellajlexneri strains are 
most frequently associated with endemic outbreaks of shigellosis in developing countries 
[16]. S.jlexneri is highly contagious with only as few as 10-100 bacterial cells required for 
infection [ 17). The increasing global burden of shigellosis due to the numerous mechanisms 
the bacterium bas evolved to evade human defense responses and the rapid emergence of 
multi-drug resistant strains, has resulted in the World Health Organization prioritizing the 
need to develop an effective vaccine against S.jlexneri [15]. 
1.3 Pathogenesis of Shigellajlexneri 
Shigel/a invades the colonic and rectal epithelia of human and non-human primates in a 
complex multi-step process. This results in an acute inflammatory response which culminates 
in severe epithelial tissue damage. Destruction of the epithelial layer leads to the clinical 
symptoms of abdominal cramping, diarrhoea, and bloody, mucoid stool typical of shigellosis 
[l]. The process of colonic invasion and destruction is outlined in Figure 1.2 and discussed 
stepwise in the following sections. 
3 
Serotype Y 
a. Glucosylation i b. Acetylation c. Phosphorylation 
Serotype1a i • 
Serotype1b ~ 
.. r Serotype4av 4 [J 
serotype 2a a!J Serotype 3a 1111!! 
... 
Serotype2b a! 
' 
Serotype3b 
serotype4a Serotype4b 
r SerotypeXv 
' 
... 
---
1.3 
SerotypeYv I 1 -,2 
-r -,"" ~45% 
serotype 5a Serotype7b ~ 
Serotype 5b 
" 
I 
SerotypeX 
" 
- Rhamnose 
Serotype1c 
- l 
serotype1d 
-
" 
aJil 
.-., N-acetlyglucosamine 
• Glucosyl group 
• 0-acetyl group 
A phosphoethanolamine group 
Figure 1.1: Serodiversity in S. jlexneri. Diagrammatic representation of the chemical 
composition of the different serotypes of S.jlexneri. The basic 0-antigen (Serotype Y) 
consists of repeating units of the rhamnose-rhamnose-rhamnose-N-acetylglucosamine 
tetrasaccharide. Serotypes differ by the addition of either glucosyl (a), o-acetyl (b) or 
phosphoethanolamine (c) groups to different sugars within basic tetrasaccharide unit via 
linkages as indicated. 
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1.3.1 Crossing the epithelial barrier 
The apical surfaces of host colonic epithelial cells are well protected by microvilli bearing 
filamentous brush border glycocalyx which prevents the entry of pathogens. To overcome 
this ban-ier, S. jlexneri cells exploit the transcytotic properties of host microfold (M) cells to 
enter the underlying sub-epithelial pocket [ 18] . M cells are specialized epithelial cells in the 
follicle-associated epithelium (FAE), that sample and transport luminal antigens across the 
epithelial ban-ier into au intraepithelial pocket (formed by the basolateral membrane of the M 
cells). Trauscytosed antigens are taken up by macrophages and lymphocytes occupying the 
intraepithelial pocket ofM cells and initiate a mucosa! immune response [19]. S.jlexneri 
cells induce uptake into M cells by causing membrane ruffling to form an endocytic vacuole, 
which transports bacterial cells into the M cell. The same mechanism is used during invasion 
of epithelial cells [20]. Internalized S. jlexneri cells degrade the endocytic vacuole and are 
released into the intraepithelial pocket of M eel ls. 
There have been reports suggesting that Shigella cells may also manipulate tight-junction 
associated proteins between epithelial cells to gain access to the sub-epithelial space [21]. In 
the later stages of infection, Shige!la exploit the host ' s inflammatory response to increase 
bacterial entry into the sub-epithelial space. 
1.3.2 Macrophage apoptosis 
Within the intraepithelial pocket ofM cells, Shigella are engulfed by resident macrophages, 
however bacterial cells escape macrophage attack by triggering macrophage apoptosis. 
Apoptosis is induced by the virulence plasmid encoded invasion protein antigens (Ipa), 
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particularly IpaB [22). Macrophage apoptosis releases Shigella cells into the sub-epithelial 
space. 
Infected macrophages release pro-inflammatory cytokines IL-18 and IL-1~ through the 
activation of capsase-1 [22). The released IL-1~ recruits polymorphonuclear (PMN) cells to 
the site of infection. PMN cells penetrate through the epithelial barrier to reach bacterial cells 
in the intestinal lumen and in the process destabilize the integrity of the epithelial barrier. 
This allows lumenal bacteria access to the sub-epithelial space. Shigella cells in the sub-
epithelial space now have access to the less-protected, basolateral face of epithelial cells [23 , 
24]. 
1.3.3 Bacterial adherence and invasion of epithelial cells 
Shigella cells released into the sub-epithelial space adhere to the basolateral surfaces of 
colonic epithelial cells which is followed by bacterial invasion, intra and intercellular spread. 
Adherence to host tissue is a prerequisite for bacterial infection. The molecular mechanisms 
that govern Shigella adherence to host tissues have not yet been fully characterized. Previous 
studies have reported that bacterial cells use the type three secretory (T3SS) apparatus, 
particularly the Ipa proteins to preferentially bind to host receptors expressed on the 
basolateral side of epithelial cells. These receptor proteins include a5~1 integrin, to which the 
secreted IpaB-C-D complex binds [25] , and CD44, a major cell surface receptor of 
hyaluronic acid to which IpaB binds [26]. 
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Figure 1.2: Schematic representation of the main steps invo lved in Shigel!a pathogenesis. 
(!) Shigel/a crosses the epithelial barrier by transcytosis through microfold (M) cells. The 
bacteria also manipulate tight junctions between epithelial cells to gain paracellular access to 
the sub-mucosa. 
(2) S.jlexneri cells in the sub-mucosa are engulfed by macrophages. Shigella evades 
macrophage attack by induci11g macrophage apoptosis resulting i.n the secretion of 
pro inflammatory cytokines, interleukin I~ (IL I~) and IL-1 8. 
(3) Free Shigella cells invade the epithelial cells through their basolateral side by the 
secretion of effector proteins through the type-ill secretion system (T3SS). Bacteria enter the 
epithelial cytoplasm and spread to adjacent cells by the active polymerization of actin. 
( 4) Invasion of epithelial cells triggers the NFKB-mediated up-regulaticm of interleuki.n-8 
(IL8) production and secretion. 
(5) Proinflammatory signals produced by apoptotic macrophages and infected epithelial cells 
attract polymorphonuclear neutrophil (PMN) cells to the site of infection. The influx of PMN 
disintegrates the epithelial lining, which initially exacerbates the infection and tissue 
destruction by facilitating the invasion of more bacteria. 
(6) IL-18 produced by apoptotic macrophages activate natural killer (NK) cells and T cells to 
produce interferon y (IFN-y) which in turn activates a protective immune response involving 
macrophages and fibroblast cells. 
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After adhering to the basolateral membrane of epithelial cells, Shigella cells inject effector 
molecules into host cells through the T3SS. These effector molecules induce host cytoskeletal 
rearrangement to fonn macropinocytic pockets that engulf adherent bacterial cells into the 
host cell cytoplasm [27]. Skoudy and colleagues have identified the host Ezrin proteins 
belonging to the ERM family (ezrin-radixin-meosin) as important factors that are required for 
this cytoskeletal rearrangement [28]. Mammalian cells expressing a dominant negative fonn 
ofEzrin show reduced S.jlexneri invasion [28]. As in the case of macrophages, IpaB 
facilitates the lysis of epithelial macropinocytic vacuoles resulting in the release of the 
pathogen into the epithelial cell cytoplasm. 
In the cytoplasm, non-motile Shigella cells replicate and spread to adjacent cells by the active 
polymerization of actin via a polarly expressed IcsA protein [29]. In this manner S. jlexneri 
is able to multiply and spread within the intestinal epithelial layer whilst avoiding exposure to 
the extracellular environment and it's circulating immune cells. Bacterial invasion and 
intracellular multiplication culminates in epithelial cell damage which generates the clinical 
symptoms of watery diarrhoea, severe abdominal pain and cramping and bloody mucoid stool 
characteristic of shigellosis. 
1.4 Host immune responses to S. jlexneri 
1.4.1 Innate immune response 
Colonic epithelial cells act as a primary line of defense by providing an impermeable physical 
barrier to invading pathogens. The renewal of host epithelial cells is an important i1mate 
defense response that prevents bacterial colonization. Iwai et al. indicate that the Shigella 
effector protein IpaB, when injected into epithelial cells, down-regulates host cell cycle 
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proteins which limit epithelial cell renewal [30].The [paB-mediated cell cycle arrest 
contributes to the efficient colonization of host cells. This suggests that Shigella influences 
epithelial cell renewal in order to promote bacterial colonization of the intestinal epithelium. 
Epithelial cells secrete antimicrobial peptides such as def ens ins (like HBD-1) and 
cathelicidins (like LL-37) in response to inflammation and infection at mucosa! surfaces [31 , 
32]. Intestinal epithelial surfaces are thus covered with a mixture of antimicrobial peptides 
[33]. Islam et al, have shown that early in infection, Shige!la cells down-regulate the 
expression of antimicrobial peptides HBD-1 and LL-37 to escape this innate immunes 
response [34]. They proposed that the down-regulation of these antimicrobial peptides 
promotes bacterial adherence and invasion. 
Once S. .flexneri cells cross the host epithelial barrier and invade the epithelia l cells, their 
pathogen-associated molecular patterns (PAMPs) are recognized by various host pathogen 
recognition receptors (PRRs), including toll-like receptors (TLRs) and nod-like receptors 
(NL Rs) [35-41]. Detection of P AMPs induces host innate signaling pathways, including 
those mediated by NF-KB and the mitogen activated protein kinases (MAPK) [ 42-45]. The 
activation of these pathways results in the secretion of pro-inflammatory cytokines, 
chemokines and antimicrobial peptides. The severe inflammation which is characteristic of 
shigellosis has been associated with the up-regulation of several cytokines including IL- IP, 
IL-6, IL-8, IL-18, TNF-a, TNF-P, TGF-p and IFN-y [46]. More recently IL-22 , IL-17 A and 
IL-l 7G have been identified as first responders to S. .flexneri infection [ 47] . IL-18 released by 
apoptotic macrophages activates NK cells and T cells to produce rFN-y (Figure 1.2.6), a 
chemokine that plays an essential role in the early protection by activating macrophages and 
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fibroblast cells with increased bactericidal activity [ 48, 49]. S. jlexneri virulence plasmid-
encoded OspF, OspG and IpaH4.5 have been shown to suppress the production of cytolanes 
by interfering with the activation of the NF-KB and MAPK signaling pathways [50-53] . 
Although the pro-inflammatory responses may be responsible for the increased entry of 
bacterial cells into the sub-epithelial space, they are also important for the control and 
containment of infection. 
1.4.2 Humoral immune response 
Several serological studies of humans and animal experiments following natural infection and 
vaccination have revealed that Shigel/a-specific immunity is characterized by the induction of 
a humoral response. This humoral response is the major component of protective immunity 
against shigellosis. Bacterial LPS is the key antigenic factor that activates both systemic and 
mucosa! immune responses [54-56]. Protective immunity provided by the host antibody 
response to Shigella is serotype specific as previous infection or vaccination offers little or no 
protection against infection by heterologous serotypes [57-59]. This suggests that a large 
proportion of the hum oral response is directed to the 0-antigen, the serotype-specific 
determinant of the LPS. Antibodies against Ipa proteins are also produced after natural and 
experimental infection and are believed to contribute to protection [54, 60, 61]. Antibodies 
produced in response to Shigella infection have complement-mediated bactericidal activity 
[62] and promote opsonophagocytic killing by mononuclear cells [63] . 
Mucosa! slgA and serum IgG have been implicated in generating serotype-specific immunity 
against Shigella [64, 65]. The strong serotype-specific SlgA and serum IgG responses to 
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Shigella infection correlates with protection data from epidemiological and sero-
epidemiological studies [66, 67]. It has long been debated whether protective immunity is 
predominantly due to mucosa! slgA anti-0-antigen antibodies, by serum IgG antibodies or by 
both. Strong mucosa! slgA anti-0-antigen antibody responses have been observed post wild 
type infection and experimental challenge [54, 68-73]. Other studies have identified serum 
IgG anti-0-antigen antibody response, as key elements of the protective immune response 
[74-76]. Additional research is needed to define the roles of intestinal slgA and serum IgG 
antibodies in mediating protection against Shigella. 
1.4.3 Cellular immune response 
In comparison to other intracellular bacteria, very little is known about cell mediated immune 
(CMI) responses to Shigella. This is largely due to the absence of a natural mouse infection 
model for shigellosis. In vitro studies have shown that Shigella antigens can activate T cell 
responses [77-79]. In vivo studies using the murine pulmonary model of shigellosis have also 
shown that T and NK eel ls play a critical role in clearing Shigella [ 49]. Islam et al. have 
previously reported that Shigella induces the cellular activation ofT and B cells in infected 
patients [80]. More recently Thi 7 has been identified to play a role in the adaptive response 
to Shigella infection [81]. In addition to these findings, the cytokines induced during Shigella 
infection, particularly IL-18 produced by apoptotic macrophages, are known to induce both 
Thi and Th2 lymphocyte responses [82 , 83] . The increased frequency and severity of 
shigellosis in AIDS patients (deficient in CD4+ T cells) furtl1er suggest that a CMI response 
provides protection against shigellosis [84-86]. 
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1.5 Virulence genes of S. flexneri 
Several S. flexneri virulence genes that are required for bacterial invasion and colonization of 
intestinal cells have been identified in chromosomal pathogenicity islands (PAD (Table 1.1) 
and on the large virulence plasmid of S. flexneri (Table 1.2). Given the S. jlexneri genome is 
remarkably similar to £. coli (the sequence divergence between the two is only about 1.5% 
[87]), it is not unusual that the majority of S. flexneri virulence genes lie on the 220 kb 
virulence plasmid which is unique to Shigella and essential for pathogenesis [88]. 
The core region of the virulence plasmid, !mown as the entry region, is conserved between S. 
jlexneri serotypes. This region covers 31 kb of the plasmid and carries 34 genes required for 
pathogenesis. The genes in the entry region are organized into two clusters that are 
transcribed in opposite directions. Based on their functions, genes in the entry region are 
further categorized into four groups ; effector proteins secreted by the T3SS (Ipa proteins), 
proteins required for the assembly and secretion ofT3SS effector proteins (Mxi/Spa 
proteins), chaperone proteins (Ipg proteins) and finally proteins required for the transcription 
of virulence plasmid genes (VirB and MxiE) [89]. The expression of genes in the entry region 
is under the tight control of a regulatory network, which responds to environmental changes 
encountered upon bacterial entry into hosts such as temperature shift to 37 °C, changes in pH, 
osmolality and iron levels [90-92]. 
Chromosomally-encoded factors , such as VirR and OmpR-EnvZ, are the initial elements of 
the regulatory cascade that sense and react to environmental changes. These proteins then 
induce the expression of virulence plasmid-encoded transcription activators, VirF, VirB and 
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MxiE. Gene expression from the virulence plasmid destabilizes the plasmid, resulting in high 
rates of plasmid loss. It is therefore critical to monitor strains for the maintenance of 
virulence plasmids. The common approach to monitor the presence of the virulence plasmid 
is to grow cells on Congo red agar plates, components of the virulence plasmid bind to Congo 
red and result in red pigmentation in the colonies [93]. A PCR based detection method is also 
used to confirm the presence of the virulence plasmid using prin1ers designed to amplify 
distinct regions of the plasmid [94]. 
1.6 Shigella vaccine development 
Advances in our understanding of the pathogenesis of S.jlexneri and the identification of 
several virulence factors have led to the development of multiple vaccine candidates. 
However a commercially viable Shigella vaccine still eludes us. Several factors are 
responsible for the slow pace of Shigella vaccine development. The lack of a relevant small 
animal model of shigellosis and serotype-specific immune responses elicited by Shigella 
strains have been the leading impediments to vaccine development. Over the past five years, 
despite these obstacles, substantial progress has been made in Shigella vaccine development. 
The most recent Shigella vaccines can be broadly categorized into two groups; serotype-
specific vaccines or conserved antigen vaccines. Recent advances in Shigella vaccine 
development over the past five years have been outlined in Table 1.3. 
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Table 1.1: Chromosomal virulence genes of S .. flexneri adapted from (89] 
PAI 
SHl-1 
SHl-2 
SHI-0 
SRL 
Gene 
sigA 
picA 
set/A , set /B 
iucA to iucD, iutA 
gtrA, g trB , gtr1ype 
fecA to fecE,fecl, 
f!cR 
Biochemical activi!l' 
lmmunoglobulin A-like cytopathic 
protease 
Serine protease, mucinase 
Enterotoxin ShETI 
Role in virulence 
Intestinal fluid accumulation, cytopathic toxin 
Mucus permeabilization, serum resistance, 
Hemagglutinat ion 
Intestinal fluid accumulation, development of watery 
diarrhoea 
Siderophore (aerobactin) production and Iron acqui siti on 
transport 
Modification of O antigens, serotype Evas ion of host immune response 
conversion 
Ferric dici trate uptake Iron acq ui sition 
Reference 
[95, 96] 
[96, 97] 
[98, 99] 
[100-1 02] 
[5] 
[103, 104] 
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Table 1.2: Virulence plasmid-encoded virulence genes of S. flexneri 
Gene 
virA 
virF 
virB 
virG (icsA) 
icsB 
icsP 
mxi/spa locus 
ipaA 
iP,aB 
ipaC 
ipaD 
ipaH 
Biochemical activi!r 
Cysteine protease 
Positive regulation of virB and virG 
Positive regulation oflpa and mxi-spa locus 
Active polymerization of act in 
Serine protease 
Encodes type 3 secretion system (T3SS) 
Vinculin activation 
Membrane fusion 
Actin polymerization 
Effector protein 
E3 Ubiquitin ligase 
Role in virulence Reference 
Facilitates entry and intercellular (105, I 06] 
spread by degrading microtubules 
Adherence, invasion and intracellular [ I 07, I 08] 
spread 
Adherence, invasion and intracellular [ I 09] 
spread 
Inter and intracellular spread [29] 
Protects lcsA by preventing -- [ I I 0-112] 
autophagic recognition 
Cleavage oflcsA, modulation of [] 13, 114] 
actin-based motility 
Invasion - (115] 
Efficient invasion, actin cytoskeleton [ I 16] 
rearrangements, disassembly of 
cell-matrix adherence 
Control of type 3 secretion, - · [117] 
translocon formation, phagosome 
escape, macrophage apoptosis 
Translocon formation, filopodium [118] 
formation, phagosome escape, 
disruption of EC tight junctions 
Regulates secretion oflpa proteins and [119] 
insertion of IpaB and lpaC into host 
cells 
Assists in escape from macrophage [ 120] 
vacuole. Host cell transcriptome 
modulation, 
reduction of inflammation 
15 
1.6.1 Serotype-specific Shigella vaccine candidates 
Serotype-specific vaccines are designed to stimulate acquired immunity and serotype-specific 
protection. This category of vaccines include live attenuated strains, killed whole cell 
formu lations, conjugate vaccines (composed ofO-antigen molecules conjugated to a protein 
carrier) and genetically engineered 0-antigen protein fusions. Live attenuated vaccine 
candidates are generated by mutating virulence and metabolic genes required for bacterial 
invasion and survival. These vaccines introduce a repertoire of Shigella antigens to the 
mucosa! immune system and elicit a strong serotype-specific response. Live attenuated 
Shigella vaccine candidates have been shown to induce protective immunity against virulent 
challenge in volunteer studies [69, 121] . The main limitation of live attenuated vaccines has 
been achieving the right balance between safety and immunogenicity. A number oflive 
attenuated Shigella vaccine strains have been engineered to carry mutations in critical 
metabolic genes required for bacterial survival within hosts, such as the guaBA, iuc, msbB2 
and aroA-D genes (Table 1.3). Shigella virulence and toxin genes including virG, sen and six, 
have also been used as attenuation targets to design live vaccine candidates. The 
identification of new Shigella virulence factors will help us bridge the gap between the safety 
and irrununogenicity of live attenuated vaccines. 
1.6.2 Conserved antigen vaccine candidates 
Conserved antigen vaccines are designed to provide heterologous protection against multiple 
serotypes of Shige!la. These vaccines comprise of purified virulence factors expressed across 
multiple serotypes such as the lpa proteins, outer membrane proteins-OmpA and IcsP (Table 
1.3). The most promising conserved antigen vaccine has been the lnvaplex vaccine developed 
at the Walter Reed Anny Institute ofResearch. lnvaplex is a complex of purified LPS and lpa 
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Table 1.3: Recent advances in Shigella vaccine development: Vaccines candidates developed in the past five years 
Vaccine Candidate Descrietion Develoemental stage Route Reference 
Live attenuated vaccines 
S. dysenteriae I CVD 1256 !';.guaBA, /';.sen, /';.stxA , /';.virG Preclinical Oral (122] 
S. sonnei WRSs2, 3 /';.virG, /';.senA, /';.senB, /';.msb82 Preclinical, non-human primate Oral [123-125] 
S. flexneri 2a SC602 /';.virG, /';.iuc Phase 1- 11 Oral [126] 
S. jlexneri 2a WRSf2G 11 , 12, 15 /';.virG, /';.senA, /';.senB, /';.msbB2 Preclinical Oral (127, 128] 
S. dysenteriae 1 WRSd I /';.virG, /';.stxAB Phase I Oral [129] 
S. enterica serovar Typhi strain Ty2 I a-Ss Salmonella Ty2 I a strain stably expressing Preclinical, murine pulmonary Intraperitoneal [130] 
S. sonnei LPS model 
Con.i!!.gate vaccines 
GlycoVaxyn bioconjugate S. dysenteriae I LPS-exoA Phase I Parenteral (131] 
Synthetic oligosaccharide 0-antig_~n 
-
mimic- tetanus toxoid Pree I inical Parentera l [132,_133] 
- -- -- - -- ---- -Conserved antigen vaccines 
Purified !pa proteins S. jlexneri 2a lpaB plus lpaD Preclinical Intranasal (134, 135] 
GMMA vesicles Outer membrane and Preclinical Intranasal [136] 
periplasmic proteins 
Conserved proteins JcsP, SigA Protein fragments Preclinical Mucosa! [137] 
lnvaplex LPS plus lpaB, lpaC and lpaD Phase II Intranasal (138, 139] 
OMV Purified non-capsulated and capsulated Preclinical, murine pulmonary Oral and (140-142] 
OmpA OMV model Intranasal 
OmpA Preclinical , murine pulmonary Intranasal [143] 
model 
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proteins (IpaB, IpaC and IpaD) which has been shown to be immunogenic after intranasal 
delivery in human volunteers [138, 139). Although conserved antigen vaccines are safe and 
provide broad-spectrum protection, they suffer from lower immunogenicity and generally 
require adjuvants to boost the immune response. 
1. 7 Bacteriophages 
The tem1 bacteriophage has been derived from "bacteria" and the Greek "phagein " meaning 
to devour, as bacteriophages are the natural predators of bacteria. Bacteriophages are widely 
distributed in locations populated by bacterial hosts such as soil , sea water and the intestines 
of animals [144-146). Bacteriophages are the most abundant organisms on the planet and are 
believed to outnumber bacteria by an estimated ten-fold [147) . Thus bacteria are faced with 
the constant threat of bacteriophage predation as a result of which bacterial host and 
bacteriophages are involved in cycles of constant co-evolution. 
Bacteriophages have genetic material either in the form of DNA or RNA encapsulated in a 
protein coat, known as the capsid, which protect the genetic material and enables transfer 
between host cells. Bacteriophages possess the unique ability to laterally transfer genes 
between bacteria. This property plays a major role in bacterial evolution and increased 
pathogenicity [ 148-150). A great majority of bacteriophages carry dsDNA and are 
responsible for the intraspecific genomic diversification in bacteria [151 , 152). This 
diversification is largely due to bacteriophage induced rearrangement of the host genome and 
the lateral transfer of bacterial genes. 
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1.7.1 Temperate phages 
Based on their lifecycle, phages are divided into two basic classes : virulent and temperate 
phages. Virulent phages adopt a simple lifestyle known as the lytic cycle, that encompasses 
adsorption to host cells, penetration, phage multiplication and culminates in host cell rupture 
with the release of phage particles (Figure 1.3.A). Temperate phages adopt a more complex 
lifecycle with two reproductive options; the lytic and lysogenic cycles. Temperate phages can 
either reproduce lytically as virulent phages or they may remain as 'symbionts ' within the 
host cells through the lysogenic pathway (Figure 1.3.B). Temperate bacteriophages achieve 
this by incorporating their DNA into the host genome to form prophages, as a consequence of 
which the phage genetic material is replicated by the host (now known as a lysogen), for 
several generations. 
An important outcome of lysogeny is lysogenic conversion, where temperate bacteriophages 
induce changes in the phenotype of the host. Lysogenic conversion often involves alterations 
in the surface characteristics of the host to prevent further infection by other bacteriophages. 
Lysogenic conversion has also been found to provide selective advantages to prophages by 
increasing their virulence (discussed further in Section 1.8.3). When faced with unfavorable 
conditions such as ultraviolet (UV) radiations and chemical mutagens that damage DNA, 
prophages enter the lytic cycle and bacteriophage particles are released from lysogenized host 
cells. 
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Figure 1.3: Lifecycle of temperate bacteriophages. The lifecycle of temperate 
bacteriophages is characterized by two cycles; the lytic (A) and lysogenic (B). Both cycles 
begin with phage absorption to its receptor on the bacterial cell wall , penetration of the cell 
wall and insertion of phage DNA into host cells. A: During the lytic cycle, injected phage 
DNA directs the host to produce multiple copies of phage protein and DNA. Empty phage 
heads are assembled and packed with DNA following which the collars, tail sheath and fibre 
proteins are assembled to produce mature phage particles. Bacterial cells are lysed and 
infectious phage particles are released. B: During the lysogenic cycle, injected phage DNA is 
incorporated by the activity of phage-encoded integrase protein into the bacterial 
chromosome becoming a prophage, phage DNA is replicated along with the host DNA 
producing daughter cells carrying the prophage. Replication of the prophage continues 
/indefinitely along with cell division. The prophage can be induced of spontaneously excised 
from the bacterial genome and proceed along the lytic pathway. 
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1.7.2 Lambdoid phages 
Lambdoid phages are a group of closely related temperate phages of enteric bacteria that 
resemble bacteriophage lambda (1c), one of the most extensively studied bacteriophages 
[153]. Lambdoid phages share a common genetic map with A and lysogenize bacterial hosts 
by site-specific recombination [ 154]. All lambdoid pbages have lifecycles similar to 
bacteriophage A wherein, linear double stranded phage DNA injected into infected cells either 
circularizes and enters the lytic pathway or gets incorporated into the host chromosome and 
follows the lysogenic pathway with the concurrent repression of lytic functions. 
S. jlexneri strains are susceptible to infection by several temperate Jambdoid bacteriophages 
and the serotype-specific 0-antigen modifications in S.jlexneri are brought about by the 
temperate bacteriophage-encoded glucosyltransferase (gtr) gene cluster [5]. To date six 
serotype converting bacteriophages: SfI [155], Sil [156] , Sf!V (157], SN [158], SfX. (11 , 
159] and Sf6 [ 160] have been isolated and studied. Lysogenization of these phages bas been 
shown to convert serotype Y strains to serotype la, 2a, 4a, Sa, X, and 3b, respectively. The 
genetic organization of these serotype converting phages is conserved and their genomes 
share high sequence similarity with bacteriophage A in their head assembly and DNA 
packaging genes and their tail genes resemble a Mu-like Myovirus [5] . Apart from 0-antigen 
modification, little is known about the molecular biology of these temperate serotype 
converting phages of S. jlexneri. 
1.7.3 Bacteriophages and bacterial pathogenesis 
The notion that bacteriophages-encoded factors that enhance bacterial virulence has been 
around since 1927 when Forbisher and Brown discovered that non-toxin producing 
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Streptococci acquired the ability to produce the scarlatina! toxin 011 exposure to filtered 
supematants oftoxigenic strains [161]. We now know that the supematants carried 
bacteriophages encoding the scarlatina! toxin gene and the investigators were in fact 
describing transduction; the process by which bacteriophages transfer genes between related 
bacterial species. This discovery has led to the widespread acceptance of the hypothesis that 
bacteria acquire virnlence properties through lysogenic conversio11. Advances in sequencing 
technologies have led to a massive increase in the number of sequenced bacterial genomes. 
Analysis of these genome sequences, particularly in pathogenic bacteria, has revealed that I 0-
20% of several bacterial genomes consist of prophage DNA [ 148, 162]. Over the years 
several bacteriophage-encoded virulence factors from a range of morphologically diverse 
bacteriophages, have been identified and implicated in all stages of bacterial pathogenesis 
including; adherence, colonization, resistance to host defense responses and the production of 
exotoxins (Table 1.4). 
1.7.4 Bacteriophage-encoded virulence factors in prominent enteric pathogens 
1.7.4.1 Vibrio cholerae 
The cholera toxin (Ctx) is the only known toxin produced by V cholerae and the production 
of this exotoxin is one of the main pathogenic mechanisms responsible for the severe watery 
diarrhoea following bacterial invasion of the small intestine. Cholera toxin up-regulates 
adenylate cyclase (an enzyme that catalyzes the conversion of ATP to cAMP) activity within 
human intestinal cells. The up-regulation of this enzyme results in profuse watery diarrhoea 
[163], which is widely assumed to contribute significantly to the fecal-oral transmission of V 
cholerae [164]. Cholera toxin is encoded by the filamentous bacteriophage CTX-~ [165]. The 
delivery of the cholera toxin requires successful colonization of the small intestine by V 
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Table 1.4: Bacteriophage-encoded bacterial virulence factors 
Bacterial property 
altered 
Exotoxin Production 
C. botulinum 
C. diphtheria 
E. coli 
E. coliEPEC 
P. aeruginosa 
S. dysenteriae 
S. aureus 
V. cholerae 
Colonization/adhesion 
E.coli 
P. aer11ginosa 
S. mitis 
V. cholerae 
lnvasion 
E.coli EPEC 
S. enterica 
S. pyogenes 
S. aureus 
Increased intracellular 
survival 
E.coli 
S. enterica 
S. pyogenes 
E.coli 0157 
Altering antigenicity 
P. aeruginosa 
S. enterica 
S.J!...exneri 
Botulinum toxin 
Diphtheria toxin 
The Shiga toxin 
cdt l toxin 
Proteins or phenotype 
Pseudomonas cytotoxins 
Shiga toxins 
Staphylococca l enterotoxins, exfoliative toxins and 
toxic shock syndrome toxins 
Chol era toxi n 
The /om gene promote ad hesion to bucca l epithelial 
cells 
Phage FIZI 5 promotes adhes ion to buccal epithelial 
cells 
Pb lA and PblB, surface protein that promote adhesion 
to platelets 
TCP-l'_i lus 
Type 3 secretion system effector proteins 
Type 3 secretion system effector proteins 
Hyaluronidase 
Fibrinolysin 
The bar gene promotes surviva l in animal serum, 
SodC protein, a superox ide dismutase 
NanH, Neuramin idase 
Lysogeny up-regu lates antiphagocytic M protein 
SodC protein, a superoxide dismutase 
0-antigen modifying enzymes 
0-antigen modifying enzymes 
0-antigen modifying enzymes 
Phage Cl 
~-phage 
933, H-1 9B 
CDT-lcj, 
CTXcj, 
Bacteriophage 
933W, H-1 9A 
cj,Mu50A,cj, 13,cj,3 15 
CTXcj, 
,_ 
FlZ l 5 
SM-I 
VP I <I> 
Lambdoid prophages 
SOPcj,, Gifsy-1, Gifsy-2, Gifsy-3 , ST64B 
H4489A 
<1>13 
,_ 
Gifsy-2 , Fies- I 
Fies- I 
? 
Sp4, -10 
D3 
e•' 
Sfll , SN, Sil , SfX, Sf6 and SIIV 
References 
[166] 
[167, 168] 
[169, 170] 
[171] 
[172] 
[173] 
[174-179] 
[1 80] 
[181-183] 
[184] 
[185, 186] 
[1 87] 
[188-192] 
[193-196] 
[197] 
[176, 198] 
[199] 
[200-202] 
[203] 
[152] 
[204] 
[205,206] 
[157] 
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cholerae, which is mediated by toxin-coregulated pilus (TCP) [207-209] . TCP, encoded by 
bacteriophage VP I~ [21 OJ , is another recoguized virulence factor of V cholerae. TCP 
mediates bacterium-bacterium interactions that promote microcolony formation. These 
interactions are required for bacterial attachment and colonization of host cells [201]. 
Therefore the acquisition of phage-encoded ctx and lcp genes are crucial events in the 
evolution of pathogenic V cholerae. 
I. 7.4.2 Pathogenic E. coli 
E. coli strains are widely distributed commensals that are known to colonize the human gut. 
Several £. coli strains such as Enterotoxigenic E. coli (ETEC), Enteropathogenic E. coli 
(EPEC), Enteroinvasive E. coli (EIEC) and Enteroaggregative E. coli (EAEC) have been 
identified to be pathogenic, causing a range of infections in humans and animals [211]. The 
versatility between E. coli strains is largely on account of genomic diversity between strains 
and bacteriophages are known to be one of the major sources of this diversity as they 
facilitate the acquisition of virulence genes by horizontal gene transfer [152]. Several 
prophage-encoded virulence factors from a range of temperate bacteriophages have been 
identified in pathogenic strains of E.coli including, the shiga-toxins Stxland Stx2 (encoded 
byphages 933 and Hl 9-B, respectively) [169, 212] , the cdtl toxin (encoded by the cdtl<jl 
phage) [ 171], the !om and bar genes, from bacteriophage ').. that are required for adherence 
and serum resistance [181-183 , 199] and sod, encoding superoxide dismutase (encoded by 
phages Sp4, -10) required for survival within host cells. Furthermore, genes encoding effector 
proteins of EPEC including tccP [188], nleA-F [189], nleH [190], espL2 [191] and cif[192] 
have also been identified to be encoded by lambdoid prophages. It has been suggested that 
the acquisition of these prophage-encoded virulence factors plays a critical role in the 
conversion of non-pathogenic E. coli strain to food-borne pathogenic strains [213]. 
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1. 7 .4.3 Salmonella spp. 
Virulence and host adaptation in Salmonella is influenced by a multitude of genes, many of 
which are encoded by bacteriophages. As in the case of Shigella spp, the invasive properties 
of Salmonella enterica, require the T3SS, which inject effector proteins directly into the 
cytoplasm of host cells [214]. SopE is one of these effector proteins which, on injection into 
host cells, activates human Rho GTPases and contributes to the invasion of Salmonella [194, 
215]. GogB, Ssel, SspH I and SseK3 are other T3 SS effector proteins that have been found to 
be involved in epithelial cell uptake [ 196, 202, 216, 217]. The genes encoding effector 
proteins SopE, GogB, Ssel and SspHl are all located on temperate Salmonella phages Sopcji 
[218] , Gifsy-1 [216], Gifsy-2 [217] and Gifsy-3 [202], respectively. 
Following epithelial cell invasion, Salmonella preferentially localizes to Peyer ' s patches and 
the gipA gene ( encoded by bacteriophage Gifsy-1) has been found to be required for the 
survival of Salmonella cells in this environment [195]. Lysogeny by temperate phages thus 
contributes to the virulence of Salmonella by promoting bacterial uptake in intestinal cells 
and survival within infected Peyer ' s patches. 
Additional examples of bacteriophage-encoded virulence factors in Salmonella are the 0-
antigen modifying, gtr genes encoded by E45 [206, 219], superoxide dismutase, SodC proteins 
(encoded by bacteriophages Gifsy-2 and Fels-1) that protect bacterial cells against stress 
[220, 221] and neuraminidase (NanH) encoded by bacteriophage Fels-I [202]. 
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1.7.4.4 Shigel/a spp. 
Shiga toxins initially isolated from S. dysenleriae strains are encoded by the six-I and slx-2 
genes. The six genes in S. dysenteriae lie adjacent to lambdoid phage-like sequences 
interrupted by several insertion elements, suggesting that the toxin genes lie in a prophage 
[173]. The 0-antigen modifying genes, glr and oac, are the only phage-encoded genes that 
have been linked to the virulence of S.jlexneri [5]. The identification of several phage-
encoded virulence factors in other enteric pathogens, warrant the need to study S. jlexneri 
phages fm1her. 
1.8 In vitro and in vivo models of shigellosis 
Poorly differentiated or non-polarized cell lines such as HeLa, HEp-2 and BHK grown in 
culture flasks have been used extensively to study S. jlexneri-epithe1ia1 cell interactions in 
vitro. More sophisticated systems have also been designed to study the intricate interactions 
between S. jlexneri and host epithelia including human, Caco-2 or T84 intestinal cell lines 
grown on permeable filter supports with distinct upper (luminal) and lower (basal) chambers 
[222]. 
S. jlexneri strictly infects humans and non-human primates as a result of which there is no 
convenient animal model available for studying S.jlexneri infection. Non-human primates 
develop diarrhoea and dysentery after oral infection with a large inoculum of Shigel!a, and 
therefore is a useful animal model to evaluate the efficacy of vaccine candidates [223 , 224]. 
However the routine use of this animal model poses large ethical and economic problems. 
The lack of a relevant small animal model of shigellosis has been one of the major limitations 
to Shige/la vaccine development. A number of alternative animal models have been identified 
26 
which use mucosa! surfaces other than the colon in mice, guinea pigs and rabbits (Table 1.5). 
However, the main drawback of these models is the lack of clinical relevance of infection site 
and symptoms produced. The murine pulmonary model of shigellosis is the most extensively 
used in vivo model of shigellosis. While adult mice infected with S. jlexneri orally, fail to 
develop shigellosis, when inoculated with S.jlexneri intranasally, mice develop pulmonary 
pneumonia as a result of S. jlexneri invasion of the pulmonary epithelial lining of the trachea-
bronchial tract [225]. Although this model of shigellosis is lacking in clinical relevance 
owing to the site of infection, it has been used extensively on account of lack of alternative 
animal models. 
l.9 C"enorhabditis elegans as an in vivo model to study host-pathogen interactions 
In the 1960' s, Sydney Brenner established the use of Caenorhabditis elegans as a model 
organism for studying neurobiology, cell biology and genetics in vivo [226]. C. elegans is a 
free-living, soil-dwelling nematode (roundwonn) that feeds on bacteria present in the soil. 
The small size (- 1 mm), rapid generation time (3 days at 20 °C), their ability as self-
fertilizing hennaphrodites to produce genetically identical progeny and simple anatomy are 
some of the features that make this nematode an attractive model for in vivo studies. In the 
laboratory, C. elegans are maintained on the non-pathogenic E. coli OP50 strain; bacterial 
infection of nematodes can thus be achieved by simply replacing the E. coli strain with 
pathogenic bacteria. These unique features of C. e!egans have led to the use of this in vivo 
system to study host-pathogen interactions with an ever-growing list of bacterial pathogens 
that are known to infect C. elegans including: Salmonella enterica, Pseudomonas aeruginosa 
and Serratia marcescens [227-229]. 
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Table 1.5: Animal models of shigellosis 
Animal model Descri(!tion A(!(!lication Limitations Reference 
Macaque monkey lntragastric inoculation with Most relevant model of High infection dose required , [230) 
a high dose of Shigella shigellosis high cost, ethically unsound 
(-I0 1°CFU) develop 
shigellosis with symptoms 
similar to the human disease 
Murine pulmonary model Intranasa l inoculation with a Most commonly used in vivo Clinically irrelevant owing to [231) 
high dose of Shigella in mice model of shigellosis for the site of infection and 
causes bacterial invasion of vaccine research symptoms produced 
the pulmonary epithelial cells 
resulting in pulmonary 
pneumonia 
Newborn mice Oral infection with a high Used to study early- Newborn mice develop [232) 
dose of Shigella triggers an interactions between Shigella resistance to Shigella 4-5 
inflammatory respons that cells and the host mucosa days post birth. 
culminates in epithelial cell 
damage 
Guinea pig, Sereny Test Shigella inoculated into the The Sereny test is used Clinically irrelevant owing to [233) 
keratoconjunctival sac invade extensively for comparing the site of infection and 
the conjunctiva resulting in the virulence of Shigella symptoms produced 
keratoconjunctivitis strains 
-Rabbit-ilea! ligated assay Ligated section of the rabbit Use to study interactions The suitability for vaccine [234) 
ileum when inoculated with between Shigella cells and development has not been 
Shigella intestinal epithelial layer and detennined 
innate resp,onses to Shigella 
infection 
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1.9.1 C. elegans anatomy and lifecycle 
The C. elegans lifecycle begins with an egg stage, followed by four successive larval stages 
(Ll -L4) and an adult stage (Figure 1.4). Worms transitioning through each stage replace their 
old cuticle (exoskeleton) layer with a new cuticle layer. The entire lifecycle takes 3 days 
under optimum conditions (20 °C), however the lifecycle of these nematodes is temperature-
dependent and the entire cycle can be fast-tracked by increasing the temperature to 22 °C; 
under these conditions the nematodes can complete their entire lifecycle in about 2 days 
[235]. The availability of food is another factor that influences the lifecycle of C. elegans. 
When food is scarce, worms progress from the L1 stage into the survival and dispersal stage 
called the dauer larva. Worms can remain in this stage for up to 4 months until conditions 
improve, at which point the wonns molt and enter the L4 stage and complete their lifecycle. 
Like other nematodes, the body of C. elegans is cylindrical and unsegmented with tapering 
ends. The body is comprised of two concentric cylindrical structures separated by a 
pseudocoelomic cavity. The outer cylinder fom1s the body wall and is comprised of an outer 
protective cuticle layer making up the exoskeleton, an underlying hypodermis which secretes 
the cuticle. The outer cylinder also carries the excretory system, muscles and neurons. The 
inner cylinder of the body consists of the pharynx, intestine, and gonads in adult worms 
(Figure 1.5.A). As most pathogenic bacterial infections in C. elegans predominantly affect 
the intestine, a detailed outline of this organ follows. 
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Figure 1.4: Lifecycle of C. elegans at 22 °C. Adults lay eggs that proceed through numerous 
stages of embryogenesis, indicated as ex utero development Egg carrying fully developed 
embryos hatch to release the first larval stage (Ll ). Under optimal conditions LI larvae 
transition through three more larval stages (L2-L4) and finally develop into adults. Under 
unfavorable conditions, such as a shortage of food, L1 larvae enter a survival stage known as 
the dauer larva and worms remain at this stage until conditions become favorable. Numbers 
in blue indicate the duration of each stage at 22 °C and numbers in brackets indicate the 
average size of worms. Figure from Altun and Hall 2005 [236]. 
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1.9.2 The C. elegans intestine 
The alimentary system is one of the most complex portions of the nematode anatomy; 
comprised ofa large array of tissues and cell types [237]. C.elegans feed through a two-
lobed pharynx whose lumen is continuous with the intestinal lumen. Ingested material is 
broken down in the pharynx by the pharyngeal grinder, transported throughout the alimentary 
canal by muscular pumping and peristalsis of the pharynx, and the action of the enteric 
muscles transport waste material out of the body through the anus [238]. The nematode 
intestine is one of the major organs of C. elegans, making up 30% of the total somatic mass. 
The intestine is assembled by 20 cells which are mostly arranged in pairs to fonn 9 "int" 
rings joined to form a tube with a central lumen. Unlike mammalian intestinal epithelia, the 
C. elegans intestinal cells are not shed or renewed. This allows the study of defense functions 
in vivo, without potentially confounding cell proliferation and tissue repair [239]. 
C. elegans intestinal cells, also known as enterocytes, show striking simi larities to human 
intestinal epithelial cells, including their organization into apical and basolateral domains and 
presence of actin-rich microvilli throughout the apical domain (Figure 1.5.C). The apical 
brush border glycocalyx of the C. elegans enterocytes share the same morphology and 
function as the brush border in mammalian cells and acts as the first line of defense against 
invading pathogens. The microvilli are anchored into an actin-rich terminal web which spans 
the apical surface of the enterocyte. Like human enterocytes, the structural integrity of the C. 
elegans enterocytes is also maintained by ERM-I , a member of the ERM fami ly of proteins 
located beneath the intestinal apical surface, that coru1ect the actin cytoskeleton to the plasma 
membrane [240, 241]. Vesicular trafficking in C. elegans enterocytes resembles polarized 
trafficking in human epithelial cells, with distinct sorting to apical and basolateral sides. 
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Figure 1.5: The intestine of an adult C. elegans hermaphrodite. A-Schematic 
representation of the anatomy of an adult C. elegans hermaphrodite showing the principal 
anatomical features with the anterior end of the body, the head, towards the left and the 
posterior tail end towards the right. The nematode intestine is composed of 20 intestinal 
epithelial cells organized in nine rings. B: Schematic representation of a transverse mid body 
section of a healthy nematode showing one of the nine intestinal rings composed of two 
intestinal cells (in yellow) . C: Diagrammatic representation of a single nematode intestinal 
epithelial cell which shares similarities with human intestinal cells such as organization into 
apical and basolateral surfaces and the presence of an apical actin-rich microvilli brush 
border layer toward the intestinal lumen. Figure adapted from [242) . 
32 
These striking similarities to human intestinal epithelial cells, coupled with the ability to 
visualize these structures and processes in live animals owing to the transparent body of C. 
elegans, provides a powerful system to study bacterial infection of the intestine [243] . 
1.9.3 Immune responses in C. elegans 
Compared with mammalian systems where much is known about the cellular and molecular 
mechanisms involved in mucosa! immunity, the study of innate immunity in C. elegans is in 
its infancy. Little is known about the differences between constitutive and pathogen-induced 
responses, and pathogen-specific responses. Unlike vertebrates, C. e/egans does not have an 
adaptive immune system using specialized immune cells like lymphocytes. Therefore innate 
immunity constitutes the sole host defense mechanisms. However, the nematode has been 
found to avoid pathogens over time, this avoidance may constitute a form of adaptive 
immunity using behavioral changes instead of specialized cells [244]. 
1.9.3.1 The intestinal epithelial layer and pathogen resistance 
As in humans, the C. e!egans intestinal epithelial cells act as a physical barrier which 
provides protection from invading pathogens. This physical barrier is highly effective in 
protecting nematodes from bacterial invasion. Although several intracellular pathogens have 
been found to infect C. elegans, they fail to penetrate the epithelial barrier, with the exception 
of P. aeruginosa [242]. Mammalian intestinal cells produce antimicrobial peptides in 
response to inflammation and infection (Section 1.4. l ). C. elegans also produces 
antimicrobial peptides in response to injury or infection [245, 246], thus it has been suggested 
that the most basic cellular and molecular mechanisms of inflammation, encompassing 
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cellular migration and rapid release of antimicrobial peptides to infected tissues, are present 
in the nematode [24 7]. 
1.9.3.2 Innate immunity in C. elegans is TLR-independent 
Innate immunity relies on the recognition of microorganisms, achieved through a limited 
number of PRRs. A number of mammalian PRRs have been recognized, such as the toll-like 
receptors (TLRs) and Nod-like receptors (NLR) [248 , 249]. As a primary response to 
bacterial infection, mammalian enterocyte TLRs recognize bacterial cells by interacting with 
structurally-conserved surface molecules, particularly bacterial LPS, which leads to the 
activation of NF-KB. NF-KB then translocates into the nucleus through signaling pathways 
involving myeloid differentiation primary-response protein 88 (MYD88) and drives the 
transcription of inflammatory response genes, including those encoding cytokines and 
chemokines [250, 251]. Although a TLR homologue (TOL-1 ) has been found in C. e!egans, 
the nematode seems to detect and respond to infection in a TLR-independent manner [242]. 
The C. e!egans genome lacks NF-KB and MYD88 homologues. Furthem1ore, nematodes fai l 
to produce homologues of known mammalian cytokines. It is therefore surprising that C. 
elegans has the capacity to motmt pathogen-specific innate immune signaling cascades. 
Nematodes utilize several evolutionari ly conserved signaling pathways to produce effector 
molecules in response to infection [252]. The p38 MAPK pathway, and the insulin signaling 
pathway (DAF-2-DAF-1 6) are important mediators of innate immune responses in nematode 
intestines and have been shown to function in parallel [253] . 
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1.9.3.3 The p38 mitogen-activated protein kinase pathway (MAPK) 
The p38 MAPK signaling cascade is the main regulator of immune responses in C. elegans 
and was first identified in a forward genetic screen for mutant worms with enhanced 
susceptibility to infection with P. aeruginosa [254]. This pathway acts autonomously in the 
intestinal cells to coordinate defense responses against a wide array of ingested pathogens. 
Nematodes carrying mutations in this pathway show increased susceptibility to infection with 
both Gram-negative pathogens: P. aeruginosa [253, 254], S. enterica [255] and Yersinia 
pestis [256] and S. marcescens [257] ; and the Gram-positive pathogens Enterococcus f eacalis 
[257], and S. aureus [258]. 
The p38 MAPK signaling cascade involves the nemonal symmetry family member 1 (NSY-
1 ), SAPK/ERK kinase l (SEK-I) and p38 MAPK fami ly member 1 (PMK-1) (Figure 1.6.A). 
This pathway is orthologous to the ASK- I MAPK pathway in mammals-[252] , which is 
involved in the mammalian cellular immune response [259]. In mammals, the MAPK cascade 
acts downstream ofTLRs [260-263], however in C. e/egans the activation of this pathway is 
TLR-independent and this pathway is required for nematode defense against every intestinal 
pathogen that has been tested to date [242]. 
1.9.3.4 The insulin signaling pathway 
The DAF-2-DAF-16 (also known as FOXO) insulin-like signaling pathway in C.elegans is 
involved in metabolism, reproduction, development, lifespan and resistance to enviroruuental 
stresses [264]. This pathway also plays an important role in innate immunity [265], but its 
precise role in innate immunity remains unclear. The insulin signaling pathway has been 
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identified in response to infection with P. aeruginosa [266] , enteropathogenic E. coli [267] S. 
aureus and E.faecalis [265]. 
DAF-2 is an insulin receptor that is expressed on the surface of numerous C. e!egans cells, 
including the intesti11al epithelial cells. Insulin-like peptides (such as INS-7), up-regulated in 
response to bacterial infection [266, 268], interact with DAF-2, which subsequently inhibits 
the downstream transcription factor DAF-16 through a lcinase cascade (Figure 1.6.B). Loss of 
function mutations in daf2 activate the constitutive expression of daf-16, which increases the 
expression of several DAF-16-dependent genes [269], many of which show homology to 
antimicrobial defense genes [270, 271]. daf2 mutant worms have prolonged lifespans and 
increased resistance to death caused by both Gram positive and Gram negative bacteria [265] , 
which is most likely due to DAF-16-mediated up-regulation of antimicrobial peptides. 
Studies have shown that although the constitutive activation of DAF-16 enhances pathogen 
resistance, DAF-16 is not nonnally activated during pathogen infection [272-274] , which 
implies that DAF-16 independent pathways may be involved in nematode responses to 
intestinal pathogens. 
36 
A B C 
Intestinal lumen 
Intestinal cell cytoplasm X 
Figure 1.6: Parallel signaling pathways in C. elegans intestinal innate immune 
responses. A: p38 MAPK pathway. The NSY- l-SEK-1-PMK-1 cassette is pivotal to the 
regulation of C. elegans defense responses and is activated by the scaffolding protein TIR-1. 
B: The insulin signaling pathway (DAF-2-DAF-16) . Insulin-like peptides, e.g. INS-7, bind to 
the DAF-2 receptor, which sequentially activates the phosphatidylinositol-3 OH kinase AGE-
i , phosphoinositide-dependent kinase 1 (PDK-1 ), AKT-1 , AKT-2 and serum/glucocorticoid-
regulated kinase 1 (SGK-1) to phosphorylate, and thereby inhibit, the forkhead box 0 
transcription factor DAF-16. C: DAF-2 mutant worms constitutively express DAF-1 6, which 
up-regulates the transcription of antimicrobial peptides. 
37 
1.9.4 Using RNA interference to study the function of C. elegans genes 
In 1998, Fire and Mello reported their discovery of RNA interference (RN Ai) in C. elegans 
when they published that the injection of double stranded RNA (dsRNA) into worms resulted 
in the specific degradation of target mRNA [275]. This discovery, coupled with the 
availability of the complete genome sequence of C. elegans, has made it possible to study the 
function of essential C. elegans genes by silencing the expression of specific target genes. 
The RNAi technology in C. e!egans is well established and it provides a useful experimental 
tool on account of sequence specificity and experimental ease, as dsRNA can be introduced 
into wom1s by soaking them in a dsRNA solution [276] or by feeding worms bacteria 
engineered to produce dsRNA [277]. dsRNA introduced by either injection, feeding or 
soaking spreads throughout most of the nematode body and the RNAi effect is nearly 
systemic [278] . RNAi feeding is the least labour intensive and most inexpensive method that 
can be used to target a large number of animals simultaneously. 
1.9.4.1 The mechanism ofRNAi in C.elegans 
dsRNA taken into C. elegans cells is cleaved into small interfering RNAs (siRNA) by the 
enzyme Dicer (Figure I. 7) [279]. Dicer forms a complex with RDE-4 (a dsRNA binding 
protein), RDE-1 (believed to interact with siRNA) and DRH-1 (a DexH box helicase) [280] . 
The Dicer-complex bound siRNAs then interact with MUT-7 and RDE-2/MUT-8, nematode 
proteins found to be essential for C. elegans RN Ai [281]. siRNAs can also bind to ERI-1 
which interferes with the RNAi pathway by targeting siRNAs for degradation [282]. siRNAs 
that escape degradation and are then incorporated into a RNA-induced silencing complex 
(RISC) which bind to endogenous messenger RNA (mRNA) with complementary sequence. 
The mRNA is then cleaved and degraded by the endonuclease activity of the RISC complex 
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Figure 1.7: Schematic representation of the RNA interference pathway in C. elegans. 
Exogenous dsRNA enters nematode cells and is cleaved into siRNAs by Dicer, which forms 
a complex that includes RDE-4, RDE-1 and DRH-1 (all enzymes represented by blue ovals). 
The siRNAs are either bound by ERi-i , which targets them for degradation, or by a complex 
that includes MUT-7, RDE-2 and CSR-I which form the RISC complex (represented in 
orange), which directs them to bind to complementary, endogenous mRNA. RISC-bound 
siRNA/mRNA products are either targeted for degradation, leading to cleavage of the mRNA 
target or for the RNA-dependent RNA polymerase-mediated synthesis of new dsRNA. Newly 
synthesized dsRNA is bound and cleaved by the Dicer complex and the cycle continues, 
leading to the constitutive silencing of target mRNA. 
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and additional exonucleases. siRNAs may also bind mRNA and function as primers for 
RNA-dependent RNA polymerase (RdRP), which then synthesizes a new dsRNA that is 
subsequently cleaved by Dicer, continuing the RNAi cycle and ensuring the target gene is 
constitutively silenced. 
1.9.5 Caenorhabditis elegans as an in vivo model for shigellosis 
In the past decade, two independent groups [283 , 284] have found preliminary evidence 
suggesting C. e/egans can be used as an animal model for shigellosis. Using bacterial survival 
assays, Burton et. al. have shown that live S.jlexneri cells, carrying intact virulence plasmids, 
kill C. elegans (TD50 = 4.64 ± 0.62 days, where TD5o is the time taken to kill 50% of the 
initial wonn population) compared with wom1s fed on£. coli OP50 (TD50 = 7.61 ± 0.76 
days) . Using bacterial accumulation and toxicity assays, the authors established that live S. 
jlexneri cells persistently colonize the nematode gastrointestinal lumen and kill worms in a 
toxin-independent, infection-like process. This study also showed that the C. e/egans ABL-1 
tyrosine kinase, a homologue of mammalian c-Abl nonreceptor tyrosine kinase ABLI, was 
required for S.jlexneri-induced killing. 
More recently, Kesika et. al. [284] developed a C. e!egans survival assay in liquid cultures 
and have shown that the nematodes were more susceptible to S. jlexneri infection in liquid 
culture, with TD50 =23 ± I hours while wonns fed E.coli OP50 showed 100% survival for up 
to 55 hours. This group also showed that wonns infected with S.jlexneri laid significantly 
fewer eggs (26 ± 6 eggs per worm) compared with control worm (275 ± 15 eggs per wom1). 
Using semi-quantitative real-time polymerase chain reactions, they found that S.jlexneri 
infection resulted in the down-regulation of C. elegans antimicrobial genes clec-60 and clec-
87. 
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Data obtained from both these studies prove that C. elegans is susceptible to S. flexneri 
infection and S. flexneri suppresses nematode antimicrobial responses. The use of C. elegans 
to study shigellosis has several advantages: firstly, unlike the other animal models that have 
been used to study shigellosis, the site of bacterial infection in C. e/egans is clinically 
relevant and the nematode enterocytes share similarities with human intestinal cells, as 
described in section 1.8.2. Secondly, this model has been used extensively to study host-
pathogen interactions of a number of human pathogens, including Pseudomonas aeruginosa 
[285-290], Enteropathogenic E.coli [267, 291 , 292] Salmonella e/1/erica [255, 293-295] and 
Serratia marcescens [296, 297]. Next, C. elegans is an ethical alternative to using mice and 
primates that has been recommended by the European Centre for the Validation of 
Alternative Methods (ECV AM) [298]. And, finally, C. e/egans has a small genome (97 Mb) 
that has been completely sequenced, making it possible to carry out botl1 forward and reverse 
genetics. 
Besides the two reports mentioned above, no studies have used C. elegans as a model to 
study S.flexneri; a more comprehensive understanding of the interactions between S.flexneri 
and C. elegans is warranted in order to establish C. e/egans as a small animal model of 
shigellosis. 
1.10 Objectives of thesis 
S. flexn eri strains are the leading cause of shigellosis in developing countries and despite over 
half a century of research, a safe and effective vaccine that offers substantial protection is yet 
to be designed. The vast antigenic diversity and lack of a relevant animal model of shigellosis 
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have been the main impediments to S.jlexneri vaccine development. The broad aim of this 
thesis is to further our understanding of S. jlexneri infection by identifying and characterizing 
novel virulence factors encoded by S. jlexneri. This thesis also aims to characterize C. 
elegans as a new potential in vivo model of shigellosis. 
The specific objectives of this study are: 
l . To elucidate the role of periplasmic enzymes, L-asparaginase (AnsB) and y-
glutamyltranspeptidase (GGT) in the pathogenesis of S.jlexneri, by constructing and 
analyzing gene disruption mutants for variations in physiological and virulence 
properties. 
2. To identify pleiotropic effects caused by ansB and ggt mutations using differential in 
gel electrophoresis to compare the proteomes of mutant and wild type cells. 
3. To isolate and completely sequence the genome of serotype converting bacteriophage 
SfTI isolated from the highly prevalent S.jlexneri serotype 2a and to compare the 
genome of bacteriophage Sfll with Sfl, SfIV, SN, SfX and Sf6 to further our 
understanding of S.jlexneri phages. 
4. To identify novel phage-encoded virulence factors in S.jlexneri by characterizing the 
functions of cryptic bacteriophage SN genes in a S. jlexneri serotype Sa lysogenic 
strain . 
5. To characterize C. elegans as a new in vivo model of shigellosis by investigating the 
interactions between S. jlexneri and the C. elegans intestine using transmission 
electron microscopy. 
6. To identify nematode responses to S.jlexneri infection using differential in gel 
electrophoresis to compare the proteomes of nematodes infected with virulent S. 
jlexneri and control worms. 
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Chapter 2 
Materials and methods 
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Chapter 2: Materials and methods 
2.1 Bacterial culture conditions and media 
Liquid overnight cultures of bacteria were grown routinely in Luria Bretani (LB) broth 
(Appendix A), containing antibiotics where required, in a shaking incubator (180-200 rpm). 
For maintaining overnight cultures for propagation ofbacteriophages, bacterial strains were 
grown in NZCYM medium overnight (Appendix A). For maintenance of the virulence 
plasmid, S.jlexneri cultures were grown at 30 °C whenever possible, as at 37 °C the plasmid-
based virulence genes are expressed, making the virulence plasmid unstable and readily lost 
from bacterial cells. Bacteria were plated onto LB agar plates (Appendix A) , containing 
antibiotics as required. For long-tenn storage, strains were inoculated into 50% LB: 50% 
glycerol and stored at -80 °C. 
2.2 Bacterial strains and plasmid vectors 
All S. jlexneri and £ . coli strains and plasmids used in this study have been described in 
Tables 2.1, 2.2 and 2.3 , respectively. Cloning with pBC SK and pBS SK vectors (Figure 2.1) 
was performed in the E.coli JMI09 strain. 
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Table 2.1: S. flexneri strains used in this study 
Strain Characteristics Source 
SFLJ223 S.jlexneri 2a 2457T, devoid of the virulence plasmid. Congo [88] 
red negative and invasion negative 
. -
SFLl520 S. jlexneri 3b, Congo red positive, virulent in Sereny test. JCDDRB 
SFLl871 S.jlexneri 5a, SFLJ with SFV lysogen, int-xis disruption F. Robertson 
mutant, Congo red positive. 
- -
·- . 
---· -SFLJ339 S. flexneri Y, SFLJ , Congo red positive G. Allison 
--SFL2076 SFLI 520 carrying the helper plasmid , pKM208 F. Thanweer 
--
SFL2283 SFLl520 ansB disruption mutant, kan gene insertion This study 
SFL2285 SFLJ 520 ggt disruption mutant, kan gene insertion This study 
- -SFL2309 SFL2283 carrying pNVl372 to complement the ansB This study 
mutation 
SFL2310 SFL2285 carrying pNVl 434 to complement the ggt This study 
mutation 
SFL23 l I SFL 1223 carrying pNV 1908 expressing GFP+ This study 
SFLJ 520 carrying pNVI 908 expressing GFP+ -·-- - This study SFL2312 
SFL2283 carrying pNV1908 expr~ sing GFP+ ---SFL2313 This study 
SFL2314 SFL2285 carrying pNVI 908 expressing GFP+ This study 
- ---SFL2443 SFLI 520 carrying pNV2052 expressing OmpA This study 
SFL2444 SFL2285 carrying pNV2054 expressing YaeT This study 
---SFL2498 SFLl871 gtrV disruption mutant, cat insertion This study 
SFL2500 SFLJ 871 SFVORF28-32 disruption mutant, cat insertion Thiss tudy 
SFL2503 SFLl339 carrying pNV1908 expressing GFP+ This study 
SFL2504 SFLJ 871 carrying pNV 1908 expressing GFP+ ----- - This study 
~-~-
SFL2505 SFL2500 carrying pNV1908 expressing GFP+ This study 
SFL2506 SFL2500 carrying pNV2062 expressing SFV ORF 28-32 This study 
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Table 2.2: E. coli strains used in this study 
Strain Characteristics Source 
JMI09 recAJ supE44 endAJ hsdRJ 7 gyrA96 re/Al thi L1 [299] 
(lac-proAB) F' [traD36 proAB + lacfl lacZ 
L1Ml5} 
---- ---- - -- - - -- -- - --- -· 
82298 OP50 E.coli (CGC) [300] 
-~ - --·---------, 
JM ~9 carryingpNV1875 D.T. George* B2286 
-
------·-- ~----- __ ._._ ___ 
B2287 JMI09 carrying pNV1876 D.T. George* 
- --------·-B2290 JM109 carry_irig pNV1878 This study 
B2291 JM I 09 carrying pNV 1879 This study 
----------
B2363 El l!.5 carryj ng pNV1942 Elizabeth Tran 
-
. - - -- - - -- -·· 
B2364 El315 carryingpNV1943 Elizabeth Tran 
--- --------------- -
B2366 El315 carrying pNV1945 Elizabeth Tran 
-
--~~~---- . - -
B2367 El315 carrying pNV1946 Elizabeth Tran 
- ·-B2368 E 1315 carrying pNVI 94 7 Elizabeth Tran 
-
B2511 HT! 15 carrying the RNAi construct targeted to Vidal library 
the C. elegans aco-1 gene 
---B2512 HTll 5 carrying the RN Ai construct targeted to Vidal library 
the C. elegans cct-2 gene 
-
B2513 HTl 15 carrying the RNAi construct targeted to Vidal library 
the C. elegans eef2 gene 
-B2514 HTl 15 carrying the RNAi construct targeted to Vidal library 
the C. elegans hsp-60 gene 
-
B2515 B2298 carrying pNVl908 expressing GFP+ This study 
B2517 JM I~ carrying _p_NV2060 
~ 
--· - This study 
B2520 HTl 15 carrying the RNAi construct targeted to Arhinger library 
the C. e!egans daf/9 gene 
-B2521 HTl 15 carrying the RN Ai construct targeted to Cab lab 
the Arabidopsis CB 19 gene 
- ---
B2522 JMI09 carrying pNV2062 This study 
B2523 JM I 09 carry~ng pNV2063 - - -
- - - . 
This study 
B2502 JMI09 carrying pNV2052 , expressing OmpA This study 
B2504 JM109 carrying pNV2054, expressing· YaeT This study 
*D. T. George- these strains have been created by me during my honours. 
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Table 2.3: Plasmids used in this study 
Plasmid Characteristics Source 
pBC SK Cloning and eig:>ression vector, Cm' _ 
----
-
Str~tl!gene 
pBS II KS Cloning and expression vector, Amp' Stratagene 
IPTG inducible expression .;;ector 
------ .. --- ----,.,, 
Amersham pGEX-4T-I 
Biosciences 
pKD3 lambda red PCR KO system, cat cassette template (95) 
pKD46 lambda red PCR KO system, helper plasmid (95) 
arabinose induced 
-
pKM208 la~ bda red PCR KO system, helper p lasmid IPTG (96) 
induced 
pNVl372 ansB gene cloned into pBS II KS 
-· 
A.V. Jennison 
pNVl434 ggt gene cloned into pGEX-4T-l A.V. Jennison 
pNVl875 ansB knockout template carrying the cat gene D.T. George* 
flanked by ansB and its flanking regions, cloned 
intopBS SK 
-
pNV1876 ggt knockout template carrying tbe cal gene D.T. George* 
flanked by ggl and its flanking regions cloned into 
pBS SK 
~-
pNVl878 ansB knockout template carrying the kan gene This study 
flanked by ansB and its flanking regions, cloned 
into pBS S!( 
pNVl879 ggt knockout template carrying the kan gene This study 
flanked by ggt and its flanking regions cloned into 
pBS SK 
._PNV1908 gjjl gene cloned into _pCR 2.1 This study 
pNVl942 SfII Pstl fragment .!,_ cloned into pBS SK Elizabeth Tran 
pNY:1943 SfII Psi/ fragment 2 cloned into _pBS SK 
----
Elizabeth Tran 
-
pNVl945 SfII Psi! fragment 5 cloned into pBS SK Elizabeth Tran 
SfII Psi/ fragment 6 cloned into pBS SK 
--L --.---------
Elizabeth Tran pNV1946 
·- -- -pNVl947 Sfll Psi/ fragment 7 cloned into pBS SK Elizabeth Tran 
- -
P.!':N2052 ompA gene from SFLI 520 cloned into pBS II KS This study 
pNV2054 . yg_eT gene from SFLJ 520 cloned into pBS II KS 
-
This study 
pNV2063 pNV2062 harbouring an internal deletion within This study 
ORF 28-32 + cat gene inserted into the site of 
deletion 
pNV2062 SFV ORF 28-32 cassete from SFLI 871 cloned This study 
into pBS II KS 
pNV2060 pNV73 I harbouring an internal deletion within the This study 
gtrV cassette+ cat gene inserted into the site of 
deletion 
*D. T. George- these strains have been created by me during my honours. 
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fl( +) o rigin 135-441 
~-galactosidase o.-fragme nt 460-816 
multiple cloning site 653-760 
lac promoter 817-938 
pUC origin 1158-1825 
chloramphen icol resistance ORF 2125-2781 
chloromphenicol 
pBC SK( +/-) Multiple Cloning Site Region 
(sequence shown 598- 826) Apol H,r,ccll 
BnH!I T7Promol•r Kpnl ~?i l 09I Xhol ~II 
I I I I I 
TTGT AAAACGACGGCCAGTGAGCG CGCG T AA T ACGACT CAC TAT AGGGCGAA TTGGGT ACCGGGCCCC CC CT CGAGGT CGAC • 
M 1 J -20 pruner btnd,;"9 1>te T7 pnm..- bor>do"!I tillt KS prim..- b,ndu,g sii. •.. 
B1pl06I Nott 
7101 1'r,dlll 1col1.V TcoRI rr11 ~mal t"mHI ?•I fba l I fog I ,.0:1 fccll r,c 1 
•• GG TA TCGA T AAGCT TGA TA TCGAA TTCCTGCAGCCCGGGGGA TC CACT AG TTCT AGAGCGGCCGCCACCGCGG TGGAGCTC • 
... KSpnm..-bor><hng-111• SKprim• r bond,r19s,11t 
TJ Promot• r ~nH II . ~-gal O· ltoqmon\ 
•• CAGCTTTTGTTCCC TTT AG TGAGGG TI AA TTGCGCGC TTGGCG T AA TCATGG TCAT AGC TGTTTCC 
I l.l.,,.m•r bondn,01a,. ~ 13R .. •"'pnm•b1<,d,n9s,le 
11 (-) origin 24-330 
~-gokidosidose a-fragment 463- 81 6 
multiple doning si te 653--760 
loc promot•r 817-938 
pUC o rigin 11 58-1825 
ampicillin resistance (bla) ORF 1976-2833 
p8luescript SK(+ /-) Multiple Cloning Site Region 
(sequence shown 601-826) 
~ 1091 ~~/
1 
Kp,I 0,.,11 Xhol !.all 
I ! I I 
TTGTAMAC<W:GGCCAGTGAATIGTAATACuACTCACTATAGGGCGAATTGGGTACCGGGCCCCCCCTCGAGGTCGACGGT •. 
Ml3 20pri-t,,,,d,n~,.,. l7pr,rn..-bond,"II''° i::;pr;m.,W"'9"'" 
8,pl O~I tlc11 1"' ' 71ndlll ,coH \<<>RI \"' I ~mol 1"'"111 ~I ?'"I l~agl ,,~I ft11 t<>< I 
• -~uATMGCnGATATCGMTICCTGCAGCCCGGG~TCCACTAGTTCTAGAGCGGCCGCCACCGCGGTGGAGCTCCA .. 
_i:o; ,. ..,.,.1,,,,,:1,"11,h SKpri"'"rbo.-:1"'1!• .. 
. ~·gala. frapme n\ 
.. GCTTTIGTTCCCTTIAGTGAGOOTTAATTTCuAGCTTGGCGTAATCATGGTCATAGCTGTTTCC 
I !Jp,,-,1.1'<1,"9"• \;13 ie-.,,.~.,,..., G.,o.ng-
Figure 2.1: Plasmid maps ofpBC SK and pBS SK, used as cloning vectors in this study. The 
Multiple cloning site (MCS) in both plasmids is located within the N-tenninal region of the 
~-galactosidase gene fragment, allowing blue white screening of recombinant plasmids 
(Adapted from Stratagene). 
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2.3 DNA methods 
2.3.1 Isolation of plasmid DNA by alkaline Iysis 
Plasmid DNA was isolated using the alkaline lysis method [301]. Between l .5-3 mL of 
overnight bacteria culture was collected in eppendorftubes by centrifugation at 16,000 x g 
(Heraeus Instruments, Biofuge 13). Bacterial pellets were resuspended in I 00 µL of ice-cold 
Solution I (Appendix A) by vortexing following which 200 µL of freshly prepared Solution II 
(Appendix A) was added to lyse the cells and the tubes were inverted several times. 150 µL 
of ice-cold Solution III (Appendix A) was added to cell lysates and the solutions were mixed 
gently by inverting the tubes. Tubes were then chilled on ice for 5 minutes. The precipitate 
containing cell debris and chromosomal DNA was eliminated by centrifugation at 16,000 x g 
for 5 minutes and the supernatant transferred to a new tube. 0.5 µL of RNase (IO mg/mL) 
(Sigma) was added and tubes were incubated at room temperature for 15 minutes to degrade 
any RNA. An equal volume of phenol: chloroform (1:1 vol/vol) was added and tubes were 
vortexed and centrifuged at 16,000 x g for 2 minutes, to remove any residual RNA, protein 
and chromosomal DNA. The aqueous phase containing plasmid DNA was transferred into a 
fresh tube and DNA was precipitated by adding two volumes of 100% ethanol, followed by 
vortexing and incubation on ice for 30-60 minutes. Plasmid DNA was recovered by 
centrifugation at 16,000 x g for 5 minutes at 4 °C and the DNA pellet was washed with 1 mL 
of ice cold 70% ethanol and centrifuged at 16,000 x g for 2 minutes. DNA pellets were dried 
under vacuum using the Savant SCIOO "Speed Vac" centrifuge and resuspended in 20-50 µL 
ofMilli-Q water and stored at -20 °C. 
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2.3.2 Isolation of plasmid DNA using the Axygen miniprep Spin kit 
Plasmid DNA was isolated form overnight bacterial cultures using the Axygen MiniPrep Kit 
according to the manufacturers ' instructions. Briefly, 1.5 mL of overnight culture was 
centrifuged at max speed in a microcentrifuge for I minute (Heraeus Instruments, Biofuge 
13). Collected bacterial pellets were resuspended in 250 µL of buffer SI followed by the 
addition of 250 µL S2 buffer (provided in the kit). Tubes were inverted 5-10 times, until the 
solution became viscous. 350 µL of S3 buffer was added and the solution was mixed gently 
by inversion. Cell debris was collected by centrifugation at l 2,000 x g for IO minutes. The 
supernatant was transferred to into an Axyprep spin column. The spin column was 
centrifuged for 1 minute at 12,000 x g, the flow through discarded and 750 µL of W 1 buffer 
added to wash the column. The column was centrifuged for I minute as above and washed 
with 500 µL of buffer W2 as above. Empty spin columns were centrifuged for an additional 
minute to ensure all W2 buffer had been removed from the column. The column was then 
placed in an empty eppendorftube and the DNA eluted by the addition of30-50 µL ofMilli-
Q water. After a minute incubation at room temperature, the plasmid DNA was collected by 
centrifugation at 12,000 x g for I minute. Plasmid DNA was stored at -20 °C. 
2.3.3 Determination of DNA concentration 
The quantity of DNA in suspension was measured using the NC-1000 spectrophotometer 
Nanodrop (BioScience). Absorbance at 260 nm was detern1ined and the concentration of 
DNA in ng/µL calculated using the standard that A26o of I represents 50 µg/mL. A ratio of 
A260 run/ A280 run was also used as an indicator of the purity of the DNA sample. A ratio of 
- 1.8 is generally accepted as pure for DNA. 
so 
2.3.4 DNA separation and purification by electrophoresis 
2.3.4.1 Agarose gel electrophoresis 
Agarose gels were prepared using 0.5%-2% agrose in 0.5 x TBE buffer (Appendix A). 
Ethidium bromide was added to the gel at a final concentration of IO µg/mL. 0.5 x TBE 
buffer was used to conduct an electric current at 50-120 V. DNA samples were loaded into 
the wells ofagarose gels with 1/10 the volume of blue loading dye (Appendix A). SPP-1 
phage DNA/EcoRI (500 ng) was run as a molecular size marker (Figure 2.2). DNA was 
visualized under UV light using a Gel-Doc set-up, and photographs were taken using the 
NIH-Image program and printed on a tbemrnl printer (Mitsubishi). 
2.3.4.2 DNA purification form agarose gels 
DNA bands of interest visualized under UV light, were cut out using a sc~lpel blade and 
placed in a pre-weighted eppendorftube. The Wizard® SV Gel and PCR clean up kit 
(Promega) , was used for purification of isolated DNA fragments from the agarose gel 
fragments according to manufacturer 's specifications. Purified DNA was stored at -20 °C. 
2.3.5 Sequencing and polymerase chain reaction (PCR) 
2.3.5.1 Primer design 
Primers were designed to have similar melting temperatures, a GC content similar to the gene 
of interest, little or no false priming, and little or no secondary structure. The primers used in 
this study are listed in Table 2.4. All primers used in this study were manufactured by 
SigmaAldrich 
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kbp 
8.51 
7.35 
6.11 
4.84 
3.59 
2.81 
1.95 
1.88 
1.51 
1.39 
1.16 
0.99 
0.72 
0.48 
0.36 
Figure 2.2: Size bands (kbp) in the SPP-1 phage DNA!EcoRI marker. All agarose gels 
displayed in this study use the SPP-1 marker (GibcoBRL) 
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Table 2.4.: Primers used in this study 
Primer name 
Ml3F 
Ml3R 
AnsB-FPl 
AnsB-RP6 
AnsB-KO F2 
AnsB-SacF 
AnsB-XbaR 
Ggt-FPI 
Ggt-RP6 
Ggt-KO F2 
Ggt-SacF 
Ggt-XbaR 
Cat-FPl 
Cat-RP2 
CmF (Nhel) 
CmR (Nhel) 
Se_quence 
GTAAAACGACGGCCAGT 
GGAAACAGCTATGACCATG 
AGGCGCGAAAAGCCGCGT 
TGGGT A TTC AACGCAGA TTCA 
TGCGCAAAATGCTGCTGGC 
atctagagATGGAGTTTTTCAAAAAG 
cagagctcTTAGT ACTGA TTGAAAA T 
GATTGACGTGATTGGTCCGA 
TTGACTCGCATTTGAAAG 
GGAACTGCCGCGTGGTTTA 
cggagctcA TCACTCACTTCGCATCT 
gtctagaGT A TTTCTCCGCTTCTGC 
CACGTCTTGAGCGATTGTGTAGG 
GACATGGGAATTAGCCATGGTCC 
CTAGCTAGCCACGTCTTGAGCGATTGTGTAG 
CTAGCTAGCGACATGGGAATTAGCCATGGTC 
Tar~ene 
Ml3 F site 
MI3Rsite 
ansB upstream element 
ansB downstream 
element 
ansB upstream element 
ansB 
ansB 
ggt upstream element 
ggt downstream element 
ggt 
upstream element 
ggt 
ggl 
cat 
cat 
cat 
cat 
Comment 
Binds to the Ml 3 forward site on cloning vectors 
used in this study for primer walking 
Binds to the MI 3 reverse site on cloning vectors 
used in this study for primer walking 
Forward primer amplifying the 640 bp upstream 
element of the ansB gene 
Reverse primer amplifying the 608 bp downstream 
element of the ansB gene 
Sequencing primer binding 872 bp upstream of the 
ansB start codon 
Forward primer amplifying the ansB gene. 
Reverse primer amplifying the ansB gene 
Forward primer amplifying the 599 bp upstream 
element of the ggt gene 
Reverse primer amplifying the 618 bp downstream 
element of the ggt gene 
Sequencing primer binding 812 bp upstream of the 
ggt start codon 
Forward primer that binds 427 bp away from the 
start of the ggt gene 
Reverse primer binds 995 bp away from the start 
of the ggt gene 
Forward primer amplifying the cat gene. 
Reverse primer amplifying the cat gene 
Forward primer amplifying the cat gene with Nhel 
flanking sites 
Reverse primer amplifying the cat gene with Nhel 
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pACYCNheT ctagctagcGCCACGTTGTGTCTCAAAATC 
F 
pACYC NheI ctagctagcCGGGAAGATGCGTGATCTG 
R 
----------KanXbalF GCtctagaGCCACGTTGTGTCTCAAAA 
--
KanXbaTR GCtctagaCGGGAAGA TGCGTGATCT 
KOi TTTAAAGAAGTTCCTATTCC 
~ 
K02 ACTTCGGAATAGGAACTAAG 
ORF28- tcaGGA TCCGCCAGCGCGTT AA T AA TT 
32BamHJF 
ORF28- CCGCTCGAGCATAATGTACCCAAGAGA 
32Xho!R 
GtrVF-sacl GatgagctcTGAGAAACAAAAATGAAAAGCC 
GtrVR-Xbal acgtctagaACCA TTCAACATT AAGGC 
OmpAF(Sacl) CGgagctcGGAGA TATTCATGGCGT A TT 
OmpAR(Xbal) GCtctagaTT AAGCCTGCGGCTGAGT 
YaeTF(Sacl) CGgagctcGAGTTAGTT AGGAAGAAC 
YaeTR(Xbal) GCtctagaTT ACCAGGTTTT ACCGAT 
-HisG-qRTF GCGCTGTGGCATTAAAATCA 
HisG-qRTR ATTACCAGACAGGGAATGTC 
kan 
kan 
kan 
kan 
cal 
cal 
gtrV 
glrV 
ompA 
ompA 
yaeT 
yaeT 
hisG 
hisG 
flanking sites 
Forward primer amplifying the kan gene with Nhel 
flanking sites 
Reverse primer amplifying the kan gene with Nhel 
flanking sites 
Forward primer amplifying the kan gene with a 
Xbal flanking sites 
Reverse primer amplifying the kan gene with A 
Xbal flanking sites 
Reverse primer that binds towards the start of the 
cal gene and reads out of the 5' end into flanking 
resgions 
Forward primer that bind to the 3' end of the cal 
gene. 
Forward primer amplifying the SFV ORF 28-32 
gene cassette 
Reverse primer amplifying the SFV ORF 28-32 
gene cassette 
Forward primer amplifying the GtrV gene with a 
5' sacl site 
Reverse primer amplifying the GtrV gene with a 5' 
Xbal site 
Forward primer amplifying the ompA gene with a 
5' Sac] site 
Reverse primer amplifying the ompA gene with a 
3' Xbal site 
Forward primer amplifying the yaeT gene with a 5' 
Sac] site 
Reverse primer amplifying the yaeT gene with a 3' 
Xbal site 
Forward quantitative real time PCR p rimer 
Reverse quantitative real time PCR primer 
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RplL(qRT-F) CGGTTGAAGCTGCTGAAGAA rp/L Forward quantitative real time PCR primer 
RplL(qRT-R) TGCAGATTCTACCAGGTCTT 
-------..-----··-ra,-------., 
rpll 
--· -·---
Reverse quantitative real tim~CR primer 
Udp(qRT-F) G CCGCATATTAATGTGGGTG udp 
- - ·-· 
Forward quantitative real time PCR primer 
£ dp (qRT-R) AGCGCAGTCGTACATTCGAA 
----··-·-
udp 
- - - . - --
Reverse quantitative real time PCR primer 
mdh(qRT-F) GCGGAACTGAAAGGCAAACA mdh Forward quantitative real time PCR primer 
mdh(qRT-R) CCTGCTCGGTAAAACTAACG mdh Reverse quantitative real time PCR primer 
--------- ---- --- - --OmpA( qRT-F) CCAATCACTGACGATCTGGA ompA Forward quantitative real time PCR primer 
OmpA(qRT- GCCAGTGTCGTGGTCTTTAA ompA Reverse quantitative real time PCR primer 
R) 
GroEL(qRT- GCTGATCATCGCTGAAGATG groEL Forward quantitative real time PCR primer 
F) 
GroEL(qRT- GCATAGCTTTACGACGATCG groEL Reverse quantitative real time PCR primer 
R) 
DnaK(qRT-F) GAACCGGTAACTGAAGCTGT dnaK Forward quantitative real time PCR primer 
DnaK(qRT-R) GGTCGGTTCGTTGATGATAC dnaK Reverse quantitative real time PCR primer 
--------------------· ... -PpsA(qRT-F) CCTCAACGTTCAGGGTTTTG ppsA 
-- -
Forward quantitative real time PCR primer 
PpsA(qRT-R) CTGGTGCACACGATAAGAGA ppsA Reverse quantitative real time PCR primer 
-~----
- - --gadB (qRT-F) TATGGACCCGAAACGCATGA 
--- --·--
gadB 
- -
Forward quantitative real time PCR primer 
gadB(qRT-R) TGCGGGAACTCATAGTTACC 
----
gadB 
--- ··-
Reverse quantitative real time PCR primer 
tig(qRT-F) CGCTATCAACCTGAAGAAAG 
. --
tig 
-
Forward quantitative real time PCR primer 
tig(qRT-R) CAGACCTTCTACGGAACCAT 
- ·- ---· 
tig 
------
Reverse quantitative real time PCR primer 
FtsZ(qRT-F) GCTGTCGTCACTAAGCCTTT 
-· -
flsZ Forward quantitative real time PCR primer 
FtsZ(qRT-R) GTTTGTCGTTCGGGATAGTG 
-----
.ftsZ 
--- ~-- - -
Reverse quantitative real time PCR primer 
RpsA(qRT-F) GGGTAGCTATCGCTAAACGT - rpsA Forward quantitative real time PCR primer 
-- -- - -
RpsA(qRT-R) GAAACGTGTACCAGACCTTC rpsA Reverse quantitative real time PCR primer 
-~ --------, 
--·- ····- -· YaeT(qRT-F) TGAACGTTGATGCGGGTAAC yaeT Forward quantitative real time PCR primer 
- -}'_aeT (qRT-R) ACCATGCACCTTCCATCTGA yaeT Reverse quantitative real time PCR primer 
- - - -- - ----Hsp-6-RT-F GGAGATAAGATCATCGCTGT hsp-6 Forward quantitative real time PCR primer 
- -- - -- -- - - -
Hsp-6-RT-R TCGAAGACGCCCTTTTGGAT hsp-6 Reverse quantitative real time PCR primer 
Act-2-RTF TCCAAGAGAGGTATCCTTAC - ------ - act-2 -- ---- Forward quantitative real time PCR primer 
-- - - - - -Act-2-RTR AGGTCTCGAACATGATTTGG act-2 Reverse quantitative real time PCR primer 
-·· - ---
-- ·---
Forward quantitative real time PCR primer Aco-1-qRTF TCGTTACAACGAGCTTCCAA aco-1 
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Aco-1-qRTR 
Cct-2-qRTF2 
Cct-2-qRTR2 
Hsp-60RTF 
Hsp-60qRTR 
Unc-41qRTF 
Unc-41qRJR 
Unc-54qRTF 
Unc-54qRTR 
Daf-19qRTF2 
Daf- I 9qR TR2 
Eef-2qRTF 
Eef-2_gRTR 
CGGCTGGAACTCCAGTAAAA 
ATGGGAATCGACATCGAGAA 
GGAAGAAACCATGCACAACT 
ATCGAGCACATCACCGAT 
TGACACGGTCCTTCTTCTCT 
TATCAGTATAAGGTTGAAATCG 
CAATTCGGTAGCCTTGTTGA 
GCAGGTTTTGGAGGATCAAT 
TTGAGGGTGACCTCATTTCC 
CGCCGTACTATCAGTATTCAA 
GGAAGCTCGTTGATTGTTCG 
AACCTTCCAACGTATCGTTG 
GAGCTTGTCAACTTGAACTC 
aco-1 
cct-2 
cct-2 
hsp-60 
hsp-60 
unc-41 
unc-41 
unc-54 
unc-54 
daf-19 
daf-19 
eef-2 
eef:.2 
Reverse quantitative real time PCR primer 
Forward quantitative real time PCR primer 
Reverse quantitative real time PCR primer 
Forward quantitative real time PCR primer 
Reverse quantitative real time PCR primer 
Forward quantitative real time PCR primer 
Reverse quantitative real time PCR primer 
Forward quantitative real time PCR primer 
Reverse quantitative real time PCR primer 
Forward quantitative real time PCR primer 
Reverse quantitative real time PCR primer 
Forward quantitative real time PCR primer 
Reverse quantitative real time PCR primer 
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2.3.5.2 Sequencing reaction and purification 
All clones and gene disruption mutants obtained in this study were confinned by sequencing. 
Sequencing was performed using the BigDye Terminator method. Approximately 50-200 ng 
of DNA was added to 3.5 µL of 5 X BigDye reaction buffer, 1 µL BigDye Terminator and 
0.125 µM of primer in a 20 µL reaction. The sequencing reaction was then subjected to 
thermal cycle sequencing using the following parameters: 
Denaturation Step 96°C for 10 seconds, x 25 
Prin1er Annealing Step 50°C for 5 seconds, x 25 
Extension Step 60°C for 4 minutes, x 25 
Purification of the products from the BigDye Terminator sequencing reaction was achieved 
by ethanol precipitation. The 20 µL reaction was transferred to an eppendorftube containing 
2 µL of 3M NaOAc (pH 4.6), 2 µL of I 25 mM EDTA and 50 µL of 100% ethanol. After a 
brief vortex, the tube was centrifuged at 16,000 x g (Heraeus Instruments, Biofuge 13) for 30 
minutes at 4 °C. The ethanol was gently decanted and the DNA pellet washed thrice in 70% 
ethanol, with 2 minute spins between washes. The pellet was then dried for IO minutes under 
vacuum using the SC I 00 "Speed Vac" centrifuge (Savant). The dried sample was sent for 
automated sequencing at the Biomolecular Research Facility (BRF) (JCSMR, ANU). 
2.3.5.3 Sequence analysis 
Sequences obtained from reactions sent to the BRF were stored and analysed using 
pDRA W32 (http ://www.acaclone.com/), CLC Main Workbench version 6.5, Bioedit [302] 
and/or ClustalW2 (http ://www.ebi .ac.uk/Tools/clustalw2/index. html). 
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2.3.6 PCR amplification of genes 
PCR reactions were performed using either iTaq polymerase (Scientifics) or Pfa Ultra Il 
polymerase (Stratagene). The high fidelity Pji1 Ultra II polymerase was used for amplification 
of genes for cloning and sequencing, whi le iTaq polymerase was used for screening and 
colony PCR (Section 2.6.5). Generally, 20 µL PCR reactions were set up containing the 
following : I x PCR buffer, 0.125 µM forward primer, 0.125 µM reverse primer, 0.2 mM 
dNTPs, 0.5 U of iTaq or 0.25 units of Pfu Ultra II, and template DNA. The amount of DNA 
template used varied based on the type of DNA template used, typically for plasmid DNA 
templates between 50-200 ng of DNA was used. The annealing temperature was detem1ined 
from the primer composition using the equation: Tm = 2x [A+ T] + 4x [G+C]. The following 
PCR parameters were used for all PCR reactions : 
Initial Denaturation Step 95 °C for 2 minutes, x 1 
Denaturation Step 95 °C for 30 seconds, x 35 
Primer annealing Step 3-5 °C below lowest Tm of primer pa.ir for 30 seconds, x 35 
Extension Step 72 °C for 1 minutes/kb for Taq or 2 minutes/kb for pfi1 ultra II, x 35 
Final Extension Step 72 °C for 7 minutes, x I 
PCR amplified fragments were visualized on agarose gels (Section 2.4.1 ). 
2.3.6.1 Colony PCR 
Colony PCR was used to screen for potential transfom1ants , gene disruptions in S.jlexneri 
strains, the presence of virulence plasmids , and for the isolation of chromosomal and 
virulence plasmid-encoded genes. Single colonies of the strain of interest or transfonnants 
were obtained by dilution streaking onto LB agar plates containing the appropriated 
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antibiotic. Individual colonies were suspended in I 00 µL of Milli-Q water and boiled at I 00 
~C for 10 minutes to disrupt bacterial cells. 5 µL of this crude bacterial lysate was mixed with 
0.125 µM of each prin1er, 0.2 mM of dNTPs, I x iTaq buffer, and 0.5 U of iTaq polymerase 
(Scientifics). This 20 µL PCR reaction mix then underwent the same PCR cycle parameters 
as described in Section 2.5.4 and amplified PCR fragments were visualized on agarose gels 
(Section 2.4. l ). 
2.4 Cloning techniques and DNA manipulations 
2.4.1 Restriction enzyme digestion 
Plasmid, chromosomal and PCR-amplified DNA samples were digested according to the 
manufacturer ' s instructions (New England BioLabs). In a standard digestion reaction 
containing about I µg DNA, 5-15 U of enzyme was used for cloning, and 2 U of enzymes for 
screening. Enzyme digestion reactions were arrested by either the addition of loading buffer, 
precipitation, or heat inactivation. In cases where DNA was digested with two different 
enzymes that failed to function in a single buffer, DNA was first digested with the enzyme 
requiring the lower-salt buffer, or alternatively, the enzyme that was more resistant to heat-
inactivation. The first enzyme reaction was halted by precipitation before digestion with the 
second enzyme was performed. 
2.4.2 Dephosphorylation of DNA 5'-termini 
Plasmjd DNA fragments linearized using single restriction endonucleases, were treated with 
calf intestinal alkaline phosphatase (CIAP, Fermentas) to cleave the 5' phosphate group. This 
was done to prevent plasmid re-ligation. For dephophorylation, linearized plasmids were 
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added to a reaction mixture with a final volume of 50 µL containing l x CIAP buffer and 
0.25- 1 U ofCIAP followed by incubation at 37 °C for 30 minutes. The CIAP enzyme was 
heat inactivated at 85 °C for 5 minutes. Plasmid DNA was then separated using agarose gel 
electrophoresis and purified as described in Sections 2.4.1 and 2.4.2 . 
2.4.3 Ligation reactions 
T4 DNA ligase (Promega) was used to ligate vector with insert DNA. Reactions containing 
vector to insert ratios of either, 1 :3 , 1:6, or l: 10, 1 x ligase buffer and 0.3- 1.0 U ofT4 DNA 
ligase in a final volume of 10 µL were incubated overnight at 15 °C. The ligated recombinant 
plasmids were then transfonned into electrocompetent cells or stored at -20 °C. 
2.4.4 Transformation of DNA into competent cells 
2.4.4.1 Preparation of electrocompetent cells 
Electrocompetent cells were used for all transformations as these cells show much higher 
transformation efficiencies compared to chemically competent cells. Overnight bacterial 
cultures were diluted I : 100 into 250 mL fresh LB (Appendix A), containing the appropriate 
antibiotics, and grown at 3 7 °C for E. coli strains and 30 °C for S. jlexneri strains, for 
approximately 3 hours, until the cells reached mid log phase (OD600 = 0.6 - 0.8). Cells were 
harvested by centrifugation at 9,500 x g, 4 °C for 10 minutes (Sorvall RC 5C Plus Centrifuge 
with SLA3000 rotor). All subsequent steps including centrifugation were carried out at 4 °C. 
The supernatants were discarded and bacterial pellets were washed thrice in sterile ice-cold 
Milli-Q water, twice in 100 mL and the last time in 50 mL. Cells were collected by 
centrifugation at 9,500 x g, 4 °C for 10 minutes after each wash. The cell pellets were then 
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resuspended in 25 mL steri le ice-cold Milli-Q water and transferred into 50 mL centrifuge 
tubes and centrifuged at 13,000 x g, 4 °C for IO minutes, using the SS-34 rotor. Pellets were 
then resuspended in I mL sterile cold 10% (v/v) glycerol, transferred into 2 mL eppendorf 
tubes and centrifuged at 16,000 x g, 4 °C for 5 minutes. Cell pellets were resuspended in 200-
400 µL of sterile cold 10% (v/v) glycero l. Aliquots of 40-50 µL were made into pre-chilled 
eppendorf tubes and cells were stored at -80 °C. 
2.4.4.2 Determining the efficiency of competent cells 
In order to detennine the efficiency of a batch of competent cells, 10 ng of plasmid, pBC SK 
DNA (Figure 2.1) was transformed into an aliquot of cells as described in Section 2. 7.3. l 00 
fold dilutions of the recovered cell suspension were plated onto LB agar plates containing 
chloramphenicol (25 µg/mL) and incubated overnight at 37 °C. Resulting colonies were 
counted to detennine the number of transformed cells in 1 mL of the original cell suspension. 
Efficiency was expressed as number oftransfonned cells per l µg of DNA. Therefore the 
figure determined from transfom1ing cells with IO ng of pBC SK was multiplied by 102. 
Efficiency varied depending on the type of cells but generally ranged from I 06-109 
transfonned cells/µg of DNA for E.coli and 104-105 transformed cells/µg of DNA for S. 
jlexneri. 
2.4.4.3 Transformation of DNA into electrocompetent cells 
Aliquots of electrocompetent cells were thawed on ice and between 2-4 µL of either plasmid 
DNA or ligation mixes were added. The DNA/cell mixtures were then transferred into pre-
chilled electrocuvettes (Bio-Rad). Electroporation was carried out using the Genepulser (Bio-
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Rad) set at 2.5 kV, 200 Q and 25 µFD. Immediately following electroporation, 1 mL of LB 
was added to the cuvette. The solution was then transferred to a clean eppendorftube and the 
cells were allowed to recover for I hour at 37 °C for £. coli strains and 30 °C for S.flexneri 
strains. Bacterial cells were collected by centrifugation at 16,000 x g for 2 minutes (Heraeus 
Instruments, Biofuge 13) and resuspended in I 00 µL of LB before spreading on an LB agar 
plate containing the appropriate antibiotics. Plates were incubated overnight at 37 °C for£. 
coli strains and 30 °C for S. flexneri strains. The resulting colonies were then screened by 
colony PCR (Section 2.5.5) or restriction enzyme digestion of isolated plasmids (Section 
2.6.1) to identify required clones. 
2.5 Screening techniques for cloned plasmids and gene disruption mutant strains 
2.5.1 Antibiotic selection 
25 µg/mL of chloramphenicol (Appendix A) added to LB or LB agar was used to select for 
cells containing the plasmid pBC SK or derivatives of the same. Lambda-red mediated PCR 
knockout strains, containing an integrated chloran1phenicol or kanamycin gene were selected 
on LB agar plates containing 35 µg/mL and 50 µg/mL (Appendix A) of chloramphenicol and 
kanamycin, respectively. I 00 µg/mL of ampicillin (Appendix A) was used to select for cells 
containing plasmids pBS KS , pKM208, and pKD46 or their derivatives. 
2.5.2 Blue-white screening 
Plasmids pBC SK and pBS KS have their polylinker located within a lacZ' gene fragment 
(Figure 2.1), thereby facilitating blue-white screening. Cells transformed with recombinant 
plasmids derived from pBC SK and pBS KS were selected on plates containing the 
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appropriate antibiotics as described in section 2.8.1. The resulting colonies were then patched 
onto LB agar plates containing 20 µg/mL iso-propyl-P-DD-thiogalactopyranoside (IPTG) , 20 
µg/mL 5-Bromo-4-chloro-3-indolyl P-D-galactopyranoside (X-Gal) and the appropriate 
antibiotics. Plates were incubated at 3 7 °C for 12-16 hours. Any blue colonies were discarded 
as this suggests that they produced functional Lacz protein, indicating that the polylinker was 
not disrupted by the insert. White colonies were positively selected for further screening by 
colony PCR (Section 2.5.5) or plasm.id MiniPrep and restriction enzyme analysis (Section 
2.6.1) as these indicate that the lacZ gene has been disrupted. Positive clones were finally 
confirmed by sequencing. 
2.6 PCR Lambda red recombinase gene disruption in S. jlexneri strains 
2.6.1 Generating knockout templates carrying antibiotic cassettes flanked by regions 
of homology to target genes of interest 
Genes of interest were cloned into pBS KS as described in Figure 2.3. Ligation mixes were 
transfotmed into electrocompetent E. coli JMI09 cells (Section 2.7.3) and transformants were 
screened by antibiotic selection and blue-white screening (Section 2.8.1 and 2.8.2). Primers 
flanked by restriction digest si tes were designed to create deletion within the gene of interest 
and introduce restriction enzyme sites into the deleted region (Figure 2.3). The cat and kan 
genes encoding chloramphenicol and kana.mycin resistance, respectively, were amplified 
from pKD3 and pACYC, respectively using primers flanked by the same restriction digest 
sites as above. Both PCR products were digested with the appropriate restriction enzymes and 
antibiotic cassettes were cloned into the deleted region of the gene of interest (Figure 2.3). 
Ligation mixes were transformed into electorcompetent E. coli JM I 09 cells and 
transfonnants were screened by antibiotic selection (Section 2.8.1 ). The antibiotic gene 
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flanked by 500 - 1000 bp regions of homology to the gene of interest, was isolated from the 
plasmid using PCR. 
2.6.2 PCR transformation into red-recombinase induced strains 
AS. jl.exneri strain of interest was transformed with either pKD46 or pKM208, helper 
plasmids (Table 2.3) carrying genes encoding enzyme required for A red-mediated 
homologous recombination (Figure 2.4). Electrocompetent cells of the S.jl.exneri strains 
carrying the helper plasmid were freshly prepared. Briefly, 125 mL of SOB media (Appendix 
A), containing JOO µg/mL ampicillin, was inoculated with 2.5 mL overnight culture and 
incubated at 30 °C for 1.5 hours. Expression of the helper plasmid was induced by the 
addition of 1 mM IPTG (for pKM208) or 100 mM arabinose (for pKD46) followed by an 
incubation period of 2 hours at 30 °C, to ensure that the heat sensitive helper plasmid and 
bacterial virulence plasmids were not Jost. Electrocompetent cells were ·prepared as described 
in section 2.7.1 and resuspended in 200 - 400 µL of I 0% (v/v) glycerol. Aliquots of 40- 50 
µL were used and - 1 - 2 µg of the appropriate knockout template was used to transform the 
freshly prepared S. jl.exneri electrocompetent cells, expressing the helper plasmid encoded 
genes. Cells were recovered in SOC media (Appendix A), containing 1 mM IPTG (for 
pKM208) or I 00 mM arabinose (for pKD46) and recovered for 3 - 4 hours at 30 °C. 
Recovered cells were plated on LB agar plates, containing the required antibiotic, and 
incubated at 30 °C for upto 3 days. Resulting colonies were routinely restreaked onto fresh 
LB plates containing the required antibiotics to eliminate contaminants and false positives. 
Colonies were screened for successful disruption by colony PCR (Section 2.5.5). Gene 
disruption mutants were sequenced to confirm the insertional inactivation of target genes. 
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A: Gene of in terest with it's flanking regions amplified from the bacterial chromosome using PCR 
C: An internal deletion 
created in the gene of 
interest us ing PCR 
+ 
l 
--B: Digestion with 
l appropriate restriction enzymes and ligat ion into vector 
l D: Required antibiotic resistance gene flanked by 
appropriate restriction 
enzyme sites amplified using 
+ PCR i 
-
l E: Digestion with appropriate restriction enzymes and ligation of the antibiotic 
F: Isolation of knockout 
template DNA using PCR 
Knockout template DNA 
transformed into freshly 
prepared lambda red 
recombinase 
electrocompetent cells 
Figure 2.3: Schematic representation of the steps involved in the generation and isolation of 
a knockout template for the PCR-mediate targeted gene disruption. A: The gene of interest is 
first isolated from the bacterial chromosome using PCR and (B) cloned into an appropriate 
cloning vector (pBS KS is used in this study as this vector carries the ampicillin resistance 
gene thus allowing for antibiotic screening for insertion of the cat and ka,l genes). C: An 
internal deletion is created in the gene of interest using primers Pl and P2 carrying 
appropriate restriction enzyme sites. D: The required antibiotic resistance gene cassette (cat 
and ka,l genes were used in this study) is amplified using the same restriction enzyme sites 
cloned into the gene of interest. E: The vector (pBS KS + gene of interest with internal 
deletion) and insert (antibiotic cassette) are digested with the selected restriction enzyme and 
ligated together. Ligation mixes are transformed into appropriate E. coli strains and 
transfonuants are identified by antibiotic selection (positive clones are resistant to both 
chloramphenicol/kanamycin and ampicillin). F: PCR reactions using primes P3 and P4 were 
set up to isolate the knockout template. 
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Figure 2.4: Schematic representation of the lambda red-mediated recombineering approach 
for gene disruption. In this technique a knockout template carrying an antibiotic cassette 
flanked by - 500-1000 bp regions of homology to regions flanking the target gene, is 
transformed into the strain of interest carrying a helper plasmid (pKD46 or pKM208) 
expressing the lambda phage genes y, ~, and exo whose products are required to prevent 
degradation oflinear DNA and for homologous recombination. Introduction of the knockout 
template into S.jlexneri strain carrying the helper plasmid, the large regions of homology 
facilitate homologous recombination producing a double cross-over reaction resulting in the 
replacement of the target gene with the antibiotic cassette. 
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2. 7 Characterization of gene disruption mutants 
2.7.1 Growth curves 
Overnight bacterial cultures were di I uted I :20 by adding 5 µL of bacterial culture to I 00 mL 
of LB or minimal essential salts media (MM) (Appendix A), this dilution was designated 
time 0, the culntres were incubated at 30 °C and 37 °Cina shaking incubator (180 rpm). At 
30 minute intervals, I mL of culture was transferred to a microcuvette and the optical density 
of the suspension was measured at 600 run on a visible light spectrophotometer (Phillips SP6-
550), against an LB blank. Graphs of the optical density versus time were plotted to generate 
growth curves. 
2. 7.2 Measurement of asparaginase and glutaminase activity 
The asparaginase and glutaminase activities of SFL 1520, SFL2283 and SFL2285, were 
measured using the ammonia assay kit (Sigma) with log phase culture supernatants , 
according to the manufacturer' s instructions. Briefly, fresh log phase cells were harvested and 
washed once in I x phosphate buffered saline (PBS), and 3 x 108 colony fanning units (CFU) 
of bacteria was resuspended in 1 ml of I x PBS with 5 mM asparagine or glutamine. Aliquots 
were collected after 30, 60, 90 and 180 minutes of incubation at 37 °C and centrifuged to 
precipitate bacterial cells. The ammonia concentration in the cell-free supernatants was 
measured using the ammonia assay kit, according to the manufacturer ' s guidelines. 
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2.8 RNA methods 
2.8.1 Isolation of total bacterial RNA 
Overnight cultures of S. jlexneri strains grown at 30 °C (to maintain virulence plasmids) were 
diluted I :50 in LB or MM media and grown to mid log phase (OD6oo = 0. 7-0.8) at 37 °C. The 
volume of bacterial cultures corresponding to l x 109 CFU was estimated (Section 2.13.3) 
and bacterial cells were harvested by centrifugation. Bacterial pellets were treated with with I 
mL ofTRIZOL reagent (Invitrogen) and tubes inverted 20 times fo llowed by incubation at 
room temperature for 5 minutes. 200 µL of chlorofonn was added to cell suspensions and 
samples were agitated vigorously and incubated at room temperature for 15 minutes to 
precipitate proteins. Samples were centrifuged at 12,000 x g for IO minutes at 4 °C following 
which the aqueous phase containing RNA and some contaminating DNA, was collected. The 
chloroform treatment was repeated to eliminate contaminating DNA. The aqueous phase 
collected after the second chlorofom1 treatment was treated with 500 µl of ice-cold 
isopropanol and incubated at -20 °C overnight to precipitate bacterial RNA. RNA was 
collected by centrifugation at 12,000 x g, for 20 minutes at 4 °C. RNA pellets were washed 
using l mL of freshly prepared 75% ethanol. RNA pellets were air-dri ed and dissolved in 50 
µl of nuclease-free water. The isolated RNA was cleaned up using the Qiagen RNeasy Kit, 
this step was performed to remove any residual DNA and organic salts. The amount of RNA 
isolated was quantified (Section 2.3 .3). One microgram of isolated RNA was treated with 20 
units of Turbo DNase (Ambion) to eliminate any contaminating genomic DNA. 
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2.8.2 Reverse transcription polymerase chain reaction 
200 ng ofDNase treated RNA was used to set up reverse transcription reactions using 
Superscript II (Invitrogen) and random hexamer primers according to the manufacturer ' s 
instructions. All reactions were set up with a negative control containing no reverse 
transcriptase (NRT) to ensure that the RNA preparations were free of genomic DNA. l µl of 
cDNA along with the NRT was used to set up PCR reactions (Section 2.5.4) using gene-
specific primer to detem1ine if the target genes were expressed under the conditions studied. 
2.8.3 Quantitative real time reverse transcriptase PCR (qRT-PCR) 
qRT-PCR was performed on the cDNA samples using the power SYER Green RT-PCR kit 
(Applied Biosystems) according to the manufacturer' s instructions except, primers were used 
at a final concentration of0.4 µMand the final reaction volume was reduced to IO µl from 
the reconunended 20 µl. Expression of hisG was used as a control to normalize the 
expression of all bacterial genes as the expression of this housekeeping gene should remain 
constant in all bacterial strains used in this study. All qRT-PCR reactions were performed in 
triplicate with a NRT and NTC set up for each run. Reactions were run in a Rotor-Gene Q 
Real-Time cycler (Qiagen) with the following program; 
Initial Denaturation Step 95 °C for IO minutes, x I 
Denaturation Step 95 °C for 15 seconds, x 45 
Primer annealing Step 55 °C 15 seconds, x 45 
Hold step I 40 °C for 5 minutes, x 45 
Hold step 2 55 °C for l minute, x I 
Melt 55 °C to 99 °C, with I °C increase in every IO seconds. 
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The Rotor-Gene Q series software package (Qiagen) was used to analyse the results of qRT-
PCR runs and melt curves were also examined for each run to ensure that reactions were free 
of non-specific products and primer dimers. 
2.9 Protein methods 
2.9.1 1-D SDS PAGE and western blotting 
2.9.1.1 Preparation of whole cell Iysates 
Log phase cultures of bacterial strains were obtained and the volume corresponding to l x 
JOJO CFU was detem1ined (Section 2.13.3). Bacterial cells corresponding to 1 x JOJ O CFU 
were harvested by centrifugation and the cell pellets were washed in 1 x PBS and 
resuspended in the appropriate amount of2 x sample loading buffer (Appendix A). Samples 
were boiled for IO minutes and loaded onto 12% SOS-PAGE gels. 
2.9.1.2 Isolation of secretory proteins 
Overnight cultures of the required S. jlexneri strains were diluted 1 :20 in LB broth and grown 
to late log phase (OD6oo = 0.8 - 0.9) at 37 °C. The secretion of type 3 effector proteins was 
induced by adding Congo red (final concentration IO mM) following which cells were 
incubated at 3 7 °C for 30 minutes. Bacterial cells were harvested by centrifugation and the 
supematants were passed through 0.45 µM filters (Sartorius) to eliminate cellular debris. 
Secretory proteins were precipitated using 25 % trichloroacetic acid (TCA) in acetone and 
incubation on ice for 20 minutes. Protein precipitates were collected by centrifugation at 
8,500 x g, for 10 minutes at 4 °C and washed twice using acetone. Mild sonication using a 
sonic water bath was used to suspend protein pellets in acetone. Washed protein pellets were 
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allowed to dry completely following which they were resuspended in solubilization buffer 
(Appendix A). Protein concentration was estimated using tbe BCA kit (Pierce) according to 
the manufacturer ' s instructions and 20 µg of supernatant protein samples were loaded onto 12 
% (v/v) SDS-PAGE gels for Western blots. 
2.9.1.3 lD SDS- PAGE gel preparation and electrophoresis 
Mini SDS-PAGE gels were cast using the Mini-Protean electrophoresis apparatus (BioRad). 
5 mL of 12% resolving gel mixture was prepared fresh and poured into the gel cast unit, 0.1 % 
SDS was gently overlaid on top of the unploymerized gel to prevent drying, and the gel was 
allowed to polymerize at room temperature for 30 minutes. The SDS solution was then 
replaced with 2 mL of 5% stacking gel mixture and the required combs were inserted and the 
gel was allowed to polymerize for 45-60 minutes. After tbe gel set, the comb was removed, 
the wells rinsed out with 1 x SDS-PAGE running buffer (Appendix A) and the gel was placed 
in the electrophoresis tank. Both the inner and outer chambers of the tank were filled with 
running buffer, protein samples were loaded and allowed to separate at 100-150 V until the 
dye front reached the end of the gel. The Prestained Page-Ruler ladder (Fermentas) was used 
as a marked (Figure 2.5) 
2.9.1.4 Coomassie staining of SDS-PAGE gels 
The SDS-PAGE gels were soaked in Coomassie Brilliant Blue R250 dye (Appendix A) 
overnight to allow for visualization of protein bands. Excess stain was washed off and the 
gels were treated with destain solution (Appendix A) for 2-3 hours until the background stain 
faded and the protein bands were clearly visible. 
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Figure 2.5: The PageRuler Prestained protein ladder (Fermentas) used in SDS-PAGE gels. 
Sizes indicated are only approximate, the lot-specific exact marker sizes are provided with 
each batch of marker. (Figure adapted from Frementas). 
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2.9.1.5 Western blotting 
Protein concentrations were estimated using the BCA kit (Pierce) according to the 
manufacturer's instructions following which the appropriate amount of each protein 
preparation was loaded onto two 12% SDS-PAGE gels and allowed to separate (Section 
2.12.1.3). One of the gels were stained with Coomassie Brilliant blue R250 to ensure equal 
loading of samples. Once samples were equalized the separated proteins on the second gel 
were transferred onto Hybond-P PVDF membranes (Millipore) and blocked in 5% skimmed 
milk in I x PBS at 4 °C overnight. Following blocking the membranes were washed thrice in 
1 x PBS containing 0.05% (v/v) Tween-20 (PBST) (Sigma). Membranes were then incubated 
with the primary antibodies (A11ti-lpaB and Anti-lpaD antisera generated in-house in mice or 
aHp-BamA obtained from Trevor Lithgow, Monash University) for 2 hours. Unbound 
antibodies were washed off using three washes with PBST as outlined above, following 
which the membranes were incubated with the secondary antibodies (Anti-mouse lgG; 
Sigma) for I hour. Membranes were washed thrice using PBST. The binding of antibodies 
was then detected by chemiluminescence using SuperSignal West Pico Chemiluminescent 
Substrate (Pierce) as described by the manufacturer. Chemiluminescence was then detected 
using the Fisher Biotec chemiluminescence system. 
2.9.2 Differential in gel electrophoresis (DIGE) and liquid chromatography mass 
spectrometry (LCMS) 
2.9.2.1 Isolation of total bacterial protein for differential in gel electrophoresis 
Overnight cultures of SFL1520 (wild type parent), SFL2283 (6.ansB) and SFL2285 (6.ggl) 
grown at 30 °C, were diluted 1: 100 in LB media and grown to log phase at 37 °C. Bacterial 
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cells were harvested by centrifugation and washed thrice using cell wash solution (Appendix 
A). Bacterial pellets were resuspended in 500 µI of cell lysis buffer (Appendix A) and 
incubated on ice for IO minutes. Subsequently, the suspensions were sonicated l O times for 
15 s with 30 s intervals on ice. Cellular debris was sedimented by centrifugation at 14,000 x 
g, 4 °C for IO minutes. Supernatants were treated with IO volumes of ice-cold acetone and 
incubated at -20 °C overnight to precipitate proteins. The protein pellets were washed thrice 
using ice-cold acetone and air dried. Acetone-free proteins were solubilized in 200 µI of cell 
lysis buffer (Appendix A) and pH was adjusted to 8.5. 
For DIGE, total protein from wild type and both mutant strains were isolated from four 
independent experiments. Protein concentration was determined using the BCA kit (Pierce) 
and Bradford method [303]. 500 µg of each protein sample was labeled with fluorescent dyes 
Cy3 or Cy5 (GE Healthcare), an internal standard, consisting of 250 µg of each sample, was 
labelled with Cy2. Samples were labeled with CyDye DIGE Fluors (minimal dyes) from the 
Ettan DIGE kit (GE Healthcare), according to the manufacturers ' instructions with minor 
modifications as described by Mathesius et al. [304]. Briefly, 500 µg of each protein sample 
was labeled with 400 pmol amine reactive cyanine freshly dissolved in anhydrous dimethyl 
formamide (DMF). CyDye labeling was carried out on ice and in the dark for 30 minutes. 
Each reaction was terminated using IO nrnol lysine to eliminate any unbound dye. Labeled 
samples were treated with DTT (20 mg/ml) and Bio-arnpholytes (50 µI/ml). To identify 
differences in the proteomes of wild type and mutant S.jlexneri strains, 500 µg of total 
protein from the wild type parent (SFLI 520) labeled with Cy3 or Cy5 was combined with 
500 µg of oppositely labeled proteins from each mutant strain. Each wild type-mutant pair 
was then mixed with 500 µg of the combined protein preparations labeled with Cy2 as an 
internal control. 
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2.9.2.2 2-D electrophoresis 
2-D electrophoresis was performed in darkness to maintain the stability of the Cy dyes. 
Immobiline pH 3-10 or 3-7 NL Drystrips (24 cm, GE Healthcare) were used for the first 
dimension isoelectric focusing (IEF). The strips were rehydrated overnight in rehydration 
solution (Appendix A). Wild type-mutant pairs with internal controls were loaded onto 
rehydrated Immobiline strips and IEF was carried out in a Multiphor II Electrophoresis 
System (GE Healthcare) at 20 °C for a total of 35,000 volt hours [304]. For separation of 
proteins across the second dimension, self-cast 12.5% SDS-PAGE gels were prepared using 
the EttanDaltsix system (GE Healthcare). The gels were cast using low fluorescent glass 
plates, which are compatible with the Ettan DIGE system. Focused first dimension strips 
were equilibrated as described by [304] and placed on the second dimension gels. SDS-
PAGE was carried out at 10 °C in SDS ruru1ing buffer (Appendix A) at 600 V, 10 mA, and 
2.5 W per gel for the first hour; 600 V, 40 mA, and 13 W per gel until the brornophenol blue 
front reached the bottom of the gel. 
2.9.2.3 Gel imaging and image analysis 
After second dimension electrophoresis, DIGE-labeled proteins were visualized using a 
Typhoon Trio laser scanner (GE Healthcare). Gels were scanned with the specific excitation 
wavelengths of <:::y3 (532-nm laser and a 580-mn band pass 30 emission filter) , Cy5 ( 633-11JTI 
laser and a 670-mn band pass 30 emission filter) and Cy2 (488-nm laser and a 580-nm band 
pass 40 emission filter). Spot detection and analysis was carried out using the DeCyder 
Version 5 (GE Healthcare) software package followed by careful manual confim1ation and 
rematching of matching errors. Statistics and identification of differentially expressed spots 
were carried out in the DeCyder DIA and BV A modules ( one-way ANOV A). 
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2.9.2.4 In gel trypsin digestion of protein spots and LC-MS 
After analysis of gel images identified spots of interest were excised from the 2D-DIGE gels 
using an Ettan spot picker (GE Healthcare). The spot picker was calibrated and tested several 
times prior to spot excision. In-gel trypsin digest was carried out as described by Mathesius et 
al. [304) with a few modifications. Briefly, excised protein spots were washed four times in 
acetonitri le: 50 mM ammonium bicarbonate (50:50, v/v) . Spots were then dried in 100% 
acetonitrile for 30 minutes fo llowing which they were air dried to eliminate all acetonitrile. 
Gel pieces were rehydrated using a trypsin solution (20 units; Promega) and incubated for 2 
hours at 4 °C (to allow the trypsin solution to diffuse through the gel) followed by overnight 
incubation at 37 °C. Peptides were then extracted from the gel pieces using an extraction 
buffer consisting of acetonitrile: water: trifluoroacetic acid (TFA) (50%:50%: I%, v/v) 
followed by gentle sonication in a sonic water bath for 40 minutes. This extraction step was 
performed twice using a reduced volume of extraction buffer and 20 minutes sonication the 
-
second time round. Peptides were collected and dried completely to remove all traces ofTFA. 
Dried peptides were resuspended in 20 µl of acetonitrile: water: fonnic acid 
(10%:89.9%:0.1 %, v/v). Digested, desalted peptides were identified by LC-MS/MS (at the 
Mass spectrometry facility, The Australian National University, ANU). Proteins were 
identified through MS/MS spectra using the MASCOT database (Matrix Science). One 
missed cleavage per peptide was allowed and a mass tolerance between 0.3 and 0.1 Da was 
used in most searches, unless otherwise specified. Carbamidomethylation was set as a fixed 
modification and oxidation (M) as a variable modification . 
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2.10 Cell culture 
Baby hamster kidney (BHK) cells were routinely grown at 37 °C in Minimal essential 
medium (MEM) FIS (lnvitrogen) supplemented with 10% (v/v) foetal calf serum (FCS) 
(GIBCO) in a 5% CO2 humidified atmosphere. For adherence and invasion assays, cells were 
inoculated in 6-well tissue culture plates at 6 x 103 cells/well in 3 mL media and grown to 75-
80% confluency. For the coverslip adherence assay, sterilized coversilps were placed into the 
wells of 6-well plates and BHK cells were grown over the covers lips. 
2.10.1 Subculturing cells 
The epithelial cell line, BHK was used in all tissue culture assays in this thesis. The cells 
were grown in 25 cm2 or 75 cm2 tissue culture flasks (Falcon, Becton Dickinson) to 70% 
confluency. MEM with 10% (v/v) FCS and 200 µg/mL of neomycin and streptomycin and 
120 µg/mL of penicillin was prewam1ed to 37 °C. The media in the flasks was poured off and 
5 mL sterile l x PBS (Appendix A) was added to wash off any remaining media. This 
washing step was repeated and followed by the addition of2 mL of0.05% (w/v) Trypsin-
0.20% (w/v) EDTA. The flask was incubated at 37 °C for approximately 5 minutes. The 
reaction was halted by the addition of 4 mL ofMEM as soon as the cells began to lift off the 
floor of the flask. Trypsinized cells were resuspended in the media by gentle pipetting to 
obtain a unifonn solution. IO µL of this solution was treated with an equal volwne of 0.4% 
(w/v) trypan blue and incubated at 37 °C for 5 minutes. JO µL of this solution was loaded 
onto a haemocytometer to determine the number of viable cells per mL (Section 2.13.2). 
About l.5 x 105 cells were used to seed a new 25 cm2 flask containing 10 mL MEM/FCS and 
1.7 x 106 cells were used to seed a 75 cm2 flask containing 20 mL MEM/FCS. Flasks were 
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incubated at 37 °C, 5 % CO2. Media was changed every 2 days until the next passage was 
required. 
2.10.2 Counting cells with a haemocytometer 
Cells were counted using the Improved Neubauer Haemocytometer from Baxter Scientific. 
The cell suspension was dropped onto the edge of the haemocytometer and the solution was 
pulled under the cover slip by capillary action. The slide was viewed using a light microscope 
under 100 X magnification and the number of dye excluding cells in each of the four corner 
squares and the centre square were counted. The number of cells in the squares was averaged 
and this number was multiplied by 104 to give the number of cells per mL. 
2.10.3 Preparing bacterial inocula for in vitro cell culture assays _ 
Overnight cultures of required bacterial strains were diluted 1: I 00 in LB containing the 
appropriate antibiotics and allowed to grow to log phase (OD600 = 0.6 - 0.8) at 37 °C. 
Bacterial cells were harvested from 50 mL of cultures by centrifugation and washed using ice 
cold 1 x PBS. Washed cells were resuspended in I mL of I x PBS and the number of cells in 
the suspension was calculated using an absorbance-based method. Briefly, bacterial pellets 
were resuspended in 750 µL of ice cold Ix PBS and transferred into pre-chilled eppendorf 
tubes. Cells were washed using I x PBS and resuspended in 200 µL of ice cold PBS by 
vigorous vortexing. 7, 8, 9, and 10 µL ofresuspened cells were transferred to eppendorftubes 
containing 1 mL l x PBS and the optical density of the cell suspensions was measured at 600 
run on a visible light spectrophotometer (Phillips SP6-550), against a PBS blank. The volume 
of cell suspension corresponding to 0.D. 600=1 was detennined as the number of cells at this 
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OD is assumed to be around 2.5 x I 08 CFU/mL, from previously generated growth curves. 
Using this information, the volume of cell suspensions corresponding to 2.0 x 108 CFU/mL 
was resuspended in cell cnlture media to obtain the bacterial inoculum for all cell culture 
assays. I 00 µL of the inoculum was removed and used to make serial dilutions. The 
appropriate dilutions were plated in duplicate to obtain the bacterial count in the infecting 
inoculum. The remaining bacterial inoculum was supplemented with the appropriate 
antibiotic to maintain selection for any introduced plasmids. The tubes were kept on ice while 
the BHK cells were prepared for cell culture assays. 
2.10.4 Preparing BHK monolayers for in vitro cell culture assays 
The BHK monolayers grown to 70-80% confluency in 6-well plates were washed twice using 
I X PBS. I mL prewam1ed, cell culture media containing no antibiotics or FCS was added to 
each well and monolayers were incubated at room tempreature for 10 minutes. The medium 
was removed and 2 mL of each bacterial inoculum (Section 2.13.3) was gently applied to 
duplicate wells. The plates were centrifuged at 2,400 x g for 10 minutes at room temperature 
(Beckman GS-6R Benchtop Centrifuge). 
2.10.5 Invasion Assay 
Two 6 well plates were seeded with BHK cells and grown to confluency over 3 days. Two 6-
well plates were required for this assay; an intracellular bacterial plate and a total bacterial 
plate with 2 wells per sample on each plate to carry out the assay in duplicates. BHK 
monolayers infected as described in section 2.13.4 were incubated at 37 °C, 5% CO2 for 2 
hours to allow bacterial invasion of the epithelial layer. Monolayers were washed twice using 
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1 mL 1 x PBS to wash off any unbound bacteria. The wells on the intracellular bacterial 
plates were treated with 1 mL MEM + 10% FCS +16 µg/mL gentamycin. Gentamycin cannot 
penetrate epithelial cells therefore this antibiotic kills bacterial cells on the surface of the 
monolayer and not intracellular bacteria. The wells on the total bacterial plates were treated 
with 1 mL MEM + I 0% FCS (so all attached extracellular bacterial + intracellular bacteria 
survive). Plates were incubated at 37 °C for 2 hours and washed thrice in 1 x PBS to remove 
any killed or unattached bacteria. 200 µL of0.05% (v/v) Triton X-100 in Ix PBS was added 
to each well and incubated at room temperature for 10 minutes to lyse the marrunalian cells. 
800 µL of LB was added to each well and agitated with a Pasteur pipette to obtain 
homogenous suspensions of bacterial cells. Solutions were transferred into eppendorftubes 
and placed on ice. The bacterial cell suspensions obtained from each well were serially 
diluted in 1 x PBS and appropriate dilutions were plated on duplicate LB agar plates 
containing the appropriate antibiotics . Plates were incubated overnight at 37 °C and colonies 
obtained were counted and used to calculate the number of intracellulaF and total-associated 
bacteria for each strain. 
% Intracellular Bacteria= 
% Adherent Bacteria = 
% Invasion= 
Average Number of Bacteria counted on Intracellular plate 
- ------------------ X 100 
Number of Bacteria in Inoculum 
Average Number of Bacteria counted on Total plates 
X 100 
Number of Bacteria in Inoculum 
Average Number of Bacteria counted on Intracellular plates 
X 100 
Average Number of Bacteria counted on Total platl 
80 
2.10.6 Bacterial adherence assay 
BHK cells in 6-well plates were infected with 4 x 108 CFU of each strain. Bacterial cells were 
allowed to infect the monolayer for 90 minutes at 37 °C, 5% CO2. Unbound bacterial cells 
were washed off the BHK monolayer using I x PBS after which the mammalian cells were 
lysed using 0.05% (v/v) Triton-X in Ix PBS. Appropriate dilutions of the cell lysates were 
plated on LB agar plates carrying the approptiate antibiotics to determine the number of 
adherent and intracellular bacterial cells. 
2.10.7 Coverslip adherence assay 
The coverslip adherence assay was perfom1ed based on the protocol developed by Cravioto et 
al, [305]. Briefly, overnight cultures of all S.jlexneri strains grow at 30 °C were diluted and 
grown to Jog phase at 37 °C (OD6oo = 0.6-0.8). 4 x 108 CFU of each strain was used to infect 
a confluent layer ofBHK cells grown on coversilps placed within wells of 6-well culture 
plates. The plates were incubated for 90 minutes at 37 °C to allow for infection. The 
coverslips were washed thrice in 1 x PBS to remove any unbound bacterial cells. Samples 
were fixed using fresh 70% (v/v) methanol following which they were stained with I 0% 
Giemsa stain for 30 minutes. Excess stain was washed off. Coverslips were mounted on glass 
slides and examined using an oil immersion lens. 
2.11 Mouse studies 
All animal work was performed under the approval of the ANU Animal Experimentation 
Ethics Committee. 
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2.11.1 In vivo studies: mouse pulmonary model 
6-8 week old female Balb/c mice weighing approximately 20-25 g (Animal Resource 
Centre, WA) were inoculated intranasally with a sub-lethal dose (2 x JO 7 CFU/ 10 µL) of the 
pathogenic wild type SFLl520 strain, SFL2283 (!':iansB) or SFL2285 (!':iggt). The mice were 
lightly anesthetized with isoflurane prior to inoculation. 20 mice were euthanized 24 and 48 
hours post infection and their lungs were extracted and homogenized in PBS with 0.05% 
Triton-X. Appropriate dilutions of the homogenates were plated on LB agar with antibiotics, 
where appropriate, to obtain the live counts of intracellular bacteria per lung. 
2.11.2 Monitoring infected mice 
Infected mice were monitored for 48 hours post infection for the development of symptoms. 
Weights were recorded over this period and the degree of sickness was scored. Based on the 
symptoms of illness displayed, mice were scored as healthy, moderately healthy, mildly sick, 
medium sick, sick and severely sick as described below; 
Symptom Score Key 
I. Healthy: Smooth coat, groomed, active 
2. Moderately Healthy: Showed slightly ruffled coats otherwise appeared 
healthy 
3. Mildly Sick: Showed slightly ruffled coats, slight hunch and slight 
lethargy 
4. Medium Sick: Showed ruffled coats, slight hunch and lethargy. 
5. Sick: Showed ruffled coats, pronounced bunching and 
lethargy 
6. Severely Sick: Showed a very ruffled coat, acutely hunched and 
immobile 
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2.12 Bacteriophage techniques 
2.12.1 Propagation of bacteriophage 
U.V. induction was used to induce bacteriophage Sill from the serotype 2a S.jlexneri strain 
NCTC4 (SFL2345) [ 156] An overnight culture of SFL2345 was diluted 1: 10 in LB media 
and grown to log phase at 37 °C. Bacterial cells were harvested by centrifugation and 
resuspended in half the original volume of 10 mM MgS04. Half of the cell suspension was 
transferred into a petri dish and irradiated with U.V. light for 2 minutes using a U.V. lamp 
placed l O cm above the culture plate. An equal volume of LB media was added to the 
irradiated cells and cultures were incubated overnight at 37 °C. The remaining bacterial 
suspension was also incubated overnight as a non-irradiated control. Bacteriophage SfV was 
isolated from overnight cultures of SFLI 693, an SfV lysogenized SFLl. SfV is unstable in 
this strain therefore growing SFL1693 overnight at 37 °C leads to the spontaneous induction 
of SfV. The overnight cultures carrying induced bacteriophage were treated with chlorofonn 
and the bacteria/phage mix was incubated at 37 °C for 25 minutes. Unlysed bacterial cells 
and other cellular debris were collected by centrifugation and the supernatant containing 
bacteriophages was passed through a 0.45 µm filter to collect bacteriophage stocks. 
Bacteriophage stocks of Sfll and SfV were collected and propagated on a serotype Y strain, 
SFL124 (SFL1353) [306] . For propagation, equal volumes ofa log phase culture ofSFL1353 
in NZCYM medium (Appendix A) were added to phage stock incubated overnight at 37 °C 
with shaking. 
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2.12.2 Titration of phage 
Phage numbers in stock solutions were titrated by measuring the efficiency ofplaquing 
(EOP) . Overnight bacterial cultures were diluted I :20 in LB media and grown to log phase at 
30 °C with shaking. 3 mL aliquots of soft agar (Appendix A) was prewam1ed to 42 °C. Serial 
dilution ( I 01-108) of phage stocks were made in SM buffer (Appendix A) and I 00 µL 
aliquots of each dilution added to appropriately labeled eppendorftubes. Equal volumes of 
log phase bacterial culture was added to each eppendorftube and the phage/bacteria mix was 
incubated in a water bath at 37 °C for 20 minutes. The phage/bacteria mix was added to the 
prewarmed soft agar, mixed gently, poured onto a LB agar plate and allowed to set. Plates 
were incubated overnight at 37 °C and the number of plaques on each plate were counted and 
the number of plaque forming units per mL (PFU/mL) was calculated to detennine the 
bacteriophage titer in the original stock. 
2.12.3 Purification of bacteriophage 
Purification of SfII and SfV phage preparations was performed as described for phage 
lambda [30 I]. An overnight culture of phage/bacteria mix treated with chloroform (Section 
2.15.l) was transferred into centrifuge bottles and centrifuged at 8,250 x g, 4 °C for 10 
minutes in a Sorvall RC SC Plus centrifuge, using a SLA300 rotor. The supernatants were 
transferred into fresh centrifuge bottles and centrifuged again to remove any remaining 
bacterial cell debris . Supernatants were collected and treated with I µg/mL of both RNase 
and DNase (Sigma), and stirred at room temperature for 30 minutes. 5.84% (w/v) NaCl was 
added to each solution and stirred for 8 minutes, following which the mixtures were 
incubated on ice for 60 minutes. Solutions were centrifuged at 13,000 x g, , 4 °C for 20 
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minutes. Supernatant were transferred into sterile flasks and 10% (w/v) Polyethylene glycol 
(PEG) was added, following which solutions were stirred slowly at room temperature until all 
the PEG dissolved. This was followed by incubation on ice for 60 minutes and centrifugation 
at 16,000 x g, 4 °C for 20 minutes. The precipitated phage pellets were dried and resuspended 
in a minimal volume of gelatin-free SM Buffer (Appendix A). Any residual PEG was 
removed by chlorofonn extraction. The resulting phage suspension was purified by CsCl 
density gradient centrifugation (final density of solution= 1.40-1.45 g/ml) at 110,000 x g for 
24 hat 15 °C in a swinging bucket rotor. Resulting phage bands were aspirated and dialysed 
against l L of gelatin-free SM buffer containing I M NaCl at 4 °C overnight followed by two 
repeated dialysis in l L of SM buffer for 3 h at room temperature. Dialysed phage 
preparations were filter sterilized and stored at 4 °C. 
2.12.4 Isolation of bacteriophage DNA 
Purified bacteriophage preparations were extracted with chloroform thrice to remove any 
residual PEG and cellular debris. The aqueous phase collected from each chlorofonn 
extraction was treated with 150 µg ofproteinase K (Roche) in 0.5% SDS, 20 mM EDTA, JO 
mM Tris-HCI and incubated at 55 °C, for 30 minutes to disrupt bacteriophage particles and 
release phage DNA. DNA was extracted using an equal volw11e of phenol and the aqueous 
phase was collected and extracted with phenol thrice followed by a final extraction with 1: J 
phenol :chloroform. The aqueous phase was collected and dialysed overnight at 4 °C with 
stirring and three changes of TE buffer (Appendix A) to remove all traces of phenol. Purified 
phage DNA was removed from the dialysis tubing and stored at 4 °C. 
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2.12.5 Determining bacteriophage host range 
To determine the host range ofbacteriophages Sil and SN, 20-50 µl of purified phage 
preparations were streaked across LB agar plates. Once phage streaks were completely dry, 
overnight cultures of the required bacterial host strains were streaked across the 
bacteriophage streak. Plates were incubated overnight at 30 °C to allow bacteriophage 
particles to infect each host strain tested. After incubation, the appearance of lysis zones on 
the bacterial streaks across the bacteriophage streak was examined. Bacterial strains were 
categorized as susceptible to bacteriophage infection (S) if they showed zones of lysis and 
resistant to bacteriophage infection (R) if they failed to display zones of lys is. 
2.13 C. elegans techniques 
2.13.1 C. elegans strains and growth conditions 
Unless otherwise stated all C. elegans strains were obtained from the Caenorhabditis 
Genetics Center (CGC, University of Minnesota, USA). The C. elegans wild type N2 strain 
[300] was routinely used in this study. A hsp-6::GFP transcriptional reporter strain-SJ4 100 
(provided by Carolyn Behm, ANU) was also used in this study to monitor the expression of 
HSP-6 in nematodes infected with various S.jlexneri strains. Nematodes were maintained at 
22 °Con modified nematode growth medium (NGM, 0.35% peptone) agar medium seeded 
with E. coli OPSO [226]. To prevent the formation of dauer worms were transferred onto 
fresh E. coli OPSO lawns. 
86 
2.13.2 E. coli strains 
C. e/egans were cultured with E. coli OP50, (CGC), an auxotrophic mutant deficient in uracil 
production, as a result of which it grows slower than the wild type strain [300]. For all RN Ai 
feeding experiments the E.coli HTl 15 (DE3) was used, as this strain lacks RN Ase Ill and 
expresses the T7 polymerase on exposure to IPTG [277] . 
2.13.3 Obtaining a synchronized population of young adult Nematodes 
A mixed population of worms was chuncked onto E. coli OP50 lawns on 9 cm or 15 cm 
NGM plates. Worms were allowed to grow for 2-3 days at 22 °C until there were lots of eggs 
and gravid adults on the plates. Eggs and adult wom1s were then transferred into 15 or 50 mL 
falcon tubes using 2-5 mL of sterile S-basal (Appendix A) and allowed to sediment for 5-10 
minutes at room temperature. The S-basal solution was removed and 500 µI of alkaline 
hypochlorite solution (Appendix A) was added to the tubes. Worm pellets were agitated by 
vigorous vortexing for 90 seconds at room temperature and tubes were filled with S-basal. 
Eggs were collected by centrifugation at 500 x g for 3 minutes. Eggs were washed with S-
basal several times, to remove all the belach. 5 mL of S-basal was added to the tubes and 
eggs were allowed to hatch overnight at room temperature with shaking. L 1 ' s were then 
concentrated by centrifugation at 500 x g for 3 minutes, following which they were quantified 
and seeded onto E. coli OP50 lawns and allowed to grow to the L4 stage at 22 °C. 
2.13.4 Liquid killing assays 
Overnight cultures of S. jlexneri strains maintained at 30 °C were diluted 1 :50 in LB media 
and grown to log phase at 37 °C (OD600 = 0.6-0.8). A synchronized population ofL4 stage C. 
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elegans wonns collected off E. coli OP50 plates, was treated with 200 µg/mL of gentamycin 
for 3 hours and washed thoroughly with S-basal to remove any residual antibiotic. This 
antibiotic treatment was to remove any surface-bound E. coli OP50 cells. Approximately 20-
50 washed L4 's were transferred into each well of a 24-well plate containing 100 µL of the 
appropriate log-phase bacterial culture to be tested. The volume of solution in each well was 
adjusted to 500 µL with S-basal and plates were incubated at 22 °C for up to 48 hours. The 
number of live wom1s in each well was scored at 12 hour intervals and the percentage 
survival was calculated. Worms that showed no pharyngeal pun1ping and remained inlmobile 
on tapping the plate were considered dead. A minimum of three replicates for each test strain 
was set up per trial. 
2.13.5 C. elegans bacterial accumulation assays 
All bacterial strains used for the accurnulation assay were grown overnight at 37 °C on 
modified NG agar medium to stimulate expression of virulence plasmid-encoded genes [283]. 
Plates were cooled to room temperature before they were inoculated with 50-100 
synchronized young adult nematodes (L4's) that have been treated with gentamycin (Section 
2.13.4). The wom1s were allowed to grow at 22 °C for 24 hours, after which l 0-20 wom1s 
were picked off each bacterial lawn and washed thoroughly using sterile S-basal with 1 mM 
of sodium azide to anesthetize the animals. The wom1s were treated with 200 µg/mL of 
gentamycin for 3 hours after which they were washed thoroughly using S-basal with 1 mM of 
sodium azide to remove any residual antibiotic. Washed wonns were suspended in S-basal + 
0.1 % Triton-X and lysed by mechanical disruption using glass beads [284]. Appropriate 
dilutions of the lysates were plated onto LB agar with the appropriate antibiotics, to obtain 
intraluminal bacterial counts. 1n order to visualize bacterial accumulation within nematode 
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intestinal lumens , wonns were fed S.jlexneri strains tagged with GFP+. Following 24 hours 
of infection, bacterial fluorescence was observed using the EVOS digital inverted microscope 
(Advanced microscopy Group-AMG). 
2.13.6 Isolation of Total Nematode RNA 
Approximately 50,000 synchronized young adult worms were infected with either E. coli 
OP50 or S.jlexneri serotype 3b for 24 hat 22 °C. Adult worms were separated from eggs and 
bacterial debris using sucrose floatation [307]. Infected adult wom1 pellets were snap frozen 
in liquid nitrogen. 700 µl ofTrizol reagent (Invitrogen) was added to the frozen wonn pellets 
followed by vigorous vortexing at room temperature until the pellets completely thawed. 
Samples were then subjected to three freeze-thaw cycles by snap freezing them in liquid 
nitrogen followed by rapid thawing at 37 °C. In order to completely homogenize the samples 
and denature proteins, samples were subjected to six cycles of vortexing- at room temperature 
for 30 seconds followed by 30 seconds on ice. Samples were centrifuged at 14,000 x g, 4 °C 
for IO minutes. The aqueous phase was transferred into a fresh eppendorf tube and l 00 µl of 
chlorofonn was added. Samples were mixed thoroughly by vortexing followed by incubation 
at room temperature for 15 minutes. To separate DNA from RNA, tubes were centrifuged at 
14,000 x g, 4 °C, 15 minutes. The aqueous phase was transferred into a fresh eppendorf tube 
and 500 µl of ice-cold isopropanol was added and tubes were vortexed and incubated at room 
temperature for 30-90 minutes to precipitate RNA. RNA was collected by centrifugation at 
14,000 x g, 4 °C, 10 minutes. RNA pellets were washed with l mL of ice-cold 75% ethanol, 
air-dried for 15-30 minutes and resuspended in 35 µl of nuclease-free water. 5 µl aliquots of 
each RNA preparation was stored at -80 °C. 
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2.13.7 qRT-PCR of nematode mRNA 
2.13.7.1 Primer design for qRT-PCR 
Primer pairs were designed to amplify aco-1, cct-2, eef2, dafl9, hsp-60, unc-41, unc-54, 
and hsp-6 from mRNA isolated form adult C. elegans grown of either E. coli OP50 or wild 
type S. jlexneri 3b (SFLI 520) for 24 hours. The C. elegans act-2 gene which encodes actin 
was used as a control gene to normalize all reactions, as the mRNA levels of act-2 were 
expected to remain constant in the worms fed different dsRNA. Primers were designed to 
span exon-exon junctions conserved between the different isoforms of each target gene. 
BlastN searches were perfonned to ensure that primers did not bind to any other region in C. 
elegans genome. Primers were designed according to the instructions provided in the ABI 
power SYBR Green manual. Briefly, each primer was 20 bp long with a GC content in the 
30-80% range and Tm between 58-60 °C, care was also taken to ensure that the 5 nucleotides 
in the 3' end contained no more than two G and/or C. The complete list of qRT-PCR primers 
can be found in Table 2.4. 
cDNA was synthesized from 200 ng of total RNA isolated for wom1s fed either E.coli OP50 
or wi ld type Shigellajlexneri 3b (SFL1520) for 24 hours. Reverse transcription reactions 
were set up using Superscript II (Invitrogen) and random hexamer primers according to the 
manufacturer ' s instructions. qRT-PCR reactions were set up as described in Section 2.11 .3. 
2.13.8 Isolation of Total Nematode Protein 
Approximately 500,000 young adult nematodes were infected with E.coli OP50 (control) and 
wild type S. flexneri 3b (SFL 1520) for 24 hours at 22 °C. Post infection the nematodes were 
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washed thoroughly using sterile S-basal with 1 mM of sodium azide. Wonns were treated 
with 200 µg/mL of gentamycin for 3 hours to reduce the presence of bacterial spots on the 
gels. Sucrose floatation was used to separate adult worms from eggs and any bacterial debris. 
Infected wonns were snap-frozen in liquid nitrogen and the frozen pellets were ground to a 
fine powder using fine glass powder in an ice-cold mortar and pestle. The ground wonns 
were resuspended in solubilisation buffer (Appendix A). The suspensions were homogenized 
and kept on ice, following which they were sonicated 5 times for 10 s with 30 s intervals on 
ice. Samples were centrifuged at 14,000 x g, 4 °C for 10 minutes to sediment cellular debris. 
Y. th volume of 100% TCA was added and proteins were precipitated by incubation on ice for 
15-30 minutes. Precipitated proteins were collected by centrifugation at 14,000 x g, 4 °C for 
10 minutes. Pellets were washed using 200 µl of ice-cold acetone and incubated at -20 °C for 
5-10 minutes. The acetone wash was repeated thrice following which the isolated proteins 
were air dried and resuspended in 20-30 µl of 0.2 M NaOH followed by 100-200 µl of 
solubilization buffer (Appendix A). Protein concentration was determined using the Bradford 
method [303] and 2 mg of each sample was labeled with fluorescent dyes Cy3 or Cy5 (GE 
Healthcare) an internal standard, consisting of 1 mg of each sample, was labeled with Cy2. 
Differential in gel electrophoresis was performed as described in Section 2.12.2. 
2.13.9 RNAi Experiments 
2.13.9.1 RNAi constructs 
RNAi feeding strains consisted of E. coli HT! 15 transformed with an RNAi plasmid, pL4440 
with a fragment of the target gene cloned into its multiple cloning site (MCS). The MCS of 
pL4440 is flanked by two T7 polymerase promoters in opposite orientations such that a gene 
cloned into the MCS is expressed as dsRNA when T7 polymerase in induced (Figure 2.6). E. 
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coli HTI 15 harboring genes-encoding double stranded RNA targeted towards, aco-1 
(ZK455.7), cct-2 (T2 IBI 0.7) and hsp-60 (Y22D7 AL.5), were obtained from the Ahringer lab 
library (provided by Peter Boag, Monash University) and the dafl9 (F33Hl.l) RNAi 
construct was obtai ned from the ORF-RN Ai Library v 1.1 (Source Bioscience). 
2.13.9.2 Feeding protocol for RNA interference (RNAi) in C. elegans 
Glycerol stocks of E. coli HTI 15 strains carrying the required RNAi vector (expressing 
double-stranded RNA targeting the gene of interest) were grown overnight on LB agar 
containing I 00 µg/mL ampicillin. Single colonies from the overnight cultures were then 
inoculated into LB broth containing I 00 µg/mL ampicillin and allowed to grow overnight at 
37 °C. Expression of specific dsRNA from each RN Ai construct was induced at 37 °C using 
IPTG at a final concentration of I mM for 3 hours. After induction, bacterial cells were 
harvested by centrifugation and resuspended in a small volume of LB (0-.5-1 mL). Induced 
cells were spread onto NGM plates containing Carbenicillin (final concentration 100 µg/mL) 
and IPTG (final concentration I mM). The plates were allowed to dry. Synchronized LI 
larvae were seeded onto the RNAi lawns and allowed to grow to the L4 stage at 22 °C. 
During this period developing worms feed on the respective E. coli HTI 15 strains carrying 
the required RNAi vector and in the process the target gene is knocked down. RNAi silenced 
L4 worms were harvested and treated with gentamycin (at a final concentration of200 
µg/mL) for 3 hours. These wonns were then used to set up bacterial accumulation assays 
(Section 2.13.5) and liquid killing assays (Section 2.13 .4). 
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IPTG 
E. coli HT115 
Figure 2.6: Schematic diagram of RN Ai in C. elegans by the feeding method using 
pL4440 and E. coli HT115(D3). A gene of interest (or fragment of the gene of interest) is 
cloned into pL4440 between two T7 polymerase promoters in opposite orientations (blue 
arrows). IPTG induces the expression of T7 polymerase in the E. coli cells. T7 polymerase 
binds to the two T7 promoter regions in pL4440 and drives the expression of the cloned 
genes to produce dsRNA. C. elegans feeding on these E. coli strains take up dsRNA into their 
cells which results in the silencing of target genes. 
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2.13.10 Microscopy of C. elegans 
2.13.10.1 Fluorescence microscopy 
20-30 adult nematodes infected with GFP+-tagged S.flexneri strains and £. coli, were picked 
and washed to remove surface-bound bacteria. Washed wonns were anesthetized with I mM 
sodium azide in S-BASAL and transferred into 96-well plates. Fluorescence was observed 
using the GFP filter on the EVOS digital inverted microscope (AMG). 
2.13.10.2 Electron Microscopy 
50-100 adult wonns were picked off from virulent and avirulent S. flexneri lawns 1 day, 4 
days and 6 days post infection. For prolonged infection periods, worms were transferred onto 
fresh S. jlexneri lawns each day. Worms were transferred into Beem capsules and washed 
thrice using S-basal. In order to penetrate the nematodes thick cuticle la~er, live wonns were 
fixed, rinsed and stained using the microwave-assisted irradiation protocol developed by Hall 
et al. [308]. A Pelco Biowave oven at the Centre of Advanced Microscopy (CAM, ANU), 
was used for the microwave assisted fixation ofwonns. To minimize excessive heating of 
samples during prolonged irradiation, animals were kept in Beem capsules containing liquid 
fixati ves that were then placed on top of the Pelco Coldspot device inside the over chamber 
and a temperature probe was used to monitor temperature and the restriction temperature was 
set to 39 °C. Worms were treated with fixing solution 1 (Appendix A) and irradiated twice (5 
min ON and 3 min OFF) followed by a 60 minute incubation at room temperature. Samples 
were then rinsed thrice in wash solution (Appendix A) each wash step was followed by a 
cycle of irradiation for 1 minute and incubation at room temperature for IO minutes. Washed 
samples were treated with fixing solution 2 (Appendix A) and irradiated twice (5 min ON and 
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3 min OFF) followed by a 15 minute incubation at room temperature. Samples were rinsed 
thrice in wash solution as described above and incubated at room temperature for 7 minutes 
that was followed by three rinse cycles using 0.15 M sodium acetate buffer pH 5.2. Samples 
were stained using 0.5% uranyl acetate in 0.15 M cacodylate buffer pH 7.2 and two cycles of 
irradiation (5 min ON and 3 min OFF) followed by incubation at 4 °C overnight. Stained 
samples were rinsed thrice in 0.15 M sodium acetate buffer pH 5.2 followed by three washes 
using 0.15 M cacodylate buffer pH 7.2 and incubated at room temperature for 7 minutes . 
Samples were dehydrated at room temperature using the following dehydration cycles; 50% 
ethanol for IO minutes, 70% ethanol for IO minutes, 80% ethanol for IO minutes, 90% 
ethanol for IO minutes, three treatments with I 00% ethanol for IO minutes each. This was 
followed by infiltration of the sample at room temperature with the resin LR-White using the 
following infiltration regime; 2: I I 00% ethanol: LR White 2 hours, 1:1 I 00% ethanol: LR 
White 2 hours , two treahnent with 100% LR White for 2 hours each. LR White was cured at 
65 °C under nitrogen gas overnight. Thin sections were obtained using a.Power Tome XL 
ultramicrotome (RMC, Boekeler Instruments, Tucson, AZ at the Albert Einstein College of 
Medical (AECOM)). Sections were collected on copper slot grids and stained with 2% uranyl 
acetate in 50% ethanol for 10 minutes and with lead citrate (Reynolds's fornmlation) for 15 
minutes. TEM micrographs were collected on a Phillips CM! 0 electron microscope at 
AECOM. 
2.14 Statistical analysis 
Statistical analysis was carried out in collaboration with Terry Neeman at the Statistical 
Counselling Unit, ANU. Data analysis was carried out using the PRISM (version 4.02) and 
GenStat software packages. Statistical difference between strains/groups were determined 
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using the t-test (when two sets of data were compared) and a One-way analysis of variance 
(ANOVA) followed by post hoc analysis using Dunnett ' s, Bonferroni Multiple Comparison 
and LSD tests (when more than two data sets were analyzed) . Survival curves were 
compared using the Kaplan-Meier analysis and Logrank tests were used to determine if 
survival curves were significantly different. When analysing data from un-balanced 
experiments (where the number of biological repeats varied between strains), linear mixed 
models were generated using restricted maximum likelihood (REML) to compare all data 
sets. 
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Chapter 3: Characterizing the role of L-asparaginase 
(AnsB) and y-glutamyltranspeptidase (GGT) in the 
virulence of Shigella flexneri 
3.1 Jntroduction 
A clear understanding of the bacterial genes expressed at various steps of host-pathogen 
interactions can facilitate the identification of potential attenuation targets and vaccine 
candidate antigens. To identify immunogenic proteins expressed during infection, Jennison 
and colleagues [309] used 2-dimensional gel electrophoresis (2DE) to separate the soluble 
and membrane-bound protein fractions of a S. jlexneri serotype 2a strain, 2457T. Separated 
proteins were probed with sera from shigellosis patients, to identify immunogenic bacterial 
proteins. Using this approach, they identified two cbromosomally encoded, periplasmic 
enzymes, L-asparaginase (AnsB) and y-glutamyltranspeptidase (GGT) from the membrane 
fractions of S.jlexneri. Interestingly AnsB and GGT have been shown to be antigenic in a 
number of other bacterial pathogens, including £. coli, Salmonella spp. , Campylobacter 
jejuni and Helicobacter pylori [310-314], but have not been characterized in S. jlexneri, thus 
making them potential candidates for vaccine studies. 
The E.coli AnsB, which shares 99.l % amino acid (aa) identity with S.jlexneri AnsB, is an 
enzyme that converts L-asparagine to L-aspartate and ammonia. AnsB has high affinity for L-
asparagine. Expression of ansB is induced by anaerobiosis and positively regulated by the 
cyclic AMP receptor protein (CRP) and the fnr gene product [31 5]. The E. coli y-
glutamyltranspeptidase (GGT), which shares 99% aa identity with S.jlexneri GGT, cleaves y-
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glutamyl linkages in compounds such as glutathione and transfers the y-glutamyl group to 
other amino acids and peptides [316]. 
In this study, a reverse genetic approach was used to characterize the role of AnsB and GGT 
in the virulence of S.jlexneri serotype 3b. Recombineering, a A-red-mediated PCR-based 
approach [317] , was used to lrnockout the ansB and ggt genes from the wild type serotype 3b 
strain of S. jlexneri (SFLI 520). SFLI 520 was chosen because it was identified as a highly 
virulent strain, in the murine pulmonary model of shigellosis. The ansB and ggt genes were 
successfully disrupted by generating insertional mutations. The effects of each mutation on 
bacterial physiology and virulence was analyzed using in vitro growth studies, cell culture 
assays and two in vivo models of shigellosis, namely the murine pulmonary model and the C. 
e!egans infection model, a new potential animal model of shigellosis (discussed in Chapter 
5). Both AnsB and GGT were found to promote the adherence of S.jlexneri to host cells. 
To investigate how AnsB and GGT affect bacterial virulence, the proteomes of each mutant 
strain was compared to that of the wild type S.jlexneri serotype 3b strain using differential 
in-gel electrophoresis (DIGE). This approach identified a prominent outer membrane protein, 
OmpA to be up-regulated in ansB mutants. DIGE analysis of the ggt mutant identified many 
differentially expressed proteins which constitute the cl regulon, expressed in response to 
environmental stresses. These findings highlight the importance of AnsB and GGT in the 
pathogenesis of S.jlexneri, paving the way to designing new vaccine strategies. 
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3.2 Results 
3.2.1 lnsertional inactivation of ansB and ggt in the wild type S. jlexneri serotype 3b 
ansB and ggt knockout templates, carrying the kanamycin resistance gene (ka,l) flanked by 
600- 1000 bp regions homologous to each target gene were generated in plasmids, pNV1875 
and pNVl 876 ( carrying ansB and ggt knockout templates, respectively) as described in 
Section 2.6.1. The ansB and ggt knockout templates were isolated from pNVl 878 and 
pNV1879, respectively by PCR using the AnsBFPI - AnsBRP6 and GgtFPI - GgtRP6 primer 
pairs (Table 2.4), respectively. 
Insertional inactivation of target genes in potential ansB (SFL2283) and ggt (SFL2285) 
mutants was confirmed by colony PCR using a forward primer, which binds to a region 
upstream of the knockout template and a reverse primer, which binds within each knockout 
template (Figure 3.1.A and B). The PCR product obtained from SFL2283 (- 3.5 kb) using 
AnsB-K02 and AnsB-RP6 (Table 2.4) primers was - 1 kb larger than that obtained from the 
parent strain (- 2.5 kb) , confirming the insertion of the kanamycin resistance (kanR) gene into 
the ansB gene (Figure 3.1.A and C). The PCR product obtained from SFL2285 (- 3.7 kb) 
using Ggt- K02 and Ggt- RP6 primers, is simi lar in size to the PCR product obtained from 
the parent strain (-3.7 kb) as expected because the knockout template generated was designed 
to replace 1 kb of the coding region of ggt with the ka,l gene (- 1 kb) (Figure 3.1.B and C). 
Insertional inactivation of the ansB and ggt genes in SFL2283 and SFL2285, respectively was 
confirmed by sequencing. 
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Figure 3.1: Confirming the insertional inactivation of the ansB and ggt genes in an S. 
flexneri serotype 3b (SFL1520). A and B: Schematic representations of the PCR-based 
screening approach used to confirm the insertional inactivation of ansB and ggt genes, 
respectively. All PCR reactions were set up using a forward primer (FP) which binds 
upstream of the knockout template within the bacterial chromosome and a reverse primer 
(RP) which binds to the 3' end of the inserted knockout template. C: Results of colony PCR-
based screening of potential ansB (SFL2283) and ggt (SFL2285) mutants. D: Colony PCR to 
confinn the presence of the 220 kb virulence plasmid in SFL1520, SFL2283 and SFL2285. 
M: SPP-1 EcoRJ marker, relevant marker sizes are indicated. apy (in blue) primers amplify 
the 1.16 kb, apy gene from the wild type 3b strain,SFLI 520 as well as both mutant strains, 
SFL2283 and SFL2285. virG (in red) primers amplify the 1.39 kb icsA/virG gene from all 
strains tested. 
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Excessive handling and manipulation of S.jlexneri strains often result in the loss of the 
virulence plasmid; therefore, the presence of the virulence plasmids in the wild type 
(SFL 1520), ansB (SFL2283) and ggt (SFL2285) mutant strains was confirmed by PCR using 
apyl and virG specific primers before every assay perfonned in this study. These two genes 
were chosen as they lie on opposite sides of the 220 kb, virulence plasmid. Results of apyl 
and virG PCR reactions confirmed that both mutant strains carry intact virulence plasmids 
(Figure 3.1.D). 
3.2.2 Assessing the expression and secretion of virulence-plasmid encoded Jpa proteins 
The S. jlexneri virulence plasmid-encoded invasion protein antigens (Ipa) are important 
components of the T3SS needle complex. Virulent strains of S.jlexneri have well-established 
mechanisms that regulate the expression and secretion of these Ipa proteins. Western blotting 
was perfonned to compare the levels of IpaB and IpaD, two prominent type 3 effector 
proteins, in the wild type (SFL 1520), LlansB (SFL2283) and Llggt (SFL2285) strains to 
detennine if the mutant strains efficiently express and secrete virulence-plasmid encoded 
proteins. Secretory proteins were isolated from SFL 1520, SFL2283 and SFL2285 (Section 
2.9.1.2) and the levels ofipaB and IpaD in secretory proteins was determined using anti-IpaB 
and ant-IpaD antibodies, respectively. A S.jlexneri strain devoid of the virulence plasmid 
(SFLl223) was used as the negative control. No differences in the expression and secretion 
ofipaB and IpaD were detected in the LlansB (SFL2283), Llggt (SFL2285) and the wi ld type 
3b strain (SFLl520) (Figure 3.2). These results suggest that expression and secretion of key 
virulence plasmid-encoded proteins remain unaffected by ansB and ggt mutations 
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Figure 3.2: Western immunoblots of IpaB and IpaD levels in wild type S. flexneri 
serotype 3b and ansB and ggt mutant strains. 20 µg of secreted proteins preparations 
isolated from wild type (SFLJ 520) and !J.ansB (SFL2283) and !J.ggt (SFL2285) were 
separated using SDS-PAGE, following which they were electroblotted onto PVDF 
membranes and probed with anti-[pa B (A) and anti-lpaD (B) primary antibodies. The levels 
of secreted lpaB (- 62 kDa) and IpaD (- 34 kDa) produced by all strains was visualized using 
a chemilumenescence reader. No differences were observed in the secretory levels of the 
invasion proteins between mutant and wild type strains. 
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3.2.3 Physiological characterization of ansB and ggt mutations in S. jlexneri 
3.2.3.1 Confirming the expression of ansB and ggt in SFL1520 cells grown in vitro 
Before perfom1ing any physiological studies, reverse transcriptase polymerase chain reaction 
(RT-PCR) was used to confirm the expression of ansB and ggt in the wild type S.jlexneri 
serotype 3b (SFL1520), grown in vitro under nutrient rich or starved conditions (Figure 3.3). 
Total RNA was isolated from the wild type S.flexneri serotype 3b grown at 37 °C in LB and 
MM (Section 2.8.1) and cDNA was synthesized as describe in section 2.8.2. The ansB.compF 
and ansB.compR primers were used to amplify ansB (expected product 1046 bp) and ggt-
Sacl and ggt-XbaI primers were used to amplify ggl (expected product 548 bp). RT-PCR 
data indicated that both the ansB and ggl genes were expressed in wild type S. .flexneri cells 
grown in vilro, suggesting that these genes encode products required for bacterial growth in 
vitro 
3.2.3.2 Measuring the effects of ansB and ggt mutations on cellular asparaginase and 
glutaminase activities 
AnsB is an identified L-asparaginase in E. coli that catalyzes the conversion ofL-asparagine 
to L-aspartate with the release of ammonia. Ammonia release assays were perfonned to 
detennine if this function was conserved in S. .flexneri. Bacterial cells expressing L-
asparaginase, when treated with asparagine, would breakdown asparagine and release 
ammonia, thus increased ammonia levels correlate with increased breakdown of asparagine. 
SFL 1520, SFL2283 and SFL2285 cells were treated with asparagine and the amount of 
released anu:nonia was measured as described in section 2. 7 .2. Results of ammonia assays 
show that the wild type S.jlexneri serotype 3b (SFL1520) and t:,ggt (SFL2285) (carrying 
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Figure 3.3: Reverse Transcriptase PCR (RT-PCR) to determine if the ansB and ggt 
genes are expressed in wild type S. flexneir serotype 3b (SFL1520) cells growth in vitro. 
A: expression of ansB in SFL1520 grown in nutrient rich Luria Bertani (LB) broth and 
minimal media (MM). B: expression of ggt in SFLl 520 grown in LB broth and MM. Each 
set ofRT-PCR results is accompanied by a no template control (NTC) and a no reverse 
transcriptase control (NRT) to check for contamination from the PCR reagent and 
chromosomal DNA, respectively. 
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intact ansB) released significantly more ammonia than the !:,.ansB strain (SFL2283) (Figure 
3.4.A). These results suggest that AnsB in S.jlexneri functions as an L-asparaginase. 
GGT in H. pylori and C. jejuni has been identified as a glutaminase that breaks down 
glutamine to glutamate and releases anunonia. Ammonia assay were performed to detennine 
if GGT in S. jlexneri hydrolyses glutamine to glutamate. No differences in arrn11onia levels 
were detected in SFL1520, SFL2283 and SFL2285 cells treated with glutamine (Figure 
3.4.B). These results suggest that GGT in S.jlexneri does not function as a glutaminase as 
was determined in H. pylori and C. jejuni. 
3.2.3.3 Effects of mutations on bacterial growth 
After establishing that both ansB and ggt genes were expressed in wild type S.jlexneri cells 
grown in vitro, growth studies were performed in order to determine if the metabolic 
activities of AnsB and GGT were required for in vitro growth of S.jlexneri. Liquid cultures 
of SFLl 520, SFL2283 and SFL2285 cells were grown at 30 °C or 3 7 °C and the optical 
density of cultures was measured at 30 minute intervals. No mutation-related growth defects 
were detected when strains were grown under nutrient rich (LB media) conditions at both 37 
°C and 30 °C (Figure 3.5 A and B). To detennine if AnsB and GGT were active under 
stressed conditions, growth studies were perfonned under nutrient starved conditions using 
MM (Figure 3.5 C and D). No significant (p > 0.05, ANOVA) growth retardation was 
observed in !:,.ansB or t:,.ggt mutant strains, suggesting that AnsB and GGT are not essential 
for bacterial growth in vitro. 
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Figure 3.4: Ammonia assays used to determine the asparaginase and glutaminase 
activities of ansB and ggt mutants. S. jlexneri parental strain SFLI 520 or isogenic mutant 
1',ansB (SFL2283) and l',ggt (SFL2285) strains at 3 x I 08 colony forming units (CFU) per ml, 
were incubated in phosphate buffered saline (PBS) with 5 mM asparagine (A) or glutamine 
(B). Ammonia production was measured after 60 minutes (A) and 180 minutes (B) incubation 
at 37 °C. Hydrolys is of asparagine and glutam.ine was measured by quantifying ammonia 
production. Error bars represent the standard error obtained from three independent 
experimental measurements. 
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Figure 3.5: Growth studies to assess the effect of ansB and ggt mutations on bacterial 
growth. A-D represent growth curves of the wild-type S.jlexneri serotype 3b strain 
(SFLI 520-black), ansB (SFL2283-red) and ggt (SFL2285-blue) mutants, plotted as optical 
density readings at 600 nm (OD600) (y-axis) versus time (x-axis). A: Growth in Luria-Bertani 
(LB) broth at 37 °C, B: Growth in minimal media (MM) at 37 °C. C: Growth in LB at 30 °C, 
D: Growth in MM at 30 °C. Statistical analysis using the Log Rank test revealed no 
significant difference in the growth patterns under all four conditions examined p > 0.05. 
Results represent the means of three experimental repeats with standard errors (error bars). 
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3.2.4 Virulence studies 
3.2.4.1 In vitro Virulence Assays 
3.2.4.1.1 Bacterial adherence assays 
in vitro adherence assays were perfom1ed using BHK cells to investigate whether AnsB or 
GGT were required for bacterial adherence to epithelial cells (Section 2.10.6). Results of in 
vitro adherence assays indicate that AansB (SFL2283) and Aggt (SFL2285) are significantly 
less adherent than the wild type parental strain (SFLI 520) (Figure 3.6.A). Complementation 
of ansB and ggt mutations in SFL2309 and SFL23 I 0, respectively restored bacterial 
adherence suggesting that the decrease in adherence of the mutant strains was on account of 
ansB and ggt mutations. 
3.2.4.1.2 Coverslip adherence assays 
In order to visualize the differences in the adherence of the mutant and wild type strains, a 
covers lip adherence assay was performed (Section 2.1 0. 7). Consistent with bacterial 
adherence assays, Giemsa staining of infected BHK monolayers showed a decrease in the 
number of adherent bacteria in monolayers infected with l::,ansB (SFL2283) and !:,ggt 
(SFL2285) strains (Figure 3.6.C and D) compared with wild type S.jlexneri serotype 3b 
(SFL1520) (Figure 3.6.B) and complemented strains SFL2309 and SFL2310 (Figure 3.6.E 
and F). The number of adherent bacteria per BHK cell was detem1ined in three independent 
blind experiments to validate the microscopic fu1dings. !:,ansB (SFL2283) and !:,ggt 
(SFL2285) cells show a significant drop in the number of adherent bacterial cells when 
compared with SFLI 520, SFL2309 and SFL23 IO (Figure 3.6.G). Results of in vitro 
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Figure 3.6: Results of in vitro adherence assays for wild type S. flexneri serotype 3b 
strain (SFL1520), AansB (SFL2283), Aggt (SFL2285), SFL2309 (SFL2283 + a plasmid 
copy of ansB) or SFL2310 (SFL2285 + a plasmid copy of ggt). A: Bacterial adherence to 
baby hamster kidney cell s plotted as percentage adherence, a ratio of the number of adherent 
and intracellular bacteria to the total number of bacterial cells in the infecting inoculum (y-
axis). Results represent the means of three independent blind repeats with standard errors. B-
F: Results of coverslip adherence assay perfonned to compare the adherence properties of 
SFLJ 520 (B), SFL2283 (C), SFL2285 (D), SFL2309 (E) and SFL23 l O (F). Covers lips 
containing each bacterial strain were stained with Giemsa stain and examined using an oil 
immersion lense. G: A graph depicting the number of adherent bacteria counted per BHK 
cell under 1000 X magnification (y-axis). Results are the mean of 10 cells across 10 fields 
with standard errors, counted at random in a blind experiment. 
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adherence assays suggest that AnsB and GGT are involved in the preliminary stages of S. 
jlexneri infection. 
3.2.4.2 In vivo Virulence Assays 
3.2.4.2.1 C. elegans bacterial accumulation assays 
To detem1ine if the defective adherence of /'J.ansB and /'J.ggt strains observed in vitro had an 
effect on bacterial virulence, preliminary in vivo studies were canied out in C. elegans. 
Burton and colleagues [283) have demonstrated that virulent S. jlexneri strains accumulate in 
the intestinal lumina of C. elegans and kill nematodes, whereas avirulent S. jlexneri strains 
are digested by the nematodes. Young adult hem1aphrodite nematodes were fed S.jlexneri 
serotype 3b (SFL1520) , /'J.ansB (SFL2283), /'J.ggt (SFL2285) and complemented strains 
SFL2309 (SFL2283 + ansB) and SFL23 l O (SFL2285 + ggt) for 24 hours and bacterial 
accumulation assays were carried out as described in section 2.13 .5.-C. elegans fed SFLl 520 
show accumulation of the virulent, wild type parental strain (SFLI 520) in their intestinal 
lumina, whereas worms fed both /'J.ansB (SFL2283) and l'!.ggt strains (SFL2285) had 
significantly decreased intraluminal bacterial counts (Figure 3.7.A). Complementation of 
ansB and ggt mutations in SFL2309 and SFL2310, respectively, increased bacterial 
accumulation, suggesting that AnsB and GGT are required for S. flexneri virulence in C. 
elegans. 
To confinn bacterial accumulation in the nematode intestinal lumina, nematodes were fed 
GFP+ tagged S. jlexneri strains and visualized by fluorescence microscopy (Section 
2.13. l 0.1). Wild type S.jlexneri accumulated in the nematode intestinal lumen (Figure 
3.7.B). No fluorescence was detected in worms fed the /'J.ansB and /'J.ggt strains (Figure 3.7.C 
and D, respectively). 
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Figure 3. 7: in vivo characterization of ansB and ggt mutations using C. elegans bacterial 
accumulation assays. A: Young adult hermaphrodite nematodes were fed S.flexneri 3b 
(SFLI 520), !:iansB (SFL2283), !:iggt (SFL2285), SFL2309 (SFL2283 + plasmid copy of 
ansB) or SFL23 l O (SFL2285 + plasmid copy of ggt) for 24 hours. 20 nematodes were picked 
and mechanically disrupted to release internalized bacteria. Diluted lysates were plated on LB 
agar plates carrying appropriate antibiotics, and colonies were scored in order to quantify S. 
flexneri cells associated with each nematode. Statistical analysis performed using One-way 
ANOV A show increased accumulation of SFL1520, SFL2309 and SFL23 l O and digestion of 
SFL2283 and SFL2285 in the nematode gut. Results represent the means of three 
experimental repeats with standard error (error bars) B: Young adult hermaphrodite 
nematodes infected as above with GFP+-tagged SFL1520 (B), SFL2283 (C) and SFL2285 
(D) . Wild type S.flexneri 3b accumulates in the nematode intestinal lumen while !:iansB 
(SFL2283) and !:iggt (SFL2285) strains fail to accumulate in the worm gut lumen. Scale bar = 
400 µm. 
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and C), which was consistent with the data generated by the bacterial accumulation assay. 
GFP+ accumulation assays could not be performed on the complemented strains, as the 
plasmid expressing GFP+ (pNV1908) was incompatible with the plasmids used for 
complementation of ansB and ggt mutations. 
3.2.4.2.2 C. elegans liquid killing assay 
Kesika and colleagues have previously shown that virulent strains of S.jlexneri kill C. 
elegans in liquid culture (284]. Liquid killing assays were perfonned to compare the killing 
rates of !'iansB (SFL2283), l'iggt (SFL2285) and the wild type 3b strain (Section 2.134). C. 
elegans fed with wi ld type S. jlexneri serotype 3b (SFLI 520), died much faster (TD so= 42 h) 
than wonns fed with /'iansB (SFL2283) and l'iggt (SFL2285) (less than 50% killing in 48 
Hours; Figure 3.8). These findings along with the bacterial accumulation data, suggest that 
AnsB and GGT are required for the virulence of S. jlexneri in C. e/egans. 
3.2.4.2.3 Murine pulmonary model of shigellosis 
As preliminary in vivo studies in C. elegans indicated that the !'iansB and l'iggt strains showed 
reduced virulence, these strains were also tested using the well-established murine pulmonary 
model of shigellosis (83 , 225 , 318]. Six to eight week old female Balb/c mice (Animal 
Resource Centre,WA) were inoculated intranasally with a sub-lethal dose (2 x I 07 CFU/ l 0 
µL) of the wild type pathogenic strain (SFLI 520), l'iansB (SFL2283) and l'iggt (SFL2285). 
When inoculated intranasally, virulent strains of S. flexneri colonize the lungs of infected 
mice and cause pneumonia. The lung counts obtained from mice inoculated with the !'iansB 
and l'iggt strains 24 hours post infection were significantly lower than mice infected with the 
wild type strain (Figure 3.9.A). 
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Figure 3.8: Results of S . .flexneri-mediated killing assays in C. elegam. The above graph 
represents the results of C. elegans liquid killing assays. 20 synchronized adult nematodes 
were treated with log phase cultures of S.jlexneri 3b (SFL1520), t::.ansB (SFL2283), or t::.ggt 
(SFL2285) strains grown at 37 °C to express virulence factors. Infected nematodes were 
monitored for 48 hours and survival was scored every 12 hours. Results represent the mean of 
three independent blind experimental repeats with standard errors (error bars). Worms treated 
with ansB and ggt mutant strains show a significant increase in the survival rates compared to 
nematodes infected with wild type S.jlexneri 3b (p < 0.05 , Log Rank test). 
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Figure 3.9: Lung counts of mice inoculated intranasally with a sub-lethal dose (2 xI07 
CFU) of S. jlexneri 3b (SFLI520), AansB (SFL2283) or Aggt (SFL2285). 20 mice per 
strain were euthanized 24 hours post-inoculation, and their lungs were isolated and 
homogenized. Dilutions of the homogenates were plated to determine the number of bacterial 
cells. Results represent the mean values of lung counts obtained from 20 mice infected with 
each strain in a blind experiment with standard errors (error bars). Statistical analysis 
performed using One way ANOV A, shows a significant decrease in the lung counts of mice 
infected with both the ansB and ggl mutant strains, 24 hours post infection. 
115 
The results of mouse studies further demonstrate that AnsB and GGT are required for the 
initial stages of infection. 
3.2.5 Identification of changes in the S. jlexneri proteome caused by ansB and ggt 
mutations 
Differential in-gel electrophoresis (DIGE) was performed to identify why .dansB and .dggt 
strains show reduced adherence. Total bacterial protein was isolated from SFLJ 520, 
SFL2283 and SFL2285 cells grown to log phase in LB at 37 °C (Section 2.9.2. l ). Proteins 
were differentially labeled with Cy dyes and separated using DIGE (as described in Section 
2.9.2). Gels were scanned and analysed using the DeCyder Version 5 software package 
(Section 2.9.2.3). Seventeen differentially expressed proteins in /::,.ansB (SFL2283) (Figure 
3.10.A) and 31 differentially expressed spots in /::,.ggt (SFL2283) strains (Figure 3.11 .A) were 
recognized and excised from the gels for identification by peptide sequencing as described in 
section 2.9.2.4 and submitted to the Mass Spectrometry Facility, ANU for LC-MS analysis. 
Proteins were identified using MASCOT (Matrix Science) database searches, as described in 
section 2.9.2.4. Six out of seventeen recognized ansB proteins, were identified (Figure 
3.11.1-6 and Table 3.1) and seven out of thirty-one ggt proteins were identified (Figure 
3.12.1-6 and Table 3.2). 
The chaperone protein DnaK, was found to be up-regulated in both /::,.ansB (SFL2283) and 
/::,.ggt (SFL2283). In SFL2283, expression of all six identified proteins (RplL, Udp, Mdh, 
OmpA, GroEL and DnaK) was up-regulated. In SFL2285, expression of three (out of seven) 
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Figure 3.10: A: Differential in-gel electrophoresis analysis of the AansB proteome. The 
above gel represents total proteins of wild type S. flexneri serotype 3b and !:;.ansB, 
differentially labeled with Cy3 and Cy5. Highlighted regions represent differentially 
expressed proteins in the !:;.ansB identified using the DeCyder version 5 software package. 
Arrows indicate proteins identified by peptide mass fingerprinting. B: Graphs 1-6 represent 
the differential expression of spots identified by peptide mass fingerprinting. All six proteins 
identified to be differentially expressed in the /:;.ansB are up-regulated in the mutant strain. 
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Table 3.1: Differentially expressed spots in the ansB mutant 
Sopt Gene Differential Accession Description Predicted Observed Coverage n (peptides Score ?value 
·No. name expression in number pl/Mwt pI/Mwt (%) matched) One Way 
mutant (UniProt) (kDa) (kDa) ANOVA 
1 rp!L Up-regulated QOSY14 ribosomal protein L 7 /L 12 4.6/12.3 4.7/10.0 19 2 36 0.014 
2 udp Up-regulated F5MTS6 5.81/27.3 5.8/28.0 32 4 41 2.7e-005 
Uridine ohosohorvlase 
3 mdh Up-regulated F5NLQ6 5.61 /32.5 
Malate dehvdrogenase 
5.5/39.0 44 5 123 0.0041 
4 ompA Up-regulated QOT678 5.87/37.4 4.7/39.00 23 7 43 0.02 
ompA Outer membrane 
protein 3a 
5 groEL Up-regulated QOSXD6 4.85/47.46 4.8/67.00 29 11 130 0.047 
60 kDa chaperonin 
6 dnaK Up-regulated I6CN04 4.83/69. 13 4.8/6.9 31 13 175 0.00046 
Chaperone protein DnaK 
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Figure 3.11: A: Differential in-gel electrophoresis analysis of the Aggt proteorne. The 
above gel represents total proteins of wild type S. jlexneri serotype 3b and t,.ggl differentially 
labeled with Cy3 and Cy5 . Highlighted regions represent spots that are differentially 
expressed in the t,.ggl identified using the DeCyder version 5 software package. Arrows 
indicate spots identified by peptide mass fingerprinting. B: Graphs 1-6 represent the 
differential expression of spots identified by peptide mass fingerprinting in wild type and ggl 
mutant strains. 1: YaeT and PpsA were identified from the same spot as these two proteins 
have very similar molecular weights and pl values. The expression of RpsA, DnaK, Tig and 
FtsZ is up-regulated in 1:,.ggl, while the Y aeT, PpsA· and GadB are down-regulated in 1:,.gg1. 
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Table 3.2: Differentially expressed spots in the ggt mutant 
Sopt Gene Differential Accession Description Predicted Observed Coverage n Score P value 
-No. name expression in number pl/Mwt pl/Mwt (%) (peptides One Way 
mutant (UniProt (kDa) (kDa) matched) ANOVA 
1 ppsA Down-regulated F5MM47 4.93/86.95 4.9/90.00 22 13 114 0.024 
Phosphoenolpyruvate 
svnthase 
2 yaeT Down-regulated I0V9F3 4.93/90.62 4.9/90.00 II 8 43 0.024 
Outer membrane protein 
assemblv factor BamA 
3 rpsA Up-regu lated POAG70 4.89/6 1.23 4.9/68.00 36 14 208 0.01 2 
30S ribosomal protein 
4 dnaK Up-regu lated I6CN04 4.83/69. 13 4.8/67.00 57 9 1535 0.013 
Chaperone protein DnaK 
5 tig Up-regulated POA852 4.83/48.16 4.8/50.00 60 13 267 0.045 
Tri!!!!er factor 
6 gadB Down-regulated P69912 5.29/53 . 16 5.2/49.00 28 7 125 0.029 
Glutamate decarboxylase 
7 fts.Z Up-regulated F5QTJ4 4.67/39.79 4.3/38.00 7 I 43 0.00034 
Cell division protein 
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spots were down-regulated (PpsA, YaeT, and GadB) and four proteins (RspA, DnaK, FtsZ 
and Tig) were up-regulated. YaeT and PpsA were identified from the same spot, both these 
proteins have very similar molecular weights and pl values, hence it is not nnusual that they 
appear in the same region on the gel and it is likely that, the excised spot contained peptides 
from both proteins. The DeCyder software package identifies differentially expressed spots, 
by comparing the fluorescence produced by differentially labeled, wild type and mutant 
proteins in a selected region. If several proteins are present in the region of interest, the 
software fails to identify individual proteins. Therefore the overall difference in fluorescence 
produced by the wild type and mutant proteins, in such regions is taken into account to 
detennine if the spot is up-regulated or down-regulated. Because YaeT and PpsA were 
identified from the same region on the gel , we can.not conclude whether both proteins are 
down-regulated or if one protein is up-regulated while the other is down-regulated. 
3.2.5.1 qRT-PCR to confirm DIGE analysis 
Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was 
perfonned to confirm DIGE results (Figure 3.12). The transcript levels of identified proteins 
were analysed using qRT-PCR, in three independent biological replicates, using the bacterial 
hisG gene as a control gene to normalize the expression of all tested genes. Consistent with 
the DIGE analysis, the expression of rp/L, udp, ompA, groEL and dnaK was up-regulated in 
6.ansB (SFL2283), no significant differences were observed in the expression of mdh (Figure 
3.12.A). qRT-PCR also confirmed that the expression of rspA, dnaKJtsZ and tig (Figure 
3.12 B) were up-regulated and gadB (Figure 3.12.C) was down-regulated in t.ggt (SFL2285). 
Contrary to the DIGE analysis , the expression of yaeT and ppsA was found to be up-regulated 
at the transcript level in t.ggt (SFL2285) (Figure 3.12. B). This result, coupled with the fact 
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Figure 3.12: Reverse transcription quantitative PCR (qRT-PCR) to verify differential 
in-gel electrophoresis (DIGE) analysis. A: qRT-PCR analysis of differentially expressed 
spots identified in the 1',.ansB (SFL2283). The levels of mRNA transcripts of 1pll, udp, 
groEL, dnaK and ompA, in SFL2283 are significantly higher than SFLI 520 (p < 0.005 , 
unpaired, t-test), verifying the DIGE analysis. B: qRT-PCR analysis of differentially 
expressed spots in the /',.ggt (SFL2285). mRNA levels of tig, ftsZ, 1psA, and dnaK in 
SFL2285 are significantly higher that SFLI520 (p < 0.005 , unpaired, t-test), verifying DIGE 
analysis. mRNA levels ofyaeT, andppsA contradict the DIG E analysi s. C: qRT-PCR 
analysis of the expression levels of gadB in S. flexneri 3b (SFLI 520) and the ggl mutant. A 
significant decrease in the mRNA levels of gadB in SFL2285 is consistent with the DIGE 
analysis. The expression of all genes was normalized to the housekeeping gene, hisG. The 
data presented are the means of three biological repeats, and error bars indicate the standard 
errors of the means. 
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that both YaeT and PpsA were identified from the same spot, makes it difficult to determine 
if levels of both YaeT and PpsA proteins were down-regulated in f'..ggt, as indicted by the 
DIGE analysis. 
3.2.5.2 Western blots to determine the levels of Y aeT in wild type and !J.ggt cells 
Conflicting results regarding the expression of yaeT in ggt mutant cells were observed in this 
study, with the DIGE analysis suggesting a possible decrease in YaeT protein levels and 
qRT-PCR data indicating the up-regulation of yaeTtranscripts in ggt mutant cells . To 
confinn the effect of mutating ggt on the expression of YaeT in SFL1520, Western blots were 
performed using aHp-YaeT (generously donated by Trevor Lithgow, Monash University). 
Whole cell lysate of wild type (SFLI 520) and f'..ggt (SFL2285) were prepared (Section 
2.9 .I.1) and separated using 12% SDS-PAGE gel electrophoresis. Following which, the 
proteomes of SFLI 520 and SFL2285 were probed with aHp-YaeT to compare the levels of 
YaeT in each of these strains. Results of western blots indicate that the expression of YeaT is 
down-regulated in f'..ggt, which is consistent with the DIGE analysis (Figure 3.13). These 
results along with the results of qRT-PCR data, suggest that two conflicting mechanisms 
potentially regulate the expression ofYaeT in SFL2285 cells. 
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Figure 3.13: Western immunoblots of YaeT in wild type S. jlexneri serotype 3b 
(SFL1520) and the ggt mutant strain (SFL2285). Total bacterial protein was isolated from 
cultures corresponding to 1 x I 09 CFU from both SFLI 520 and SFL2285. Proteins were 
separated using SDS-PAGE, following which they were electroblotted onto PVDF 
membranes and probed with anti-HpYaeT. Anti-Rabbit IgG (Sigma) was used as the 
secondary antibody and the levels ofYaeT (- 90 kDa) in each strain was visualized using a 
chemiluminescence reader. The expression ofYaeT in SFL2285 is down-regulated when 
compared with SFLI 520. 
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3.2.5.3 Overexpression of OmpA in SFL1520 and increased expression of YaeT in the 
!J.ggt strain 
Since ansB and ggt mutants showed decreased adherence, OmpA and YaeT, two outer 
membrane proteins, identified to be differentially expressed in 1'1ansB and 1'1ggl strains were 
selected for further study. DIGE analysis suggested that the expression of OmpA was up-
regulated in 1'1ansB cells and the up-regulation of this protein was consistent with increased 
expression of ompA mRN A. To detennine if up-regulation of OmpA in 1'1ansB cells was 
responsible for decreased bacterial adherence, OmpA was overexpressed in the wild type 
strain (SFLl 520), by introducing pNV2052 (pBS SK + ompA) into SFLl 520, to generate 
SFL2443 (SFL1520 + ompA). qRT-PCR was performed to compare the levels of ompA in 
SFLl 520, SFL2283 and SFL2443. SFL2443 showed a significant increase in the expression 
of ompA compared to the wild type strain. No significant differences were observed ompA 
transcripts in SFL2443 and SFL2283 (Figure 3.14.A). 
To determine if the down-regulation ofYaeT in SFL2285 (1'1ggl) , was responsible for the 
decreased adherence of this strain, SFL2285 was transformed with pNV2053 (pBS SK + a 
plasmid copy of yea7) to create SFL2444 (L1ggr + yae7). qRT-PCR was perfom1ed to 
compare the levels ofyaeT in SFLl 520, SFL2285, SFL2444 (Figure 3.14.B). The expression 
of yaeT transcripts in SFL2444 was significantly higher than wild type and 1'1ggl mutant cells 
(Figure 3.14.B). Western blots using aHp-YaeT were also performed to compare the levels of 
YaeT in SFLl520, SFL2285 and SFL2444 (Figure 3.14.C). Western blots failed to show a 
significant increase in YaeT levels in SFL2444 when compared with SFL2285. 
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Figure 3.14: Comparing OmpA and YaeT levels in wild type S.flexneri and AnsB and 
-Ggt mutant strains. A: Reverse transcription quantitative PCR (qRT-PCR) analysi s to 
detennine the transcript levels ofompA in SFL1520 (wild type S.jlexneri serotype 3b), 
SFL2283 (t<.ansB) and SFL2443 (SFLI 520 + pNV2053 carrying ompA). ompA levels in 
SFL2443 are significantly higher than SFL1520 (p < 0.005 , unpaired, t-test). B: qRT- PCR 
analysis to compare the transcript levels of yaeT in SFL 1520, SFL2285 (!<.gg1) and SFL2444 
(SFL2285 + pNV2054 carrying yael). yaeT expression in both SFL2285 and SFL2444 are 
higher than SFLI 520 (p < 0.005 , unpaired, t-test). Expression of all genes was nom1alized to 
the housekeeping gene hisG. The data presented are the means of three biological repeats , 
and error bars indicate the standard errors of the means. C: Western inununoblots using anti-
HpYaet, to compare the levels ofYaeT protein in SFLI 520, SFL2285 and SFL2444. No 
observable differenced in the levels ofYaeT in SFL2285 and 2444. 
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SFL2443 and SFL2444 were then used to perfom1 cell culture adherence assays and in vivo 
C. elegans bacterial accumulation assays to assess whether the decreased adherence shown 
by the ansB and ggl mutant strains was a result of the differential expression of outer 
membrane proteins, OmpA and YaeT, respectively. 
3.2.5.3.1 In vitro adherence assays of SFL2443 and SFL2444 
Adherence assays were performed using SFL1520, SFL2443 (SFL1520 + pNV2052), 
SFL2283 to determine if the up-regulation of OmpA was responsible for the decreased 
adherence of tJ.ansB cells. Results of in vitro adherence assays indicated that the 
overexpression of OmpA in the wild type strain significantly decreased bacterial adherence, 
as SFL2443 cells were less adherent than SFLl 520 (Figure 3.15). in vitro adherence assays 
were also performed using SFLl 520, SFL2285 and SFL2444 (SFL2285 + pNV2054) to 
detennine if the down-regulation ofYaeT was responsible for the decreased adherence of 
tJ.gg1 cells. SFL2444 was significantly more adherent than SFL2285 but less adherent than 
SFL1520, suggesting that the increased expression ofYaeT in the ggl mutant strain increases 
the adherence of this mutant strain but fails to restore bacterial adherence to wild type levels 
(Figure 3.15). 
3.2.5.3.2 In vivo C. elegans bacterial accumulation assays of SFL2443 and SFL2444 
In vivo bacterial accumulation assays in C. elegans were performed to determine if the 
overexpression of ompA in wild type S. jlexneri decreased bacterial virulence in vivo. Results 
of in vivo C. elegans bacterial accumulation assays using SFLJ 520, SFL2283 and SFL2443 
were consistent with in vilro adherence assays and s_uggest that the overexpression ofOmpA 
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Figure 3.15: Results of in vitro adherence assays for SFL2443 (SFLl 520 overexpressing 
ompA) and SFL2444 (SFL2285 + yae1), wild type S. jlexneri 3b (SFLl 520), !::iansB 
(SFL2283), L1ggt (SFL2285) strains plotted as percentage adherence, a ratio of the number of 
adherent and intracellular bacteria to the total number of bacterial cells in the infecting 
inoculum (y-axis). There is a significant decrease in the adherence of SFL2443 (SFLl 520 
overexpressing ompA) compared to SFL 1520. SFL2444 (SFL2285 with increased expression 
ofyae7) is significantly more adherent than SFL2285. Results are the means of three 
independent blind repeats with standard errors (error bars). Statistical significance was 
determined using one way ANOVA with post hoc Bonferroni's Multiple Comparison Test. 
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Figure 3.16: Results of in vivo C. elegans bacterial accumulation assays. Young adult 
hermaphrodite nematodes were fed S.jlexneri 3b (SFL1520), t:i.ansB (SFL2283), SFL2443 
(SFLl 520 overexpressing ompA), t:i.ggt (SFL2285) or SFL2444 (SFL2285 + yaeT) for 24 
hours. 20 nematodes were picked and mechanically disrupted to release internalized bacteria. 
Diluted lysates were plated on LB agar plates carrying appropriate antibiotics, and colonies 
were scored in order to quantify S.jlexneri cells associated with each nematode. There is a 
significant decrease in the accumulation of SFL2443 (SFLl 520 overexpressing ompA) 
compared to SFL1520. The accumulation of SFL2444 (SFL2285 with increased expression 
ofyaeT) in the nematode intestinal lumen is significantly higher than SFL2285. Results are 
the means of three independent blind repeats with standard errors (error bars). Statistical 
significance was detemuned using one way ANOVA with post hoc Bonferroni's Multip le Comparison 
Test. 
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in wild type 3b, reduces bacterial accumulation in nematodes to levels similar to ilansB 
(SFL2283) (Figure 3.16). This in vivo system was also used to detennine if the increased 
expression of yaeT in the 1',ggt mutant restored the virulence of this strain. SFL2444 cells 
showed increased accumulation in the nematode intestinal lumen compared to SFL2285. 
However the increased expression of yaeT in SFL2444 failed to restore bacterial 
accumulation to the wild type levels (Figure 3.16). Results of both the BHK adherence assays 
and C. elegans bacterial accumulation assays suggest that outer membrane protein OmpA is 
responsible for the decreased virulence shown by 1',ansB and YaeT is one of the factors that 
decreases the virulence of l',ggt strains. 
3.2.5.3.3 Morphology of AansB and Aggt cells 
TEM was used to compare the intestinal lumens of C. e!egans infected with wild type S. 
jlexneri serotype 3b (SFLI 520), 1',ansB (SFL2283) and l',ggt (SFL2285) cells. Ultrathin 
sections of animals infected with each strain for 24 and 96 hours were examined. 24 hours 
post infection, wonns infected with SFLI 520 had intact bacterial cells within their intestinal 
lumens and consistent with bacterial accumulation and GFP+ fluorescence assays, no 
intralumenal bacterial cells were observed in worms infected with SFL2283 and SFL2285. 
Ninety six hours post infection, intraluminal bacteria were observed in wonns infected with 
SFLl520, SFL2283 and SFL2285 (Figure 3.17). Interestingly, intraluminal 1',ansB cells bad 
irregular cell envelopes (Figure 3.17.B and E) while wild type S.jlexneri cells had well 
defined cell boundaries (Figure 3.17.A and D). These findings indicate that the up-regulation 
of OmpA may disrupt the integrity of the bacterial cell envelope which would have a direct 
effect on bacterial adherence. Very few intraluminal l',ggt cells were observed 96 hours post 
infection and no differences were observed in the cellular morphologies of wild type and 
1',ggt cells. 
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C D 
Figure 3.17: Morphology of wild type and ansB mutant cells in the intestinal lumina of 
C. elegans. Transmission electron micrographs of transverse mid body sections of C. elegans 
infected with wild type S.jlexneri serotype 3b (SFLl520) (A, C), l'iansB and (SFL2283) (B, 
D) for 96 hours. l'iansB cells have irregular cell envelopes when compared with intraluminal 
SFLl520 cells (as indicated by white arrowheads). IEC-nematode intestinal epithelial cell ; 
MV-microvilli; IL-nematode intestinal lumen; b-bacterial cells. 
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3.3 Discussion 
This chapter characterizes the role of metabolic enzymes, AnsB and GGT in S.jlexneri 
virulence. ansB and ggt genes were successfully disrupted in a highly virulent S. jlexneri 
serotype 3b strain using the A red-mediated PCR-based approach [317]. The effect of 
mutations on bacterial virulence was assessed using in vitro cell culture assays and two in 
vivo models, C. elegans and the murine pulmonary model. Results of in vitro bacterial 
adherence assays and both in vivo models of shigellosis suggest that the expression of AnsB 
and GGT is required for S.jlexneri virulence and both enzymes appear to be essential for the 
initial stages of bacterial pathogenesis . 
3.3.1 AnsB and GGT aid S. jlexneri adherence to host cells, in an lpaB-independent 
manner 
The successful establishment of bacterial infection requires adherenc€ to host tissue. 
Members of the family Enterobacteriaceae, use a plethora of strategies to adhere to host 
tissues, ranging from the use of pili to the secretion of highly specialized adhesion molecules 
[3 19]. The molecular mechanisms used by S. jlexneri to adhere to host cells are relatively 
unknown and understanding these mechanisms may allow us to target specific bacterial 
effectors molecules in novel therapeutic measures. 
A recent study identified OspEI and OspE2 mediated bacterial adherence following exposure 
to bile salts [320]. Type I fimbriae are the most common adhesins in Gram-negative bacteria. 
Fimbriae including the type 1 fimbria have been identified in S. jlexneri [321 , 322] , and it has 
been hypothesized that these fimbriae aid bacterial adhesion. It has been long known that the 
entry of S. jlexneri into host tissue depends on T3SS. encoded factors. Previous studies have 
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shown that the bacterial T3SS lpa proteins, especially IpaB facilitate adherence to 
ma1mnalian tissue (25 , 26, 323]. IpaB produced by S.jlexneri during infection, interacts with 
the host hyaluronic receptor CD44 and mobilizes this host receptor in cholesterol-rich lipid 
rafts. This interaction facilitates bacterial adherence and entry into host cells through the 
recruitment of a cascade of signaling molecules (323]. 
The results of western immunoblots using anti-[paB antibodies indicate that the IpaB levels 
are conserved between wild type and t.ansB and t.ggt strains (Figure 3.2). The impaired 
adherence shown by these mutant strains therefore suggests that there may be an IpaB-
independent mechanism involved in S.jlexneri adherence to host cells. 
3.3.2 AnsB and S. jlexneri adherence 
3.3.2.1 Metabolic activity of AnsB and bacterial virulence 
The L-asparaginase activity of AnsB has previously been shown to enhance bacterial 
colonization of mammalian cells by increased hydrolysis of asparagine, in the case of H. 
pylori [324,325] and C.jejuni (314, 326, 327] however, the role of this enzyme in S.jlexneri 
virulence has not yet been elucidated. The results of ammonia release assays (Figure 3.4.A) 
suggest that AnsB in S. jlexneri functions as an L-asparaginase, as is the case in E. coli (315] 
and S. enterica (328]. This reaction features in several metabolic pathways including 
nitrogen, cyanoamino acid, alanine and aspartate metabolism (329] . 
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The involvement ofL-asparaginase in several metabolic pathways suggests that mutating 
ansB could lead to metabolic impairments, which in turn, could decrease overall bacterial 
fitness. However, no differences in the growth rates of ansB mutant and wild type strains 
were detected in this study, which suggests that although ansB is expressed and functional in 
wild type S. jlexneri cells grown in vitro, the activity of this enzyme is not required for 
bacterial growth in vitro under nutrient rich and nutrient starved conditions (Figure 3.5). 
These findings suggest that the virulence phenotypes observed in this study are not likely to 
be a result of metabolic impaim1ents leading to decreased bacterial fitness. 
Bacterial adherence has been found to be favored by local environmental factors such as the 
alkaline milieu of the intestine, humidity and anaerobiosis [330]. Since the expression of 
AnsB has been known to be induced by anaerobiosis , it seems likely, that this enzyme could 
play a role in bacterial survival within the harsh environments of the gastrointestinal tract. 
The activity of AnsB could also be required for the expression and secretion of potential 
adhesins. 
3.3.2.2 Up-regulation of OmpA in ansB mutants, and defective adherence 
Comparative analysis of the proteomes of the ansB mutant and wild type S. jlexneri strains 
indicated that this mutation results in the up-regulation of several S. jlexneri proteins (Figure 
3.10 and Table 3.1) including proteins involved in stress responses (DnaK and GroEL), 
protein translation (RplL), metabolism (Udp and Mdh) and an outer membrane protein 
(OmpA). 
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OmpA is a prominent outer membrane protein found in Gram-negative bacteria, whose role 
in pathogenesis has been extensively studied [33 l, 332]. Studies in E. coli [333] and EHEC 
[334, 335] have shown that OmpA, plays a key role in the initial stages of bacterial adherence 
and invasion. OmpA is involved in maintaining the structural integrity of cellular outer 
membranes [336, 337]. The up-regulation ofOmpA in t:;.ansB could therefore disrupt the 
integrity of the bacterial outer membrane, which could explain the decreased adherence of 
t:;.ansB cells. To determine the effects of elevated OmpA levels on bacterial adherence, 
OmpA was overexpressed in the wild type strain. Overexpression ofOmpA in wild type S. 
jlexneri decreased bacterial adherence to BHK cells and accumulation in C. e!egans (Figure 
3. 15 and 3 .16). These results suggest that the decreased adherence of the ansB mutant strain 
may be attributed to the up-regulation of OmpA (identified using DIGE and confirmed using 
qRT-PCR). 
It is generally believed that the overexpression of membrane proteins affects the integrity of 
cell membranes and cell viability [338] . Therefore the overexpression of OmpA would affect 
cellular protein homeostasis, which in turn could have an effect on the overall integrity of the 
cellular envelope. TEM micrographs ofintraluminal i!ansB cells indicate that the integrity of 
the bacterial cell envelope is compromised on knocking out the ansB gene and this phenotype 
is most likely a result of the up-regulation of OmpA. These findings suggest that the defective 
adherence of ansB mutant cells could be due to OmpA-mediated disruption of the bacterial 
cell envelope integrity. 
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3.3.3 GGT and S. flexneri adherence 
3.3.3.1 Metabolic activity of GGT and bacterial virulence 
Studies in H. pylori [312, 339] have identified GGT as an important virnlence factor, playing 
a ro le in bacterial colonization and pathogenesis [311 , 340-342]. Similarly, studies in C. 
jejuni have also shown that ggt mutants show defective colonization of mice [343] and avian 
intestinal cells [344]. The glutaminase activity of GGT enables H. pylori and C. jejuni cells to 
use extracellular glutamine and glutathione as a somce for glutamate, and it has been 
suggested that GGT-mediated hydrolysis of glutamine, is required for the virulence of these 
pathogens [311 , 325, 345]. To determine if the glutamjnase activity ofGGT in H. pylori and 
C.jejuni, is conserved in S.jlexneri , ammonia assays were performed. No differences were 
observed in the amount of ammonia produced by wild type and !',ggt cells treated with 
glutamine, which suggests that GGT in S.jlexneri fails to hydrolyse glutamine. This is not 
unusual as the protein sequence of GGT in S. flexneri only shares - 50% amino acid identity 
with GGT in both H. pylori and C.jejuni. 
Previous studies in£. coli have indicated that GGT enables bacterial cells to utilize 
exogenous glutathione (GSH) as a source of cysteine and glycine, suggesting that the 
physiological role of GGT in £. coli could be catalysis of the initial step of cysteine/glycine 
salvage [346]. Since S. flexneri is a close relative of£. coli, and the protein sequence of GGT 
in S.jlexneri shares 99% aa identity with its E.coli counterpart; it is likely that the primary 
function of GGT in S. jlexneri is glutatruone metabolism. The results of in vitro growth 
studies (Figure 3.5) indicate that the enzymatic activity of GGT is not required for bacterial 
growth under nutrient rich and starved conditions. It therefore seems likely that although not 
136 
essential, GGT may contribute to ability of S.jlexneri to cope with growth limiting factors 
during infection. 
3.3.3.3 Differential expression of YaeT (BamA) in ggt mutants and defective adherence 
Previous studies in S. flexneri and enteropathogenic £. coli have indicated that the Y aeT 
(BamA) in combination with BamD, constitutes the core component of the bacterial assembly 
machinery, which is essential for the proper folding, secretion and assembly of 
autotransporter proteins and adhesins [347-349]. The differential expression of this protein in 
the ggt mutant strains would therefore affect the folding and secretion of a plethora of 
autotransportes including lcsA and adhesion molecules. 
Conflicting results regarding the expression of yaeT in ggt mutant cells were observed in this 
study, with the DIGE analysis and western immunoblots suggesting decreased levels ofYaeT 
protein and qRT-PCR data indicating the up-regulation ofyaeTtranscripts in ggt mutant 
cells. These results suggest that two competing effects potentially control YaeT levels in ggt 
mutant cells, transcriptional up-regulation of yaeT and translational-down-regulation of YaeT 
protein. 
Although several studies have characterized the structure and function of bacterial YaeT, 
little is known about the regulation of YaeT expression. Rhodius A. et al. identified yaeT as a 
core member of the crE-regulon, which is activated in response to envelope stress, thus 
suggesting that the expression of yaeT mRNA is increased on account of envelope stress. 
Another study in S. typhimurium reported that iJhfq strains show overexpression ofYaeT 
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protein suggesting that protein levels are negatively regulated by Hfq or an siRNA-type 
mechanism (350]. In this chapter, DIGE analysis and western immunoblots suggest the 
down-regulation ofYeaT while qRT-PCR results indicate an increase inyaeTtranscripts in 
t,,.ggt. These results could suggest that two competing effects potentially control YaeT levels 
in ggt mutant cells, transcriptional up-regulation of yaeT possibly due to increased activity of 
crE -mediated stress responses ( discussed above) and translational down-regulation of Y aeT 
possibly due to Hfq-mediated silencing (350]. 
The down-regulation of YaeT in the ggt mutant strain would, result in the faulty folding and 
secretion of autotransporters and other essential adhesion molecules which could explain the 
defective adherence observed in t,,.ggt (SFL2285). In support of this hypothesis, increasing 
the expression ofyaeT in ggt mutant cells (SFL2444) increased the adherence of this mutant 
strain, indicating that YaeT may play a role in S.jlexneri adherence. J:Iowever although 
increasing the expression of yaeT in ggt cells increased bacterial adherence, these cells were 
still significantly less adherent than the wild type strain, suggesting the virulence phenotype 
of the ggt mutants may be a result of the combined effect of multiple factors. 
3.4 Conclusion 
In this chapter, periplasmic enzymes, AnsB and GGT have been identified as novel virulence 
factors in S. j/exneri. Results of in vitro adherence assays and in vivo virulence assays 
indicate that both enzymes are involved in the early stages of S.j/exneri pathogenesis. 
Differential-in gel electrophoresis identified that ansB and ggt mutants exert pleotropic 
effects on the expression of a number of S. jlexneri genes including two prominent bacterial 
outer membrane proteins, OmpA and YaeT that are known to be required for adherence to 
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host cells. Virulence assays performed using wild type cells overexpressing OmpA, suggest 
that the up-regulation ofOmpA could be the leading cause for the defective adherence of 
ansB mutant cells. Data obtained from the DIGE analysis of ggt mutant cells, suggest that the 
mutation of this gene, activates a crE-mediated stress response as indicated by the differential 
expression of several members of the crE regulon (Discussed in Chapter 6). I propose that 
GGT modulates the virulence of S.jlexneri by regulating extracellular glutathione levels, 
which is cri tical to maintaining the redox homeostasis of the periplasmic compartment, 
required for the folding and assembly of membrane proteins. The requirement of AnsB and 
GGT for the virulence of S.jlexneri makes them attractive candidates for designing new 
vaccine strategies . 
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Chapter 4: Determining the complete genome sequence of 
S. flexneri bacteriophage, Sfll and the identification and 
characterization of potential bacteriophage, SfV-encoded 
virulence factors 
4.1 Introduction 
S.jlexneri strains are susceptible to infection by several temperate, lambdoid bacteriophages. 
The vast majority of the bacteriophage genome is of no benefit to the bacterial host as it 
orchestrates the redirection of bacterial resources towards the maintenance and production of 
its own viral particles. A subset of the bacteriophage genome has been found to encode 
virulence factors that play a role in bacterial pathogenesis and survival within mammalian 
hosts [351]. The list of bacteriophage-encoded virulence factors is gro-wing and this field of 
research is of importance as bacteriophage-encoded products have been found to play a role 
in many aspects of bacterial pathogenesis (Table 1.4). 
To date in S.jlexneri, the 0-antigen modifying genes - the glucosyltransferase (glr) and the 
0-acteyltrensferase (oac) clusters are the only set of bacteriophage-encoded genes that have 
been linked to bacterial pathogenesis [5]. Previous studies in both Gram-positive and Gram-
negative pathogens have identified bacteriophage genes that are involved in different stages 
of bacterial pathogenesis [351 , 352] (Table 1.4); these fmdings warrant the need to study S. 
jlexneri phages further. 
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Obtaining the complete genome sequence of an organism is one of the most efficient ways to 
gain insight into its complex biology. Five S.jlexneri bacteriophages have been completely 
sequenced; SfV [158] , Sfl [155] , SfIV [157] , Sf6 [160] and SfX [12] . Here, bacteriophage 
SflI was isolated from a S. jlexneri serotype 2a strain and completely sequenced. S. jlexneri 
serotype 2a accounts for the majority of S. jlexneri isolates in humans [ 16] hence it is 
important to understand why this strain is so prevalent. Sill is a serotype converting phage 
that carries the gtrll gene cluster, which convert serotype Y strains to serotype 2a strains. In 
addition to serotype conversion through 0-antigen modification, bacteriophage SfII may 
contribute more to Shigella pathogenesis. Io order to investigate this hypothesis, the complete 
Sfll genome sequence was analysed and compared to the genomes of Sfl, SfIV, SfV and Sf6 
and other published lambdoid phage genomes. 
While the Sil genome was being sequenced, virulence studies were performed to determine 
if bacteriophage SN-encoded genes contribute to the virulence of S.jlexneri. Preliminary 
virulence studies were performed to compare the virulence of a S. jlexneri serotype Y 
(SFL 1339) strain carrying no bacteriophage genes, and a SfV lysogen in the SFL1339 
background (SFL1871). To stabilize SfV in this lysogenized strain for genetic manipulations, 
the integrase and excisionase (int-xis) genes of the phage were previously knocked out to 
prevent the excision of SfV from the host chromosome (Roberts, PhD thesis, ANU). In vitro 
cell culture assays and C. elegans bacterial accumulation and survival assays were used to 
compare the virulence of the 'phage-less ' SFLl 339 strain and the SfV lysogen (SFLl 871 ). 
Results of these virulence assays indicate that the presence of bacteriophage SfV genes 
increased the virulence ofSFL1339. 
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Previous studies have shown that the gtr cluster of S. flexneri is required for pathogenesis 
[353] and the lysogen used in this study carries the gtrV cassette. Therefore one can argue 
that the increased virulence of the lysogen could be due to the gtrV-mediated 0-antigen 
modifications of SFLI 339. To determine if Sf\/ genes outside of the gtr cluster, also 
contribute to bacterial virulence, all the uncharacterized bacteriophage genes that lie upstream 
of the gtrV cluster in Sf\/ (14 genes in total) and one gene encoding a DNA adenine 
methylase were selected for further virulence studies. These genes were selected based on 
prior knowledge of phage gene expression during its Jifecycle. During the lysogenic cycle 
phage genes encoding structural elements, late regulatory and lytic proteins, are repressed. 
Therefore uncharacterized proteins lying in these regions were omitted in this study. Phage 
genes expressed in the lysogen included those involved in the maintenance oflysogeny, 
providing superinfection immunity and other genes that benefit the host strain. Reverse 
transcription polymerase chain reaction (RT-PCR) was used to detennine if the 15 selected 
uncharacterized phage genes were expressed in the host when grown in vitro at 37 °C. Using 
this approach, 13 out of 15, selected Sf\/ genes were identified to be expressed in the 
lysogen. The expression of Sf\/ genes in the lysogenized host suggests that these genes may 
provide some benefit to the host. 
A cassette of five Sf\/ genes (01fs28-32) identified to be expressed in the lysogen, with 
homologues in S.flexneri bacteriophage SflV (orfs 30-34) and£. coli phage cdtI was selected 
for further study. This five gene cassette was deleted from the Sf\/ lysogen using the A red-
mediated PCR-based approach [317]. In vitro cell culture assays and in vivo C. elegans 
virulence assays indicated that the expression of genes within the 01f28-32 cluster contribute 
to the virulence of the host strain. 
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4.2 Results 
4.2.1 Complete Genome Sequence of SITT: a Serotype Converting bacteriophage of the 
highly prevalent, Shigellaflexneri serotype 2a 
4.2.1.1 Sequencing bacteriophage SITT 
Elizabeth Tran, at the University of Adelaide, previously generated an SfII library, by 
dividing the Sill genome into 8 fragments , using Psi/ digests and cloning individual 
fragments into pBlueScript vectors [ 156]. We obtained this library and sequenced fragments 
1, 2, 4, 6 and 7, in plasmids pNV1942 , pNV1943, pNV1944, pNV1946, pNV1947 (Table 
2.3), respectively, using Sanger sequencing. The Ml3 Forward and Reverse primers, 
complementary to the multiple cloning sites ofpBlueScript vectors, were initially used to 
obtain phage sequences. Plasmids ca1Tying fragments 3, 5 and 8 were not available therefore 
these fragments were isolated from the SfII lysogen (SFL2345) by PCR, using Fragment.3.F-
Fragment.3.R and Fragment.8.F- Fragrnent.8.R primer pairs, respectively (Figure 4.1 ). Primer 
-
walking was used to fill in gaps and detem1ine the arrangement of fragments. DNA 
sequences were assembled into contigs using Bioedit [302]. Putative ORF 's were identified 
using the NCBI ORF Finder and CLC Main Workbench version 6.5. 
4.2.1.2 Overview of the Sfll genome 
The complete genome of bacteriophage Sill has been deposited in GenBank under the 
accession no. KC736978. The genome of SfII is linear, double-stranded, of 41 ,475 bp with an 
average G+C content of 49.17%, corresponding to 58 coding sequences (CDSs). Most of the 
genome (71.57%) is predicted to be transcribed from the sense strand while 19.14% of the 
genome including the gtr cluster, is predicted to be transcribed by the antisense strand. 
Database searches of the 58 predicted CDSs using NCBI BlastX identified, 41 CDSs had 
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Figure 4.1: Sequencing strategy used to completely sequence bacteriophage SfII. The 
above figure is a diagrammatic representation of bacteriophage Sfll in the lysogenic strain, 
SFL2345. The SflI genome can be divided into 8 fragments by Pstl digests. Fragments I , 2, 
4, 6 and 7 (fragments highlighted in blue) were sequenced from plasmid clones donated by 
ElizabethTran, (University of Adelaide) . Fragments 5, 8, and 3 (in red) , were isolated from 
SFL2345 by colony PCR using region specific primers (arrows), following which they were 
sequenced. 
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assigned fimctions and 17 as hypothetical proteins. A complete list of the 58 predicted ORF ' s 
is presented in Table 4.1. A fimctional map of Sfll based on the above predictions is 
presented in Figure 4.2. Thirteen Rho-independent terminators were predicted using the 
ARNold [354] and TransTem [355] terminator prediction tools (Table 4.2). 
4.2.1.3 Alignments of bacteriophage Sfll with other published lambdoid phage genomes 
The genome of bacteriophage Sfll was initially compared to previously sequenced lambdoid 
phages isolated from, S.jlexneri, E.coli and Salmonella, using progressiveMauve [356] 
(Figure 4.3). The results of multiple alignments indicate that bacteriophage Sfll shares high 
levels of DNA sequence similarity with S. jlexneri phages, Sfl (98% nucleotide identity and 
51 % coverage; BlastN), SfIV (97% nucleotide identity and 63% coverage; BlastN) and SfV 
(98% nucleotide identity and 59% coverage; BlastN). Considerable similarity was also 
observed with E. coli phages cdtl (97% nucleotide identity and 12% coverage; BlastN) and 
phiP27 (80% nucleotide identity and 12% coverage; BlastN) and Salmonella phage ST64B 
(84% nucleotide identity and 28% coverage; BlastN). SflI showed limited similarity to the 
other lambdoid phages included in this study (Figure 4.3). 
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Figure 4.2: Complete genome of bacteriophage Sm. Schematic representation of the Sfll genome, with its predicted coding regions and some 
functional assignments. The arrowheads indicate the direction of transcription. Predicted Rho-independent terminator structures are indicated as 
hairpin structures. 
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ORF Gene co- Size Mol. Function Related phage p roteins GcnBank BlastX 
ol'dinates and (aa) mass Access ion no. e \'alue 
orientation (kDa)/ (%identity) 
pl 
Sill_! 126-620 164 17.85/ Small tenninase Putative phage tenninase, small subunit , P27 fami ly protein YP 002115130 5e- I 15(100) 
9.4 subunit Small tenninase subunit fEnterobacteria phage SN] NP- 599033 4e-11 3(99) 
Tenninase small subunil fEnterobacteria phage Sfll AFR52509 4e-I 13(99) 
sm_2 617-2350 577 65.25/ Large tenninase Bacteriophage V large tenninase subunit fShigella sp. 09] WP 00008816 I 0.0(99) 
5.6 subunit Tenninase large subunit [Enterobacteria phage Sil] AFR52510 0.0(99) 
Large tenninase subunit [Enterobac teria phage SN] NP _599034 0.0(98) 
Tenninase larne subunit rSa!monella oha2:e ST64Bl NP 700375 0.0(91) 
Sf1I_3 2362-2544 60 6.38/ Putative integral Putative membrane protein fE. coli 2731 1501 \VP 001297668 2e-15(!00) 
9.1 membrane Hn>othetical protein 003 [Enterobacteria phage SO] AFR525 11 3e-14(97) 
protein Hypothetical protein SFV 0236 f S. jlex11eri 5 str. 840 I] YP 687817 le-13(94) 
Putative integral membrane protein [ Salmonella phage NP _700376 2e- 14(94) 
ST64Bl 
sm_4 2544-3785 41 3 46.12/ Phage portal Phage portal protein, HK97 family [E coli 2.4168] WP 001524100 0.0(99) 
6.1 protein Portal protein rsalmonella phage ST64B] NP -700377 0.0(99) 
Portal orotein fEnterobacteria ohae:e sm AFR52512 0.0(99) 
s rn_5 3763-44 13 216 23.98/ Probead HK97 family phage prohead protease [E coli SMS-3-5] YP 00 1743250 6e- I 54(100) 
5.5 protease Putative phage pro-head protease [Enterobacteria phage SfI] AFR52513 7e-l 54( I 00) 
Pro-head protease [Salmonella pha_ge ST64Bl NP 700378 5e- 152(99) 
sm_6 4428-5633 401 44.26/ Major capsid Phage major capsid protein [Enterobactetia phage Sfl] AFR525 14 0.0(99) 
5.3 protein Phage major capsid protein, HK97 family [E. coli 2.4168] EI165486 0.0(99) 
Major cansid nrotein preclll'sor fSalmonella nbae'e ST64Bl NP 700379 00(96) 
sm_1 5683-5883 66 7.12/ Hypothet ical Putative bacteriophage protein f £. co/il WP 0014 59469 2e-24(100) 
9.1 protein Hypothetical protein Sfl _ 007 [Enterobacteria phage Sf1] AFR52515 2e-23(96) 
Hypothetical orotein sb? [Salmonella ohae:e ST64Bl NP 700380 6e- 19(86) 
s m _8 5886-6209 107 12.56/ I-lead-tail Phage gp6-like head-tai l connector protein rE. coli 3.26081 EIH56530 I c-72(100) 
4.6 connector Phage gp6-like head-tail connector protein [E. coli 27311 SO] EMW82796 4e-72(99) 
protein Hypotl1etical protein SfVp06 fEnterobacteria phage SfVl NP 599038 8e-4 1(68) 
s m _9 6206-6616 136 15 .62/ I-lead tai l Putative phage head-tail adaptor rEnterobacteria phage SO] AFR52516 le-96(100) 
8.9 adaptor Phage head-tai l adaptor [E coli KIT! 59] EOW56935 4e-96(99) 
Hvoothetica l orotein SNo07 fEnterobacteria ohage SNl NP 599039 2e-64(96) 
sm_ 10 6591-7097 168 19.78/ Hypothe1 ical Hypothetical protein Sfl_OOIO [Enterobacteria phage Stl] AFR52517 2e-75(100) 
12.1 protein Hypotl1etical protein SfVp08 fEnterobact eria phage SfVl NP 599040 7e-74(98) 
sm_ 11 7094-7654 186 20.79/ Hypothet ical Hypothetical protein ECDEC l OF 6192 f E coli DECIOFl EHW836!0 8e-134(100) 
4.4 protein Hypothetical protein Sfl_OOI l [Enterobacteria phage Sfl] AFR52518 2e- I 31(98) 
SfVo09 rEnterobacteria nhage SfVl NP 59904 1 4e- 132(99) 
Sf1I_I2 7663-7833 56 6.39/ Hypothetical Hypothetical protein SfVp IO [Enterobacteria phage SfV] NP_599042 2e-3 l(I00) 
9.3 protein Hypothetical protein Sfl_00 12 [Enterobacteria phage Sfl] AFR525 18 2e-31(100) 
Hypothetical protein sb l 2 rSalmo11ella phage ST64Bl NP 700385 2e-24(85) 
s m _13 78 17-93 13 498 53.23/ Tail shea th Tail sheath protein [Enterobacteria phage SN] NP 599043 0.0(99) 
5.5 protein Tail sheath protein fEnterobacteria phage Sf1l AFR525 19 0.0(98) 
BacterioohaQe Mu tail sheath nrotein (GoL) f E. cohl WP 000155705 0.0(99) 
s m _14 9313-9669 118 12.92/ Hypothet ical Hypotheti cal protein SNpl2 [Enterobacteria phage SN] NP 599044 2e-82(100) 
4.8 protein HypOlhetical protein Sf1_0014 [Enterobacteria phage Sf1] AFR52520 2e-82(100) 
Tail rube protein rSalmonella oha_ge ST64Bl NP 700387 9e-65(83) 
s m _ 15 9669-9938 82 9.94/ Putative Phage protein fE. coli UMNK881hypothetical protein YP 006132129 3e-58(!00) 
5.2 bacteriophage Putative bacteriophage protein [Enterobacteria phage SfI] AFR52522 2e-54(99) 
orotein SfVDl 3 rEnterobacteria ohae:e Stvl NP 599045 7e-57(98) 
sm_16 !0080-119 15 6 11 65.39/ Tail protein Tail protein [Enterobacteria phage SfV] NP 599046 0.0(99) 
9.1 Tail protein fEnterobacteria oha_ge sm AFR52523 00(99) 
S!11_17 l 1934-13304 456 49.43/ Tail/DNA DNA circulation protein r E. coli MS 11 9-71 ZP 0710501 8 0.0(99) 
5.6 circulation Hypothetica l protein Sf1_0017 [Enterobacteria phage Sf1] AFR52524 0.0(98) 
orotem Tail/DNA circulation orotein rEnterobacteria ohae'e SfVl NP 599047 0.0(98) 
sm_18 13301- 14380 359 39.19/ Tail protein MuP protein [Enterobacteria phage SfIJ AFR52525 0.0(99) 
5.1 Tail protein rEnterobacteria phage SM NP 599048 00(99) 
sm_19 14380- 14928 182 19.58/ Tail protein Tail protein [Enterobacteria phage SN] NP_599049 2e-129(99) 
6.9 Tail orotein rEnterobacteria ohae:e Sfll AFR52526 2e-129(99) 
S111_20 14925-15353 142 16.36/ Tail protein Phage GP46 family protein [E coli DECI4B] EHX73482 2e-96( !00) 
5.8 Tail protein [Enterobacteria phage SN] NP _599050 I e-95(99) 
Putative tail protein fEnterobacteria pha_ge Sfll AFR52527 le-95(99) 
sm_21 15340-16398 352 38.18/ Tail protein Phage tail protein [ £. coli KTE3 I] EOU82947 0.0(100) 
5.0 Tail protein [Enterobacteria phage SN] NP _599051 0 0(99) 
Hypothetical protein Sfl 002 l fEnterobacteri a ohage sm AFR52528 00(98) 
sm_22 16389- 16973 194 21.73/ Ta il protein Tail protein [Enterobacteria phage Sfl] AFR52529 8e-130(100) 
5.1 Tail protein [Enterobacteria phage SfVJ NP 599052 2e-129(98) 
Tail orotein IE. coli DEC7Bl EHW00738 6e-127(97) 
sm_23 16977-17627 216 22.64/ Hypothetical Unnamed protein product [S.jlexnel'i 2a str. 301) NP_ 706263 9e-147(100) 
7.7 oro1ein Hypotl1etical protein SfVp2 ! fEnterobacteria phage SfVl NP 599053 2e-134(95) 
Hvoolhetical oro tein Sfi 0023 I Enterobacteri a oha!!e sm AFR52530 4e- 134(95) 
s m _24 17599- 18033 144 16.25/ Tai l fibre Phage tail fiber protein [Sjlexneri 2a str. 301] NP 706262 2e-102(100) 
5.1 assembly Caudovirales tail fibre assembly family protein [S.jlen,eri EGK28007 2e- l 02 (JOO) 
protein VA-6] 
Pu tative phage tail fiber protein [Enterobacteria phage Sfl] AFR5253 1 5e-91(92) 
Tail fibre assembly protein rEnterobacteria phage SM NP 599054 4e-9 1(91) 
Sf1l_25 J 8806-19855 349 40.12/ Acyltransferase Acyltransferase family protein [ S. f!e;meri 2a str. 2457T] EFSI 1261 0.0( 100) 
9.2 Hypothetical protein SF0309 rS.Jle:meri 2a str. 301] NP 706261 0.0(100) 
Acyltransferase fami ly protein [Sflexneri K-304] EGK3 1482 0.0( 100) 
Acyltransferase [ S. flexneril WP 0006 13535 5e- J57(99) 
Sf1!_26 20308-2 1498 396 45.46/ Transposase Transposase DDE domain protein [S. flexneri 2a str. 2457T] EFSI 1262 0.0(99) 
10.5 Transposase ISS03 [S.flexneri] WP 001 11 1520 0.0(99) 
T ransposase r £. co/il WP- 016 159268 0.0(99) 
S01_27 21887-23348 486 55.78/ Serotype- Glucosyl tranferase II [ S. flexneri phage Sill] AAC39273 0.0(100) 
9. 1 speci fic Glucosyl tranferase II [S.flexneri 2a str. 2457T] NP 83604 1 0.0(99) 
glucosyhransfer gtrll gene product [S. flexneh 2a str. 30 I] NP)06259 0.0(99) 
ase 
s m _28 23344-24274 309 34.85/ Bactoprenol Bactoprenol glucosyl transferase [S.jlexneri 2a str. 301] NP _ 706258 0.0( 100) 
6.9 glucosyltransfer Bactoprenol glucosyl transferase [ Shigel!a phage Sill] AAC39272 0.0( 100) 
ase Bactoprenol glucosyltransferase [Enterobacteria phage SN) NP 599056 0.0(98) 
Bactoprenol elucosvltransferase rEnterobacteria phage sm AFR52533 0.0(98) 
s m _29 24270-24633 120 13.31 Putat ive Unknown protein [Shigella phage Sfll] AAC39271 2e-70(100) 
9.6 flippase Putat ive flippase fEnterobacteria phage SN] NP 599057 2e-69(99) 
Flippase [Enterobacteria phage Sfl] AFR52534 2e-69(99) 
JZ!rAJ gene product fS. {lemeri 2a Sir. 3011 NP 706257 2e-68(98) 
s m _3o 24894- 26058 387 44.94/ Integrase Phage integrase family site-specific recombinase AFR52475 0.0(99) 
9.8 [Enterobacteria phage Sil] 
Integrase [Enterobacteria phage SN] NP 599058 0.0(98) 
Pha2:e inle!!fase f S. flexneri 2a str. 2457Tl l\'P- 836047 0.0(99) 
sm_3 1 25935 - 26351 138 15.56/ Excisionase Excisionase [Escherichia coli] WP 00 1310200 2e-96(99) 
9.7 Excisionase rEnterobacteria phage SfY] ZP 0593798 1 le-94(96) 
Excisionase [Enterobacteria phage Sil] AFR52476 le-74(95) 
Excisionase fShigella phage SfXl AADI0294 6e-1 9(4l) 
Stll_32 26284- 26590 101 12.12/ Hypothetical Hypothetical protein SNp28 fEnterobacteria phage SN] NP 599060 2e-66(100) 
4.8 protein Conserved hypothetical protein [Sjle:meri 2a str. 30 1} AAN41957 2e-66(100) 
Conserved hypothetical protein; CPS-53 (KpLEl) prophage CAQ88 120 l e-65(99) 
fE. (errsusonii ATCC 354691 • 
S111_33 26589-26952 120 13.79/ Hypothetical H}1)othetical protein SNp29 [Enterobac-teria phage Stv] NP_599061 5e-82(99) 
4.7 protein Conserved hypothetica l protein; CPS-53 (K.pLE I) prophage CAQ8812 1 5e-82(99) 
[E.ferg11sonii ATCC 35469] yp 00 1272549 4e-80(96) 
Hypothetical orotein Pcdtl eo36 rPhage cdtll EHW00692 3e-76(99) 
SIT1_34 26943-27479 110 20.38/ H}1)othet ical Conserved hypothetical protein; CPS-53 (KpLEl) prophage CAQ88122 le- 124(97) 
5.5 protein [E.ferg11sonii ATCC 35469] 
Hypothetical protein SfVp30 [Enterobacteria phage SfV] NP 599062 4e-124(96) 
Hypothet ical protein Pcdt l gp37 rPhage cdtn YP - 001272550 3e-126(97) 
SlI1_35 27535- 27873 112 12.58/ Hypothetical Hypotl1etical protein HMPREF9542_02137 [£. coli MS I 17- EGB88400 3e-71(95) 
10.6 protein 31 
Conserved h}1)othetical protein [E. fe1g11sonii A TCC 35469] CAQ9 1833 2e-61 (96) 
Hypothetical protein Pcdt l !!040 [Phage cdtn YP 00 1272553 4e-24(64) 
S01_36 27994-281 85 63 7.23/ Hypothetical Hypothetical protein HMPREF9534_ 01518 [£. coli MS69- EFJ82427 9e-37(100) 
4.9 protein I] le-35(98) 
Hvvo1.hetical protein EcE22 4050 rEscherichia coli £221 EDV83662 
S01_37 28703-29395 230 25.65/ CI repressor Putative cl regulatory protein f £. coli ETEC HI 04071 YP 006 11 3860 4e-J 67( I 00) 
6.0 Putative cl regulatory protein [£. coli O I 57:H43 str. T22] EN007 177 7e- 167(99) 
Regulatory protein fSalmonello phage ST64Bl NP 70041 1 3e-133(83) 
S1ll_38 29493-29753 86 9.76/ Cro repressor Antirepressor Cro [£. coli 0 103:H2 str. 12009] YP 003220518 Je-54(100) 
9.5 Putative antireprcssor protein Cro [£. coli 0111 :H- str. YP=003237J74 3e-52(94) 
11128] 
Putative lambda repressor- li ke DNA-binding domain- YP _002411623 6e-54(99) 
containing protein f E. coli UMN026l 
sm_39 29746-30297 183 20.0 J/ Phage Phage transcriptional regulator fE. coli KTE228l ELD55966 9e-J 32(99) 
4.8 transcriptional Phage regulatory protein CU [£. coli 0103:H2 str. 12009] YP 003220519 4e-121 (99) 
regulator Hvoothetical nro1ein Pcdtl im43 fPha2e cdtfl YP- 00 1272556 6e- J 18(90) 
s m _4o 30294-30632 112 12.2/ Hypothetica l Hypothetical protein f Esche,ichia sp. TW093081 WP 001087375 5e-54(99)) 
9.1 protein e l 4 prophage protein[£. coli 055:H7 str. CB9615] YP _003502582 le-62(99) 
Conserved hypothetical protein; el4 prophage [E.fergusonii CAQ88 132 5e-62(96) 
ATCC 354691 
s m_4I 30642-31538 313 35/8.6 Replication Replication protein [£. coli] WP 000104970 0.0(99) 
Phage replication protein O f £. coli KTE681 E0\165900 0.0(99) 
Phage O orotein familv orotein rs. {lexneri VA-61 EGK28948 0.0(99) 
sm_42 31586-32071 167 18.5 1/ PerC PerC transcriptional activator family protein, CPS-53 NP_4J6858 7e- J l 1(99) 
9.9 transcriptional (KpLEJ) prophage; f £. coli str. K-1 2 substr. MGI 655] 
activator family PerC transcriptiona l activator family protein [£. coli EMU72183 le- I 09(98) 
orotein MP0215521 
149 
PerC transcriptional activator family protein (£. coli DH I J Yl' 006091263 l e-1 10(99) 
PerC lranscriptional activator family protein [Shigella sp. EGJ06486 6e-109(99) 
D91 
Stll_43 32072-32725 21 7 24.50/ DNA adenine DNA adenine methylase [Enterobacteria phage SN] NP 599073 2e-160(100) 
5.8 methylase Putative DNA adenine methylase [Phage cdtll Yl' - 001272560 4e-158(99) 
Phage N-6-adenine-methyhransferase rE. coli DEC7Bl EH\V00771 4e- 159(99) 
sm_44 32722- 33048 108 12.03/ LexADNA- LexA DNA-binding domain protein[£. coli 96. 154] EllOOl 72 2e-72(99) 
9.3 binding domain Lex.A fami ly transcriptional regulator [E. coli] WP 0002 10154 Se-72(99) 
orotein Hvoo thetical orotein SNo42 rEnterobacteria ohage SM NP -599074 3e-70(95) 
sm_4s 33045-33434 129 14.] 7/ RusA family Endode0>,J1ri bonuclease RusA family protein [£. coli] WP 001501070 2e-89(100) 
9.3 protein Crossover junct ion endodeoxyribonuclease [Enterobacteria NP _) 99075 2e-89(99) 
phage SN] 
Holliday junction resolvase [Phage cd1I] Yl' 001272562 Se-89(98) 
sm_46 33454-34251 265 29.77/ KilA-N domain KilA-N domain protein fE. coli DEC7Bl EHW00778 0.0(99) 
9.2 Kil A-N domain protein [ S. f!e:1.11e,i VA-6] EGK28953 0.0(99) 
Hvnothetical orotein SNo44 fEnterobacteria phage SfVI NP 599076 2e- !63(87) 
s m _47 34259- 35248 329 37.13/ Hypothetical Hypothetical protein c3 I 87 rE. coli CFT0731 NP 755069 0.0 (99) 
7.71 protein Hypothetica l protein mEp460 _ 049 [Enterobacteria phage AFM76086 0.0(99) 
mEp460] 
Hypothetic-al prolein SD15574_5395 [S. dysenreriae 155- EGl88864 0.0(99) 
741 
Sfl1_48 35266- 35577 103 11.7/ Antitenninator Phage antitern1ination Q fami ly protein [E.coli Jurua 20/ 10] EMX57588 3e-64(89) 
9.3 protein Q Phage antitermination protein Q f£. coli El 167] EGC09492 le-63(88) 
Antitennination protein Q homolog from lambdoid WP _001205449 7e-54(72) 
prophage DLPI 2 rE. co/il 
S!T1_49 35581-36165 194 2 1.83/ Hypothetical Hypolhetical pro tein f E. co/fl WP 001 122063 le- 113(100) 
9 .0 protein Hypothetical proteinERBG 04465 r£. coli E l 167] EGC0949 ! 3e- ! 33(99) 
Putative membrane orotein r E. coli Jurua 20/ l 01 WP 004030018 2e-35(!00) 
s m _5o 36 173-37195 340 38.45/ Hypothetical Hypot11etical protein ECJURUA2010_0091 [£. coli Jurua EMX57590 0.0(100) 
8.9 protein 20/10] 
Hypotl1etical protein ERBG 04464 r £. coli E 11671 EGC09490 0.0(99) 
Hypothetical protein EC2726800 0411 [£. coli 27268001 EMX8 1086 0 0(99) 
sm_s1 37481-37807 108 11.47/ Holin Phage holin, lambda fantily [E.coli Jurua 20/10] EMX5759! I e-55(!00) 
9.7 Lambda family protein phage holin [£. coli E 1167] EGC09489 8e-55(99) 
Hohn rEnterobacteria phage SfVl NP 599081 3e-53(97) 
s m _52 3781 1-38287 158 17.8 1/ Lysin Lysozyme [E. coli Jurua 20/ IO] 
-
EMX575921 6e-! 13(100) 
9.0 Lysin [Enterobacteria phage SN] NP 599082 2e-!09(96) 
Phage lysin f £. coli AA861 EGH3717 4e-l 12(99) 
SfJJ_53 38271-38663 130 14.58/ RZ Rz lyt ic protein from phage origin, coiled-coil[£. coli] WP 001356120 6e-76(100) 
9.4 Putative Rz lytic protein[£. coli E22] ED\18264 1 2e-63(83) 
Putative Rz lvtic orotein fEnterobacteria phage SM NP 599083 2e-57(76) 
Sfl1_ 54 38386-38820 144 16.37/ RZI Hypothe1ical pro1ein [£. coli) WP 001181631 l e-73(!00) 
9.8 Putative Rzl lytic protein[£. coli B str. REL606] YP _::-003043948 3e-46(76) 
Rz lytic protein from phage origin, coi led-coil lE. coli] WP 00 1356120 8e-43( !00) 
Putative Rzl lvtic orotein-fEnterobac1eria oha2e SM NP -599084 le-42(73) 
sm_s5 39323-39949 208 23 .76/ IS91 l orfB IS91 l orfB [S.jlexne,i 2a str. 2457T] NP 835950 2e-136(]00) 
IO.I IS9 1 l orfB rS.Jlexne,i 2a str. 301 1 NP- 706457 2e-I 36( I 00) 
IS91 l orfB rs.jlexne,i Sa str. M90T] NP 085444 Se- 136(100) 
Putative transposase Orffi fEnterobacteria phage Sf61 NP 958229 le-135(100) 
s m _s6 39976-40278 JOO 11.54/ IS9! l orfA IS91 l orfA rS.Jle.rneri 2a str. 2457T] NP 837023 4e-65(100) 
9.9 S91 l ORF ! rS.flexneri 2a str. 30Il NP 706169 7e-65(!00) 
IS ORF! [S.j7ex11eri 5a str. M90TJ NP_085444 2e-64( 100) 
Gene 56 orotein rEnterobacteria phage Sf61 NP 958230 4e-65( !00) 
Sl1!_57 40429-4 1049 206 22.8 1/ Hypothetical Hypothet ical protein [£. coli] WP 000634417 3e-147(!00) 
5.4 protein Hypothetical protein ECJURUA20!0_0095 [£ coli Jurua EMX57594 3e-! 47(!00) 
201!01 
sm_ss 41 125-41475 116 13 .16/ HNH HNH endonuclease family protein[£. coli Jurua 20/10] EMX57595 le-78(100) 
10.2 endonuclease Hypothet ical protein sb56 [Salmonella phage ST64B] NP 700429 2e-74(93) 
HNH endonuclease family protein[£. coli DEC7B] EH\\1007681 2e-74(95) 
Hypothetical protein SNp53 [Enterobacteria phage SN] NP 599085 4e-74(93) 
HNH endonucleasc family pro1ein [Enterobacteria phage ms2sos le-73(94) 
sm 
Table 4.2 : Putative Rho-independent terminators in the Sfll genome 
Position Gene Sequence Sh·and predicted 
free 
energy of 
terminator 
bnirpin 
"cal/mol 
2380-2411 - Sfll_ 2 GCGCCTCTGGTGGGCGTGCTGGGGGCGCTTIT Plus -19.3 
4066-4108 s m 4 GCACACATGAAGGCCGGTTCGTTAACCGGCCTTTCTATTGGGT Plus -14.60 
6859-6898 Sffi- 9 GAGAGGGAAACCGCCGTA TCACCGGTGaTTITTATCCGGC Plus -6.60 
7457-7500 st1C10 CTGAATCGTCATGAGCTGATTTATCAGTTCGaTTTTTCGGTCAT Plus -8.80 
11928- s n-(16 CTGTTAATGAGTCCCACTCCGGTGGGATfrTTTATGTAC Plus -9.80 
11966 
Sfl1_17 - CGGTGCCGGTGTTGAACGACTGGCGCGGGATTTCAGTGTG 13366-- Plus -12 .90 
13405 
15468-- Sfl1_20 -c;TATGCGGCGGCGCTGCATACGGTTTACGGTTA - Plus -15.0 
15500 
i8769- sm_i5 AA TGAT AAAAAGGCGCAA TT AA TTGCGCCTTITTATAGAT'A T minus -I I.GO 
18810 
21423- Sf11_27 TACTTCGGTAAGTGCTGGCCAACCGGCACaaTATCTTTTCAGG minus -11.90 
21465 
24704- Sfl1_30 ~ AAACATGTAAAGCCTTGCAAGCCATTGTGAGGC<ITATGTGTCTCAG minus -10.30 
24750 
28211- Sill_36 TGGGCTCGATGCCATGTGCGGTGAGCTCACTTTTCAAAAC Plus -17.8 
28250 
-28639- Sill_37 CCCATCCATCGGCCACCGAAAGGTGGCTTTITATTACCT minus -1 5.10 
28677 
39842- Sfl1_56 - CAGCCCGTCTGCCGTCTGGTTTITCAGGACGGTTTTTCCAGTAT Plus -7.6 
39885 
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Figure 4.3: Alignment of bacteriophage Sfll with its closest lambdoid phage homologues using progressiveMauve. The above figure 
represents the comparison of the Sfll genome with its closest relatives. Colored outlined blocks surround regions of the genome sequence, that 
show homology to part of another genome. The colored bars inside the blocks are related to the level of sequence similarities. 
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4.2.l.4 Alignments of the coding regions of bacteriophage St11 and S. flexneri phages 
Sfl, SfIV and SfV 
Since Sill showed a high degree of similarity to other S. jlexneri phage, the coding regions of 
Sfll were aligned with the protein coding regions of S.jlexneri phages Sfl, SflV and SfV, to 
gain insight into the degree of conservation among S. jlexneri phages (Figure 4.4). Several 
functional modules were identified to be conserved between S. jlexneri phages, Sfll, Sfl, 
SflV and SfV. These include the small and large teminases, genes-encoding structural 
proteins, regulatory and lytic genes. The main differences between S. jlexneri Sill, SfV and 
Sfl lie in their 0-antigen modifying genes, immunity, replication and Nin regions. 
4.2. l.5 Comparing the host ranges of S. flexneri phages, Sfll and SfV 
The host ranges of bacteriophages Sfl and SflV have been previously determined [ 155, 157]. 
Here the host ranges of bacteriophages Sill and Sf\/ were determined using twelve S. jlexneri 
serotypes (la, lb, le, 2a, 2b, 3a, 3b, 4a, 4b, Sa, X and Y) as described in section 2.12.5 . SfV 
was capable of infecting seven of the twelve S. jlexneri serotypes tested (serotypes 1 a, 1 b, 2a, 
2b, 3b, 4b, and Y) whi le Sfll only infected three (serotypes 3b, Sa and Y) (Table 4.3). 
Previous studies indicated that Sfl only infects serotypes X and Y [ 155) while SflV infects 
serotypes I a, 1 b, I c, X and Y [ 157]. It is surprising that although these phages have high 
degree of sequence similarities, their host ranges vary significantly with serotype Y being tl1e 
only common serotype infected by all four phages. 
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Figure 4.4: Comparison of the coding regions of Stll with other seroty,pe converting phages of S. flexneri. Coding regions of SflI were 
aligned to annotated coding regions ofSfl (JX509734), SflV (KC814930) and SfV (NC_003444) using CLC Main Workbench version 6.5 . 
Arrows represent coding regions and indicate the direction of transcription. Conserved functional modules between the phages have been 
indicated (solid lines). Bar graphs represent% conservation in the nucleotide sequence. 
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Table 4.3: Host range of S. flexneri bacteriophages Sfll and SfV 
Bacterial strain 
SFL1499 (Sjlexneri la) 
SFL 1496 (Sjlexneri 1 b) 
SFLl 500 (Sjlexneri le) 
SFL2345 (Sjlexneri 2a) 
SFLl 510 (Sjlexneri 2b) 
SFL1516 (Sjlexneri 3a) 
SFLl520 (S.jlexneri 3b) 
SFLl 253 (S.jlexneri 4a) 
SFL1350 (S.jlexneri 4b) 
SFLI 871 (Sjlexneri Sa) 
SFLI 537 (Sjlexneri X) 
SFL1353 (S.jlexneri Y) 
Infection by Infection by 
Bacteriophage Sfll Bacteriophage SfV 
R s 
R s 
- ---------------
R R 
------ _ ______.____.. - ._ -----
R s 
--- - ·--. R s 
- -------
R R 
- ------ -- - -
s s 
---------R R 
- ----- ----- ---~ 
R s 
. ------ --------- - ----- ···-
s R 
-- -- - -- -R R 
--- - -- -
s s 
R represents bacterial strains resi stant to bacteriophage infection while S represents strains 
susceptible to infection by phage. 
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Bacteriophage tail proteins identify bacterial receptors and initiate infection. Since large 
variations were observed in the host ranges of S. jlexneri serotype converting phages, the 
amino acid sequences of the tail proteins of Sfll, Sfl, SfIV, and SN were compared using 
BlastP, to identify differences in the tail proteins of these phages (Table 4.4). Most of the tail 
proteins of these four phages show over 98% aa identity. The main differences between the 
tail proteins of all four phages are as follows; ( 1) Sfll _ 7 annotated as a hypothetical protein is 
unique to SfII and Sfl with no homologues in SfIV and SN. (2) Sfll_ l2 has no homologue in 
SfIV, and shows < 95% identity with the corresponding protein in Sfl and SN. (3) SfII_ 15 
and Sfll_ 16 show < 50% identity with the SfIV homologues . ( 4) Sfll _ 24, which encoded the 
tail fibre assembly protein shows < 92% identity with homologues in Sfl, SfIV and SN. 
These differences in the amino acid sequences of tail proteins could account for the varied 
host ranges of Sfl, Sill, SfIV and SN. 
4.2.2 Identification and characterization of potential bacteriophage SfV-encoded 
virulence factors 
While the genome of bacteriophage Sill was being sequenced, virulence studies were carried 
out using the completely sequenced S.jlexneri bacteriophage, SN. SN is a serotype 
converting S.jlexneri phage that encodes the 0-antigen modifying gtrV, gene cluster. 
Lysogenization of SN results in the conversion of serotype Y strains to serotype Sa strains 
[357, 358]. To detem1ine if lysogenization of bacteriophage SN improved the virulence of S. 
jlexneri serotype Y (SFLl 339), the virulence of SFLl 339 was compared with a SN lysogen 
previously created in this serotype Y background (SFLl 871 ). The SN integrase (int) and 
excisionase (xis) genes were previous ly knocked out of SFLl 871, in order to stabilize the 
lysogen by inhibiting bacteriophage excision (Roberts, PhD thesis, ANU). In vitro adherence 
and invasion assays and in vivo C. elegans bacterial 
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Table 4.4: Comparison of amino acid sequences of predicted tail proteins of S. flexneri 
bacteriophages Sfll, Sfl, Sf1V and Stv. 
Sf11CDS % identity % identity with % identity 
with Sf1 Sf1V with Stv 
homologue homologue homologue 
Sf11_7 (Hypothetical protein) 97 No homologue No 
homologue 
Sf11_8 (Il_ead-tail connector protein) 100 100 100 
Sfll _9 (Head-tail ad!!ptor p__rotei!!) 
-
100 
~ ---
10.Q 
~ 
100 
Sf11_10 (Hyp_?thetica] protein) 100 100 98 
--- - - -Sfll_ll (Hypothetical l!_rotein) 98 99 99 
--- -
Sf11_12 (Hypo!hetic~I protein) 94 No homologue 68 
Sf11_13 (Tail sheath protein) - - 100 100 100 
- --
-Sf11_14 (Hypothetic!!.! protein) 100 100 100 
- ---- --- ---
Sfll_l~ (Hy()otheticl!.!. protein) 99 46 98 
-- ___ __,_ 
--~ ~- -
Sf11_16 (!_ail protein)~ 99 24 99 
Sf11_17 (Tail/DNA circulatio n -------- 98 --- 9-8- -- 9 8 
l!_l"Otein) 
Sf11_18 (Tail t>_rotein) 99 99 99 
--
~ 99 -~ 1 00 - 99 § fll_19 (Tail protein) 
·-- - -·-----~-
--------------
--
sm_~ (Tail protein)_ 98 99 99 
Sf1I_21j J'ail protein} 99 99 -~- 99 
__. ____ - ---
-~---
Sf1_!_22 (Iail p5 otein) 99 99 98 
~fll-~3 (Hypothetic!_I pro!ein) 95~ ------- 95 .,. --- ------ -95 
-Sf1I 24 {Tail fibre assembll erotein} 92 92 91 
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accumulation and killing assays were perfonned to compare the virnlence of S. jlexneri 
serotype Y and the SfV lysogen. 
4.2.2.1 Lysogenization of wild type S. flexneri serotype Y by bacteriophage Stv, 
increases bacterial virulence 
4.2.2.1.1 Stv genes enhance the adherence and invasion of S. flexneri serotype Yin 
vitro 
In vitro adherence and invasion assays were perfom1ed using BHK cells (as described in 
Section 2.10.5) to investigate whether the presence of the SfV genome enhanced the 
virnlence of SFLI 339 (serotype Y strain). Results of four independent in vitro assays 
indicated that lysogenization of S. jlexneri serotype Y by SfV, significantly increased 
bacterial adherence and invasion (Figure 4.5.A and B). This phenotype was consistently 
observed across all four repeats however there were large variations in the numerical outputs 
between repeats. To account for numerical variations between experimental repeats, plate ID 
was set as the blocking factor and one way ANOV A was used to determine statistical 
significance. These findings suggest that there are genes within the SfV genome that 
contribute to bacterial virnlence. 
4.2.2.1.2 Stv genes increase the accumulation of S. flexneri serotype Y in the C. 
elegans intestinal lumina 
To determine if the increased adherence and invasion of the SfV lysogen (SFL1871) 
observed in vitro had an effect on bacterial virulence; preliminary in vivo studies were carried 
out in C.elegans. Results of the C. elegans bacterial accumulation showed pronounced 
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Figure 4.5: Bacteriophage Stv genes play a role in bacterial adherence and invasion in 
vitro . A: Adherence of S. jlexneri serotype Y (SFL1339), compared to a SfV lysogen in 
SFL1339 (SFL1871), plotted as percentage adherence, a ratio of the number of adherent and 
intracellular bacteria to the total number of bacterial cells in the infecting inoculum (y-axis). 
B: Invasion of BHK monolayers by SFL 1339 and SFLJ 871 , plotted the percentage of the 
number of intracellular bacteria to the total number of adherent and intracellular bacteria. 
Lysogenization of S. jlexneri serotype Y by SfV, results in a significant increase in the 
adherence and invasion of this strain (p < 0.05 , one way ANOV A with plate ID set the 
blocking factor). Results are the means of four independent biological repeats with standard 
errors ( error bars). 
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Figure 4.6: SfV genes increase the accumulation of S.jlexneri serotype Yin the C. 
elegans intestinal lumen. A: Results of bacterial accumulation assays. Young adult 
he1111aph.rodite nematodes were fed either S.jlexneri serotype Y (SFL1339) or a SfV lysogen 
in the serotype Y background (SFLl 871) for 24 hours. 20 nematodes were picked and 
mechanically disrupted to release internalized bacteria. Diluted lysates were plated on LB 
agar plates carrying appropriate antibiotics, and colonies were scored to quantify S. jlexneri 
cells associated with each nematode. Results represent the means of four independent 
biological repeats. Statistical analysis perfonned using one way ANOV A with the plate ID 
set as the blocking factor , shows a significant increase in the accumulation of SFLl 871 when 
compared with SFLI 339. B and C: Representative images of GFP+ accumulation assays. 
Young adult hermaphrodite nematodes infected as above with SFL2503 (SFL1339 expressing 
GFP+) and SFL2504 (SFLI 871 expressing GFP+) for 24 hours. Infected nematodes were 
visualized using the EVOS fluorescence microscope. Nematodes infected with SFL2504 
show accumulation of the lysogenized bacterial cells within their intestinal lumina (C) while 
wonns infected with SFL2503 have no bacterial cells within their lumina (B). Scale bar = 
400 µm. 
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accumulation ofthe SfV lysogen (SFL1871) within the intestinal lumina of infected wom1s, 
compared with S.jlexneri serotype Y (SFL1339), which was digested by the nematodes 
(Figure 4.6.A). In order to confinu bacterial accumulation, nematodes were fed GFP+-tagged 
SFL1339 and SFL1871 (SFL2503 and SFL2504, respectively) and 20-30 animals were 
observed using fluorescence microscopy. Worms fed SFL2504 (GFP+-tagged SFL1871) 
showed accumulation of GFP+-tagged bacterial cells within their intestinal lumiua (Figure 
4.6.C), while no detectable fluorescence was observed in worms fed SFL2503 (GFP+-tagged 
SFLl 339) (Figure 4.6.B). These results suggest that the virulence of S. jlexneri serotype Y 
increases on incorporating the SfV genome into the bacterial genome. 
4.2.2.1.3 Stv genes increase S. flexneri serotype Y-mediated killing of C. elegans 
C. e/egans liquid killing assays were performed as described previou-sly [284] , to determine if 
the accumulation of SFLJ 871 in the intestinal lumina of nematodes resulted in increased 
killing of wo1ms. Results of liquid killing assays indicate that C. e/egans fed the SfV lysogen 
(SFL187 l), died much faster than wonus maintained on serotype Y (SFL1339) (p < 0.001 , 
Logrank test) (Figure 4.7). These findings along with the bacterial accumulation suggest that 
bacteriophage SfV genes enhance the virulence of S.jlexneri serotype Yin C. elegans. 
4.2.2.2 Identification of potential Stv genes that contribute to the virulence of its host 
Virulence studies indicated that lysogenization of S. jlexneri serotype Y by SfV increases the 
virulence of this strain. In order to determine if uncharacterized SfV genes contribute to host 
virulence, comparative geuomics was used to identify 15 uncharacterized, cryptic 
bacteriophage genes in SfV (Table 4.5 and Figure 4.8.A). Reverse transcription polymerase 
chain reaction (RT-PCR) was used to determine if the identified cryptic phage genes were 
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Figure 4. 7: Bacteriophage SfV genes increase S. flexneri serotype Y-mediated killing of 
C. elegans. Synchronized young, adult, hermaphrodite nematodes were treated with log 
phase cultures of S. flexneri serotype Y (SFLI 339) and a SfV lysogen (SFLJ 871 ), grown at 
37 °C to express virulence genes. Worms were scored for survival every 12 hours. Results 
represent data obtained from four independent blind biological repeats each with at least four 
technical repeats (each technical repeat with 20-50 nematodes) with standard error (error 
bars). Wom1s infected with SFLJ 87 1 show a significant decrease in survival rates when 
compared to wonns fed SFL1339 (p < 0.0001 , Logrank test). 
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Table 4.5: List of uncharacterized genes in bacteriophage SfV 
SfV gene Location Homologue in Sill Homologue in SflV 
(%Identity, E value- (%Identity, E value-
BLASTP) BLASTP) 
SfVp28 22042<----22347 sm 32 orf30 
(100%, le-74) (100%, le-74) 
- -- . 
SfVp29 22347<----22709 sm 33 orf3 l 
(99%, 6e-90) (I 00%, 6e-9 l) 
- -·-SfVp30 22700<----23236 sm 34 orf32 
(96%, 7e-132) (99%, 5e-137) 
SfVp31 23364 <----24188 None orf33 
(99%, 0.0) 
----- ---
SfVp32 24254<----24616 None orf34 
(100%, 3e-86) 
._ ___ -
SfVp33 252]7<----25513 None None 
SfVp36 26695--->27246 sm 39 orf39 
(90% 3e-l 20) _______ (90%, 8e- J 25) 
SfVp38 28072--->28308 None None 
- -SfVp40 29126--->29614 sm 42 orf42 
(94%, le-113) (94%, le-115) 
-- -
SfVp41 296]4--->30267 sm 43 None 
(100%, 5e-J 68) 
SfVp42 30264--->30590 sm 44 orf43 
(91_%, 3e-78) 
-- -~ 
(96%, 9e-79) 
SfVp44 30996--->3]805 sm 46 orf44 
(87%, 7e-l 78) (67%, 2e-126) 
-· -SfVp45 31885--->32802 sm 47 otl45 -
(99%, 0.0) 
----
(99%,0.0) 
SfVp47 33818--->340)2 None None 
SfVp_48 34162--->352)4 Non'e None 
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Figure 4.8: Detection of SfV gene expression in the Iysogen, SFL1871 by reverse transcriptase PCR (RT-PCR). A: Schematic 
representation of the SfV genome (black arrows represent functional modules) with the cryptic SN genes selected for expression study 
highlighted (blue arrows). Hairpin structures indicate Rho-independent terminators predicted previously [158) . B: Expression of cryptic SfV 
genes within the lysogen (SFLJ871) was determined using RT-PCR. Randomly primed cDNA was produced from total RNA isolated from a 
mid-log phase culture of SFL 1871 . cDNA was used to set up PCRs with p'rimers specific for SN genes of interest ( +ve). Each set of RT-PCR 
results was set up with a no reverse transcriptase control (-ve) to check for contamination from the chromosomal DNA. The names of the 
screened genes of interest appear above the gels. orf28, orj29, 01f30, 01f3J, orf32, orj36, orf38, orf41, m:f42, or/44, or/45, or/47 and or/48 (13 
out of 15 genes screened) are expressed in the lysogen when grown in vitro at 37 °C. No PCR products seen in the orf33 and 40 +ve lanes, 
suggesting that these two genes are not expressed in the SfV lysogen. 
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expressed in the host (SFLI 871) when grown in vitro at 3 7 °C (S. flexneri virulence genes 
are expressed at this temperature). Results ofRT-PCR suggest that 13 out of the 15 
uncharacterized genes were expressed in the host grown in vitro, under the conditions used 
(Figure 4.8 .B). SfV orf28, orf29, orj30, 01j3J , orj32, 01j36, o,f38, o,f41 , 01f42, 01f44, 01f45, 
01f47 and 01f48 were expressed in the lysogenic strain, while 01f33 and 01f40 were not 
expressed. The expression of bacteriophage genes in the lysogenized host, suggests that these 
genes may provide some benefit to the host. 
4.2.2.3 Disruption of the SfV orf28-32 gene cluster in SFL1871 
Results ofRT-PCRs indicate that orf28, o,f29, orj30, 01f31 and 01j32 are all expressed in the 
SfV lysogen. orfs28-32 lie upstream of the gtrV cluster and all 5 genes are transcribed by the 
anti sense strand. To investigate if the expression of genes within this gene cluster contributed 
to the virulence of SFLI 871, the 01f28-32 five gene cluster was disrupted in SFLI 871 using 
the A red-mediated PCR-based approach to generate SFL2500 (!101f28-32) [317]. The 
insertional inactivation of orfs28-32 in SFL2500 was confinned by colony PCR using the 
GtrB.BglII.R and orf28-32.R primers. The PCR product isolated from SFL2500 is - 4.1 kb 
and smaller than the PCR product isolated from the parent strain, SFLI 871 as expected 
(Figures 4.9.A, Band C). The insertional inactivation of orfs28-32 in SFL2500 was further 
confirmed by sequencing. The slide agglutination test using monovalent anti-TypeV antisera 
(Seiken) was used to confirm the expression of the gtrV cluster in !1orfs28-32 (SFL2500). 
The virulence of this mutant strain (!101f 28-32) was determined using the in vitro BHK 
invasion assays and in vivo C. e!egans accumulation and killing assays. The presence of 
virulence plasmids in all strains was confirmed by PCR using apyl and virG specific primers 
before each assay perfonned in this study. 
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Figure 4.9: Confirming the insertional inactivation of SfV orfs28-32 in SFL2500. A: A 
diagrammatic representation of the arrangement of the or.fs28-32 locus in SFL187l. B: 
Diagrammatic representation of the orj28-32 locus in SFL2500 (1',,,orf28-32) . C: Colony PCR-
based confirmation of the insertional inactivation of orfs28-32 in SFL2500 using the 
GtrB.BglII.R and orf28-32 .R primers (indicated by black arrowheads). A 4.1 kb PCR product 
was successfully isolated form SFL2500 suggesting the insertional inactivation of the orf28-
32 locus. 
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4.2.2.4 Knocking out SIV or/28-32 increases the adherence of SFL1871 in vitro but 
decreases invasion 
In vitro adherence assays indicate that the !'ior/28-32 strain (SFL2500) was more adherent to 
BHK cells compared with the Stv lysogen (SFLl 871) (Figure 4.10. A). To ensure that the 
increased-adherence phenotype of SFL2500 resulted from the disruption of the 01:(28-32 
genes, plasmid pNV2062, expressing 01:(28-32, was introduced into SFL2500 to generate 
SFL2506. Complementation of the 01:(28-32 mutation significantly decreases the adherence 
of the 01:(28-32 mutant strain (SFL2500) (Figure 4.1 O.A). These results suggest that the 
disruption of this 5 gene cluster is responsible for increasing the adherence of the host strain. 
Results of invasion assays however, indicate that SFL2500 is less invasive than SFL1871 and 
SFL2506 (Figure 4.10. B), suggesting that the expression of one or several genes in the Stv 
01:(28-32 gene cluster enhances the invasive capacity of the bacterial host. Results of 
SFLJ871 and SFL2500 in Figures 4.10.A and B represent data obtai11ed from nine 
independent biological repeats while results of SFL2506 represent data obtained from four 
independent biological repeats. SFL2506 was generated after five initial experiments were 
canied out using the wild type and mutant strains alone, therefore only four repeats of the 
complementation experiment could be carried out in conjunction with the wild type and 
mutant strain within the given time frame . To account for this unbalanced experimental set 
up, linear mixed models were generated using REML to compare the virulence ofSFL1871 , 
SFL2500 and SFL2506. 
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Figure 4.10: Results of in vitro assays for SFLI871 (Stv Iysogen in serotype Y), SFL2500 
(11orf28-32 in SFL1871) and SFL2506 (SFL2500 + plasmid expressing orf28-32). A: 
Adherence of SFL 1871, SFL2500 and SFL2506 plotted as percentage adherence, a ratio of 
the number of adherent and intracellular bacteria to the total number of bacterial cells in the 
infecting inoculum (y-axis). The adherence of SFL2500 is significantly increased when 
compared with SFLl 871 and SFL2506 (p < 0.00 I, one way ANOV A, with post hoc LSD 
Test). B: Invasion ofBHK monolayers by SFLl 871 , SFL2500 and SFL2506, plotted as a 
percentage of the munber of intracellular bacteria to the total number of adherent and 
intracellular bacteria. SFL2500 is significantly less invasive than SFLI 87 l and SFL2506 (p < 
0.01 , One Way ANOVA, with post hoc LSD Test). Results are the means of at least three 
independent biological repeats with standard errors (error bars). Linear mixed models were 
generated using REML to compare the vimlence of these strains as the number of 
experimental repeats per strain was unbalanced. 
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4.2.2.5 The expression of genes within the SfV or/28-32 gene cluster is required for 
accumulation of SFLI871 in C. elegans 
Bacterial accumulation assays in C. elegans were performed to investigate whether the 
defective invasion of the borf28-32 observed in vitro, affected the virulence of the host strain 
in vivo. Young adult nematodes were infected with SFL1871 (SN lysogen), SFL2500 
(bor/28-32 in SFL1871) or SFL2506 (SFL2500 + a plasmid copy of the or/28-32 gene 
cluster) and bacterial accumulation assays were performed 24 hours post infection. Results of 
bacterial accumulation assays suggest that the bor/28-32 strain (SFL2500) is less virulent 
than the SN lysogen (SFLI 871) in vivo, as SFL2500 showed reduced accumulation when 
compared with SFLI 871 (Figures 4.11.A). Bacterial accumulation was restored on 
complementation of boif28-32 in SFL2506 suggesting that the expression of one or several 
of these genes is essential for bacterial virulence. Results of SFLI 871 and SFL2500 in 
Figures 4.11 .A represent data obtained from seven independent biological repeats while 
results of SFL2506 represent data obtained from three independent biological repeats. To 
account for this unbalanced experimental set up, linear mixed models were generated using 
REML to compare the virulence ofSFLl 87 1, SFL2500 and SFL2506. 
SLF2500 was tagged with GFP\ in SFL2505 and worms infected with this strain were 
compared with nematodes infected with SFL2504 (GFP+-tagged SFL1871) using 
fluorescence microscopy. SFL2505 cells appear to accumulate in the nematode pharynx but 
failed to accumulate in the nematode intestinal lumen (Figure 4.11.C) while SFL2504 cells 
accumulated in the intestinal lumina of infected worms (Figure 4.11.B). These results suggest 
that the expression of SN genes within the orf28-32 cluster enhances the virulence of its host 
strain. GFP+ accumulation assays could not be carried out on the complemented strain as the 
plasmid used for complementation of the oif28-32 mutation was not compatible with the 
plasmid expressing GFP+. 
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Figure 4.11: Expression of SfV orfs28-32 is required for accumulation of SFLI871 in the 
intestinal lumen of C.elegans. A: Results of bacterial accumulation assays. Young adult 
hermaphrodite nematodes were fed the SfV lysogen of serotype Y (SFL! 871 ), !).01f 28-32 
(SFL2500) or its complement, SFL2506 (SFL2500 + a plasmid copy of orj28-32) for 24 
hours . 20 nematodes were picked and mechanically disrupted to release internalized bacteria. 
Diluted lysates were plated on LB agar plates carrying appropriate antibiotics, and colonies 
were scored in order to quantify S. jlexneri cells associated with each nematode. There is a 
significant decrease in the accumulation SFL2500 compared with SFL! 871 and SFL2506 (p 
< 0.00 I, one way ANOV A with post hoc LSD Test). Results are the means of at least three 
independent biological repeats with standard errors (error bars). Linear mixed models were 
generated using REML to compare the virulence of these strains as the number of 
experimental repeats per strain was unbalanced. Band C: Representative images ofGFP+ 
accumulation assays. Young adult hermaphrodite nematodes infected as above with SFL2504 
(SFL 1871 expressing GFPJ and SFL2505 (SFL2500 expressing GFP+) for 24 hours. Infected 
nematodes were visualized using the EVOS fluorescence microscope. Nematodes infected 
with SFL2504 show accumulation of the lysogenized bacterial cells within their intestinal 
lumina (8) while wonns infected with SFL2505 have no bacterial cells within their lumina 
(C). Scale bar = 400 µm. 
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4.2.2.6 The expression of genes within the Stv orf28-32 gene cluster is not required for 
the SFL1871-mediated killing of C. elegans 
Liquid killing assays were performed (Section 2.13.4) to determine if the decreased 
accumnlation of SFL2500 in the nematode intestinal lumina had an effect on nematode 
killing. Results of liquid killing assays suggest that genes within the orf28-32 gene cluster are 
not essential for nematode killing, as nematodes fed SFL2500 showed similar survival rates 
as worms fed SFLI 871 (p = 0.0621, Logrank test) (Figure 4.12). The results of in vivo 
bacterial accumulation assays are consistent with in vitro invasion data and suggest that the 
expression of SN-encoded orj28, 01j29, o,f30, o,f31 and/or orj32 enhances the virulence of 
the host strain at the onset of infection. Results of nematode killing assays however suggest 
that the expression of these genes has no effect on prolonged infection. 
4.3 Discussion 
4.3.1 Complete Genome Sequence of SfII 
In this chapter, bacteriophage Sill, isolated from a virulent S.jlexneri 2a serotype, strain 
NCTC4 [ 156], was completely sequenced. Previous electron microscopy data [156] shows 
that SflI morphologically resembles bacteriophages belonging to group Al , comprising the 
family Myoviridae and order Caudovirales [359). SflI confers its host with the serotype-
converting 0-antigen modifying glucosyltransferase (gtr) genes. Not much is known about 
temperate bacteriophages of S. jlexneri outside their role in serotype conversion. To further 
our understanding of S. jlexneri phages, the genome of SfII was compared to the genomes of 
other Jambdoid phages. 
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Figure 4.12: Stv orfs28-32 are not required for S. flexneri-mediated killing of C. 
elegans. Synchronized young, adult, hermaphrodite nematodes were treated with log phase 
cultures of a SfV lysogen in a serotype Y background (SFLJ 871-in black) or f..01f28-32 in 
SFLJ 871 (SFL2500-in grey) grown at 37 °C to express virulence genes . Wonns were scored 
for survival every 12 hours. Results represent data obtained from three independent 
biological repeats each with at least four technical repeats (each technical repeat with 20-50 
nematodes) with standard error (error bars). No significant differences in survival rates of 
wom1s infected with SFL2500 and SFLJ 871 (p = 0.0621 , Logrank test) we observed. 
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Nucleotide and protein homology searches with other published S.jlexneri phage genomes 
indicate that Sfll, like Stv, Sfl, SflV, Sf6 and SfX, is a member of the temperate, lambdoid 
group of bacteriophages with conserved arrangements of early and late genes. Genome 
alignments of S.jlexneri phages indicate that the genomes ofSffi, Sfl, SflV, and Stv were 
very similar (>95% nucleotide identity). The main differences between S.jlexneri Sffi, Sfl, 
SflV and Stv lie in their 0-antigen modifying gtr cluster, immunity, replication and Nin 
regions. The Sfll genome, like Sfl, SflV, and Stv differs considerably from Sf6 (3% 
coverage; BLASTN) and SfX (5% coverage; BLASTN). Multiple alig11111ents using 
progressiveMauve indicate that Sfll also shares homology with other lambdoid phages 
including E. coli phages, cdtl and ~27 and Salmonella phage ST64B. 
The entire Sfll can be divided into 6 functional modules based on the predicted functions of 
coding regions. Each functional module of bacteriophage Sffi is discussed in subsequent 
sections. 
4.3.1.1 DNA packaging 
Experiments in the l 970 's suggest that during the assembly of phage particles, phage DNA is 
inserted into a prefom1ed protein shell , known as the procapsid or prohead [360, 361]. 
Packaging of bacteriophage DNA into procapsids is driven by the hydrolysis of ATP which 
involves two bacteriophage proteins namely, the large and small tenuinases. These 
tenuinases recognize DNA for packaging, translocate the DNA to the proheads and transfer it 
into the porheads through a ring of portal proteins. 
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Sfll_ 1 and SflI _ 2, encode phage small and large terminase subunits, respectively. The amino 
acid sequences of the small and large terminases ofphages SflI, Sfl, SflV and SfV, are very 
similar (>98% an1ino acid identity), which suggests that these phages use the same packaging 
mechanisms. Analysis of the Sfll nucleotide sequence show cohesive end (cos) sites spanning 
the 59 bp-125 bp region adjacent to the terminases. These findings provide strong evidence 
suggesting that SflI, like Sfl, SflV and SfV, uses the bacteriophage lambda-like packaging 
mechanism where, virion genomes are generated by cos site-specific DNA cleavage at the 
beginning and end of every packaging event. 
4.3.1.2 Structural proteins 
Sfll_3 encodes a putative integral membrane protein which is also present in the Sfl and 
Salmonella ST64B genomes. The function of this protein remains unknown but based on the 
location of this gene in the genome; it is possible that Sf1I_3 encodes a protein required for 
DNA packaging. Sfll_ 4, SflI_5 and SflI_6, encoding phage portal protein, prohead protease 
and major capsid protein, respectively are conserved between Sfl, SflV, ST64B and E. coli 
phage, HK97. Little homology was found between the Sfll_ 4, Sfll_5 and SflI_ 6 and SfV o,fs 
3, 4 and 5. The Sfll portal protein (SflI_ 4), proheads protease (SflI_5) and major capsid 
proteins (SflI_6) consist of 371,228 and 401 amino acids, respectively, while their SFV 
counter parts consist of 424, 200 and 409 amino acids, respectively. Pairwise alig1m1ents of 
the Sfll and SfV portal and capsid proteins show several amino acid changes between the two 
S. jlexneri phages. These proteins are required for successful assembly of the capsid as well 
as the condensation of DNA within the capsid. 
The size and sequence variations between the Sfl[ and SfV portal, prohead protease and 
major capsid proteins suggest that the procapsid assembly mechanism used by these two S. 
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fiexneri phages could vary. However, it should be noted that it is not unconunon for divergent 
homologues of the lambdoid phage family to vary significantly in their amino acid sequences 
yet maintain function. For instance, the crystal structures of several portal proteins from 
tailed bacteriophages showing little amino acid similarity, show similar polypeptide folds of 
their central domain which leads to the belief that they are highly divergent homologues 
[362). Thus although the SflI and SN portal and capsid proteins do not show sequence 
similarities, these proteins could be divergent homologues showing conserved structures and 
functions. 
SflI_7-24, encoding proteins required for tail structure and assembly, have homologues in 
Sfl, SfIV, SFV, HK.97, ST64B and <j>P27 phages (Figure 4.3). Host recognition by tailed 
phages occurs through interactions between attachment sites on tail proteins and host 
receptors molecules. The amino acid sequences of the tail proteins of SflI, Sfl, SfIV, and SN 
were compared to identify differences in the tail proteins of these phages. Most of the tail 
proteins of S. flexneri infecting phages are over 95% identical at the amino acid level. This 
would suggest that these phages possibly infect the same bacterial host strains. Interestingly, 
the host range of all four phages vary considerably, with SN showing the broadest host range 
(capable of infecting serotypes I a, I b, 2a, 2b, 3b, 4b, and Y), followed by SfIV (which 
infects serotypes la, lb, le, X and Y), Sill (infects serotypes 3a, Sa and Y) and Sfl (infecting 
serotypes X and Y). SflI_24, which encoded the tail fibre assembly protein shows <91 % 
identity with homologues in Sfl, SfIV and SN. The phages tail fibre is an important phage 
protein that binds to bacterial receptors for adsorption [363-365). A recent study in P. 
aeruginosa phages, PaPl and JG004, reported that a single point mutation in the tail fibre 
assembly proteins of these phages, significantly alters their host ranges [366] . Therefore it is 
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likely that the varied host ranges of S. flexneri phages is due to amino acid changes in their 
tail fibre proteins. 
4.3.1.3 0-antigen modification 
SflI_27 encodes gtrll, the gene responsible for the type specific modification of the 0-
antigen in S.flexneri 2a strains. SflI_28 , 29, 30 and 31 were identified as gtrB , gtrA , integrase 
and excisionase, respectively. Homologues of these genes were seen in other lamboid phages 
including Sfl, SflV, Stv, Sf6, SfX and Salmonella phages e34, ST64T and ST104. As 
expected no similarity was observed between gtrll and the type-specific 0-antigen modifying 
gene of S.jTexneri phages. gtrA and gtrB on the other hand appear to be highly conserved 
among several lambdoid phages. 
4.3.1.4 Early Regnlatory elements in Sfll 
SflI_37, 38 and 39 are homologous to phage regulatory proteins, cl, Cro and ell, respectively. 
This suggests that Sill like Sfl, SfIV, Stv and most other lambdoid phages, uses the lan1bda-
like repression model to regulate gene expression. In lambdoid phages, the cl and cro genes 
lie adjacent to each other and are transcribed in opposite directions, thereby regulating the 
expression of early and late phage genes, respectively [367]. This regulatory cascade, 
therefore determines whether the phage follows the lytic or lysogenic pathway. The binding 
of cl repressor molecules to operator sequences flanking the cl genes, promotes lysogeny and 
inhibits the transcription of late genes [367]. The Cro protein has higher affinity to the 
operator sequence flanking cl, thus it dislodges the cl repressor from this operator and 
prevents further expression of the cl repressor. This in tum, promotes the transcription of late 
genes which trigger the lytic pathway. 
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Homologues of cIIl and N proteins, other lambda regulatory elements, although present in 
Sfl, were not observed in Sfll. The N protein is an important protein in the regulation of 
bacteriophage 'A., as this protein allows RNA polymerase to transcribe several phage genes, 
including ell and cIII, genes required for DNA recombination and integration of the prophage 
[368, 369]. The presences of a Rho-independent terminator downstream of the cl gene 
(SflI_37), suggests that one of the hypothetical protein Sfll_32-36, although not homologous 
to N, could potentially perfonn the function of the N protein in bacteriophage Sfll. 
4.3.1.5 DNA Replication 
Sfll_ 41-46, encompass the DNA replication module of bacteriophage SflI as these genes 
encode proteins homologous to known replication proteins (Table 4.1 ). Based on BlastX 
results the following putative functions were assigned; Sil_ 41 (phage-0 protein family) , 
Sfll_ 42 (putative transcriptional activator) , Sfll_ 43 (DNA adenine methylase), Sfll_ 44 
(LexA like DNA-binding protein), SflI_ 45 (RusA-DNA recombination and holiday junction 
resolvase), Sf!I_ 46 (KilA-N domain protein-a DNA binding protein transcription activator). 
The arrangement of genes in the replication modules of SflI and Sfl vary significantly (Figure 
4.4) . The arrangement of replication genes in Sfll, SflV and SN are similar with the main 
differences being SflI_ 42, 43 and 45 homologues are not present in SflV and Sfll_ 41 has no 
homologue in SN. 
In bacteriophage A, the origin of replication lies in the middle of the phage replicative O gene, 
similarly, in Sfll, the nucleotide sequence of SflI _ 41 contains direct repeats 
(TTCTGACCCGTCAAAA; nt 30,935-30,949; 30,950-30,964 and 30,965-30,979) which are 
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characteristic features of an origin of replication. This suggests that Sill_ 41 is an initiator of 
bacteriophage DNA replication similar to the lambdoid O protein [370]. 
4.3.1.6 Late Regulatory elements in Sfll 
The late regulatory module of Sill has an organization similar to that of other lambdoid 
phages . SfII_ 48, encodes the phage antitenninator Q, a protein that regulates the expression 
oflytic proteins in lambdoid phage. SfII_51-54, encode the phage lytic genes; holin, lysin, 
RZ and RZl, respectively. The SfII lytic cassette is highly similar to the lytic cassettes of 
SflV, SfV, ST64B and bacteriophage "A.. 
Sffi_58 encodes a HNH endonuclease domain protein which bas homologues in Stl, SflV 
and SfV. This gene is also present in lan1bdoid phages HK97, Mu, q,P27, and Salmonella 
phage ST64B. The HNH domain has been identified in a range of DNA-binding proteins, 
performing DNA binding and cleavage functions [371 , 372]. The precise function of this 
protein in lambdoid phages has not yet been elucidated but it has been proposed that this 
DNA-binding protein could play a role in controlling the timing oflysis [157]. 
4.3.1.7 Genes unique to Sfll 
Analysis of the SfII genome sequence identified several proteins which did not have 
homologues in other S.jlexneri phages. The following genes are unique to Sfll; SfII_25 
(acyltransferase), Sffi_27 (gtr!I) , Sill_26, SfII_55 and SfII_56 (insertion elements) and 
Sf1I_35, Sf1I_36, Sfll_ 40, SflI_ 49, SflI_ 50 and Sffi_57 (hypothetical proteins). It will be 
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interesting to study these hypothetical proteins in the context of bacteriophage evolution and 
S. jlexneri serotype 2a pathogenesis. 
4.3.2 Characterizing cryptic SfV genes and the identification of novel SfV-encoded 
virulence factors 
4.3.2.1 Lysogenization of wild type S. flexneri serotype Y by bacteriophage SfV, 
increases the virulence of the host strain 
To detem1ine if the presence of bacteriophage SN in a S.jlexneri serotype Y strain 
(SFLl339) had an effect on the virnlence of this strain, virnlence assays were perfonned 
using the serotype Y strain and an SN lysogen (SFLI 871) created in the serotype Y 
background. Results of in vitro cell culture and in vivo C. elegans virulence assays indicate 
that lysogenization of SFLI 339 by SN significantly increases the viru lence of this strain. 
These findings suggest that bacteriophage SN genes contribute to the virulence of its host. 
The presence of the 220 kb virulence plasmid in both SFLl871 and SFLl339 was confirmed 
using PCR to amplify apyl and virG prior to each virulence study, to ensure that both strains 
carried intact virulent plasntids. However, the stability of the virulence plasmid in these 
strains was not tested over the course of each experiment; therefore although unlikely, we 
carmot rule out the possibility that SFL1339 harbors an unstable virulence plasmid. The loss 
of the virulence plasmid from SFLl339 would also result in the phenotypes observed in this 
study. However, based on prior knowledge of bacteriophage genes increasing the virulence of 
a plethora of bacterial hosts (Sections 1.7.3 and 1.7.4), it is likely that lysogenization of S. 
jlexneri serotype Y with SN increases the virulence of the host strain. 
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West and colleagues have previously shown that the phage-encoded glucosylation of S. 
jlexneri 0-antigen, shortens the LPS molecule which in turn enhances the T3SS function and 
promotes bacterial invasion [353]. The SN lysogen used in this study (SFLl 871) carries the 
gtrV cassette therefore it is possible that 0-antigen modification of the lysogen would 
increase the virulence of this strain. The focus of this study, however, was to identify 
uncharacterized SN genes and determine if any of these genes contribute to host virulence. 
Therefore we proceeded to identify uncharacterized SN genes and determine if a.ny of these 
genes were expressed in the lysogen. 
4.3.2.2 Uncharacterized SfV genes expressed in the SfV Iysogen, SFL1871 
To determine if SfV genes outside of the glrV cluster contribute to the pathogenesis of the 
lysogen (SFLJ871), RT-PCR was performed to identify uncharacterized SN genes that were 
expressed by the lysogenic strain grown at 37 °C (Figure 4.8.B). 15 uncharacterized genes 
(orf28, 01j29, 01f30, 01f31, o,f32, o,f33 01f36, or/38, 01f40, 01f41, 01f42, 01f44, 01f45, or/47 
and 01f48) were selected for expression screening by RT-PCR based on prior knowledge of 
gene expression throughout the phage lifecycle (Figure 4.8.A). 
01j28-32 which encompass a 5 gene cassette lying downstream of the 0-antigen modifying 
cluster, was selected for expression screening as these genes encode hypothetical proteins of 
unknown functions with homologues in a number ofprophage-related genes in E.coli and 
Salmonella spp. Furthermore, this gene cassette is also present in S.jlexneri phage SfIV and 
the E. coli phage cdtl. This conservation across multiple prophage and phage genomes 
potentially suggest an essential function of these genes. RT-PCR-based expression screening 
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indicates that the orf28-32 gene cassette is expressed in the Stv lysogen, suggesting that 
these genes maybe beneficial to the host. 
01f33 and 01f47-48 were previously identified to form part of morons (158]. Morons are 
transcriptionally independent units that are believed to be expressed in prophages, and their 
expression has been proposed to confer a selective advantage on the host (3 73]. Therefore 
these genes were included in the expression screen. Results ofRT-PCRs indicate that 01f33 is 
not expressed in the Stv lysogen while 01f47 is expressed and 01f48 is weakly expressed 
(Figure 4.8.B). 01f33 is unique to Stv and no homologues of this gene were seen in S. 
jlexneri phages Sf!, Sill and Sf!V. Although BlastP analysis of the Orf33 amino acid 
sequence identified similar hypothetical proteins in E. coli and Salmonella prophages, 
analysis of the 01f33 sequence failed to identify a ribosome binding site (RBS) upstream of 
this Orf, which suggests that this Orf could have been previously mis-annotated [ 158]. 
Therefore the fact that 01f33 was not expressed in the lysogen could simply be because this 
region fails to encode a protein. 
01f41 and 01f48 were selected as they encode proteins showing high identity to DNA adenine 
methyltransferases (Dam). Dams have been shown to play an important role in the virulence 
of a number of pathogens including Salmonella, Haemophilus, Yersinia and Vibrio species 
and in pathogenic E.coli (374, 375]. Both 01f41 and 01f48 were identified to be expressed in 
the Stv lysogen, suggesting that the bacteriophage SfV-encoded Dams may play an 
important role in the virulence of S. jlexneri strains. 
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SN orf36, 01f40, 01f42, 01f44 and 01f45 were selected for expression screening as these 
genes encode hypothetical proteins, many of which have DNA-binding sites. Furthermore, 
these genes are also present in Sill and StlV suggesting an important role in S.jlexneri phage 
biology. SN 01f38 shares homology with a hypothetical protein with unknown function 
present in several E. coli and Salmonella prophages. This gene is unique to SN therefore it 
was included in the expression screen. Results ofRT-PeRs indicate that all the above genes 
except 01f40 are expressed in the SN lysogen. 
Homologues of 01f40 are also present in Sill (Sill_ 42) and StlV (o,f42). BlastP analysis of 
the amino acid sequence of0rf40 identified this protein as a member of the perC 
transcriptional activator family of proteins. The Pere protein of EPEe has been previously 
identified as an activator of the locus of enterocyte effacement (LEE) pathogenicity island 
[376] , which encodes the T3SS required for the virulence ofEPEe [377]. The chromosome 
of EPEe strains encodes several copies of Pere-like protein showing varying degree of 
similarities to Pere, all located within prophages or porphage-like regions scattered 
throughout the chromosome [376]. SN Orf40 shows limited homology to EPEe Pere (32% 
identity) therefore it is possible that there are other copies of Pere-like proteins within the S. 
.flexneri chromosome, that activate the expression of the T3SS. In this case, the SN-encoded 
perC gene would be redundant and its expression would not benefit the host, this could 
explain why 01f40 is not expressed in the lysogen. 
Attempts were made to generate knockout templates to disrupt all 13 genes identified as 
expressed in the SN lysogen but only the orf28-32 cassette could be successfully knocked 
out within the given time frame. 
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4.3.2.3 Construction of orf28-32 knockout mutant, SFL2500 
In the SfV genome, 01j28, 01j29, 01f30, 01f3l and 01f32 are transcribed from the antisense 
strand. SfV sequence analysis by Aillison el al [ 158], identified no tem1inator sequences in 
the 01j28-32 region. This finding coupled with the expression of all five genes in the lysogen, 
suggests that these genes could form part of an operon. Since 01j28, 01j29, 01f30, 01f3l and 
01f32 were all identified to be expressed in SFLI 871 , we decided to knockout this 5 gene 
cassette as a prelinlinary step to identify if the expression of any of these genes contributed to 
the virulence of the host strain. The 01j28-32 locus was successfully disrupted in SFL2500 
using the A red-mediated PCR-based approach [317]. Attempts were also made to knockout 
each of these genes individually. Although 01j29, 01f30 and 01f32 were successfully disrupted 
in SFLJ 871 , the virulence plasnlids were lost from all of these mutant strains. Therefore they 
could not be used for further virulence studies. 
4.3.2.4 Predicted role of SfV Orfs28-32 in bacterial hosts 
Virulence assays perfonned in this study suggest that the expression of one or several genes 
in the 01j28-32 gene cluster is required for bacterial invasion in vitro and for accumulation in 
C. elegans. In vitro adherence assays however indicate that knocking out 01j28-32 increases 
the adherence of the SfV lysogen. The increased adherence of SFL2500 (1':,.01j28-32) , 
suggests that the expression of one or several of these genes could potentially repress the 
expression of bacterial adherence factors. BalstP and conserved domain (CDD) searches 
[378] were performed to identify the possible functions of Orf28 , Orf29, Orf30, Orf3 l and 
Orf32. 
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4.3.2.4.1 orf28 encodes a putative DNA-binding protein that could negatively regulate 
the expression of host genes 
BlastP analysis of0rf28 identified homologues of this protein, annotated as hypothetical and 
DNA-binding proteins in E.coli and S.jlexneri prophages. CDD searches identified the 
presence of the N-tem1inal region of the Herpes-lCP4 protein in Orf28 (Figure 4.13 .A). The 
lCP4 family of viral proteins is required for the transcription of early and late viral genes in 
the Herpes simplex vims (HSY) [379]. The N-terminal region ofICP4 contains sites for 
DNA-binding and the binding ofICP4 represses transcription from three Herpes genes (LAT, 
lCP4 and ORF-P). These genes have high affinity-ICP4 binding sites spanning their 
transcription initiation regions [380-382]. Faber and Wilcox identified the ICP4 binding sites 
upstream of the icp4 mRNA start site using DNA-binding immunoassays [380]. They 
compared the sequence ofICP4 binding sites in different strains ofHSV and proposed a 
consensus sequence; nnATCGTCnnYnCCGRCnnCRYCR where, n represents positions with 
no apparent consensus; R- represents purines at these positions; Y- represents pyrimidines at 
these positions. BlastN analysis failed to identify the above consensus sequence in published 
whole genome sequences of S.jlexneri serotypes 2a and Sa. 
The presence of an N-terminal ICP4 domain in Orf28 coupled with its homology to several 
bacterial DNA-binding proteins, suggests that this protein may be a transcriptional repressor 
of host gene expression. The expression oforj28 in the SN lysogen (SFL1871) could have a 
negative effect on the expression of bacterial proteins required for adherence. This hypothesis 
could explain why o,f28-32 mutant cells show increased bacterial adherence. Further studies 
to identify potential Orf28 binding sites in the host chromosome, would provide valuable 
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infonnation regarding bacteriophage-mediated regulation of host vimlence genes and the 
possible identification of novel S. jlexneri adherence factors. 
4.3.2.4.2 orf29 encodes a hypothetical protein that may be involved in RN Ai-based 
immunity 
BlastP analysis indicated that Orf29 encodes a hypothetical protein present in numerous£. 
coli and Salmonella prophages. CDD searches identified a Cas l O _ III domain in the N-
tenninal region of Orf29 (Figure 4. I 3.B) and a DUF55 I domain (domain of unknown 
function) in the C-tenninal region of Orf29. Cas IO_ III is a member of the CRlSPR (Clustered 
Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR associated proteins) 
protein system in prokaryotes. The CRlSPR/Cas system (CASS) is a mechanism of defense 
against invading phages [383-385) and it has been hypothesized that this system functions 
like the eukaryotic RNAi systems [386) . It has also been proposed that the cas genes encode 
proteins required for the prokaryotic siRNA-like system [386). CaslO protein is the largest 
subunit of Type 3 CRlSPR-Cas systems and is homologous to polymerases and cyclases but 
the actual biochemical activity ofCas!O remains unknown [387). The presence ofa CaslO 
domain in SN Orf29, could suggest that this protein is involved in the RNAi-based immunity 
of the lysogen, if this is the case, the expression of this gene in the lysogen would be to 
prevent infection by other phages. 
It remains unclear at this stage whether the expression of 01f29 is responsible for the 
phenotypes observed in this study. However, the presence of a Cas !O _III domain in Orf29 
and the conservation of 01f29 across S.jlexneri phages, SfII (S.f11_33) and SfIV (01f _3I) and 
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Figure 4.13: Results of conserved domain searches of SfV Orf28 (A) and Orf29 (B). 
Conserved domain searches were performed using the NCBI Conserved Domain Database 
(CDD), to identify the potential functions ofSfV Orf28 and Orf29. A: CDD searches 
identified a Herpes ICP4 N-terminal domain in Orf28. B: A caslO_III domain was identified 
in SfV Orf29. Amino acid sequence alignments of identified conserved domains are 
presented below each gene with the conserved amino acids in red. 
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E. coli phages cdtI (gp36), could suggest a new conserved RN Ai-based immunity mechanism 
in these bacteriophages. 
4.3.2.4.3 or/30 encodes a putative phosphodiesterase that may regulate the 
virulence of the host strain by modulating oxidative stress responses 
BlastP analysis of the amino acid sequences of0rf30 indicate that this protein belongs to the 
HD-3 superfamily. Consistent with BlastP analyses, CDD searches identified the presence of 
a HD-3 domain in Orf30. Members of the HD-3 superfamily are characterized by the 
presence of HD domains, which are metal dependent phosphohydrolases that catalyze 
phosphodiesterase reactions [388]. Enzymes belonging to the phosphodiesterase class of 
proteins have previously been identified as a virulence factor in numerous enteric pathogens 
including enterohemorrhagic E. coli [389, 390], C. jejuni [391 ], H. py lori [392] , K. 
pneumonia [393] and Salmonella spp [394]. Bacterial phosphodiesterases positively regulate 
the oxidative stress response by modulating cyclic di-GMP (c-di-GMP) levels [395 , 396]. In 
bacteria, c-di-GMP is an important second messenger regulating the expression of genes 
involved in several essential functions including cell surface remodeling and adhesion [396], 
biofilm formation (397, 398] , and the virulence of animal and plant pathogens [399, 400]. 
The predicted HD-3 domain in SN Orf30 suggests that this protein may exhibit 
phophodiesterase activity which could influence the virulence of the host strain. If this were 
the case, the absence of0rf30 in SFL2500 would lead to decreased resistance to oxidative 
stress which in tum would decrease the virulence of this strain. Further virulence studies 
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using an 0,130 knockout mutant need to be conducted to detem1ine if0rf30 modulates the 
virulence of the host. 
4.3.2.4.4 01f31 and or/32 encode hypothetical protein with unknown functions 
BlastP and CDD searches identify Orf3 l as a member of the DUF2303 superfamily of 
proteins. Members of the DUF2303 family of proteins are hypothetical proteins with 
conserved domains. BlastP analysis identified homologues of Orf32 in several E. coli and 
Salmonella prophages annotated as hypothetical proteins. CDD analysis identified no 
conserved domains in Orf32 . It remains unclear at this stage whether Orf3 I or Orf32 are 
responsible for the virulence phenotypes observed in this study. 
Although CDD searches provide some insight into the potential roles of these hypothetical 
proteins it should be noted that the observed e-values are not very small. Thus the above 
predicted functions of SN orj28, 01f29, 0,130, 0,131 and 01132 remain speculatitive at this 
stage and require further experimental verification. 
4.4 Conclusion 
In this chapter the complete genome sequence of S. jlexneri bacteriophage, SflI was 
determined. Nucleotide and protein homology searches with other published S.jlexneri phage 
genomes indicate that Sfll, like Sfl, SflV, SN, SfX and Sf6, is a member of the temperate, 
lambdoid group ofbacteriophages with conserved arrangements of early and late genes. 
Although the Sfll genome shares similarities with Sfl, SflV and SN, the host ranges of all 
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four phages differ significantly, with SfV showing a much broader host range than the other 
three phages. The main differences between S.jlexneri Sill, Sfl, SflV and SfV lie in their 0-
antigen modifying gtr cluster, immunity, replication and Nin regions. 
While the Sil genome was being sequenced, virulence studies were carried out in the 
completely sequenced S. jlexneri phage SfV. Preliminary virulence studies using a S. jlexneri 
serotype Y and an SfV lysogen in the same background, indicated that genes within the SfV 
genome increase the virulence of the host strain. 15 uncharacterized SfV genes were selected 
as virulence candidate genes. RT-PCR analysis identified 13 out of the selected 15 candidate 
genes (or/28-32, 01f36, 01f38, 01f41-42, 01f44, 01f45, 01f47 and 01f48) as expressed in the 
lysogen. The OJj28-32 gene cassette was successfully disrupted in the SfV lysogen and 
virulence assays indicated that the expression of one or several genes within this gene 
cassette increase the virulence of the lysogen. Each of these genes now needs to be 
characterized individually to identify their specific contribution, if any, to the virulence of the 
host. Construction of further gene disruptions could not be accomplished within the given 
time frame. The results of this study suggest the bacteriophage genes outside of the 0 -antigen 
modifying gene cluster contribute to the virulence of S. jlexneri strains. 
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Chapter 5 
Characterizing a new animal model for shigellosis-
C. elegans 
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Chapter 5: Characterizing a new animal model for 
shigellosis- C. elegans 
5.1 Introduction 
S.jlexneri has a very narrow host range and only infects human and non-human primate 
hosts, as a result of which there is no simple intestinal small animal model available. The lack 
of a relevant in vivo model of shigellosis bas been one of the major impediments to the 
development of preventive and therapeutic measures. A number of alternative animal models 
have been identified that use mucosa! surfaces outside of the colon as sites of infection. The 
most commonly used in vivo models of shigellosis are the murine pulmonary model of 
shigellosis [83 , 225 , 318] and the guinea pig keratoconjunctivitis model [233]. However, both 
these in vivo models lack chnical relevance, as the site of S.jlexneri infection and symptoms 
produced do not mirror S.jlexneri infection in humans. 
In recent years the soil-dwelling roundworm, Caenorhabditis elegans, has been used 
extensively to study host-pathogen interactions in vivo, uncovering a wealth of info mm ti on 
about microbial virnlence factors and host defense responses [ 40 I]. This in vivo model is 
particularly useful to study enteric pathogens, as the nematode intestinal cells share 
morphological similarities with human intestinal cells, including apical , finger-like microvi lli 
anchored into a cytoskeletal terminal web composed of actin and intenuediate filaments. In 
addition, the human innate inunune system shares many characteristics with that of C. 
elegans (Section I. 9 .3) and thus mechanisms of bacterial and host responses may be 
paralleled in mammalian cells [402]. 
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A range of bacterial virulence factors have been shown to be required for both nematode and 
mammalian pathogenesis [288 , 289, 294, 403-405], further validating the use of C. elegans as 
a relevant in vivo model to study host-pathogen interactions. On account of these 
characteristics, the li st of bacterial pathogens that are known to infect C. elegans is growing 
and includes prominent human pathogens such as S.enterica, P. aeruginosa, EPEC and S. 
marcescens [227-229, 267]. 
In the past decade, two independent groups [283, 284] have found preliminary evidence 
suggesting C. elegans can potentially be used as an in vivo model for shigellosis. These 
studies demonstrate that S. jlexneri kills C. elegans in an infection-like process that requires 
live bacterial cells harboring intact virulence plasmids. Both studies also report that S. 
jlexneri accumulates in the C. elegans intestine and kills the nematodes on solid media [283] 
and in liquid culture [284]. However, C. elegans as a model for shigellosis has not been 
completely understood as the S. jlexneri-mediated killing response and the nematode 
responses to S. jlexneri infection remain unknown. 
This study aims to further our understanding of the interactions between S. jlexneri and C. 
elegans in order to establish this in vivo model as a viable alternative to study S.jlexneri 
pathogenesis. Transmission electron microscopy was used to shed light on the cellular 
interactions between S. jlexneri cells and the C. e/egans intestinal cells. To gain insight into 
S. jlexneri-induced host responses, the proteome of nematodes infected with S. jlexneri was 
compared with control wom1s. 
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5.2 Results 
5.2.1 Wild type S. jlexneri serotype 3b kills C. elegans and killing requires the 
expression of bacterial virulence plasmid-encoded genes 
Previous studies have reported that wild type S.jlexneri serotypes 2a [283] and 2b [284] kill 
C. elegans. Here, the S. jlexneri 3b strain (SFLJ 520), shown to be virulent in the murine 
pulmonary models of shigellosis, was chosen, to characterize the pathogenesis of this strain 
in C. e!egans. Liquid infection assays [284] were perfom1ed to determine if SFLJ520 kills 
nematodes. An avirulent S.flexneri (SFLJ223) (which does not carry the virulence plasmid) 
and the£. coli OP50 strain (laboratory strain that nematodes are maintained on) were 
included as control strains in this study. 
The results of liquid killing assays (Figure 5.1) indicate that SFLJ 520 kills nematodes, while 
nematodes maintained on the control strains show prolonged survival. Consistent with 
previous studies, the results of liquid mortality assays indicate that S. flexneri requires the 
virulence plasmid-encoded factors for C. elegans killing, as the survival of worms fed 
SFLl520 (carrying an intact virulence plasmid) is significantly reduced compared with 
worms fed SFL1223 (Figure 5.1). S.jlexneri serotype 3b kills nematodes in liqnid culture 
with a TD50= 46 ± l h (Figure 5.1 ). The main drawback of using the liquid killing assay was 
that nematode survival rates could not be detennined after 48 hours. This was due to the large 
number ofLl /L2 progeny larvae, which masked the adults, making it difficult to score 
survival. However, since the liquid killing assay is reproducible and fast, this assay was 
employed as an in vivo virulence assay in this thesis. 
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Figure 5.1: S. flexneri is pathogenic to C. elegans. Survival curves of wild-type N2 
nematodes when fed E.coli OP50 (in black), an avirulent, virulence plasmid-cured S.fl-exneri 
(SFL1223) strain (in blue), or virulent S.jl.exneri serotype 3b strain (in red) . Survival of 
nematodes in liquid culture. 20-50 synchronized adult nematodes were treated with log phase 
cultures of E.coli OP50, SFL1520 or SFL1223 strains grown at 37 °C. Infected nematodes 
were monitored for 48 hours and survival was scored every 12 hours. Survival curves 
represent data from three independent experiments, each using 20-50 nematodes. Nematodes 
fed SFLI 520 show a significant decrease in survival rates in liquid cultures (p < 0.0001 , Log 
rank test) . 
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5.2.2 Wild type S. jlexneri accumulates in the nematode intestinal lumen 
Burton et al, [283] have previously shown that virulent S.jlexneri serotype 2a kills C. elegans 
by accumulation in the intestinal lumen, while avirulent S. jlexneri strains are digested by the 
nematodes. Bacterial accumulation assays using wild type S.jlexneri serotype 3b (SFL1520), 
avirulent S. jlexneri (SFL 1223), and E. coli OP50 (B2298) were performed to determine 
whether the SFL1520-mediated killing of nematodes correlated with bacterial accumulation 
in the nematode intestinal lumen. The results of the bacterial accumulation assays confirmed 
that S. jlexneri serotype 3b-mediated killing of nematodes is associated with bacterial 
accumulation in the intestinal lumen (Figure 5.2. A). 
To confirm the accumulation ofSFLl520 in the intestinal lumina of nematodes, wom1s were 
fed GFP+ -tagged S. jlexneri serotype 3b (SFL23 l 2), avirulent S. jlexneri (SFL23 l l) and E. 
coli OP50 (B2515). The profile of GFP+-tagged bacterial accumulation in the nematode gut 
was examined using fluorescence microscopy. Results of GFP+ accumulation assays further 
confinned that wild type S.jlexneri serotype 3b (SFL1520) accumulates in the nematode 
intestinal lumen while the avirulent strain (SFL1223) and E.coli OP50 are digested (Figure 
5.2. B). 
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Figure 5.2: Virulent S. jlexneri serotype 3b accumulates in C. elegans intestinal lumen 
24 hours post infection. A: Young adult hermaphrodite N2 nematodes were fed either E. 
coli OP50 (82298), a virulent S. jlexneri (SFLI 223) or virulent S. jlexneri serotype 3b 
(SFLl 520) for 24 hours at 22 °C. 20 worms were picked off each bacterial lawn, disrupted 
using glass beads and appropriate dilutions of each lysate were plated on LB agar to obtain 
bacterial counts. SFL1520 shows a significant increase in bacterial accumulation compared 
with SFL1223 and E. coli OP50 (p < 0.001 , One Way ANOVA). Results represent the means 
of three independent experimental repeats with standard errors (error bars) . B: Young adult 
hermaphrodite N2 nematodes were fed E. coli OP50, avirulent S.jlexneri (SFLl223) or 
virulent S. flexneri 3b (SFLl 520) tagged with GFP+ for 24 hand fluorescence was observed 
using the EVOS digital inverted microscope (AMG). Scale bar= 400 µm. 
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A recent study reported that fluorescence produced by live and dead bacteria in the nematode 
intestinal lumen is indistinguishable [ 406]. Furthermore the bacterial accumulation assays 
also fails to distinguish between live bacterial accumulation in the pharynx and bacterial cells 
that have made it past the pharyngeal grinder. Taking these factors into account, the results of 
bacterial accumulation observed using the accumulation assay and fluorescence assays fail to 
conclusively show that live bacterial cells evade grinding by the nematode grinder and 
accumulate in the intestinal lumen. 
To determine if live S.jlexneri cells accumulate in the nematode intestinal lumina, 
transmission electron microscopy (TEM) was used to compare the intestinal lumina of 
nematodes fed avirulent S. jlexneri SFL 1223 and virulent S. jlexneri serotype 3b (SFLI 520) 
over three time points, 24, 96 and 144 hours post infection. TEM micrographs clearly 
indicate the presence of intact S.jlexneri serotype 3b (SFL1520) cells in infected nematode 
intestinal lumina, with the bacterial load increasing over time (Figure 5.3). These 
observations provide strong evidence suggesting that virulent S. jlexneri cells escape 
nematode grinder-mediated breakdown and accumulate in the C. elegans intestinal lumina. 
5.2.3 Intraluminal S. flexneri cells produce outer membrane vesicles (OMVs) and 
invade the C. elegans intestinal epithelial cells 
TEM micrographs revealed that S.jlexneri serotype 3b cells within the nematode intestinal 
lumen produce putative outer membrane vesicles (OMVs) (Figure 5.4.A and B). OMVs are 
secreted elements produced by Gram negative bacteria as part of a bacterial stress response, 
induced during infection of host tissues [ 407]. 
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Figure 5.3: Virulent S. jlexneri serotype 3b escape pharyngeal grinding and accumulate 
in the C.elegans intestinal lumen. A: Schematic representation of the C. elegans body plan 
with the plane of sections highlighted (artwork by Altun and Hall, © Wonnatlas). B: 
Transverse section of the mid-body of a healthy nematode with the intestinal cell highlighted 
in yellow. C-H: Transmission electron micrographs of the transverse mid-body sections of 
animals feeding on plasmid-cured, a virulent S. flexneri (SFLI 223) (C, E, G) and virulent S. 
flexneri serotype 3b (D, F, H) for 24 h (C, D), 96 h (E, F) and 144 h (G, H). !EC-intestinal 
epithelial cell; mv-microvilli; IL-intestinal lumen; b-intact S. flexneri cells. 
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S.flexneri OMVs contain the invasion protein antigens-Ipa proteins (IpaB, C & D) that are 
required for bacterial adherence, invasion and survival within infected tissues. It has been 
previously shown that the production ofOMVs by S.flexneri cells provides a mechanism for 
the delivery of virulence factors to host tissues [408]. The identification of putative S.flexneri 
OMVs in the C. elegans intestinal lumen therefore suggests a potential mechanism for the 
delivery of bacterial virulence factors required for invasion and survival, to the nematode 
intestinal cells. 
Using TEM, intracellular S. flexneri cells were observed 96 and 144 hours post infection 
(Figure 5.4.C and D, respectively). These observations indicate that virulent S.flexneri cells 
cross the protective, apical microvilli boundary of intestinal cells and enter the intestinal cell 
cytoplasm. TEM micrographs also suggest that intraluminal S.flexneri cells degrade the 
nematode intestinal microvilli (Figure 5.4.E). These findings are highly significant as, 
although several studies have shown that intracellular mammalian pathogens kill C. elegans 
by persistently colonizing the intestinal lumen, most of these pathogens remain extracellular 
and fail to invade the nematode intestinal cells [243] . 
5.2.4 Other phenotypes observed in the cytopathological examination of infected 
nematodes using transmission electron microscopy (TEM) 
5.2.4.1 Worms infected with wild type S. fle.\:neri for 24 hours display symptoms of 
fluid imbalance in the intestinal epithelial cells 
24 hours post infection several nematodes infected with S.flexneri serotype 3b display signs 
of fluid imbalance (Figure 5.5). TEM micrographs of mid-body sections of animals infected 
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Figure 5.4: lntraluminal S. jlexneri cells produce putative outer membrane vesicles 
(OMVs) and invade C.elegans intestinal epithelia. A-E: TEM micrographs of transverse 
mid-body sections of young adult nematodes infected with wild type S.flexneri serotype 3b 
(SFL1520) for 24 h (A, B), 96 h (C) and 144 h (D, E). A, B: Intraluminal bacterial cells 
produce putative outer membrane vesicles (OMVs); red arrowheads indicate OMV shedding 
from bacterial cells. C, D: White arrowheads indicate intracellular bacterial cells that have 
penetrated the ciliated epithelial barrier of the intestinal cell, 96 and 144 h post infection. E: 
Intraluminal S.flexneri cells degrading the apical microvilli boundary (asterisk) of the C. 
elegans intestinal cells. IEC- intestinal epithelial cells ; mv-microvilli; IL-intestinal lumen; 
TW-terminal web ; b-intraluminal bacterial cells; OMV-outer membrane vesicles. 
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with SFLI 520 for 24 hours are characterized by diluted intestinal cell cytoplasm, fluid-filled 
pseudocoelom (the circulatory fluid-equivalent in nematodes) and shrunken tissues floating in 
the excess fluid (Figure 5.5 .B and D). This phenotype was observed in 9 out of22 (41%) 
animals observed. In comparison, animals fed SFL1223 have well -defined intestinal cells and 
organs (Figure 5.5 .A and C). However, this phenotype was not observed in animals infected 
with SFLl520, 96 and 144 hours post infection. These observations suggest that S.jlexneri 
potentially causes fluid imbalances in nematodes at the onset of infection. However, since 
only 41 % of infected animals examined in this study displayed this phenotype, further studies 
need to be conducted to confirm that this observation is not due to fixation artifacts. 
In order to determine if nematodes infected with SFLl520 for 24 hours accumulate fluid, 
light microscopy was used to compare the anatomy of animals infected with SFL 1520 and E. 
coli OP50. Results of light microscopy fai led to identify prominent changes indicating fluid 
retention, such as swelling and ill-defined cellular structures in the intestines of worms 
infected with E.coli OP50 and SFLl520 (Figure 5.6.A and B, respectively). The light 
microscopy images did, however, indicate that nematodes infected with SFLl520 showed a 
larger gap between the intestinal cell membranes and the nematode body walls when 
compared with control worms. This observation could suggest accumulation of fluid in these 
wom1s. Further experiments using markers to track fluid movements in infected worms 
would shed light on this phenotype. Light microscopy also indicated that nematodes infected 
with SFLI 520 appear to retain embryos. 
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SFL1223 (Avirulent S. {lex11er1) SFL1520 {Virulent S. flex11eri) 
A B 
Pseudocoelom 
Figure 5.5: Worms infected with wild type S. jlexneri for 24 hours display symptoms of 
fluid imbalance in the intestinal epithelial cells. This Figure shows transverse sections of 
C. elegans mid-bodies with intestinal cells highlighted (yellow boxes) 24 hours post infection 
with wild type S. jlexneri serotype 3b, SFL1520 (B and D) and the a virulent S. jlexneri strain, 
SFL1223 (A and C). Nematodes infected with SFL1520 show highly damaged intestinal 
cells, with the intestinal cytoplasm lacking ground substance. Nematodes infected with 
SFL1520 are also characterized by fluid-filled pseudcicoelom, and shrunken tissues floating 
in the excess fluid (Band D). Nematodes infected with SFL1223 have well defined intestinal 
cell cytoplasms and the body of these animals is not filled with pseudocoelomic fluid (A and 
C). 
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Figure 5.6: Montage of light microscopy images of nematodes infected with virulent S. 
flexneri and E. coli OPSO. Young adult hermaphrodite N2 nematodes were infected with 
either S. flexneri serotype 3b (SFL1520) or E. coli OP50 (B2298) for 24 hours at 22 °C Light 
microscopy was used to compare the anatomy of worms infected with SFL1520 (B and B') 
and B2298 (A and A') using the EVOS digital inverted microscope (AMG). No prominent 
differences in the diameter of wonns fed either SFLl520 or B2298 were observed. Larger 
gaps (indicated by red lines) were observed between the intestinal cells and the body wall in 
nematodes infected with SFL1520 when compared with worms fed B2298. Nematodes 
infected with SFLl 520 appear to retain developing embryos (B); this phenotype is not seen in 
wonns fed B2298 (A). Scale bar A and B = 200 µm and A' and B' = 50 µm 
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5.2.4.2 Infected worms retain embryos and show accumulation of cytoplasmic yolk 
granules 
Consistent with light microscope images, TEM micrographs also indicate that worms infected 
with SFL1520 seemed to retain advance-stage embryos. In normal worms, the embryos stay 
within the mother up to the 64-cell stage. TEM analysis of worms infected with SFLl 520 
suggests that these wonns retain advanced embryos, well beyond the 64-cell stage (Figure 
5.7.A and B). Kesika and colleagues have previously reported that nematodes infected with 
vimlent S.jlexneri lay fewer eggs when compared with worms fed E.coli OP50 [284]. 
Embryo retention observed in worms infected with SFLl 520 could explain the decreased egg 
laying reported by Kesika et al. 
TEM analysis of infected worms also identified a significant accumulation of yolk granules 
in the intestinal cells of nematodes infected with SFL1520 when compared with animals 
infected with the avimlent strain (Figure 5.8.A and B). The accumulation of yolk granules in 
the intestinal cells could suggest defects in endocytosis, cell -cell signaling and trafficking. 
These defects could account for the fluid imbalance seen after 24 hour infection. 
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Figure 5. 7: Nematodes infected with S. jlexneri serotype 3b retain embryos. This figure 
shows longitudinal sections of C. elegans infected with wild type S. jlexneri serotype 3b, 
SFL 1520 for 24 h (A) and 96 h (B). Nematodes infected with SFL 1520 retain developed 
embryos well beyond the 64-cell stage. Boxes highlight regions that have been magnified. 
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Figure 5.8: Accumulation of yolk in intestinal cells infected with wild type S. flexneri for 
96 hours: Transverse mid-body sections of nematodes infected with a virulent S. flexneri 
showing very little yolk accumulation (A and B) and SFL1520 (virulent S. flexneri) showing 
accumulated yolk granules in the cytoplasm (C and D). Yellow boxes highlight the intestinal 
cells and arrows indicate a few of the yolk granules. 
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5.2.5 Identification of nematode responses to S. jlexneri infection using DIGE 
DIGE was performed to gain insight into S. flexneri-induced responses in C e!egans. Total 
protein was isolated from nematodes infected with S.flexneri serotype 3b (SFL1520) and E. 
coli OP50 for 24 hours. A 24 hour infection period was selected as significant accumulation 
of SFLl 520 in the nematode intestinal lumina was observed at this time point (Figure 5.2). 2 
mg of total protein, isolated from four independent experiments, was used to perform DIGE. 
Analysis ofDIGE results using the DeCyder version 5 software package identified 41 S. 
flexneri-induced nematode proteins (with 37 up-regulated and 4 down-regulated proteins) 
(Figure 5.9). All 41 identified spots were excised from the gels for identification by peptide 
sequencing. Peptides were isolated from excised protein spots as described in section 2.9.2.4 
and submitted to the Mass Spectrometry Facility, ANU, for LC-MS analysis. Proteins were 
identified through sequenced peptides using MASCOT (Matrix Science) database searches. 
MASCOT searches using stringent search parameters (mass tolerance between 0.3 and 0.1 
Da), only identified significant protein hits for 7 out of 41 spots (Table 5.1 ). Since the 
theoretical molecular weights (Mwt) and pl values of the 7 identified proteins, AC0-1 , CCT-
2, EEF-2, DAF-19, HSP-60, UNC-54 and UNC-41 , were consistent with the Mwt and pl of 
spots predicted from the DIGE gels, it is likely that these proteins are S. jlexneri-induced 
responses in C e!egans. Therefore these proteins were investigated further. 
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Figure 5.9:A: A representative 2 dimensional gel electrophoresis image of the S.jlexneri-
induced proteome of C elegans. Red arrows indicate the protein spots identified AS 
differentially expressed in response to S.jlexneri infection. All numbered spots were excised 
from the gel and submitted for LC-MS analysis. Proteins were identified through sequenced 
peptides using MASCOT (Matrix Science) (see Table 5.1 ). B: Differentially expressed spots 
identified using high stringency MASCOT search parameters. Graphs depicting the 
differences in standardized log abundance of identified spots in worms infected with virulent 
S. jlexneri (SFL 1520) and control worms maintained on E. coli OP50 across three biological 
replicates calculated using the DeCyder version 5 sofrn:are package. 
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Table 5.1: Predicted S. flexneri-induced responses in C.elegans identified through Peptide Mass Fingerprinting using high stringency 
MASCOT search parameters 
Identified Gene Shige//u-i nd uced change Description Predicted Observed Peptide No of Score P value (One 
protein name in expression pl/Mwt pl/Mwt (kDa) Coverage peptides Way 
(kDa) (% ) Matched ANOVA) 
Puta ti ve stoned 8 - unc-4 / Down-regulat ed Potential adapter protein, which may be 4.81/190.58 4.8/-94 .00 3 7 27 0.029 
like protein in vo lved in endocytic vesic le recycling of 
synaptic vesic les 
Myosin-4 unc-54 Up-regul ated Encodes a muscl e myosin class II heavy cha in 5.59/225.958 5.2/96.00 8 5 134 0.038 
(M HC 8 ) . Expressed in the intestine. In volved 
in pharyngeal pumping and egg laying 
Probable aco-1 Up-regulated Enzyme that catalyzes the isomerizat ion of 5.49/97. 11 5.5195.00 14 5 86 0.022 
cytoplasmic citrate to isocit rate via cis-aconi tate. Requ ired 
aconitatc for iron homeostas is 
hvdratasc 
Elongat ion factor eef-2 Up-regulated Catalyzes the GTP-dependent ribosomal 6. 1/95.47 5.5/95.00 18 8 72 0.022 
2 translocat ion s te p during translati on elongation. 
Required for cmbryogencsis 
RFX-like daf- 19 Up-regulated A transcription factor that regulates genes of 5.97/9 1.42 5. 1/86.00 2 3 24 0.040 
transcription cil iated sensory neurons. daf /9 mutants are 
factor defecti ve in their abi-l ity to taste or sme ll and are 
suscept ible to bacterial in fection! 
Chaperon in hsp-60 Up-regulated Heat shock prote in implica ted in mitochondrial 5.31/60.24 5.1/68 .00 49 20 1446 0.040 
homolog Hsp-60 prote in import and macromolecula r assembly. 
Requ ired fo r response to ox idative stress 
T-complex cct-2 Up-regulated Molecular chaperone; assists the folding of 5.65/53.38 5.6/67.5 6 2 4 1 0.047 
protein I subuni t proteins upon ATP hydrolysis. 
beta I 
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5.2.5.1 Confirming the results of DIGE analysis using quantitative real-time reverse 
transcription PCR (qRT-PCR) 
Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was used 
to compare mRNA levels of the seven identified nematode proteins, AC0-1, CCT-2, EEF-2, 
DAF-19, HSP-60, UNC-54 and UNC-41, in worms infected with S.flexneri serotype 3b 
(SFLI 520) and control worms maintained on E. coli OP50 (Figure 5.10). Total RNA was 
isolated from nematodes fed SFL1520 and control worms, fed E.coli OP50 (Section 2.13.6). 
cDNA was synthesized and qRT-PCRs were performed (Section 2.13. 7). The C. elegans act-
2 gene, which encodes actin, was used as a control gene to nonnalize all reactions, as the 
mRNA levels of act-2 are expected to remain constant in healthy and infected worms. 
Consistent with the DIGE analysis, qRT-PCR indicated a significant increase in the transcript 
levels of cct-2, daf 19, hsp-60 and unc-54 and a decrease in the levels of unc-41 transcripts in 
wonns infected with SFLI 520. No statistically significant differences were observed in the 
transcript levels of aco-1 in infected and control worms (p > 0.05 , unpaired t-test). aco-1 
encodes cytosolic aconitase, an enzyme whose expression is regulated post-translationally by 
iron levels. This would explain why although AC0-1 levels are elevated in response to S. 
f!exneri infection, the mRNA levels in infected and control wonns remain unchanged. 
Contrary to DIGE analysis , the expression of eef 2 appears to be down-regulated at the 
transcriptional level , suggesting that the EEF-2 protein levels in infected worms are also 
potentially regulated post-transcriptionally. 
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Figure 5.10: Reverse transcription quantitative PCR (qRT-PCR) analysis of S.jlexneri-
induced genes predicted by DIGE analysis. Transcript levels of aco-1, daf 19 and unc-
4 J(A), cct-2, hsp-60, unc-54 and eef2 (B) were measured in synchronized young adult wild 
type animals feed ing on E. coli OP50 or infected with S. jlexneri serotype 3b for 24 h. Data 
represent the means of three biological replicates, each replicate measured in triplicate and 
normalized to the control gene, act-2, expressed as the ratio of the corresponding S. jlexneri-
induced levels and the basal E. coli OP50 levels. Asterisks indicate statistically significant 
differences identified using unpaired Student ' s /-tests and error bars represent standard error. 
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5.2.5.2 RNAi-mediated knockdown of aco-1, cct-2, daf-19 and hsp-60 
Results ofDIGE analysis suggest that AC0-1 , CCT-2 DAF-19 and HSP-60 are up-regulated 
in response to S.jlexneri infection. In order to determine if the increased levels of these 
nematode proteins in response to S. jlexneri fanned part of the nematode protective 
mechanism, the expression of these genes was knocked down using the RN Ai technology 
(Section 2.13.9). aco-1, cct-2, daf 19 and hsp-60 were selected for RN Ai knockdown studies 
as RN Ai constructs to knock down these genes were readily available. 
RNAi-silenced aco-1, cct-2, daf-19, hsp-60 and pCB19 (a non-specific dsRNA control) 
nematodes were prepared by feeding, as described in section 2. 13.9 .2 . Young adult RNAi 
aco-1, cct-2, daf/9, hsp-60 and pCB19 (RNAi control) nematodes were infected with log 
phase cultures of S.jlexneri serotype 3b (SFL1520), avirulent S.jlexneri-.(SFL1223) or E.coli 
OPSO (B2298). RNAi worms were used to perform bacterial accumulation and liquid killing 
assays to detennine if these S.jlexneri-induced genes play a role in protecting nematodes 
against S. jlexneri infection. 
5.2.5.3 The effect of silencing S. jlexneri-induced host response genes on nematode 
survival 
Survival was scored for 48 hours and killing curves were generated from the results of three 
independent, blind experimental repeats. aco-1 RNAi wonns fed S.jlexneri serotype 3b 
showed a significant increase in survival rates compared with the RNAi control wom1s (p < 
0.0366, Log rank test) (Figure 5.11.B). cct-2 RN Ai nematodes appeared to be more 
susceptible to SFL1520 infection (TD50 38 ± 2 h compared with TD50 = 46 ± I h of control 
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Figure 5.11: The effects of silencing S. jlexneri-induced host response genes on 
nematode survival. After RN Ai knockdown of S. jlexneri-induced genes aco-1 (B), cct-2 
(C), dafl9 (D) and hsp-60 (E), young adult hermaphrodites were treated with log phase 
cultures of either E. coli OP50, avirulent S. jlexneri (SFL1223) or virulent S. jlexneri serotype 
3b (SFL1520) and scored at 12 hour intervals for survival. A: Nematodes treated with pCB19 
(RNAi control vector) were used as a non-specific dsRNA control. Results represent data 
obtained from four independent biological repeats each with at least four technical repeats 
(each technical repeat with 20-50 nematodes) with standard error (error bars). The survival 
curves ofRNAi worms infected with S.jlexneri serotype 3b were compared with RNAi 
control-pCB 19 worms infected with S.jlexneri serotype 3b (grey, dashed curves); and 
asterisks indicate statistically significant differences in survival curves (p < 0.05), identified 
using Log rank tests. 
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wom1s, p < 0.0001, Log rank test) (Figure 5. 11.C). daf-19 RNAl wonns showed increased 
susceptibility to S. jlexneri-mediated killing at earlier time points in comparison with RN Ai 
control worms (24 and 36 hours, p< 0.0001, Log rank test) (Figure 5.11. D). These 
observations suggest that DAF- I 9 is involved in the initial nematode protective mechanisms. 
hsp-60 RN Ai worms were slightly more susceptible to S. jlexneri-mediated killing (TD so 45 ± 
I) compared with control wom1s (TDso46± 1 h, p < 0.0416, Log rank test). 
5.2.5.4 The effect of silencing S. jlexneri-induced host response genes on bacterial 
accumulation 
Bacterial accumulation and GFP+ accumulation assays were also performed using the aco-1, 
cct-2, daf-19, hsp-60 and pCB19 (RNAi control) RNAi worms, to determine if the silencing 
of S.jlexneri-induced nematode genes bad an effect on bacterial accumulation. The enhanced 
resistance of aco-1 RN Ai wonns to SFL1520 infection in liquid culture (Figure 5.11.B) 
correl ated with decreased bacterial accumulation (Figure 5.12.A and C). These observations 
suggest that Aco-1 acts as a negative regulator of host responses to S. flexneri infection. 
The increased killing of cct-2 RNAi worms (Figure 5.11.C) correlates with increased 
bacterial accumulation (Figure 5.12.A and D). These results suggest that CCT-2 induces or 
contributes to host protective mechanisms. Bacterial accumulation assays showed increased 
bacterial accumulation in daf-19 RNAi wonns (Figure 5.12.A and E) compared with the 
RNAi control worms. Increased bacterial accumulation in daf-19 silenced worms suggests 
that the expression of this gene is required to control or elin1inate intraluminal S. flexneri. No 
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Figure 5.12: The effects of silencing S. jle.xneri-induced host response genes on 
accumulation of virulent S. jlexneri in the nematode intestinal lumen. After RN Ai 
knockdown of S.jlexneri-induced genes aco-1 , daf-19, hsp-60 or pCB 19 as an RN Ai 
negative control, young adult hermaphrodites were transferred onto lawns of virulent S. 
jlexneri (SFL1520) for 24 h. A: 20 worms were picked off bacterial lawns and disrupted, 
following which appropriate dilutions of each lysate were plated onto LB agar to obtain the 
intestinal bacterial counts. Results represent the means of three independent experimental 
repeats with standard error (error bars); asterisks indicate statistically significant differences 
(p < 0.005, unpaired I-tests). pCB 19 (B), aco-1 (C), cct-2 (D), daf-19 (E) and hsp-60 (F) 
RNAi knockdown animals were transferred onto GFP+-tagged SFL1520 for 24 h. 
Fluorescence was observed using the EVOS digital inverted microscope (AMG). Scale bar = 
400 µm. 
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significant differences were observed in S.jlexneri accumulation between hsp-60 RNAi and 
control wom1s (Figure 5.12.A and F). 
5.2.6 Nematode proteins predicted to be induced by S.jlexneri infection using two-
dimensional differential in-gel electrophoresis and low stringency MASCOT search 
parameters 
Since MASCOT searches using stringent search parameters only identified seven out of 41 
potential S.jlexneri-induced nematode proteins, the stringency of the search parameters was 
decreased in an attempt to identify the remaining proteins. Using low stringency MASCOT 
search parameters (mass tolerance = 0.6 Da instead of0.3 Da), significant hits for 39 out of 
41 spots were obtained, with many spots corresponding to more than one protein (Table 5.2). 
Some of these proteins (UNC-22, NHR-77 and ClOC6.6) were identified-more than once in 
different spots and thus represent different isoforms, which could be the result of post-
translational modifications or different splice variants of the same protein or protein 
degradation. Theoretical molecular weights (Mwt) and pl values of identified proteins were 
compared with the Mwt and pl of spots on the DIGE gels. Peptide coverage and distribution 
were also taken into account to eliminate false positive hits. Using these parameters, 46 
potential nematode proteins induced in response to S.jlexneri serotype 3b infection were 
identified (Table 5.2). Six out of the 39 spots corresponded to more than one positive 
identification (spot numbers 7, 8, 11 , 25 , 26 and 32) which could be due to false identification 
or the presence of several proteins with similar Mwt and/or pl values in these regions on the 
gels. The proteins identified using low stringency MASCOT search parameters were 
subdivided into different categories based on their biological functions. This subdivision of 
the identified proteins showed that most of the nematode proteins induced by S. jlexneri 
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Spot 
No • . 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Table 5.2: Predicted S.flexneri-induced responses in C.elegans identified through Peptide Mass Fingerprinting using low stringency 
MASCOT search parameters 
Pathogen-
induced change MASCOT Theoretical Observed Sequence 
in expression Identified protein UniProt Id Gene Name Biological function/relevant RNAi phenotypes Score Mwt (Da)/pl Mwt(Da)/pl coverage 
Vacuola r protein 
sorting-associated 
Down-regulated protein 26 VP526 CAEEL vps-26 Prote in transport/ Premature death 25 40926/5.81 >94000/4.8 4% 
Uncharacterized NTE Predicted to be involved in phosphatidylcholine metabolic 
Down-regu lated family protein VOL CAEEL ZK370.4 process/ No RNAi phenotypes specified 27 153212/6.53 >94000/5.2 2% 
Putative stoned B- Locomotion and endocytosis/ defective movement, nervous 
Down-regu lated like protein 5TN8 CAEEL unc-41 system morphology variant 27 190581/4.81 >94000/4.8 3% 
Up·regulated 
UPF0533 protein TPC13 CAEEL C56C10.7 Probable trafficking protein/ No RNAi phenotypes specified 29 45329/5.48 >94000/5.6 3% 
Up~regulated Probable cation -
transporting ATPa se YE56_CAEEL C10C6.6 ATP catabo lic process/ Sparse or enlarged yolk granules 31 133598/7.25 >94000/5.8 2% 
Up-regulated Locomotion, pharyngeal pumping/ bag of worms, egg laying 
Myosin-4 MY04 CAEE L unc-54 defect, sluggish, premature death 134 225958/5 .59 -95000/5.2 8% 
Up~regulated Sterile alpha and Tl R 
motif-conta ining Innate immunity, neurogeneration, differentiation/ 113781/6.9 
protein 5ARM1 CAEEL tir-1 hypersensitivity to infection, reduced gene expression 30 -97000/5.3 1% 
RING finger proteins RNF5 CAEE L rnf-5 E3 ubiquit in ligase/ extended lifespan 30 25298/6.22 -97000/5.3 9% 
Probable cytoplasmic 
Up-regulated aconitate hydratase ACOC CAEE L aco-1 Cellular Iron homeostas is, TCA/ No RNAi phenotypes specified 86 97113/5.49 -95000/5.s 14% 
Elongation factor2 EF2_CAEEL eef-2 Protein biosynthesis/ apoptosis reduced, extended lifespan 72 95477/6.1 -9500015.s 18% 
Up-regulated DNA topoisomerasel TOPl CAEEL top-1 DNA replicat ion/ shortened lifespan, defective locomotion 29 94428/9.04 -93000/s.2 2% 
Up-regulated RFX-like transcription 
91421/5.97 
factor DAF19 CAEEL daf-19 Transcr iption factor/ cilia absent 24 - 86000/5.1 2% 
Up-regu lated Uncharacterized 
YA06_CAEEL Unknown/ animals produce no or few embryos 164864/6.15 protein F54Dl.6 25 -90000/4.5 3% 
Nipped-B-like protein 
NP8L_CAEEL Cell cycle/ defective locomotion 253743/5.79 pqn-85 pqn-85 24 - 90000/4.5 4% 
Up-regulated DCT-5 OCT5_CAEEL dct-5 Acts downstream of Daf16/FOXO/ induced dauer formation 26 24045/8.06 - 90000/4.3 9% 
Up-regulated Uncoordinated UNC79_CAEEL Locomotion/ sluggish, odour chemocensory response variant 98899/6.07 protein79 unc-79 31 -85000/5.2 6% 
Up-regulated Probable FAD 
FLADl_(AEEL 59440/6.49 
synthase R53. l FAD biosysnthesis/ slow growth 28 -85000/4.45 5% 
Up-regulated Uncharacterized HEN 1 (RNA 3'end methyltransferase) of Nematode/ No RNAi 
51993/5.23 protein YKK6 CAEEL C02F5.6 phenotypes specified 29 -78000/4.4 1% 
Up-regulated Calcium-activated Potassium transport/ irregular pharyngeal pumping, 
potassium channel 5L01 CAEEL slo-1 desens itization to chemo attractants 25 131043/5.8 -72000/5.6 2% 
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Noof 
pe ptides 
matched 
2 
4 
7 
2 
5 
14 
3 
1 
8 
9 
4 
3 
7 
8 
2 
5 
4 
I 
4 
Up-regulated 60235/5.3 
17 Chaperonin homolog CH60 CAEEL hsp-60 Protein refolding, embryo larva development/ maternal steri le 1446 -68000/5.1 49% 7 
Up-regulated T-complex protein 1 
Protein folding/ apoptosis reduced, maternal sterile, oocytes 
TCPB_CAEEL lack nuclei, resistant to oxidative st ress-anima ls fa il to respond 57338/5.65 2 
subunit beta 
cct-2 to oxidative stress, endocytosis defective 41 -67500/5.6 6% 18 
Up-regulated E3 ubiquitin-prote in RPMl_CAEEL Ubiquitin protein ligase that negat ively regulates the p38 MAPK 425202/6.29 
~9 ligase rpm-1 pathway expressed in pharynx/ apoptosis reduced 28 -67900/5.1 1% 6 
Up-regulated Muscle M-line Structural component of muscle M-line/ egg laying defective, 
assembly protein UNC89_CAEEL locomotion defective, pharyngeal pumping reduced 
20 unc-89 24 8990003/5.42 -60000/4.3 2% 25 
Up-regulated Mediator of RNA 
polymerase II MEDl_(AEEL Transcription regulation/slow growth, reduced brood size 
transcription 3 
21 subunitl.1 sop-3 28 165015/8.86 - 57000/4.0 2% 
Up-regulated Heat shock 70 kDa HSP7F CAEE L Stress response/ reduced l:\TP, reduced pharyngeal pumping, 
22 protein F - hsp-6 shortened lifespan, reduced brood size 24 71086/5 .89 -55000/4.1 3% 3 
Up-regulated Regu lates muscle contraction and relaxation, expressed in the 
23 Twitchin UNC22 CAEEL unc-22 body wall, vulva, pharynx/ defective movement 49 792459/5.79 - 50000/5. 1 1% 12 
Up-regu lated Ri bosome biogenesis 
regulatory protein RRS1_CAE EL Ribosome biogenesis/maternal steri le, reduced oocytes, 
24 homolog rrbs-1 24 37962/9.97 -44000/4.9 6% 3 
Uncharacterized YMF7_CAEE L Unknown 
25 Up-regulated prote in F55H2.7 29 44124/10.08 - 42000/5.4 6% 3 
Nuclear hormone 
receptor family NHR77 _CA EEL Transcription regu lation/ No RNAi phenotypes specified 3 
member-77 nhr-77 25 42688/9 .12 -42000/5.4 11% 
Copine family prote in CPNA2_CAEE L Belongs to the cop ine fa mily and is expressed in the body wall 
26 Up-regulat~d 2 cpno-2 muscles/ No RNAi phenotypes specified 25 862013/5.21 -40000/5.S 1% 17 
Regulator of RNA dependent helicase, RNA interference, embryo genita l 
nonsense morphogenesis/ defective mRNA surveillance, reduced 
transcriptsl RENTl CAEEL smg-2 susceptibility t o RNAi 25 12 1142/6.46 - 40000/5.s 2% 3 
Germline survival Gl 51_CAEEL Meiosis/ defective oogenesis defective-1 gls-1 18 116684/8.44 - 40000/5.S 7% 5 
Up-regulated N-terminal 
acetyltransferase B 
NAA25_CAEE L 
Cata lyses acetylation of proteins/reduced number of oocytes 
complex subunit and brood size I 
27 NAA25 homolog cra-1 27 110296/6.41 -32000/4.9 2% 4 
28 Up-regulated No significant hits 
29 Up-regulated No significant hits 
Up-regulated Protein arginine N- 3 
30 methyltransferase 5 ANM5 CAEEL prmt-5 Transcription regu lation/ Increased spontaneous mutation 34 83582/5.86 -29000/4.9 2% 
Up-regulated Nuclear hormone 3 
receptor family NHR19_CAEEL Transcription regulation/ No RNAi phenotypes specified 
31 member-19 nhr-19 33 541000/9.06 -28500/4.87 5% 
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Single-stranded DNA- 1 
binding protein, MT55l_CAEEL DNA replication/ reduced hypoxia response 
32 Down-regulated mitochondrial mtss-1 27 19227/9.77 -28000/6.7 8% 
Histone H3-like 2 
centromeric protein CPARl CAEEL cpar-1 Nucleosome assembly/ reduced brood size 24 29125/7.94 -28000/6.7 6% 
Up-regulated Regulates muscle contraction and relaxation, expressed in the 19 
;B Twitchin UNC22 CAEEL unc-22 body wall, vulva, pharynx/ defective movement 29 792459/5.79 -25000/4.7 1% 
Up-regulated Multicel lular organism development/ intestinal cell proliferation 2 
Homeobox protein HM31 CAEEL ceh-31 variant 28 28834/7.82 -25000/4.7 5% 
Up-regulated Origin recognition 3 
34 complex subunit 2 ORC2_CAEEL orc-2 DNA replication/ sluggish 25 49460/6.03 -26000/5.6 5% 
35 Up-regulated UPF0046 protein YW12 CAEEL T07D4.2 Hydrolase activity/ No RNAi phenotypes specified 26 45353/9.17 -24000/4.6 9% 3 
Up-regulated Nuclear hormone 3 
receptor family NHR77_CAEEL Transcription regulation/ No RNAi phenotypes specified 
36 member-77 nhr-77 29 42688/9.12 -23000/4.6 4% 
Up-regulated 26S proteasome non- 1 
ATPase regulatory P5MD6_CAEEL ATP-dependent degradation of ubiquitinated proteins/ 
37 subunit 6 rpn-7 Increased apoptosis 31 47838/6.36 -21000/5.2 1% 
Up-regulated Mediator of RNA 3 
polymerase II 
transcription subuni t Transcription regulation/ defective egg laying, locomotion, 
38 17 MED17 CAEEL mtd-17 endocytosis 27 77767/5.74 -20000/5.5 2% 
Up-regulated Probable cation- 4 
39 transporting ATPase YE56 CAEEL C10C6.6 ATP catabo lic process/ Sparse or en larged yolk gran ules 33 133598/7.25 -20000/5.6 2% 
Up-regulated 26$ proteasome non- 3 
ATPase regulatory 
40 subunit 3 P5MD3 CAEEL rpn-3 Regulation of protein catabolic process/ increased apoptosis 24 57813/7.14 -18000/5.8 5% 
Up-regulated Cytoplasmic 1 
polyadenylation 
element-binding 
41 protein 1 CPBl_CAEEL cpb-1 Differentiation, spermatogenesis/ Reduced brood size 30 63949/8.65 -13000/5.5 1% 
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Up regulated proteins 
Down regulated proteins 
a Enzymes 
a Replicat ion 
a Transcription, translation, ribosomal structures 
• Transport 
• Chaperons 
• Locomot ion and pharyngeal pumping 
• Cell division and reproduction 
• innate immune response 
Unknown 
• o thers 
Figure 5.13: Graphical representation of the predicted biological functions of the up-
and down-regulated C. elegans proteins identified in response to S. jlexneri infection. 
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infection are involved in transcription and translation, followed closely by proteins required 
for movement and pharyngeal pumping (Figure 5.13). 
5.2.6.1 Determining the change in expression of HSP-6, a nematode protein predicted to 
be up-regulated in response to S. jlexneri infection, using low stringency MASCOT 
search parameters 
It was not economically feasible or within the scope of this project to confirm the differential 
expression of all 46 potential proteins identified by lowering the stringency of the search 
parameters. However, as a proof of concept, the expression of hsp-6 in nematodes infected 
with S.jlexneri and control worms was explored further. DIGE analysis suggested that the 
expression ofHSP-6 was up-regulated in response to S. jlexneri infection. hsp-6 was selected 
for further study as a hsp-6::GFP transcriptional reporter C.elegans strain, SJ4100 [hsp-
6::GFP(zclsl3)] , was readily available. The expression of hsp-6::GFP in SJ4 l 00 worms can 
be easily observed using fluorescence microscopy to visualize the expression of GFP driven 
by the hsp-6 promoter. Young adult SJ4 J 00 nematodes were fed E. coli OP50 or S. jlexneri 
serotype 3b (SFL 1520) for 24 hours, following which the expression of hsp-6: :GFP in the 
mitochondria throughout the nematode body was visualized using fluorescence microscopy. 
The result showed that nematodes infected with SFLI 520 exllibited increased expression of 
GFP throughout their bodies (Figure 5.14.B) compared with control worms maintained on 
OP50 (Figure 5.14.A). 
221 
C 
P ~ 0.0025 
,t/ / 
~.. !f)~ d' ,, 
,~ ~" 
# ,• 
•• # 
,/ ,I' 
~· 
Figure 5.14: Determining the change in expression of hsp-6 in nematodes infected with 
S. flexneri. Young adult, hsp-6::GFP C. elegans worms (SJ4100), were fed E. coli OP50 (A) 
or S.jlexneri serotype 3b, SFL1520 (B) for 24 hours at 22 °C. Fluorescence microscopy was 
used to visualize the expression of GFP driven by the hsp-6 promoter. Nematodes infected 
with SFLl 520 show increased GFP expression in the mitochondria throughout their bodies 
(B) compared with control worms maintained on E. coli OP50 (A and B). Scale bar= 200 
µm. C: Results of quantitative real time PCR to determine the expression of hsp-6 in 
nematodes infected with S. jlexneri. Transcript levels of hsp-6 were measured in 
synchronized young adult N2 animals feeding on E. coli OP50 or infected with S. jlexneri 
serotype 3b for 24 h. A significant increase in hsp-6 mRNA was observed in response to S. 
jlexneri infection (p = 0.0025, unpaired I-test). Data represent the means of three biological 
replicates, each replicate measured in triplicate and normalized to the control gene, act-2 , 
expressed as the ratio of the corresponding S. jlexneri-induced levels and the basal E. coli 
OP50 levels. 
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Quantitative real time PCRs were perfonned to determine the transcript levels of hsp-6 in 
wild type, N2 nematodes infected with virulent S.jlexneri and control worms maintained on 
E.coli OP50. The results of the qRT-PCR analysis show a significant increase in hsp-6 
expression in response to S.jlexneri infection (Figure 5.14.C). The results of hsp-6::GPF 
reporter gene expression studies and qRT-PCR analysis are both consistent with the DIGE 
analysis and thus validate the results of the low stringency MASCOT search results. 
5.3 Discussion 
Consistent with previous reports , in this study we confirmed that a virulent S. jlexneri 
serotype 3b strain kjlis nematodes. Nematode killing is associated with bacterial 
accumulation within the intestinal lumina of infected wonns. Bacterial accumulation and S. 
.flexneri-mediated kjlling of wonns requires the expression of virulence plasmid-encoded 
genes as a virulence plasmid-cured S.jlexneri strain failed to accumulate in nematode guts 
and also failed to kjll worms. These results show that bacterial accumulation assays and 
nematode kjlling assays can efficiently distinguish between virulent and avirulent strains of S. 
jlexneri. 
Unlike the other animal models of shigellosis, virulence assays in C. elegans are cost-
effective, reproducible and less labor intensive. Furthermore, C. e!egans liquid killing assays 
have the additional advantage of being a high-throughput method to screen the virulence of 
numerous S.jlexneri strains, as multiple replicates can be set up within each biological 
repeat. Despite the advantages of virulence assays in C. e!egans, the mechanism of S. 
jlexneri infection in nematodes and the nematode responses to infection remain unknown at 
present, limiting the use of this in vivo model of shigellosis. 
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The main aim of this study was to further our understanding of S. jlexneri infection in C. 
elegans and to assess the suitability of C. elegans as a novel animal model to study S. jlexneri 
pathogenesis. Transmission electron microscopy was used to study the cytopathology of 
infected nematodes and to track the S.jlexneri infection process in nematodes. This is the 
first report of the cytopathology of S.jlexneri infected wonns. A proteomic approach was 
also used to identify S.jlexneri-induced nematode responses. 
5.3.1 Virulent S. flexneri cells ingested by C. elegans evade pharyngeal grinding, 
accumulate in the nematode intestinal lumen and invade the intestinal cells 
Although bacterial accumulation assays and GFP+ accumulation assays suggested that 
virulent strains of S. jlexneri accumulate in the nematode gut, they do not prove this 
conclusively. The TEM micrographs obtained in this study, however clearly show intact S. 
jlexneri cells within the intestinal lumina of infected wom1s, with the bacterial load 
increasing over time (Figure 5.3). This implies that some S.jlexneri cells evade or escape 
pharyngeal grinding. The C. elegans grinder crushes ingested bacterial cells and is therefore 
the wonn's primary defense against invading pathogens. The presence of increasing numbers 
of intact S. jlexneri.cells within the nematode intestinal lumen during the course of infection, 
clearly suggests that S.jlexneri cells overcome or by pass this nematode defense mechanism. 
A recent study proposed that the presence of 0-antigen on bacterial surfaces protects 
bacterial cells from the macerating effects of the nematode grinder [255]. To test this 
hypothesis, the researchers treated an 0-antigen expressing E. coli strain and an 0-antigen 
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deficient control strain with glass beads and found that the presence of the 0-antigen 
enhanced bacterial resistance to maceration. Both virulent and plasmid-cured S. jlexneri 
strains used in our study express 0-antigens on their surface, therefore it seems unlikely that 
the presence of 0-antigen molecules alone protect bacterial cells against maceration in the 
nematode grinder. 
Wonns infected with virulent S. .flexneri are sluggish, show impaired grinding of ingested 
food and fail to lay eggs as efficiently as control worms. All these symptoms correlate with 
an overall loss of energy and deficient neuromuscular functions . Furthem10re, DIGE analysis 
identified several nematode proteins involved in locomotion (UNC-22 , UNC-41 , UNC-54, 
UNC-79 and UNC-89) and pharyngeal pumping (UNC-54, SL0-1 and HSP-6) as 
differentially expressed in response to S. jlexneri infection. The differen_tial expression of 
unc-41, unc-54 and hsp-6 was confinned by qRT-PCR. Up-regulation of hsp-6 promoter-
driven GFP expression in nematodes infected with SFL1520 was also observed. These 
observations suggest that S. jlexneri infection potentially induces overall systemic 
neuromuscular and mitochondrial defects in infected nematodes. 
The TEM analysis also showed that S. jlexneri cells cross the protective apical , microvilli 
brush border lining and invade the nematode intestinal cells. This observation is highly 
significant, as the ability of S. jlexneri cells to invade human intestinal epithelial cells, is a 
critical step in bacterial pathogenesis. During human infection, S.jlexneri cells exploit the 
transcytotic properties of specialized M cells to gain assess into the sub-epithelial space and 
invade the colonic and rectal epithelial cells via their less-protected basolateral surfaces 
(Section 1.3.1). C. elegans lacks specialized M cells and the results ofTEM analysis in this 
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study suggest that S.jlexneri invades the nematode intestinal cells through the apical side by 
degrading the protective microvilli (Figure 5.4.E). It is also possible that S. jlexneri cells enter 
the intestinal cells through tight junctions between intestinal cells, however no evidence 
supporting this hypothesis was obtained in this study. The ability of S.jlexneri to invade the 
C.elegans intestinal cells makes the use of this animal model a promising alternative to study 
shigellosis. Outside of Macaque monkeys none of the current animal models of shigellosis, 
show bacterial invasion of intestinal cells following oral infection. 
The TEM micrographs also indicate that live S.jlexneri cells within the nematode intestinal 
lumen produce structures that have the appearance of outer membrane vesicles (OMVs) 
(Figure 5.4.A and B). OMV production by gram negative bacteria in response to stress is a 
common phenomenon. Bacterial OMVs contain biologically active pro!~ins, including 
virulence factors and active proteases that can degrade host cells [ 409-411]. S. flexneri OMVs 
contain the invasion protein antigens-Ipa proteins (lpaB, C and D) that are required for 
bacterial adherence, invasion and survival within infected tissues [ 408]. It has been 
previously shown that the production ofOMVs by pathogenic bacteria provides a mechanism 
for the delivery of virulence factors to host tissues [ 412-416]. The identification of apparent 
S.jlexneri OMVs in the C.elegans intestinal lumen therefore suggests a potential mechanism 
for the delivery of S.jlexneri virulence factors to the nematode intestinal cells. However the 
identification of structures that resemble OMVs using EM is very preliminary and need 
further confim1ation by additional experiments such as using immune-EM to identify S. 
jlexneri-specific proteins in the putative OMVs. 
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5.3.2 S. flexneri infection potentially causes osmotic imbalance in nematode intestinal 
cells 
In this study, the cytopathology of several nematodes infected with S. jlexneri indicated that 
there appears to be an imbalance in intestinal osmoregulation in infected wonns at the onset 
of infection (Figure 5.5). Forty one percent of animals observed in this study displayed this 
phenotype. In healthy animals, excess internal fluid is driven out of the intestinal cells into 
the pseudocoelom, following which it is transferred into the excretory cell to be expelled out 
of the animal as urine, thereby relieving the excess [417]. The above phenotype observed in 
41 % of infected animals suggests that the normal excretory mechanism is overwhelmed by a 
high rate of fluid leakage across the luminal villi into the intestinal cell cytoplasm. 
Many animals and plants respond to the need to modify their internal ion balance by 
regulating the trafficking of certain ion transporters, channels, and exchangers. Vesicle 
trafficking and osmoregulation therefore appear to be interwoven. It is possible that virulence 
factors produced by S.jlexneri at the onset of infection could inactivate or down-regulate the 
nematode ion transporters, endocytosis, and intracellular trafficking systems. TEM 
micrographs obtained in this study provide evidence that the intestinal cells of nematodes 
infected with virulent S.jlexneri accumulate yolk granules. Yolk uptake is driven by 
receptor-mediated endocytosis. A group at Columbia University found that defects in the 
yolk receptor; rme-2 (LDL receptor superfarnily), results in accumulation of yolk in the 
intestine [ 418]. Yolk accumulation in S. jlexneri infected worms could be due to defects in 
endocytosis, cell-cell signaling or trafficking. These defects could also account for the fluid 
imbalance seen after 24 hour infection. Further experiments designed to investigate the 
distribution of the RME-2 and ion transporters in the intestinal cells of infected worn1s would 
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shed light on this hypothesis. Another possibility for defective osmoregulation in S.j7exneri 
infected worms could be that the initial innate immune response mounted by the worms in 
response to S. flexneri infection, has downstream effects on osmoregulation. 
During human infection, virulent S. j7exneri invade the lining of the small intestine, damage 
cells, causing tiny sores (ulcerations) that bleed, and allow a considerable leakage of fluid 
containing proteins, electrolytes, and water. The fluid imbalance observed in response to the 
onset of S.j7exneri infection in worms could have some correlation with the watery diarrhoea 
symptom seen in humans. However, since this phenotype was only observed in 41 % of 
animals examined in this study, further experimental validation is needed to confim1 this 
hypothesis. 
5.3.3 S. jlexneri infection in C. elegans causes embryo retention and/or defective egg 
laying 
The cytopathology of infected nematode tissues showed that worms infected with virulent S. 
jlexneri retained well advanced embryos (Figures 5.6 and 5.7). Infected worms appeared to 
be fertilizing eggs and the embryos seemed to develop normally. However, the uterus of 
infected worms was very swollen, with well-developed advanced embryos. Nonna! adult 
wonns lay eggs every 30 s to I minute. Egg laying involves several neurons, working in 
synergy with the muscles of the uterus and vulva. Embryo retention could be due to 
improper neuromuscular functions. UNC-54, UNC-89 and MTD-17, identified as S. flexneri-
induced responses in nematodes in the DIGE analysis (Tables 5.1 and 5.2), are proteins 
required for efficient egg-laying. Previously, Kesika and colleagues reported that worms 
infected with S. flexneri lay fewer eggs (26 ± 6 eggs per worm compared with 27 5 ± 15 eggs 
per wom1 in OP50 controls). They hypothesized that was due to a defect in gametogenesis. 
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TEM images obtained in this study did not provide any evidence of a defect in 
gametogenesis, but showed retention of fertilized , developing eggs, probably due to an egg-
laying defect. Embryo retention could lead to internal hatching, which could be one of the 
factors responsible for nematode death. 
5.3.4 Limitations of TEM analysis 
TEM analysis of nematodes infected with S..flexneri was carried out in collaboration with 
Professor David Hall (Albert Einstein College of Medicine, New York). Nematodes have a 
thick, impermeable external cuticle which makes fixing and staining ofworrns very 
challenging. The microwave-assisted fixing and straining protocol developed by David Hall 
(308] was used in this study. Optimizing the microwave-assisted fixing and staining protoco l 
proved challenging; samples fixed in Australia were sectioned and examined at the Albert 
Einstein College of Medicine, NYC. The time available to me to compl~te the microscopy 
was limited, just one month. It is highly likely that further analysis of infected nematode 
tissue would uncover other phenotypes. 
5.3.5 First study to scan the proteome of S. flexneri infected worms 
DIGE was perfom1ed in this study to identify S.flexneri-induced nematode responses. This is 
the first report to scan the proteome of S. flexneri infected wonus. Although DIGE analysis 
identified 41 potential S. .flexneri-i.nduced proteins in C. elegans, only seven of these proteins 
were successfully identified using MASCOT searches. DIGE analysis showed that AC0-1 , 
CCT-2, DAF-19, EEF-2, HSP-60 and UNC-54 were up-regulated and UNC-41 was down-
regulated in nematodes infected with S..f'-exneri (Table 5.1). qRT-PCRs confinued the 
differential expression of cct-2, daf 19, hsp-60, unc-54-and unc-41 predicted by DIGE 
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analysis . Results of qRT-PCR found no differences in aco-1 levels in infected worms, and the 
expression of eef 2 appeared to be down-regulated at the transcription level. These 
observations suggest that the expression of AC0-1 and EEF-2 is post-transcriptionally 
regulated in S. jlexneri infected wonns . 
On lowering the stringency of the MASCOT search parameters, significant protein hits were 
identified for 39 out of 41 spots. Although these proteins provide some insight into S. 
flexneri-induced responses in nematodes, these results need further experimental verification. 
To verify whether increased expression of the proteins predicted using these parameters was, 
in fact , induced in response to S.jlexneri infection, the expression of hsp-6, the gene coding 
one of the proteins identified using the low stringency search parameters, was investigated 
further in this study. Results of hsp-6 transcriptional reporter gene expe~_iments and qRT-PCR 
were consistent with the DIGE analysis and indicated that HSP-6 expression is up-regulated 
in response to S. jlexneri infection. These observations suggest that those proteins predicted 
using the low stringency MASCOT search parameters could be a true S. jlexneri-induced 
response. 
5.3.6 S. jlexneri disrupts iron homeostasis in the nematode intestinal cells by altering 
AC0-1 levels, potentially inducing a hypoxic response resulting in death 
AC0-1 was shown to be up-regulated in response to S. flexn eri infection. RNAi-rnediated 
silencing of aco-1 led to enhanced resistance to S. jlexneri infection. These results suggest 
that the up-regulation of AC0-1 in response to S. jlexneri infection contributes to nematode 
death. aco-1 encodes cytoplasmic aconitase, an enzyme whose expression is negatively 
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regulated post-translationally by iron levels [ 419]. In C. elegans, aco-1 is expressed in the 
cytosol of cells of the hypodennis and intestine [420]. Its manunalian homologue, iron 
regulatory protein l (IRP-1 ), expressed in the brain and intestinal cells, plays a central role in 
iron homeostasis. The up-regulation of AC0-1 in response to S. jlexneri infection therefore 
suggests that S. jlexneri potentially disrupts iron homeostasis in C. elegans. 
A recent study showed that P. aeruginosa infection disrupts iron homeostasis in C. elegans, 
causing a hif-1-mediated hypoxic response leading to nematode death [421]. Similarly, S. 
jlexneri could potentially kill nematodes by disrupting iron homeostasis, leading to the up-
regulation of AC0-1 and the induction of a hypoxic response . Results of our DIGE analysis 
also identified the nematode MTSS-1 protein as down-regulated in response to S. jlexneri 
infection. MTSS-1 is a mitochondrial single stranded DNA binding protein that is essential 
for mitochondrial DNA replication [422]. RNAi knock down of mtss-1 in worms, results in 
transcriptional alterations leading to the induction of hypoxia responses [ 422]. The up-
regulation of AC0-1 and down-regulation of MTSS-1 in response to S. jlexneri suggests that 
S. jlexneri-disrupts nematode iron homeostasis which potentially induces a hypoxic response 
culminating in death. 
5.3.7 lnnate immune responses triggered by CCT-2 and DAF-19 
RNAi experiments indicated that cc/-2 and daf-19 knock down wonns showed enhanced 
susceptibility to S.jlexneri infection (Figures 8.C, D and 9.A, D and E), suggesting that these 
responses form part of the nematode protective mechanism. CCT-2 has been predicted to 
interact with DAF-16, which fonns part of the nematode DAF-2/DAF-l 6 insulin signaling 
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pathway [423]. A previous study reported that RNAi knock down of the chaperonin cct-2, 
inhibits the nuclear localization of DAF-16 in intestinal cells [ 423], suggesting that CCT-2 is 
required for the nuclear translocation ofDAF-16. DAF-16 is a transcription factor that has 
been associated with the expression of several antimicrobial genes [271] . The increased 
susceptibility of cct-2 RNAi wonus to S. jlexneri infection could therefore be due to the 
decreased expression of antimicrobial peptides as a result of defective nuclear translocation 
of DAF-16. The up-regulation of CCT-2 in response to S. jlexneri coupled with the increased 
susceptibility of cct-2 RN Ai worn1s suggests that S.jlexneri infection activates the DAF-
2/DAF-16 insulin signaling pathway. 
The transcription factor DAF-19 bas recently been shown to play a role in the MAPK 
pathway in C.elegans [424]. DAF-19 mutant wonus display enhanced ~_usceptibility to 
killing by P. aeruginosa [424]. DAF-19 is an ortholog of the regulatory factor X (RFX), a 
transcription factor that is required for human adaptive immunity [425]. The up-regulation of 
DAF-19 in S. jlexneri infected wonus could therefore be part of the nematode innate immune 
response at the early stages of S.jlexneri infection. Furthenuore, TIR-1 was also shown to be 
up-regulated in response to S.jlexneri infection using the low stringency MASCOT searches 
(Table 5.2). TIR-1 is the toll interleukin 1 receptor domain adaptor protein in C.elegans that 
activates the p38 MAPK innate immune response. During human infection, the multiplication 
of S.flexneri cells within infected intestinal cells activates the MAPK-mediated signaling 
pathway, thus leading to the production of inflammatory chemokines and cytokines and 
antimicrobial peptides [65 , 426]. The up-regulation of both DAF-19 and TIR-1 in infected 
worms and the increased susceptibility of daf-19 RNAi worms suggests that the p38 MAPK 
pathway is potentially induced by C.elegans in response to S.flexneri infection . 
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5.3.8 Up-regulation of HSP-60 and HSP-6 in response to S. jlexneri infection, 
indicates the activation of the mitochondrial unfolded protein stress response 
Low stringency MASCOT searches identified HSP-6 as a protein that was up-regulated in 
response to S. jlexneri infection. HSP-6 is a mitochondrial associated chaperone protein 
whose expression is known to be up-regulated in response to the mitochondria-specific 
unfolded protein response (UPRm1)[427]. UPR"11 is activated by the accumulation of 
misfolded mitochondrial proteins [428]. Mitochondrial functionality is essential for cellular 
function , not only as a source of energy but also as a source of reactive oxygen species 
(ROS), thought to be causative agents of aging and disease [ 429]. Mitochondrial dysfunction 
can therefore lead to accelerated aging, oxidative stress and apoptotic cell death; therefore 
maintenance of the balance of mitochondrial folding capacity is of vital importance to the 
health ofan organism [430]. 
It has been previously shown that increase in HSP-6 expression correlates with inhibition of 
mitochondrial respiration [ 431]. The chaperone HSP-60 is another prominent UPR"11 marker. 
The up-regulation of both HSP-6 and HSP-60 in response to S.flexneri infection suggests the 
activation ofUPR1111 and the potential inhibition of mitochondrial respiration in infected 
wonns. Inhibition of respiration would result in lower energy levels which could account for 
a systemic neuromuscular defect in infected worms. 
Previous studies have shown that S.jlexneri infection of mammalian cells induced 
mitochondrial dysfunction, resulting in capsase-mediated necrotic cell death [432-434]. 
These sn1dies suggest that the oxidative stress and innate signaling pathways triggered by 
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intracellular S.jlexneri are tightly linked and these pathways converge at the mitochondria to 
control cell necrosis (432]. I therefore hypothesize that the UPR0 " response detected in S. 
flexneri-infected nematodes provides evidence that, as in mammalian infection, S.jlexneri 
potentially induces mitochondrial dysfunction, which could lead to necrotic cell death. 
5.4 Conclusion 
Unlike humans and non-human primates, the small animal models of shigellosis fail to 
develop intestinal disease upon ingestion of S.flexneri. Here we have shown that virulent 
strains of S. jlexneri are ingested by the nematode, C. elega11s, and that S. jlexneri cells 
invade the nematode intestinal cells. This is the first report to investigate the cytopathology 
and nematode responses to S.flexneri infection. DIGE analysis of the nematode proteome 
induced by S.jlexneri suggests that both the DAF-2/DAF-16 insulin signaling pathway and 
the p38 MAPK pathway are potentially induced in response to bacterial infection. Our 
findings also suggest that S.jlexneri disrupts iron homeostasis in nematodes and potentially 
induces a hypoxic response which could lead to death. The results of this study further our 
understanding of S.jlexneri infection in C. e!egans, opening up a new, convenient, 
economical alternative for screening Shigella mutant strains to identify attenuated strains for 
testing live vaccine strains and for the identification of novel virulence factors. 
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Chapter 6: General Discussion 
Diarrhoeal disease is a major public health concern and Shige/la strains account for 5-1 5% of 
the global burden of diarrhoeal disease [ 435] . Over 50 years ofresearch has led to an 
increased understanding of Shigella pathogenesis, and the identification of numerous Shige/la 
vaccine candidate antigens. However, the search for a commercially viable vaccine is 
ongoing. A thorough understanding of bacterial pathogenesis is paramount for the 
development of an effective vaccine. This thesis aimed to characterize the novel bacterial 
chromosomal virulence factors , AnsB and GGT, and identify bacteriophage-encoded 
virulence factors that contribute to host virulence. The identification of virulence factors 
expressed across multiple serotypes of S.jlexneri would be immensely valuable to the 
development of vaccines that offer heterologous protection against multiple serotypes. 
One of the major limitations of Shige!la vaccine development has been the absence of a 
relevant animal model to study shigellosis. Most of the infom1ation regarding the 
pathogenesis of Shigel/a and identification of vaccine candidate antigens gathered over the 
years, has come from in vitro cell culture studies, the in vivo murine pulmonary model and 
the guinea pig keratoconjunctivitis model of shigellosis. Although these models have been 
used extensively to uncover a wealth of information, their major limitation lies in the fact that 
both animal models lack clinical relevance in terms of the site of infection and the symptoms 
produced. To this end, this thesis aimed to assess the suitability of using the nematode C. 
elegans as a novel small animal model of shigellosis. 
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6.1 AnsB and GGT novel Shigella virulence factors 
To further our understanding of S. flexneri pathogenesis the role of L-asparaginase (AnsB) 
and y-glutamyltranspeptidase (GGT), in bacterial pathogenesis was studied. These proteins 
were selected as both proteins are imrnunogenic in S.flexneri and have not been previously 
characterized in S.flexneri. The results of this thesis indicate that ansB and ggt mutations 
decrease the virulence of S. flexneri as indicated in in vitro and in vivo virulence studies. The 
results of in vitro cell culture assays show that ansB and ggt mutations decrease bacterial 
adherence to host cells. This is the first study to identify AnsB and GGT as potential 
virulence factor of S.flexneri. Taking all the data obtained from the virulence studies and 
DIGE analysis into account, the following models have been proposed to explain the role of 
AnsB and GGT in the virulence of S.flexneri. 
6.1.1 AnsB up-regulates OmpA expression 
The results of DIGE analysis and qRT-PCR (Figures 3.10 and 3.12.A), showed the up-
regulation ofOmpA in ansB mutant cells. These observations suggest that the expression of 
OmpA is negatively regulated by AnsB in S. flexneri. The expression of OmpA has been 
known to be environmentally responsive [332]. One of the environmental factors that 
regulate the expression ofOmpA is the availability of nitrogen [436]. In E.coli, OmpA levels 
are elevated in response to nitrogen shortage [436] , to facilitate an increased uptake of 
peptides to alleviate the nitrogen shortage. One of the identified functions of AnsB is to 
provide nitrogen and carbon sources from the hydrolysis of exogenous asparagine [437] 
(Figure 6.1.A). Nitrogen depletion increases the expression of ansB in yeast [438 , 439] , 
further suggesting that AnsB plays a ro le in nitrogen metabolism. ansB mutant cells would 
thus have lower nitrogen levels compared with wild type cells; therefore I propose that the 
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expression ofOmpA in these mutant cells may be increased to alleviate this nitrogen 
shortage (Figure 6.1.C). 
The structure of bacterial cell envelopes is strictly regulated, and appropriate levels of 
envelope proteins are constantly monitored and controlled. Under normal circumstances, 
OmpA levels in cells are negatively regulated by the sRNA MicA, induced as part of the cl-
mediated envelope stress response (Figure 6.1.B). Extracytoplasmic stress such as the 
overproduction of outer membrane proteins, are known to activate crE expression, through a 
proteolytic signal transduction cascade, which ultimately leads to the cytoplasmic release of 
crE [ 440]. The transcription of micA is increased in response to cytoplasmic crE [ 441]. micA 
along with the RNA chaperone Hfq, then base pairs with and destabilizes ompA transcripts 
[ 442] (Figure 6.1.B). 
A study by Wagner and colleagues [ 443] , reported that the overexpression of membrane 
proteins in E.coli reduced cell viability. This was primarily as a result of the overexpressed 
proteins saturating the membrane trans location machinery, particularly the Sec translocon 
thereby limiting the capacity this translocon. This group reported that saturation of the Sec 
translocon by the overexpressed membrane protein had a severe impact on the cell envelope 
and cytoplasmic proteomes [443]. In E.coli, pro-OmpA molecules synthesized in the cell 
cytoplasm are translocated into the periplasmic space through the Sec translocon [444]. As 
proposed by Wagner et al [ 443], the up-regulation of OmpA in !:iansB cell could limit the 
capacity of the Sec translocon, as a result of which the proteolytic signal transduction 
machinery of the envelope stress response could be compromised in !:iansB cells (Figure 
6.!C). lfthis is the case, the crE-mediated stress response is not activated, which leads to the 
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Figure 6.1: Proposed model for how AnsB regulates the adherence of S. jlexneri. A: 
Hydrolysis of asparagine by periplasmic AnsB in wild type cells produces aspartate and 
ammonia (NH3), which then promotes cellular nitrogen metabolism. B: Sigma E (crE)-
mediated activation of micA, negatively regulates ompA levels in wi ld type cells by 
interacting with the RNA chaperone, Hfq. C: l'!.ansB cells fail to produce L-asparaginases 
(AnsB), which would lead to decreased nitrogen metabolism and therefore decreased 
intracellular nitrogen levels . Low cellular nitrogen levels activate the nitrogen stress response 
which results in the overexpression of outer membrane protein A (OmpA) to increase peptide 
uptake. Overexpression of OmpA, could saturate the Sec translocon and limit its capacity, 
which would compromise the signal transduction machinery involved in activating the crE-
mediated envelope stress response. Decreased activation of crE would mean decreased 
transcription of micA and thus cellular regulation of OmpA is inhibited. The uncontrolled 
overexpression ofOrnpA would disrupt the integrity of the cell envelope as a result of which, 
l'!.asnB strains show decreased bacterial adherence to host tissues. 
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unregulated expression of OmpA (Figure 6.1.C). This hypothesis is supported by the fact that 
we did not detect markers for envelope stress, such as the Skp or DegP chaperones, in the 
proteome of ansB mutant cells. 
6.1.2 GGT modulates extracellular glutathione levels and therefore maintains the 
redox potential of the extracellular and periplasmic compartments 
GGT in E. coli is involved in glutathione (GSH) metabolism, as it hydrolyses the transfer of 
the y-glutamyl group from GSH to amino acids and peptides (316]. GSH is one of the most 
abundant nonprotein, thiols present in proteobacteria [ 445-447]. This molecule, plays a 
critical role in protecting cells against environmental stresses such as acidity, oxidative 
stresses and osmotic shock by maintaining the proper oxidation state of proteins [ 448]. GSH 
exists in either a reduced (GSH) or an oxidized (glutathione disulfide, GSSG) form, and 
participates in redox reactions through the reversible oxidation of its active thiol [ 449]. 
Maintenance and adjustment of the ratio of [GSH] to [GSSG], allows individual subcellular 
compartments to have different, appropriate redox balances. Pittman and colleagues have 
reported that GSH plays a key role in maintaining periplasmic redox homeostasis in E. coli 
[ 450]. 
They-linkage ofGSH maintains its stability and GGT is the only enzyme known to degrade 
GSH in both prokaryotic and eukaryotic organisms. Mammalian GGTs have been extensively 
studied (316, 451], however not much is known about bacterial GGT. In E. coli, GGT is 
involved in maintaining exogenous GSH levels and ggt mutants have been previously 
reported to accumulate GSH in culture media [452]. Since S.jlexneri is a close relative of E. 
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coli, it is likely, that GGT modulates exogenous GSH levels in S.flexneri as well. If this were 
the case, Llggt cells would have elevated extracellular GSH. Suzuki and colleagues have 
previously identified a GSH importer in E. coli, YliABCD, that transports extracellular GSH 
into the bacterial periplasmic space [453]. They also indicate that although ggt mutants in E. 
coli have elevated extracellular GSH levels, the concentration of extracellular GSH decreases 
gradually over prolonged incubation, which suggests, that extracellular GSH is imported into 
cells where it is broken down, to provide cysteine and glycine sources [454] (Figure 6.2). 
Previous studies in£. coli and S. typhimurium have also reported that cytoplasmic GSH is 
transported into the periplasmic space where it is hydrolyzed by GGT to liberate glutamic 
acid and cystenylglycine [452 ,455] (Figure 6.2). Pittman and colleagues have identified a 
GSH transporter in E. coli that facilitates the transport of this molecule from the cytoplasm 
into the periplasmic space [450]. 
S.flexneri carry homologues of the ABC transporter, YilABCD, annotated as GsiABCD. 
Therefore it is likely that S. flexneri cells, like E. coli import extracellular GSH into their 
periplasmic space. Accumulation of extracellular GSH and its translocation into the 
periplasmic space of t<.ggt cells would create a reducing environment in the periplasmic 
compartment of these cells. The periplasmic space of bacterial cells is normally an oxidative 
compartment, that provides conditions favorable to the formation of protein disulfide bonds, 
to achieve proper tertiary structures [ 449]. 
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Figure 6.2: Proposed model for how GGT regulates the adherence of S. flexneri. GGT 
encodes y-glutamyltranspeptidase, an enzyme required for the hydrolysis of extracellular 
glutathione (GSH). In wild type cells GSH is transported into the periplasmic space through 
ABC transpo11ers, where it is hydrolyzed by GGT to produce y-glutamyl-amino acids and 
cysteinylglycine. Cysteinylglycine enters the cytosol where it is broken down into cysteine 
and glycine. t,,ggt cells fail to express GGT, as a result of which there is a buildup of 
extracellular GSH. GSH is a small molecule capable of entering the bacterial periplasmic 
space through the ABC transporter, GsiABCD (orange). The accumulation ofGSH in the 
periplasmic space would alter the redox potential of this space and create a reducing 
environment, which is not conducive to protein folding and assembly, therefore leading to the 
accumulation of mis-folded proteins, which in turn would trigger the <l-mediated stress 
response. yaeT, dnaK, tig andflsz are members of the <l-regulon, identified as up-regulated 
in t,,ggt cells. Activation of the <l -regulon also activates 1poN, which is a known inhibitor of 
gadB expression. The up-regulation of yaeT, dnaK, tig, flsz and down-regulation of gadB in 
t,,ggt, identified in this study, therefore suggest the activation of the cl -mediated stress 
response in these cells, which suggests the accumulation of mis-folded proteins in these cells 
most likely due to GSH accumulation. 
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I hypothesize that GSH accumulation and ttanslocation into the periplasmic compartments of 
f'..ggt cells, creates a reducing environment in this compartment that is not conducive to the 
proper folding and assembly ofperiplasmic proteins. Defective folding and assembly of 
periplasmic proteins would have a direct consequence on the assembly of outer membrane 
proteins, including adhesions. Defective assembly of surface molecule in ggt mutant cells 
could therefore explain the decreased adherence of these mutant cells (Figure 6.2). 
DIGE analysis indicated that the ggt mutation exert pleiotropic effects on the expression of 
several other S. jlexneri proteins (Figure 3.11 and Table 3.2) including proteins involved in 
translation (RpsA), cell division (FtsZ) , acid resistance (GadB), carbohydrate metabolism 
(PpsA), protein folding and transport (DnaK and Tig), and an outer membrane protein 
(YaeT). qRT-PCR analysis identified yaeT, dnaK, fig andfisz as up-regulated in f'..ggt cells 
(Figure 3.12.B), these genes have previously been identified as members of the crE regulon, 
and their expression is known to be up-regulated on crE activation [440, 456]. Both DIGE 
analysis and qRT-PCR data indicate a significant decrease in GadB levels in f'..ggt cells 
(Figures 3.11 and 3.12.C). GadB is part of the well characterized glutamate-dependent acid 
resistance (GDAR) pathway used by E.coli [457] and S.jlexneri [458]. A recent study 
identified RpoN as a negative regulator of the GDAR pathway [ 459] , which suggests, that the 
down-regulation of gadB could be due to the activation ofRpoN. 1poN is another member of 
the crE regulon whose expression is up-regulated up on crE activation [ 440]. The increased 
expression of yaeT, dnaK, fig andfisz and down-regulation of gadB transcripts in f'..ggl cells, 
therefore suggests the activation of a crE-mediated envelop stress response in ggt mutant cells 
(Figure 6.2). 
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crE activity is specifically activated by events or mutations that lead to envelope stress caused 
by the accumulation of unfolded or mis-folded proteins [ 460]. Activation of crE, up-regulates 
the transcription of a set of genes that form part of the crE regulon [ 46 I, 462]. Rl10dius and 
colleagues have previously reported that the crE regulon in bacterial cells is composed of 89 
predicted transcriptional units with a core set of genes conserved in most organisms [440] . 
These core genes coordinate the assembly and maintenance of bacterial LPS and outer 
membrane proteins in response to the accumulation of mis-folded proteins. yaeT andjisZ 
were identified as members of the core regulon. The up-regulation of yaeT and jisZ 
transcripts in t<.ggt cells, therefore suggests the activation of this pathway in response to the 
accumulation of improperly folded proteins in the periplasmic space. 
DIGE and qRT-PCR data indicate that the expression of tig and dnaK was up-regulated in ggt 
mutant cells. Previous studies in £. coli have indicated that Tig interacts with DnaK to 
facilitate protein folding [463 , 464]. The up-regulation ofDnaK and Tig in t<.ggl cells 
provides further evidence suggesting the accumulation of mis-folded proteins in these 
mutants. 
6.1.3 Future work 
> The results of this thesis led to the hypothesis that the periplasmic enzyme, AnsB, of S. 
jlexneri modulates bacterial adherence to host epithelial cells by regulating the expression 
of OmpA through the regulation of nitrogen metabolism. In order to determine whether 
low nitrogen levels do in fact increase the expression ofOmpA in S.jlexneri cells , wild 
type S. jlexneri cells can be grown under low nitrogen conditions and the corresponding 
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ompA transcript and protein levels can be measured using qRT-PCR and western blotting, 
respectively. 
>" Transmission electron microscopy and immunohistochemistry using anti-OmpA 
antibodies can be used to compare the integrity of cell envelopes and the distribution of 
OmpA in wild type and !'iansB cells. The LIVE/DEAD BacLight kit (Molecular Probes, 
lnvitrogen) which is used to differentiate between bacterial cells with intact and damaged 
membranes can be used to compare the membrane integrity of wild type and !'iansB cells. 
This kit has a mixture of the red- and green-fluorescent nucleic acid stains dyes 
propidium iodide (PI) and SYT09, respectively. SYT09 can penetrate all cells while Pl 
only enters bacterial cells with altered membrane pem1eability. Therefore when the two 
dyes are used in combination, the presence of bacteria presenting defects in membrane 
integrity causes a reduction in the green fluorescence emission [ 465}, 
>" Extracellular glutathione levels can be measured with glutathione reductase as described 
by Fahey et al [466]. To detect the accumulation of mis-folded proteins in ggt mutant 
cells protein aggregates from wild type and ggt mutant cells could be isolated and 
compared using SOS PAGE as described by Tomoyasu et al [467]. These experiments 
would shed light on the hypothesis GGT regulates the virulence of S.jlexneri by 
modulating glutathione levels which in tum maintains the redox potential of cellular 
compartments required for proper protein folding. 
>" This study identified AnsB and GGT as novel virulence factors of S. jlexneri making 
them significant candidates for the attenuation of live vaccines. Genes encoding AnsB 
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and GGT are present in all S. flexneri strains and therefore offer great promise for live 
vaccine strategies that provide heterologous protection against multiple serotypes. ansB 
and ggt can also be targeted as secondary mutations in existing Jive attenuated Shige!la 
vaccines to achieve the desirable balance between reactogenicity and immunogenicity. 
ansB and ggt mutant strains generated in this study can be tested as live vaccine 
candidates in the murine pulmonary model of shigellosis, where mice treated with sub-
lethal doses of both mutant strains cans be challenged by heterologous serotypes of wild 
type S. jlexneri strains to detem1ine if these vaccine candidates offer heterologous 
protection against multiple serotypes. It would also be interesting to generate ansB and 
ggt double mutant and test this strain as a potential live vaccine candidate. 
6.2 Bacteriophage-encoded genes in host pathogenesis 
The complete genome sequence of bacteriophage Sill was determined as one of the aims of 
this study. This was done to broaden our understanding of S.jlexneri phage biology as not 
much is known about temperate bacteriopbages of S. jlexneri ontside their role in serotype 
conversion. Sequence analysis showed that Sill contains features of lambdoid pbages and 
shares a high degree of sequence similarity with S. flexneri serotype converting phages, Sfl, 
Sill, SflV and SN. Interestingly, although these S.jlexneri phages show a high degree of 
sequence conservation, their host ranges vary significantly. Analysis oftbe Sill genome 
sequence identified seven uncharacterized genes unique to Sill. 
In vitro and in vivo virnlence studies showed that lysogenization of a S. jlexneri serotype Y 
strain with bacteriophage SN, increased the virnlence oftbe host strain. These results 
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suggest that the temperate bacteriophage, SN, encodes virulence factors. This finding was 
not surprising as several bacteriophage-encoded virulence factors have been identified in a 
range of bacterial hosts (Table 1.4). However, outside of the 0-antigen modifying gene 
cluster, no S.jlexneri phage-encoded virulence factors have been identified thus far. To 
identify potential SN-encoded virulence factors outside of the 0-antigen modifying genes, 
RT-PCR was used to detem1ine if 15 uncharacterized SN genes were expressed in the 
lysogenized host. 
RT-PCR analysis identified SN orf28, orf29, 01f30, orf31, orf32, or/36, 01f38, 01f41 , 01f42, 
01f44, 01f45, 01f47 and 01f48 as expressed within the lysogen. This observation suggests that 
the expression of these genes may be advantageous to the host. Several attempts were made 
to !mock out all 13 genes individually and as clusters, however only the SN orf28-32 five 
gene cassette could be successfully knocked out within the scope of this project. To 
determine whether genes within the SN orf28-32 cassette encode proteins that play a role in 
the pathogenesis of S.flexneri, a SN orf28-32 knockout mutant strain, SFL2500, was 
constructed. Interestingly the results of in vitro cell culture assays suggest that the deletion of 
this five gene cassette from the lysogen increased the adherence of the lysogen however 
SFL2500 was less invasive than its parent. These observations suggest that genes within this 
five gene cassette potentially contribute to different aspects of S. flexneri pathogenesis. With 
one or several genes acting as potential regulators of host gene expression (with orf28 being 
the leading contender based on conserved domain searches, as discussed Section 4.3.2.4. I) 
and other genes encoding proteins that enhance the invasive capacity of the host strain (with 
01f30 encoding a potential virulence factor, as discussed in Section 4.3.2.4.3). In vivo 
virulence studies in C. elegans, suggest that on knocking out the orf28-32 cassette, the SN 
lysogen shows reduced accumulation in the nematode intestinal lumen which suggest that one 
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or several of these genes encode virulence factors . However, mutati11g these genes had no 
effect on nematode killing which suggest that proteins encoded by the orf28-32 cassette may 
be required at the onset of infection however these proteins are not required for prolonged 
infection. Future studies should determine bacterial accumulation over extended time periods 
to determine if the decreased accumulation observed in this study is in fact only seen at the 
onset of infection. 
The results of virulence studies obtained with the OJ:/28-32 mutant open up several 
possibilities and a clear picture of the exact roles played by 01:/28-32 in the pathogenesis of S. 
jlexneri remains elusive. These results do however suggest that bacteriophage genes outside 
of the 0-antigen modifying genes may play a role in the pathogenesis of S.jlexneri strains. 
6.2.1 Future work 
~ Sequence analys is identified Sill orf35, orf36, OJf40, OJf41 , OJf49, 01f50 and OJf57, 
encoding hypothetical proteins to be unique to SID. These genes are potential candidates 
for virulence studies. RT-PCR anal ysis to identi fy which of these genes is expressed in a 
Stu lysogen would help narrow down this list and identify potential Sill genes that 
encode protein that benefit the bacterial host. 
~ Further virulence studies using individual knockout mutants of orfs28, 29, 30, 31 and 32 
will help us pin down the phage genes directly responsible for the phenotypes observed in 
this study. Alternatively, the o,j28-32 mutant strain can be complemented with each 
individual gene to identify which of the five genes increases bacterial adherence and 
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decreases invasion. orf28, orf29, orf30, orf31 and 01/32 also present in SflV and therefore 
individual knockout mutants of these genes in the SN lysogen could be complemented 
with genes isolated from SflV. orf28, 01j29, and 01j30 are also present in S. jlexneri 
phage Sfll and homologues of these genes are also present in the S.jlexneri serotype 2a 
genome (AE0056741), therefore it will be interesting to see if knocking out 01j28, 01j29 
or 01/30 in this S. flexneri 2a strain affects its virulence. 
>" Knockout mutants should be constructed for the remaining eight genes identified to be 
expressed within the lysogen, 01j36, 01j38, 01/41 , 01/42, 01/45, 01/47 and 01/48 to 
detem1ine if any of these genes contribute to the virulence or fitness of the host strain. 
>" To detem1ine why the SN iorf28-32 mutant showed increased adherence a 2-D 
proteomic screen can be used to compare the proteomes of the mutant and lysogen. 
6.3 C. elega11S as a model for shigellosis 
The results obtained from examining the cytopathology of nematodes infected with a virulent 
strain of S. jlexneri and scanning the proteome of S. jlexneri-infected worms suggest that 
several parallels exist between S. jlexneri infection in humans and nematodes. These results 
are highly significant, as they validate the use of C. e/egans as a relevant small-intestinal 
animal model of shigellosis. Some of the similarities between S. jlexneri infection in humans 
and C. elegans have been elucidated below; 
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6.3.1 Nematodes ingest S. jlexneri and bacterial cells invade the intestinal epithelial 
cells 
During human infection, S. jlexneri cells ingested via the fecal-oral route, traverse the 
gastrointestinal tract and invade the intestinal epithelial cells. Simi larly, the cytopathology of 
infected nematode tissue indicates that S. jlexneri is ingested by the nematodes, bacterial cells 
accumulate in the intestinal lumen (Figure 5.2), following which they invade the intestinal 
epithelial cells (Figure 5.3) . TEM micrographs obtained in this study suggest that S.jlexneri 
invades the nematode intestinal cells through their apical surfaces by putatively degrading the 
apical brush border (Figure 5.4). It is also possible that S. jlexneri cells gain access to the 
epithelial cells through the tight junctions between the nematode epithelial cells, and that 
bacterial cells induce their uptake by the epithelial cell by delivering T3SS effectors that 
trigger epithelial membrane ruffling and induce the formation of mactropinocytes as seen in 
human epithelial cell invasion [468]. However, no evidence to support this hypothesis was 
obtained in this study. Further TEM analysis of dead or dying wonns may enable us to 
capture the precise invasion mechanism. 
6.3.2 S. jlexneri virulence factors required for infection of mammalian tissue are also 
required for virulence in C. elegans 
Results of virulence assays perfonned in this study and a previous study by Burton and 
collegnes [283] , show that the expression of the S.jlexneri virulence plasmid genes is 
essential for bacterial accumulation and killing of C. elegans. Bacterial strains devoid of the 
virulence plasmid are digested by the nematodes in a manner similar to E. coli OP50. 
Furthermore, potential S. jlexneri virulence factors identified using in vitro cell culture assays 
and the murine puhnonary model of shigellosis in this study (AnsB, GGT and SN Orfs28-
32) were also found to be required for virulence in C. elegans. These results suggest that the 
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S. jlexneri virulence factors required for mammalian infection are also essential for infection 
in C. elegans, thereby validating the use of C. elegans as an appropriate in vivo model to 
identify novel S. jlexneri virulence factors. 
6.3.3 S. flexneri infection induces the MAPK signaling pathway in mammalian cells 
and C. elegans 
A proteomic screen of nematodes infected with S. jlexneri identified DAF-19 as up-regulated 
in response to S. jlexneri infection (Figure 5.9). RNAi experiments suggest that the S. 
jlexneri-induced up-regulation ofDAF-19 forms part of the nematode protective response 
mechanism against S.jlexneri infection (Figure 5. 11.D and 5. 12), as knocking down DAF-1 9 
increased the susceptibility of nematodes to S. jlexneri infection. DAF- 19 has recently been 
identified as a key regulator of the p38 MAPK cascade, which implies that the p38 MAPK 
signaling cascade is a potential innate response mounted by nematodes to S. jlexneri. 
Furthermore, TIR-1 was also identified to be up-regulated in response to S.jlexneri infection. 
TIR-1 is the toll interleukin I receptor domain adaptor protein in C.elegans, which activates 
the p38 MAPK innate immune response. These findings suggest that nematodes trigger the 
p38 MAPK pathway to control S.jlexneri infection . Previous studies have reported that S. 
jlexneri infection in mammals also triggers the p38 MAPK pathway [469, 470] and that this 
signaling cascade is induced by bacterial LPS. Our identification of elements of the p38 
MAPK cascade up-regulated in C. elegans at the onset of infection, suggests that the innate 
responses to S.jlexneri infection are similar in mammals and nematodes. 
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6.3.4 S. jlexneri causes mitochondrial dysfunction in humans and nematodes, which 
potentially leads to necrotic cell death 
DIGE analysis identified the nematode HSP-6 and HSP-60 proteins as S.flexneri-induced 
responses in wonns. Both these proteins are well characterized markers of the mitochondrial 
unfolded protein response. These results imply that S. flexneri infection triggers 
mitochondrial stress responses in nematodes. As a consequence of mitochondrial dysfunction 
infected cells would have reduced energy levels this in turn could result in reduced 
pharyngeal pumping and egg laying phenotypes seen in nematode infected with virulent 
strains of S.flexneri. Similarly, S.flexneri infection in mammalian cells has also been 
associated with mitochondrial dysfunction [432]. Mitochondria dysfunction in infected 
epithelial cells has been proposed to cause necrotic cell death through the increased 
production of reactive oxygen species [432]. A similar mechanism leading to necrotic cell 
death could occur in infected nematode intestinal cells as suggested by the up-regulation of 
HSP-6 and HSP-60. 
6.3.5 S.jlexneri infection triggers an inflammatory response in humans and 
nematodes that causes tissue damage and osmotic imbalance 
Previous studies in mammalian systems have shown that S. flexneri-encoded virulence 
factors, such as sigA, shell and she/2, cause fluid accumulation in infected tissues [95 , 98, 
471]. Therefore it is possible that the apparent osmoregulatory defect observed in 41 % of 
nematodes infected with S. flexneri for 24 hours (Figure 5.5), could be induced by bacterial 
virulence factors produced at the onset of infection. It is also possible that the initial 
nematode innate immune responses to S.flexneri infection could lead to defective 
osrnoregulation. 
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A previous study reported that the hyperactivity of DAF-16-mediated immunity in nematodes 
is associated with increased expression of cellular water channels, which in turn disrupts 
cellular water homeostasis and increases nematode susceptibility to pathogens [ 4 72]. DAF-16 
is closely related to the mammalian transcription factor FOX03a, which has been linked to 
inflammation in response to infection [473,474]. The up-regulation ofCCT-2 in response to 
S.jlexneri infection and the increased susceptibility of cct-2 RNAi worms suggests that the 
DAF-2/DAF-l 6 insulin signaling pathway is induced in response to infection (Figure 5.11.C 
and 5.12). These results suggest that S. jlexneri infection potentially induces an inflammatory 
response in nematodes and the fluid imbalance observed in response to the onset of S. jlexneri 
infection in worn1s could correlate with the watery diarrhoea symptom seen in humans. 
However, since this phenotype was only observed in 41 % of animals examined in this study, 
further experimental validation is needed to confirm this hypothesis. 
6.3.6 Future work 
This is a preliminary study which opens up a number of avenues that required further study to 
explore the molecular details of S.jlexneri infection in C. e/egans. Here I highlight some of 
these expreiments. 
» The results oftbe cytopathology of S.jlexneri-infected wom1s and DIGE analysis to 
identify S.jlexneri-induced nematode responses open up several possibilities of S. 
jlexneri pathogenesis in nematodes. In order to get a clearly picture of the infection 
process it would be a good idea to examine the cytopathology of dead and dying worms at 
later time points. 
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~ The results of our virulence studies clearly suggest that the S. jlexneri virulence plasmid 
is required for virulence in C. elegans. It will be interesting to identify the specific 
factors-encoded by the bacterial virulence plasmid that are required for virulence in C. 
elegans. As a preliminary step, S.jlexneri ipa and mxi-spa mutants can be tested for 
virulence in C.elegans, to determine iftbe effector proteins encoded by these loci , known 
to be essential for mamnialian infection are also critical for S. jlexneri infection of wonns. 
Following this a library of virulence plasmid mutant strains can be generated and the 
effect of each mutation on C. elegans infection can be detennined to identify the specific 
S.jlexneri effector molecules required for virulence in nematodes. 
~ The results of this thesis suggest that S. jlexneri infection potentially .activated the MAPK 
pathway in wom1s. In order to confirm this hypothesis prominent members of this 
signaling pathway such as TIR-1 , NSY-1 , SEK-I and PMK-1 should be knocked down 
(using RNAi) or knocked out following which the effect oftbese mutations on nematode 
resistance to S. jlexneri infection should be assessed. 
~ Our findings afso suggest that S.jlexneri activates the DAF-2-DAF-16 insulin signaling 
pathway. Reverse genetic studies involving the disruption of key members oftbis 
pathway such as DAF-2 , DAF-16, AGE-I and PDK-1 (Figure 1.6) and assessing their 
effect on S.jlexneri infection would help confin11 that this pathway is activated in 
response to S. jlexneri infection. 
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:.,. The results of this thesis also led to the hypothesis that S. jlexneri utilizes host iron for 
infection which in turn disrupts iron homeostasis in infected tissues. To deten11ine if iron 
molecules serve an important role in S.jlexneri infection of C. e!egans, killing assays 
using iron-chelating agents such as ciclopirox olamine (CPX) can be set up as described 
by Kirienko et al [421). 
>- Using RNAi technology the expression of aco-1 was knocked down in this study and 
knocking down the expression of this gene increased nematode resistance to S.jlexneri 
infection. In order to confirm whether the up-regulation of AC0-1 in response to S. 
jlexneri infection results in nematode death, the effect of overexpressing AC0-1 on 
nematode survival can be assessed. The expression of genes induced as part of the 
hypoxic response in S. jlexneri infected worms such as the hypoxia-inducing factor, hif-1 , 
can be measured using qRT-PCR to confinn this hypothesis. 
>- The proteomic approach used in this study to identify S. jlexneri-induced nematode 
responses only identified 7 differentially expressed nematode proteins. One of the major 
limitations of this approach is that a large amount of starting material is required for the 
successful identification of protein spots. Furthermore, proteins with extreme pls or 
molecular weights, hydrophobic proteins and low-abundance proteins are poorly 
represented on 2-D gels. To set up the DIGE experirnent in this study, 2mg of total 
protein was isolated from - 500 000 synchronized young adult worms per experimental 
repeat. These experiments were highly time consuming and labor intensive therefore 
proteins were isolated from only one time point of infection (24 h). Further high-
throughput approaches such as whole genome transcription profiling (Microarrays) and 
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whole genome shotgun sequencing (RNAseq) [475] can be employed to observe S. 
jlexneri-induced alterations in nematode cellular pathways in time-course experiments 
[239]. The results of such studies will present a clear picture of the specific pathways that 
are activated in response to S. flexneri infection over the course of infection. 
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Appendix A 
Buffers, solutions and media 
Bacterial culture 
LB Broth 
1.0 % w/v tryptone 
0.5 % w/v yeast extract 
0.5% w/v NaCl 
-Adjust pH to 7.0. Autoclave 
LB Broth Agar 
1.5 % Bacto-agar to LB broth 
-Adjust pH to 7.0. Autoclave 
Minimal essential salts media 
20% 5 X M9 salts stock solution 
0.1% IM MgS04 
0.01 % 1 M CaCl2 
0.4 % w/v glucose 
-Adjust pH to 7.0. Autoclave 
5 X M9Salts 
In 1 L 
64 g Na2HP04)H20 
15 gK2HP04 
2.5 g NaCl 
5 gN~CI 
-Adjust pH to 7.0. Autoclave 
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SOB Medium 
2.0 % w/v tryptone 
0.5 % w/v yeast extract 
0.5% w/w NaCl 
10 mMMgC'2 
IOmMMgS04 
-Adjust pH to 7.0. Autoclave 
SOC Medium 
20 mM glucose added to a final concentration to autoclaved SOB medium 
Congo red TSB agar plates 
3 % w/v tryptic soy broth 
0.15 % 4 M NaOH 
1.5 % w/v agar 
- Autoclave and add 1 % filter sterilized I % w/v Congo red solution 
Ampicillin 
I 00 mg/mL stock 
-1 g of ampicillin powder added to IO mL Milli-Q water. Filter sterilize. 
-Store aliquots at -20°C 
Chloramphenicol 
25 mg/mL stock 
-250 mg of chloramphinicol powder added to 10 mL ethanol. 
-Protect from light 
-Store at -20°C 
30 mg/mL stock 
-300 mg of chloramphinicol powder added to 10 mL ethanol. 
-Protect from light 
-Store at -20°C 
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Kanamycin 
50 mg/mL stock 
-500 mg of ampicillin powder added to JO mL Milli-Q water. Filter sterilize. 
-Store aliquots at -20°C 
Plasmid Miniprep 
Solution I 
50 mM glucose 
25 mM tris.Cl (pH 8 0) 
10 mM EDTA (pH 8.0) 
-Autoclave, Store at 4°C 
Solution II 
0.2 MNaOH 
1.0 % w/v SDS 
- Make fresh 
Solution Ill 
3 MCH3COOK 
2 M glacial acetic acid 
-Autoclave, store at 4°C. 
Agarose Gel electrophoresis 
O.SX TBE 
45 mM Tris. HCI 
45 mM boric acid 
l mMNa2EDTA 
Blue loading Dye 
1 mg/mL bromophenol blue 
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20 % (v/v) glycerol 
1D SDS-P AGE gels 
2 X Loading buffer 
100 mM Tris.RC! (pH 6.8) 
4 % w/v SDS 
20 % Glycerol 
2.5 % ~-mercaptoethanol 
0.2% bromophenol blue 
-Store at -20°C 
JO X Running buffer 
1.92 M glycine 
0.24 M Tris base 
0.1 % w/v SDS 
Coomassie Brilliant Blue Stain 
0.5 % (w/v) Coomassie blue G250 
50 % methanol 
10 % acetic acid 
Destain Solution 
l O % acetic acid 
40 % methanol 
JOxPBS 
8 % w/vNaCl 
0.2 % w/vKCl 
1.44 % w/v Na2HP04 
0.24 % w/v KH2P04 
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- pH to 7.4, autoclave 
2D SOS-PAGE 
Solubilisation buffer 
7 M urea, 
4% (w/v) CHAPS, 
I% (w/v) DTT, 
I% (v/v) Ampholytes, 
35 mM tris base 
Cell wash solution 
IO mM Tris pH 8.0 
5 mM magnesium acetate 
Cell lysis buffer 
7 M Urea 
2 M Thiourea 
30mM Tris-base 
4% (w/v) CHAPS 
Complete protease inhibitor (Roche) 
Rehydration solution 
8 M urea 
0.5% (w/v) CHAPS 
0.2% (w/v) DTT 
0.52% (w/v) bio-ampholytes 
0.6% (w/v) bromophenol blue 
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Bacteriophage methods 
NZCYM Medium 
0.1 % w/v casamino acids 
0.066% w/v MgS04 7H20 
0.167% w/v Yeast extract 
0.167% w/v NaCl 
0.5% soft agar 
I% w/v Tryptone 
0.5% w/v Yeast extract 
0.5% w/v NaCl 
0.5% w/v agar 
SM Buffer 
lOOmM NaCI 
25 mM Tris-HCL pH 7.5 
8 mMMgS04 
0.002% (w/v) gelatin 
Gelatin-free SM buffer 
100 mMNaCl 
25 mM Tris-HCL pH 7.5 
8 mM MgS04 
TE Buffer 
IO mM Tris.RC!, pH 7 .5 
I mM EDT A, pH 8 0 
C. elegans methods 
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Modified nematode growth media (NGM) 
50 mMNaCl 
0.35% (w/v) peptone 
2% (w/v) agar 
-Autoclave, cool to 55 °C 
l mMCaC!i 
I mMMgS0 4 
5 µ/mL cholesterol 
25 mM Potassium phosphate 
S-basal 
0.1 MNaCl 
0.05 M potassium phosphate pH 6.0 
1 mL cholesterol (5 mg/mL in ethanol) 
1 M potassium phosphate pH 6.0 
0.132 M K2HP04 
0.868 M KH2P04 
Alkaline hypochlorite solution 
4 M NaOH- 200 µL 
Bleach (low strength White King)- 300 µL 
Fixing solution 1 
25 mMNaCl 
I mM CaCl2 
3.5% (v/v) glutaraldehyde 
1.5% (v/v) paraformaldehyde 
0.12 M cacodylate buffer pH 7.2 
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Fixing solution 2 
2% (w/v) Os04 
0.5% (w/v) KFe(CN)G 
I mM CaC!i 
0.15 M cacodylate buffer pH 7.2 
Wash solution 
25 mM NaCl 
I mM CaCl2 
0.15 M cacodylate buffer pH 7 .2 
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